Citrus Sinensis ID: 034502

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90--
Protein Sequence
MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccEEEEEcccccHHHHccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHcccccccc
Secondary Structure Prediction (SSPRO)
cccEEccccccEEcccccccEccEEEEEEccHccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccc
Coil and Loop (DISEMBL)
mnpkisdfglarafggdeiegntnrvigtygymapeyasdgkfsvksdvFSFGILLLEIISgkknrgfyhsdnklnLIGHVSKMHTTFSNIV
Flexible Loop (DISEMBL)
MNPKISDFGLARafggdeiegntnRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMhttfsniv
Low Complexity Region (SEG)
MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV
Disordered region (IsUnstruct)
*******FGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKM********
Disordered Region (DISOPRED)
MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV
Disordered Region (DISEMBL)
MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV
Disordered Region (DISPRO)
*NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFS*I*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	92	2.2.26 [Sep-21-2011]
O81833	815	G-type lectin S-receptor-	yes	no	0.913	0.103	0.761	4e-34
Q39086	843	Receptor-like serine/thre	no	no	0.880	0.096	0.728	1e-30
O81832	783	G-type lectin S-receptor-	no	no	0.869	0.102	0.712	1e-30
O81905	850	Receptor-like serine/thre	no	no	0.880	0.095	0.728	2e-30
Q9S972	847	Receptor-like serine/thre	no	no	0.902	0.097	0.710	5e-30
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.858	0.093	0.679	7e-29
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.869	0.093	0.675	1e-28
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.913	0.133	0.619	1e-27
P0DH86	853	G-type lectin S-receptor-	no	no	0.869	0.093	0.675	2e-27
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.858	0.094	0.641	3e-27

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  143 bits (360), Expect = 4e-34,   Method: Composition-based stats.
 Identities = 64/84 (76%), Positives = 75/84 (89%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLA++FGGD+ E +TNRV+GTYGYM PEYA DG FSVKSDVFSFG+L+LEII
Sbjct: 637 MNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEII 696

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           +GK NRGF H+D+ LNL+GHV KM
Sbjct: 697 TGKTNRGFRHADHDLNLLGHVWKM 720

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  131 bits (330), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 59/81 (72%), Positives = 70/81 (86%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKISDFG+AR FG +E E NT RV+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct: 656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715

Query: 61  SGKKNRGFYHSDNKLNLIGHV 81
           SGK+N+GFY+S+  LNL+G V
Sbjct: 716 SGKRNKGFYNSNRDLNLLGFV 736

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  131 bits (329), Expect = 1e-30,   Method: Composition-based stats.
 Identities = 57/80 (71%), Positives = 69/80 (86%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MN KISDFGLAR  GGDE E NT RV+GTYGYM+PEY  DG FS+KSDVFSFG+L+LEI+
Sbjct: 602 MNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIV 661

Query: 61  SGKKNRGFYHSDNKLNLIGH 80
           SG++NRGF + ++KLNL+GH
Sbjct: 662 SGRRNRGFRNEEHKLNLLGH 681

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  130 bits (328), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 59/81 (72%), Positives = 69/81 (85%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKISDFG+AR FG DE E NT +V+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct: 663 MTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 722

Query: 61  SGKKNRGFYHSDNKLNLIGHV 81
           S K+N+GFY+SD  LNL+G V
Sbjct: 723 SSKRNKGFYNSDRDLNLLGCV 743

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  129 bits (325), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 59/83 (71%), Positives = 71/83 (85%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKISDFG+AR FG +E E NT RV+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct: 660 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 719

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           SGK+N+GFY+S+  LNL+G V +
Sbjct: 720 SGKRNKGFYNSNRDLNLLGFVWR 742

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  125 bits (314), Expect = 7e-29,   Method: Composition-based stats.
 Identities = 55/81 (67%), Positives = 71/81 (87%), Gaps = 2/81 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKI+DFGLAR FGG++IEG+TNRV+GTYGYM+PEYA DG+FS+KSDV+SFG+L+LEII
Sbjct: 660 MIPKIADFGLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEII 719

Query: 61  SGKKNRGFYHSDNKLNLIGHV 81
           +GK+N  FY  +  LNL+ H+
Sbjct: 720 TGKRNSAFY--EESLNLVKHI 738

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  124 bits (311), Expect = 1e-28,   Method: Composition-based stats.
 Identities = 54/80 (67%), Positives = 66/80 (82%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGG E   NTNRV+GTYGYM+PEYA +G FS KSDVFSFG++++E I
Sbjct: 669 MNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETI 728

Query: 61  SGKKNRGFYHSDNKLNLIGH 80
           SGK+N GF+  +  L+L+GH
Sbjct: 729 SGKRNTGFHEPEKSLSLLGH 748

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  121 bits (303), Expect = 1e-27,   Method: Composition-based stats.
 Identities = 52/84 (61%), Positives = 69/84 (82%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPK++DFGLAR FG D+ + NT+R++GT+GYMAPEYA  G+FSVKSDV+SFG+L+LEII
Sbjct: 474 MNPKLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEII 533

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SGKKN  FY +D   +L+ H  ++
Sbjct: 534 SGKKNNSFYETDGAHDLVTHAWRL 557

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  120 bits (302), Expect = 2e-27,   Method: Composition-based stats.
 Identities = 54/80 (67%), Positives = 67/80 (83%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKISDFG+AR F  DE E NT +V+GTYGYM+PEYA +G FSVKSDVFSFG+L+LEI+
Sbjct: 662 MTPKISDFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIV 721

Query: 61  SGKKNRGFYHSDNKLNLIGH 80
           SGK+NRGF++S    NL+G+
Sbjct: 722 SGKRNRGFHNSGQDNNLLGY 741

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  120 bits (300), Expect = 3e-27,   Method: Composition-based stats.
 Identities = 52/81 (64%), Positives = 70/81 (86%), Gaps = 2/81 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M PKISDFG+AR FGG+++EG T+RV+GT+GYMAPEYA +G+FS+KSDV+SFG+L+LEII
Sbjct: 652 MIPKISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEII 711

Query: 61  SGKKNRGFYHSDNKLNLIGHV 81
           +GKKN  F+   +  NL+GH+
Sbjct: 712 TGKKNSAFHEESS--NLVGHI 730

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	92
224113149	820	predicted protein [Populus trichocarpa]	0.913	0.102	0.797	2e-34
224113157	786	predicted protein [Populus trichocarpa]	0.913	0.106	0.773	2e-34
224113153	785	predicted protein [Populus trichocarpa]	0.913	0.107	0.773	2e-34
224149798	361	predicted protein [Populus trichocarpa]	0.913	0.232	0.797	2e-33
449476944	1267	PREDICTED: receptor-like serine/threonin	0.913	0.066	0.75	2e-33
224149094	310	predicted protein [Populus trichocarpa]	0.913	0.270	0.773	4e-33
224124250	820	predicted protein [Populus trichocarpa]	0.913	0.102	0.785	6e-33
449458261	814	PREDICTED: receptor-like serine/threonin	0.913	0.103	0.75	6e-33
224115116	739	predicted protein [Populus trichocarpa]	0.869	0.108	0.787	1e-32
255555125	830	S-locus-specific glycoprotein S13 precur	0.913	0.101	0.761	1e-32

>gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa]

 Score =  149 bits (376), Expect = 2e-34,   Method: Composition-based stats.
 Identities = 67/84 (79%), Positives = 76/84 (90%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEII
Sbjct: 639 MNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEII 698

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SGKK+RGFYH D+ L+LIGH  ++
Sbjct: 699 SGKKSRGFYHPDHSLSLIGHAWRL 722

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa]

 Score =  149 bits (376), Expect = 2e-34,   Method: Composition-based stats.
 Identities = 65/84 (77%), Positives = 77/84 (91%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT+RV+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI+
Sbjct: 606 MNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIV 665

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           +GKK+RGFYH DN L+LIG+  ++
Sbjct: 666 TGKKSRGFYHPDNSLSLIGYAWRL 689

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa]

 Score =  149 bits (376), Expect = 2e-34,   Method: Composition-based stats.
 Identities = 65/84 (77%), Positives = 77/84 (91%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT+RV+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI+
Sbjct: 605 MNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIV 664

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           +GKK+RGFYH DN L+LIG+  ++
Sbjct: 665 TGKKSRGFYHPDNSLSLIGYAWRL 688

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224149798|ref|XP_002336866.1| predicted protein [Populus trichocarpa] gi|222837033|gb|EEE75412.1| predicted protein [Populus trichocarpa]

 Score =  146 bits (368), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 67/84 (79%), Positives = 76/84 (90%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEII
Sbjct: 180 MNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEII 239

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SGKK+RGFYH D+ L+LIGH  ++
Sbjct: 240 SGKKSRGFYHPDHSLSLIGHAWRL 263

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  145 bits (367), Expect = 2e-33,   Method: Composition-based stats.
 Identities = 63/84 (75%), Positives = 75/84 (89%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +NPKISDFG+AR FGGD+ EGNT RV+GTYGYMAPEYA DG+FS+KSDVFSFGIL+LEII
Sbjct: 634 LNPKISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEII 693

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SG+KNRGF+  ++ LNLIGH  K+
Sbjct: 694 SGEKNRGFFRPNHALNLIGHAWKL 717

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224149094|ref|XP_002336757.1| predicted protein [Populus trichocarpa] gi|222836664|gb|EEE75057.1| predicted protein [Populus trichocarpa]

 Score =  145 bits (365), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 65/84 (77%), Positives = 77/84 (91%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT+RV+GTYGYMAPEYA+DG FSVKSDVFSFGI+LLEI+
Sbjct: 157 MNPKISDFGLARTFGGDQTEGNTSRVVGTYGYMAPEYATDGLFSVKSDVFSFGIMLLEIV 216

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           +GKK+RGFYH DN L+LIG+  ++
Sbjct: 217 TGKKSRGFYHPDNSLSLIGYAWRL 240

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa]

 Score =  144 bits (364), Expect = 6e-33,   Method: Composition-based stats.
 Identities = 66/84 (78%), Positives = 75/84 (89%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ EGNT RV+GTYGYMAPEYA+DG FSVKSDVFSFGIL+LEII
Sbjct: 639 MNPKISDFGLARMFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEII 698

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SGKK+RGF H D+ L+LIGH  ++
Sbjct: 699 SGKKSRGFCHPDHSLSLIGHAWRL 722

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus]

 Score =  144 bits (364), Expect = 6e-33,   Method: Composition-based stats.
 Identities = 63/84 (75%), Positives = 75/84 (89%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +NPKISDFG+AR FGGD+ EGNT RV+GTYGYMAPEYA DG+FS+KSDVFSFGIL+LEII
Sbjct: 634 LNPKISDFGMARTFGGDQTEGNTRRVVGTYGYMAPEYAIDGQFSIKSDVFSFGILMLEII 693

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           SG+KNRGF+  ++ LNLIGH  K+
Sbjct: 694 SGEKNRGFFRPNHALNLIGHAWKL 717

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115116|ref|XP_002316944.1| predicted protein [Populus trichocarpa] gi|222860009|gb|EEE97556.1| predicted protein [Populus trichocarpa]

 Score =  143 bits (361), Expect = 1e-32,   Method: Composition-based stats.
 Identities = 63/80 (78%), Positives = 72/80 (90%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +NPKISDFGLAR FGGD++E NTNRV+GTYGYM+PEYA DG FSVKSDVFSFG+L+LEI+
Sbjct: 591 LNPKISDFGLARLFGGDQVEANTNRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIV 650

Query: 61  SGKKNRGFYHSDNKLNLIGH 80
           SGKKNRGF H D  LNL+GH
Sbjct: 651 SGKKNRGFCHPDQNLNLLGH 670

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555125|ref|XP_002518600.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223542445|gb|EEF43987.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis]

 Score =  143 bits (361), Expect = 1e-32,   Method: Composition-based stats.
 Identities = 64/84 (76%), Positives = 74/84 (88%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MNPKISDFGLAR FGGD+ E NTNRVIGTYGYM PEYA DG FSVKSDVFSFG+L+LEI+
Sbjct: 649 MNPKISDFGLARTFGGDQNEVNTNRVIGTYGYMPPEYAIDGLFSVKSDVFSFGVLVLEIV 708

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKM 84
           +GKKNRGFYH ++ LNL+GH  ++
Sbjct: 709 TGKKNRGFYHPEHDLNLLGHAWRL 732

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	92
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.913	0.103	0.761	1e-30
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.880	0.096	0.728	1.4e-27
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.880	0.095	0.728	1.4e-27
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.869	0.102	0.712	2e-27
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.880	0.095	0.728	2.4e-27
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.913	0.124	0.607	4e-24
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.869	0.119	0.625	5.1e-24
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.934	0.127	0.593	8.5e-24
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.913	0.127	0.583	1e-23
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.880	0.095	0.658	1.1e-23

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 348 (127.6 bits), Expect = 1.0e-30, P = 1.0e-30
 Identities = 64/84 (76%), Positives = 75/84 (89%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             MNPKISDFGLA++FGGD+ E +TNRV+GTYGYM PEYA DG FSVKSDVFSFG+L+LEII
Sbjct:   637 MNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEII 696

Query:    61 SGKKNRGFYHSDNKLNLIGHVSKM 84
             +GK NRGF H+D+ LNL+GHV KM
Sbjct:   697 TGKTNRGFRHADHDLNLLGHVWKM 720

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 319 (117.4 bits), Expect = 1.4e-27, P = 1.4e-27
 Identities = 59/81 (72%), Positives = 70/81 (86%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             M PKISDFG+AR FG +E E NT RV+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct:   656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715

Query:    61 SGKKNRGFYHSDNKLNLIGHV 81
             SGK+N+GFY+S+  LNL+G V
Sbjct:   716 SGKRNKGFYNSNRDLNLLGFV 736

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 319 (117.4 bits), Expect = 1.4e-27, P = 1.4e-27
 Identities = 59/81 (72%), Positives = 70/81 (86%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             M PKISDFG+AR FG +E E NT RV+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct:   660 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 719

Query:    61 SGKKNRGFYHSDNKLNLIGHV 81
             SGK+N+GFY+S+  LNL+G V
Sbjct:   720 SGKRNKGFYNSNRDLNLLGFV 740

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 317 (116.6 bits), Expect = 2.0e-27, P = 2.0e-27
 Identities = 57/80 (71%), Positives = 69/80 (86%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             MN KISDFGLAR  GGDE E NT RV+GTYGYM+PEY  DG FS+KSDVFSFG+L+LEI+
Sbjct:   602 MNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIV 661

Query:    61 SGKKNRGFYHSDNKLNLIGH 80
             SG++NRGF + ++KLNL+GH
Sbjct:   662 SGRRNRGFRNEEHKLNLLGH 681

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 317 (116.6 bits), Expect = 2.4e-27, P = 2.4e-27
 Identities = 59/81 (72%), Positives = 69/81 (85%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             M PKISDFG+AR FG DE E NT +V+GTYGYM+PEYA DG FS+KSDVFSFG+LLLEII
Sbjct:   663 MTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 722

Query:    61 SGKKNRGFYHSDNKLNLIGHV 81
             S K+N+GFY+SD  LNL+G V
Sbjct:   723 SSKRNKGFYNSDRDLNLLGCV 743

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 285 (105.4 bits), Expect = 4.0e-24, P = 4.0e-24
 Identities = 51/84 (60%), Positives = 68/84 (80%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             M+PKISDFG+AR FG D+ + NT R++GTYGYM+PEYA  GK+SVKSDV+SFG+L+LE+I
Sbjct:   484 MHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELI 543

Query:    61 SGKKNRGFYHSDNKLNLIGHVSKM 84
             +GKKN  FY  D   +L+ +V K+
Sbjct:   544 TGKKNSSFYEEDGLGDLVTYVWKL 567

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 284 (105.0 bits), Expect = 5.1e-24, P = 5.1e-24
 Identities = 50/80 (62%), Positives = 67/80 (83%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             MNPKI+DFG+AR FG D+ E NT+R++GTYGYM+PEYA  G++S+KSDV+SFG+L+LEII
Sbjct:   485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544

Query:    61 SGKKNRGFYHSDNKLNLIGH 80
             SGKKN  FY +D   +L+ +
Sbjct:   545 SGKKNSSFYQTDGAHDLVSY 564

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 282 (104.3 bits), Expect = 8.5e-24, P = 8.5e-24
 Identities = 51/86 (59%), Positives = 69/86 (80%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             +NPKI+DFG+AR FG D+ + NT+R++GTYGYMAPEYA  G+FS+KSDV+SFG+L+LEII
Sbjct:   490 INPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEII 549

Query:    61 SGKKNRGFYHSDNKLNLIGHVSKMHT 86
             SG+KN  F  SD   +L+ H  ++ T
Sbjct:   550 SGRKNSSFDESDGAQDLLTHTWRLWT 575

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 281 (104.0 bits), Expect = 1.0e-23, P = 1.0e-23
 Identities = 49/84 (58%), Positives = 69/84 (82%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             MNPKI+DFG+AR FG D+ + NT+R++GTYGYM+PEYA  G+FS+KSDV+SFG+L+LEII
Sbjct:   473 MNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEII 532

Query:    61 SGKKNRGFYHSDNKLNLIGHVSKM 84
             SG+KN  F  +D+  +L+ H  ++
Sbjct:   533 SGRKNNSFIETDDAQDLVTHAWRL 556

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 283 (104.7 bits), Expect = 1.1e-23, P = 1.1e-23
 Identities = 54/82 (65%), Positives = 64/82 (78%)

Query:     1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             MNPKISDFG+AR FG  E + NT RV GT+GYM+PEY  +G FS KSDVFSFG+L+LEII
Sbjct:   664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723

Query:    61 SGKKNRGFYH-SDNKLNLIGHV 81
              G+KN  F+H S+  LNLI HV
Sbjct:   724 CGRKNNSFHHDSEGPLNLIVHV 745

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81833	SD11_ARATH	2, ., 7, ., 1, 1, ., 1	0.7619	0.9130	0.1030	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.254.15.1 annotation not avaliable (816 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	92
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-15
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-14
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-14
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-14
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-14
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-13
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-12
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-10
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-10
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-09
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-09
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-09
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-07
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-07
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-07
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-06
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-06
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-06
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-05
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-05
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-05
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-05
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-05
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-04
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-04
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-04
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-04
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.001
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	0.001
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.001
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	0.001
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.002
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.002
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.002
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	0.002
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.002
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.002
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.002
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.003
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	0.003
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	0.003
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.003
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	0.003
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	0.004
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	0.004
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 67.2 bits (165), Expect = 5e-15
 Identities = 29/61 (47%), Positives = 37/61 (60%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KISDFGL+R    D+      R  G      +MAPE   +GKF+ KSDV+SFG+LL EI 
Sbjct: 142 KISDFGLSRDLYDDDY----YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 197

Query: 61  S 61
           +
Sbjct: 198 T 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 66.4 bits (163), Expect = 8e-15
 Identities = 28/63 (44%), Positives = 37/63 (58%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL+R     ++  +      T G     +MAPE   DG F+ KSDV+SFG+LL E
Sbjct: 145 KISDFGLSR-----DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199

Query: 59  IIS 61
           I +
Sbjct: 200 IFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 66.4 bits (163), Expect = 1e-14
 Identities = 28/59 (47%), Positives = 35/59 (59%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFGL+R    D+             +MAPE   DGKF+ KSDV+SFG+LL EI + 
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 65.2 bits (160), Expect = 2e-14
 Identities = 28/85 (32%), Positives = 40/85 (47%), Gaps = 5/85 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFGLAR     E        +GT  YMAPE      +    D++S G++L E+++GK
Sbjct: 137 KLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193

Query: 64  KNRGFYHSDNKLNLIGHVSKMHTTF 88
               F   D  L L   + K    F
Sbjct: 194 --PPFPGDDQLLELFKKIGKPKPPF 216

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 64.9 bits (159), Expect = 3e-14
 Identities = 29/61 (47%), Positives = 38/61 (62%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KISDFGL+R    D+      +V G      +MAPE   +GKF+ KSDV+SFG+LL EI 
Sbjct: 143 KISDFGLSRDLYDDDY----YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 198

Query: 61  S 61
           +
Sbjct: 199 T 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 64.2 bits (157), Expect = 4e-14
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 3/59 (5%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEI 59
             K++DFGL++    D+    T    GT  YMAPE     G +S KSD++S G++L E+
Sbjct: 131 KVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 63.3 bits (155), Expect = 1e-13
 Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 2/80 (2%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG A+  G  E    T  V GT  +MAPE     ++   +D++S G  ++E+ +GK
Sbjct: 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Query: 64  KNRGFYHSDNKLNLIGHVSK 83
               +    N +  +  +  
Sbjct: 201 --PPWSELGNPMAALYKIGS 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 1e-13
 Identities = 28/61 (45%), Positives = 36/61 (59%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K++DFGLAR    D  E       G      + APE A   +FS+KSDV+SFGILL EI+
Sbjct: 143 KVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Query: 61  S 61
           +
Sbjct: 199 T 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.7 bits (150), Expect = 5e-13
 Identities = 28/58 (48%), Positives = 41/58 (70%), Gaps = 2/58 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +++  ++++ I  Y + APE AS G FS KSDV+SFGILL E+ +
Sbjct: 144 KVADFGLARLIK-EDVYLSSDKKI-PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 8e-13
 Identities = 29/61 (47%), Positives = 38/61 (62%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFGLAR    DE         G      + APE A+ G+F++KSDV+SFGILL EI+
Sbjct: 143 KIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198

Query: 61  S 61
           +
Sbjct: 199 T 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 60.0 bits (146), Expect = 2e-12
 Identities = 25/64 (39%), Positives = 34/64 (53%), Gaps = 3/64 (4%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEI 59
              KI+DFGLA+          T  V GT  YMAPE       +  K DV+S G++L E+
Sbjct: 135 GVVKIADFGLAKKLLK-SSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYEL 192

Query: 60  ISGK 63
           ++GK
Sbjct: 193 LTGK 196

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 56.8 bits (138), Expect = 3e-11
 Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFGL+            N ++GT  +MAPE  +   +  K+D++S GI  +E+  GK
Sbjct: 138 KLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 3e-11
 Identities = 26/62 (41%), Positives = 35/62 (56%), Gaps = 8/62 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT----YGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFG+ R    D  E +  R  G       +MAPE   DG F+ KSDV+SFG++L E+
Sbjct: 159 KIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214

Query: 60  IS 61
            +
Sbjct: 215 AT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.8 bits (132), Expect = 2e-10
 Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G+ I    +  +GT  YM+PE    GK++VKSDV+S GI ++E+  GK
Sbjct: 144 KLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 54.4 bits (132), Expect = 2e-10
 Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 10/92 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG+++          T  V+GT  Y++PE   +  ++ KSD++S G +L E+ + K
Sbjct: 143 KLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200

Query: 64  KNRGFYHSDNKLNLI-----GHVSKMHTTFSN 90
               F   +N L L      G    + + +S+
Sbjct: 201 --HPFE-GENLLELALKILKGQYPPIPSQYSS 229

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 54.1 bits (131), Expect = 3e-10
 Identities = 26/72 (36%), Positives = 37/72 (51%), Gaps = 4/72 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFGLA+    +    NT    GT  Y+APE      +    D +S G+LL E+++GK
Sbjct: 133 KLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Query: 64  KNRGFYHSDNKL 75
               FY  D K 
Sbjct: 191 --PPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 53.6 bits (129), Expect = 4e-10
 Identities = 28/60 (46%), Positives = 35/60 (58%), Gaps = 9/60 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGLA+       E +  +  G     + APE   + KFS KSDV+SFGILL EI S
Sbjct: 142 KVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 53.7 bits (129), Expect = 4e-10
 Identities = 29/61 (47%), Positives = 38/61 (62%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEI---EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFGLAR    +E    EG    +  T    APE  + G F++KSDV+SFGILL EI+
Sbjct: 142 KIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIV 197

Query: 61  S 61
           +
Sbjct: 198 T 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.5 bits (128), Expect = 6e-10
 Identities = 33/82 (40%), Positives = 47/82 (57%), Gaps = 7/82 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E    T R    +   + APE A  G+F++KSDV+SFGILL E+++
Sbjct: 142 KIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Query: 62  GKKNRGFYHSDNKLNLIGHVSK 83
             K R  Y   N   ++  V +
Sbjct: 199 --KGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.5 bits (126), Expect = 1e-09
 Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 18/79 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR     +I  ++N V+         +MAPE   D  ++V+SDV+S+GILL E
Sbjct: 252 KICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306

Query: 59  IIS-GKK-------NRGFY 69
           I S GK        N  FY
Sbjct: 307 IFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 52.0 bits (125), Expect = 2e-09
 Identities = 24/58 (41%), Positives = 33/58 (56%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 3e-09
 Identities = 26/64 (40%), Positives = 35/64 (54%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGLAR    D+   +     GT     +  PE     +FS KSDV+SFG+L+ E+ 
Sbjct: 140 KVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195

Query: 61  SGKK 64
           S  K
Sbjct: 196 SEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.4 bits (123), Expect = 3e-09
 Identities = 33/83 (39%), Positives = 48/83 (57%), Gaps = 12/83 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT----YGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFGLAR    D  + +  R  G       +MAPE   DGKF+ +SDV+SFG+L+ EI
Sbjct: 151 KIGDFGLAR----DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI 206

Query: 60  IS-GKKNRGFYHSDNKLNLIGHV 81
           ++ G++    Y + N   ++ HV
Sbjct: 207 LTLGQQP---YPALNNQEVLQHV 226

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 51.3 bits (123), Expect = 4e-09
 Identities = 24/59 (40%), Positives = 36/59 (61%), Gaps = 2/59 (3%)

Query: 4   KISDFGLAR-AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL+R  +  D     +  ++    +M PE    GKF+ +SD++SFG++L EI S
Sbjct: 164 KISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 4e-09
 Identities = 24/60 (40%), Positives = 30/60 (50%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGLA+      D            + Y APE     KFS  SDV+SFG+ L E+ +
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 4e-09
 Identities = 28/63 (44%), Positives = 36/63 (57%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFG++RA G     G+      T G     + APE  + GKFS KSDV+S+G+ L E
Sbjct: 135 KISDFGMSRALGA----GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWE 190

Query: 59  IIS 61
             S
Sbjct: 191 AFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 51.1 bits (123), Expect = 4e-09
 Identities = 21/63 (33%), Positives = 33/63 (52%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI+DFG+++    +      N  +GT  YM+PE      +S  +D++S G+ LLE  
Sbjct: 137 GEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194

Query: 61  SGK 63
            GK
Sbjct: 195 LGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.1 bits (122), Expect = 4e-09
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 5/58 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGLAR      +  + +++     + APE     KFS KSDV+S+G+LL E+ S
Sbjct: 140 KVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 4e-09
 Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 6/61 (9%)

Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GILL EI 
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIF 237

Query: 61  S 61
           S
Sbjct: 238 S 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.8 bits (121), Expect = 6e-09
 Identities = 28/60 (46%), Positives = 39/60 (65%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E    T R    +   + APE A  G+F++KSDV+SFGILL E+++
Sbjct: 142 KIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 6e-09
 Identities = 28/61 (45%), Positives = 39/61 (63%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEI---EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFGLAR    +E    EG    +     + APE  + G F++KSDV+SFGILL+EI+
Sbjct: 142 KIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAINFGSFTIKSDVWSFGILLMEIV 197

Query: 61  S 61
           +
Sbjct: 198 T 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.4 bits (120), Expect = 6e-09
 Identities = 28/60 (46%), Positives = 38/60 (63%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E    T R    +   + APE  + G F++KSDV+SFGILL EI++
Sbjct: 143 KIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 50.4 bits (121), Expect = 7e-09
 Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 6/84 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
            I+DF +A     D     T    GT GYMAPE      +SV  D +S G+   E + GK
Sbjct: 140 HITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196

Query: 64  KNRGF-YHSDNKLNLIGHVSKMHT 86
             R +  HS    + I    +   
Sbjct: 197 --RPYRGHSRTIRDQIRAKQETAD 218

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.4 bits (120), Expect = 7e-09
 Identities = 27/60 (45%), Positives = 38/60 (63%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E    T R    +   + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 142 KVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 50.1 bits (120), Expect = 8e-09
 Identities = 27/70 (38%), Positives = 37/70 (52%), Gaps = 7/70 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-- 61
           KI+DFG+AR            R +    +M PE   DG F+ K+DV+SFG+LL EI S  
Sbjct: 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLG 218

Query: 62  -----GKKNR 66
                G+ N+
Sbjct: 219 YMPYPGRTNQ 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 50.0 bits (120), Expect = 9e-09
 Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  +       +GT  YMAPE      +SVKSD++S G+ L+E+ +G+
Sbjct: 141 KLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 49.6 bits (119), Expect = 1e-08
 Identities = 23/63 (36%), Positives = 34/63 (53%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            N K+ DFGLA+  G D     T   +GT  YM+PE  +   +  KSD++S G L+ E+ 
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204

Query: 61  SGK 63
           +  
Sbjct: 205 ALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 49.4 bits (118), Expect = 1e-08
 Identities = 25/75 (33%), Positives = 45/75 (60%), Gaps = 5/75 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG+++  G +     T  V+GT  YM+PE     K++ KSD+++ G +L E+++ K
Sbjct: 141 KLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198

Query: 64  KNRGFYHSDNKLNLI 78
           +    + + N LNL+
Sbjct: 199 RT---FDATNPLNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 49.3 bits (118), Expect = 2e-08
 Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL RA     D      +  +  + + APE      FS  SDV+ FG+ L E+ +
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 49.0 bits (117), Expect = 2e-08
 Identities = 22/59 (37%), Positives = 33/59 (55%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFG++R   G     +         + APE  + G+++ +SDV+S+GILL E  S 
Sbjct: 133 KISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 3e-08
 Identities = 22/67 (32%), Positives = 34/67 (50%), Gaps = 11/67 (16%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+    DE            G     +MA E      ++ KSDV+S+G+ + E
Sbjct: 149 KITDFGLAKLLDVDE-----KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203

Query: 59  IIS-GKK 64
           +++ G K
Sbjct: 204 LMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.4 bits (115), Expect = 3e-08
 Identities = 30/66 (45%), Positives = 39/66 (59%), Gaps = 8/66 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT----YGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KISDFGL++A G DE   N  +          + APE  +  KFS KSDV+SFG+L+ E 
Sbjct: 135 KISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEA 191

Query: 60  IS-GKK 64
            S G+K
Sbjct: 192 FSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 47.9 bits (114), Expect = 5e-08
 Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 2/62 (3%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N KI D G+A+    +    NT  ++GT  Y++PE   D  ++ KSDV++ G++L E  +
Sbjct: 139 NVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT 196

Query: 62  GK 63
           GK
Sbjct: 197 GK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 48.3 bits (115), Expect = 5e-08
 Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 5/63 (7%)

Query: 2   NPKISDFGLARAF-GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           N +ISD GLA    GG +I+G      GT GYMAPE      +    D F+ G  L E+I
Sbjct: 133 NVRISDLGLAVELKGGKKIKGR----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188

Query: 61  SGK 63
           +G+
Sbjct: 189 AGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 5e-08
 Identities = 23/58 (39%), Positives = 33/58 (56%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R     E    T        + APE  +  KF+  SDV+SFGI++ E++S
Sbjct: 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 6e-08
 Identities = 26/60 (43%), Positives = 34/60 (56%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR      D +     R+     +MAPE   D  ++ +SDV+SFG+LL EI S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.5 bits (113), Expect = 6e-08
 Identities = 24/56 (42%), Positives = 34/56 (60%), Gaps = 1/56 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI
Sbjct: 144 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 47.8 bits (114), Expect = 6e-08
 Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 6/73 (8%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFG++R  +  D   + G+T   I    +M PE     KF+ +SDV+SFG++L EI 
Sbjct: 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIR---WMPPESIMYRKFTTESDVWSFGVVLWEIF 218

Query: 61  SGKKNRGFYHSDN 73
           +  K   +  S+ 
Sbjct: 219 TYGKQPWYGLSNE 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 47.4 bits (113), Expect = 8e-08
 Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G+ +        GT  YMAPE      +S+ SDV+S G+ LLE+   +
Sbjct: 145 KLCDFGVS----GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 47.2 bits (113), Expect = 8e-08
 Identities = 25/63 (39%), Positives = 33/63 (52%), Gaps = 6/63 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY---ASDGKFSVKSDVFSFGILLLEII 60
           K++DFGLAR +        TNRVI T  Y  PE    A+     V  D++S G +L E+ 
Sbjct: 140 KLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEV--DMWSVGCILAELF 196

Query: 61  SGK 63
            GK
Sbjct: 197 LGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 47.3 bits (112), Expect = 9e-08
 Identities = 28/64 (43%), Positives = 39/64 (60%), Gaps = 4/64 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL++A G D+      R  G +   + APE  +  KFS +SDV+S+GI + E  S
Sbjct: 135 KISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Query: 62  -GKK 64
            G+K
Sbjct: 194 YGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.4 bits (113), Expect = 9e-08
 Identities = 21/60 (35%), Positives = 36/60 (60%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      ++V+SD++S G+ L+E+  G+
Sbjct: 140 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 1e-07
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAF-GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA     G+ I G     +GT GYMAPE   + +++   D +  G L+ E+I G
Sbjct: 142 RISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197

Query: 63  K 63
           K
Sbjct: 198 K 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.0 bits (111), Expect = 1e-07
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 144 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 46.5 bits (110), Expect = 2e-07
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL+R    ++  ++ +  R+     +MA E   D  ++ +SDV+SFG+LL EI++
Sbjct: 167 KISDFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.5 bits (110), Expect = 2e-07
 Identities = 26/58 (44%), Positives = 32/58 (55%), Gaps = 5/58 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +     E     +       + APE   + KFS KSDV+SFGILL EI S
Sbjct: 142 KVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.3 bits (110), Expect = 2e-07
 Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGL +    D+ E    R  G    + Y APE  ++ KFSV SDV+SFG++L E+ 
Sbjct: 148 KIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205

Query: 61  S 61
           +
Sbjct: 206 T 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 46.2 bits (110), Expect = 2e-07
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 3/63 (4%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEII 60
           KI+DFG++ +   GGD         +GT  +MAPE       +  K+D++SFGI  +E+ 
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201

Query: 61  SGK 63
           +G 
Sbjct: 202 TGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 45.9 bits (107), Expect = 3e-07
 Identities = 25/69 (36%), Positives = 34/69 (49%), Gaps = 7/69 (10%)

Query: 2   NPKISDFGLARAFGGD----EIEGNTNRVIGTYGYMAPEYA---SDGKFSVKSDVFSFGI 54
             K+ DFGLA+          I    +  +GT GYMAPE     S    S  SD++S GI
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199

Query: 55  LLLEIISGK 63
            L E+++G 
Sbjct: 200 TLYELLTGL 208

Length = 384

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 45.8 bits (108), Expect = 3e-07
 Identities = 24/58 (41%), Positives = 36/58 (62%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR   GDE E N +       +MA E     KF+ +SDV+S+G+ + E+++
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 3e-07
 Identities = 26/60 (43%), Positives = 35/60 (58%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR      D +   + R+     +MAPE   D  ++ +SDV+SFG+LL EI S
Sbjct: 214 KICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.7 bits (108), Expect = 4e-07
 Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFG+ R    D+   +T    GT     + +PE  S  K+S KSDV+SFG+L+ E+ 
Sbjct: 140 KVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF 195

Query: 61  SGKK 64
           S  K
Sbjct: 196 SEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 4e-07
 Identities = 26/64 (40%), Positives = 40/64 (62%), Gaps = 6/64 (9%)

Query: 1   MNPKISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           +N KISD GL R  +  D  ++ GN+   I    +M+PE    GKFS+ SD++S+G++L 
Sbjct: 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLW 217

Query: 58  EIIS 61
           E+ S
Sbjct: 218 EVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (108), Expect = 4e-07
 Identities = 19/60 (31%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A        +  +  V+GT  +MAPE       S  SD++S G  ++E+++G 
Sbjct: 139 KLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 45.3 bits (108), Expect = 4e-07
 Identities = 20/59 (33%), Positives = 32/59 (54%), Gaps = 2/59 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFG A      + +   N V+GT  +MAPE      +  K D++S GI+ +E+  G
Sbjct: 156 KLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 45.3 bits (107), Expect = 4e-07
 Identities = 23/72 (31%), Positives = 36/72 (50%), Gaps = 11/72 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++       +       +GT  YMAPE  S  ++ + SDV+S GI  +E+  G+
Sbjct: 135 KLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Query: 64  -------KNRGF 68
                  KN+G 
Sbjct: 191 FPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.4 bits (107), Expect = 5e-07
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 144 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 45.0 bits (107), Expect = 5e-07
 Identities = 25/74 (33%), Positives = 43/74 (58%), Gaps = 6/74 (8%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFG++R  +  D   ++G     I    +MA E    GKF+ KSDV++FG+ L EI+
Sbjct: 170 KIADFGMSRNLYSSDYYRVQGRAPLPIR---WMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Query: 61  SGKKNRGFYHSDNK 74
           +  + + + H  ++
Sbjct: 227 TLCREQPYEHLTDQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.8 bits (106), Expect = 6e-07
 Identities = 22/62 (35%), Positives = 37/62 (59%), Gaps = 2/62 (3%)

Query: 1   MNPKISDFGLAR-AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           M  KI+DFGL+R  +  D  + + N  I    +M PE     +++ +SDV+++G++L EI
Sbjct: 167 MVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Query: 60  IS 61
            S
Sbjct: 226 FS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.0 bits (106), Expect = 7e-07
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 5/61 (8%)

Query: 4   KISDFGLA-RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA     G  I+G     +GT GYMAPE   + +++   D ++ G LL E+I+G
Sbjct: 142 RISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197

Query: 63  K 63
           +
Sbjct: 198 Q 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 44.8 bits (106), Expect = 8e-07
 Identities = 23/65 (35%), Positives = 40/65 (61%), Gaps = 6/65 (9%)

Query: 4   KISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPEY-ASDGK-FSVKSDVFSFGILLLEI 59
           KISDFG+++    D+I  N     + G+  +MAPE   S  + +S K D++S G ++LE+
Sbjct: 148 KISDFGISKK--SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Query: 60  ISGKK 64
            +G++
Sbjct: 206 FAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.6 bits (105), Expect = 9e-07
 Identities = 23/61 (37%), Positives = 37/61 (60%), Gaps = 5/61 (8%)

Query: 4   KISDFGLA-RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA +   G+ I G     +GT GYMAPE  ++ ++++  D +  G L+ E+I G
Sbjct: 142 RISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197

Query: 63  K 63
           +
Sbjct: 198 Q 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.5 bits (105), Expect = 9e-07
 Identities = 26/61 (42%), Positives = 36/61 (59%), Gaps = 6/61 (9%)

Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GILL EI 
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIF 310

Query: 61  S 61
           S
Sbjct: 311 S 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 9e-07
 Identities = 22/62 (35%), Positives = 38/62 (61%), Gaps = 3/62 (4%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEII 60
           N K+ DFG+A     +  + +T   +GT  +MAPE  ++GK +  K+D++S GI + E+ 
Sbjct: 139 NVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196

Query: 61  SG 62
           +G
Sbjct: 197 TG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 9e-07
 Identities = 28/66 (42%), Positives = 38/66 (57%), Gaps = 16/66 (24%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYM--------APEYASDGKFSVKSDVFSFGIL 55
           KISDFG++R    +E +G    V  + G M        APE  + G++S +SDV+SFGIL
Sbjct: 134 KISDFGMSR----EEEDG----VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGIL 185

Query: 56  LLEIIS 61
           L E  S
Sbjct: 186 LWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 1e-06
 Identities = 25/58 (43%), Positives = 32/58 (55%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 44.4 bits (105), Expect = 1e-06
 Identities = 21/60 (35%), Positives = 29/60 (48%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI D G+++              IGT  YMAPE      +S KSD++S G LL E+ +  
Sbjct: 143 KIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.2 bits (104), Expect = 1e-06
 Identities = 24/58 (41%), Positives = 34/58 (58%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T+       +MAPE   D  ++ +SDV+SFGIL+ EI +
Sbjct: 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 43.8 bits (103), Expect = 1e-06
 Identities = 24/59 (40%), Positives = 33/59 (55%), Gaps = 2/59 (3%)

Query: 4   KISDFGLARA-FGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISD GL+R  +  D        ++    +M PE    GKFS  SD++SFG++L EI S
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 43.8 bits (104), Expect = 2e-06
 Identities = 22/62 (35%), Positives = 36/62 (58%), Gaps = 2/62 (3%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
             K++DFG++        + NT  VIGT  +MAPE   +  ++ K+D++S GI  +E+  
Sbjct: 137 QAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194

Query: 62  GK 63
           GK
Sbjct: 195 GK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 2e-06
 Identities = 25/58 (43%), Positives = 31/58 (53%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D    +         +MAPE   D  ++  SDV+S+GILL EI S
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 43.7 bits (103), Expect = 2e-06
 Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 11/86 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGL+R    DE   +    +G+     +  PE     KFS KSDV++FG+L+ E+ 
Sbjct: 140 KVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY 195

Query: 61  S-GKKNRGFYHSDNKLNLIGHVSKMH 85
           S GK     Y   N    +  VS+  
Sbjct: 196 SLGKMP---YERFNNSETVEKVSQGL 218

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.8 bits (103), Expect = 2e-06
 Identities = 25/61 (40%), Positives = 35/61 (57%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNR-VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA        EG T R  +GT GYMAPE  ++ K++   D +  G L+ E+I G
Sbjct: 142 RISDLGLAVQIP----EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197

Query: 63  K 63
           +
Sbjct: 198 Q 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.4 bits (102), Expect = 2e-06
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 6/61 (9%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFG++R  + GD   I+G   R +    +MA E    GKF+  SDV++FG+ L EI+
Sbjct: 178 KIADFGMSRNLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Query: 61  S 61
            
Sbjct: 235 M 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 43.5 bits (102), Expect = 2e-06
 Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 2/75 (2%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 141 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198

Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 199 PPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 43.0 bits (102), Expect = 3e-06
 Identities = 17/81 (20%), Positives = 35/81 (43%), Gaps = 18/81 (22%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVI------------------GTYGYMAPEYASDGK 42
           M+ KI+DFG A+    +    +                       GT  Y++PE  ++  
Sbjct: 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198

Query: 43  FSVKSDVFSFGILLLEIISGK 63
               SD+++ G ++ ++++GK
Sbjct: 199 AGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 3e-06
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 2/59 (3%)

Query: 4   KISDFGLARAFGG-DEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     D  +  TN  +    +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 174 KIADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.1 bits (101), Expect = 3e-06
 Identities = 26/59 (44%), Positives = 36/59 (61%), Gaps = 2/59 (3%)

Query: 4   KISDFGLARAFGG-DEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     D  +  TN  +    +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 3e-06
 Identities = 23/58 (39%), Positives = 33/58 (56%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.8 bits (101), Expect = 3e-06
 Identities = 24/60 (40%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N         +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.7 bits (100), Expect = 3e-06
 Identities = 21/56 (37%), Positives = 31/56 (55%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 42.8 bits (101), Expect = 4e-06
 Identities = 14/30 (46%), Positives = 22/30 (73%)

Query: 32  YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           ++APE   +  FS KSDV+SFG+L+ E+ +
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 42.7 bits (100), Expect = 4e-06
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 6/81 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D GL R F       ++  ++GT  YM+PE   +  ++ KSD++S G LL E+ + +
Sbjct: 146 KLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Query: 64  KNRGFYHSDNKLNLIGHVSKM 84
               FY   +K+NL     K+
Sbjct: 204 SP--FY--GDKMNLFSLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.6 bits (100), Expect = 5e-06
 Identities = 26/62 (41%), Positives = 34/62 (54%), Gaps = 8/62 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT----YGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFG+ R    D  E +  R  G       +MAPE   DG F+  SD++SFG++L EI
Sbjct: 159 KIGDFGMTR----DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Query: 60  IS 61
            S
Sbjct: 215 TS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.3 bits (99), Expect = 5e-06
 Identities = 23/58 (39%), Positives = 34/58 (58%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFG++R         +  + I    + APE  + G++S +SDV+S+GILL E  S
Sbjct: 133 KISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.5 bits (100), Expect = 5e-06
 Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 13/67 (19%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFG+ R    DE          + G      +  PE  +  K+S KSDV+SFG+L+ 
Sbjct: 140 KVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMW 192

Query: 58  EIISGKK 64
           E+ +  K
Sbjct: 193 EVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 42.2 bits (99), Expect = 6e-06
 Identities = 23/64 (35%), Positives = 36/64 (56%), Gaps = 11/64 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL+R      +E +      T G      + APE  +  KF+  SDV+S+GI++ 
Sbjct: 146 KVSDFGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 200

Query: 58  EIIS 61
           E++S
Sbjct: 201 EVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 42.1 bits (99), Expect = 7e-06
 Identities = 26/63 (41%), Positives = 39/63 (61%), Gaps = 7/63 (11%)

Query: 4   KISDFGLARAFGGDEIEGNT--NRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEII 60
           K++DFGLARAFG   I  NT  N V+ T  Y AP+     + +S   D++S G ++ E+I
Sbjct: 140 KLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Query: 61  SGK 63
           +G+
Sbjct: 196 TGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 41.9 bits (98), Expect = 8e-06
 Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D+ EG      G     + APE  +  KF+  SDV+SFGI++ E++S
Sbjct: 147 KVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 41.9 bits (99), Expect = 9e-06
 Identities = 22/61 (36%), Positives = 36/61 (59%), Gaps = 4/61 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR F  +E    +++V  T  Y APE  Y +  K+    D+++ G +  E+++
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLN 196

Query: 62  G 62
           G
Sbjct: 197 G 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 41.5 bits (98), Expect = 1e-05
 Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 6/65 (9%)

Query: 4   KISDFGLA------RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           K++DFGL+      R    ++ E    R++GT  Y+APE       S   D +S G +L 
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192

Query: 58  EIISG 62
           E + G
Sbjct: 193 EFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 41.6 bits (97), Expect = 1e-05
 Identities = 21/60 (35%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 141 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 41.6 bits (97), Expect = 1e-05
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 2/75 (2%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+   N  +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 141 KLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 199 PPHSELHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 41.5 bits (97), Expect = 1e-05
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 1/62 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-G 62
           KI DFG++R     +      R +    +M PE     KF+ +SD++SFG++L EI + G
Sbjct: 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221

Query: 63  KK 64
           K+
Sbjct: 222 KQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.6 bits (97), Expect = 1e-05
 Identities = 19/60 (31%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG       D  +  +  ++GT  +MAPE  S   +  + D++S GI+++E++ G+
Sbjct: 157 KLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 41.5 bits (97), Expect = 1e-05
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 6/81 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D GL R F       ++  ++GT  YM+PE   +  ++ KSD++S G LL E+ + +
Sbjct: 146 KLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Query: 64  KNRGFYHSDNKLNLIGHVSKM 84
               FY   +K+NL     K+
Sbjct: 204 SP--FY--GDKMNLYSLCKKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 1e-05
 Identities = 24/58 (41%), Positives = 31/58 (53%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D    +         +MAPE   +  ++  SDV+SFGILL EI +
Sbjct: 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 41.4 bits (97), Expect = 1e-05
 Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 10/89 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG+++       +     V+GT  Y++PE      ++ KSD+++ G +L E+ S K
Sbjct: 142 KIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK 198

Query: 64  KNRGFYHSDNKLNLIGHVSK-MHTTFSNI 91
             R F       NL   V K M  TF+ I
Sbjct: 199 --RAF----EAANLPALVLKIMSGTFAPI 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 41.5 bits (97), Expect = 1e-05
 Identities = 24/61 (39%), Positives = 37/61 (60%), Gaps = 6/61 (9%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFG++R  + GD   I+G   R +    +MA E    GKF+  SDV++FG+ L E+ 
Sbjct: 169 KIADFGMSRNLYSGDYYRIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Query: 61  S 61
           +
Sbjct: 226 T 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 41.0 bits (96), Expect = 1e-05
 Identities = 21/64 (32%), Positives = 39/64 (60%), Gaps = 4/64 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNR----VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KISDFG+++    + +   TN     + G+  +MAPE      ++ K+D++S G L++E+
Sbjct: 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205

Query: 60  ISGK 63
           ++GK
Sbjct: 206 LTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 41.3 bits (97), Expect = 1e-05
 Identities = 22/62 (35%), Positives = 36/62 (58%), Gaps = 6/62 (9%)

Query: 4   KISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFG+ +    + +  EG  +   GT  Y+APE     K++   D +SFG+LL E++ 
Sbjct: 136 KIADFGMCK----ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191

Query: 62  GK 63
           G+
Sbjct: 192 GQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 40.9 bits (96), Expect = 1e-05
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLAR +  +E    TN+VI T  Y  PE    + ++    DV+S G +L E+ + 
Sbjct: 156 KLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214

Query: 63  K 63
           K
Sbjct: 215 K 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 41.0 bits (96), Expect = 2e-05
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 8/80 (10%)

Query: 4   KISDFGLA-----RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           +I+DFG A     +  G  E +G   +++GT  +MAPE     ++    DV+S G +++E
Sbjct: 144 RIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200

Query: 59  IISGKKNRGFYHSDNKLNLI 78
           + + K         N L LI
Sbjct: 201 MATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.1 bits (96), Expect = 2e-05
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 137 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 41.0 bits (96), Expect = 2e-05
 Identities = 24/61 (39%), Positives = 38/61 (62%), Gaps = 6/61 (9%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI+DFG++R  + GD   I+G   R +    +M+ E    GKF+  SDV++FG+ L EI+
Sbjct: 170 KIADFGMSRNLYSGDYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Query: 61  S 61
           +
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.8 bits (95), Expect = 2e-05
 Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 7/60 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGL+R   G+E+     + +G     +MA E  +   ++ KSDV+SFG+LL EI+S
Sbjct: 159 KIADFGLSR---GEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 40.9 bits (96), Expect = 2e-05
 Identities = 29/84 (34%), Positives = 39/84 (46%), Gaps = 9/84 (10%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR F     E  G     + T  Y APE   S   ++   DV+S G +L E++
Sbjct: 145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Query: 61  SGK---KNRGFYHSDNKLNLIGHV 81
             K   K + +     +LN I  V
Sbjct: 205 GRKPVFKGKDYVD---QLNQILQV 225

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 40.8 bits (95), Expect = 2e-05
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 7/60 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGL+R   G E+     + +G     +MA E  +   ++  SDV+S+G+LL EI+S
Sbjct: 152 KIADFGLSR---GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 40.5 bits (95), Expect = 2e-05
 Identities = 20/56 (35%), Positives = 32/56 (57%), Gaps = 2/56 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           K+ D GL R F       ++  ++GT  YM+PE   +  ++ KSD++S G LL E+
Sbjct: 146 KLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 40.8 bits (95), Expect = 2e-05
 Identities = 21/58 (36%), Positives = 35/58 (60%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    DE E + +       +MA E     +F+ +SDV+S+G+ + E+++
Sbjct: 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 40.6 bits (95), Expect = 2e-05
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 4/62 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIIS 61
           KISDFG ++   G  I   T    GT  YMAPE    G   +   +D++S G  ++E+ +
Sbjct: 149 KISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206

Query: 62  GK 63
           GK
Sbjct: 207 GK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 40.2 bits (94), Expect = 3e-05
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 2/62 (3%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +ISD GLA      + +  T    GT G+MAPE     ++    D F+ G+ L E+I+
Sbjct: 135 NVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA 192

Query: 62  GK 63
            +
Sbjct: 193 AR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.3 bits (94), Expect = 3e-05
 Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAF-GGDEI----EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLA+A   G E     E   + V     + A E   + KFS  SDV+SFG+ L E
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKENKFSYASDVWSFGVTLYE 202

Query: 59  IIS 61
           +++
Sbjct: 203 LLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 3e-05
 Identities = 21/62 (33%), Positives = 36/62 (58%), Gaps = 2/62 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K+ DFG ++ +    +  +  R   GT  Y+APE      +S K+D+FS G+LL E+++ 
Sbjct: 183 KLGDFGFSKMYAA-TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241

Query: 63  KK 64
           K+
Sbjct: 242 KR 243

Length = 496

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 40.0 bits (93), Expect = 3e-05
 Identities = 26/68 (38%), Positives = 38/68 (55%), Gaps = 6/68 (8%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFG++R  +  D   + G+T   I    +M PE     KF+ +SDV+SFG++L EI 
Sbjct: 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIR---WMPPESIMYRKFTTESDVWSFGVILWEIF 219

Query: 61  SGKKNRGF 68
           +  K   F
Sbjct: 220 TYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 39.9 bits (93), Expect = 4e-05
 Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGL+R    D  +      +G      + APE  +  KF+  SDV+S+GI++ E++
Sbjct: 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205

Query: 61  S 61
           S
Sbjct: 206 S 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 39.7 bits (92), Expect = 5e-05
 Identities = 18/60 (30%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 155 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 39.5 bits (92), Expect = 5e-05
 Identities = 18/60 (30%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 155 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 39.6 bits (92), Expect = 5e-05
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 137 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 39.7 bits (92), Expect = 5e-05
 Identities = 18/60 (30%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E++ G+
Sbjct: 155 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 5e-05
 Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 7/65 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----YASDGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D   G  N  IGT  +MAPE        D  +  +SDV+S GI  +E
Sbjct: 153 KLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Query: 59  IISGK 63
           +  GK
Sbjct: 211 LADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 5e-05
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLAR+FG       T+ V+ T  Y APE    D  +S   D++S G +  E++S 
Sbjct: 138 KLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Query: 63  K 63
           +
Sbjct: 196 R 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 39.6 bits (92), Expect = 5e-05
 Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 4/61 (6%)

Query: 4   KISDFGLAR-AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFG+ +    GD     T    GT  Y+APE     K++   D +SFG+LL E++ G
Sbjct: 136 KIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192

Query: 63  K 63
           +
Sbjct: 193 Q 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 39.3 bits (92), Expect = 6e-05
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-G 62
           K+ DFGL+R    DE     ++      +MAPE  +  +F+  SDV+ FG+ + EI+  G
Sbjct: 147 KLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLG 205

Query: 63  KKNRGFYHSDNKLNLIGHVSK 83
            K   F    N  ++IG +  
Sbjct: 206 VKP--FQGVKNN-DVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 39.3 bits (92), Expect = 6e-05
 Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISG 62
           KI DFGLAR    DE +  T  V+  Y Y APE     + ++   D++S G +  E++  
Sbjct: 143 KICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Query: 63  K 63
           +
Sbjct: 202 R 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.4 bits (92), Expect = 6e-05
 Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY--ASDGKFSVKSDVFSFGILLLEIIS 61
            ++DFGL++ F  +E E       GT  YMAPE      G      D +S G+L  E+++
Sbjct: 145 VLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Query: 62  G 62
           G
Sbjct: 204 G 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 39.1 bits (92), Expect = 7e-05
 Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 3/61 (4%)

Query: 3   PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
            K+ DFG A+     +    T    GT  Y+APE   +  +    D +S GILL E+++G
Sbjct: 132 VKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188

Query: 63  K 63
           +
Sbjct: 189 R 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 39.2 bits (91), Expect = 7e-05
 Identities = 24/73 (32%), Positives = 40/73 (54%), Gaps = 9/73 (12%)

Query: 4   KISDFGLAR--AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFG+ +   FG    +   +   GT  Y+APE     K++   D +SFG+LL E++ 
Sbjct: 136 KIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191

Query: 62  GKKNRGFYHSDNK 74
           G+     +H D++
Sbjct: 192 GQSP---FHGDDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 7e-05
 Identities = 22/63 (34%), Positives = 36/63 (57%), Gaps = 3/63 (4%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEII 60
             K++DFGLARAF G  +   T+ V+ T  Y APE     + +S   D++S G +  E++
Sbjct: 137 ALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194

Query: 61  SGK 63
           + +
Sbjct: 195 NRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 39.3 bits (91), Expect = 7e-05
 Identities = 18/60 (30%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++     + ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 156 KLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 39.3 bits (91), Expect = 7e-05
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D   G  N  IGT  +MAPE  +     D  +  KSD++S GI  +E
Sbjct: 151 KLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208

Query: 59  IISG 62
           +  G
Sbjct: 209 MAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 38.9 bits (91), Expect = 7e-05
 Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 6/64 (9%)

Query: 1   MNPKISDFGLAR-AFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           +  KI+D  L+R  F  D   +  N NR +    +MA E   + ++S  SDV+SFG+LL 
Sbjct: 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALESLVNKEYSSASDVWSFGVLLW 210

Query: 58  EIIS 61
           E+++
Sbjct: 211 ELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 39.0 bits (91), Expect = 8e-05
 Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISG 62
           K++DFGLARAF G  +   T+ V+ T  Y APE     + +S   D++S G +  E+++ 
Sbjct: 143 KLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200

Query: 63  K 63
           K
Sbjct: 201 K 201

Length = 294

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 38.9 bits (91), Expect = 9e-05
 Identities = 21/62 (33%), Positives = 34/62 (54%), Gaps = 6/62 (9%)

Query: 4   KISDFGLARA--FGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFG+ +    GG      T+   GT  Y+APE  S   +    D ++ G+LL E+++
Sbjct: 136 KIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191

Query: 62  GK 63
           G+
Sbjct: 192 GQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 39.0 bits (91), Expect = 9e-05
 Identities = 23/61 (37%), Positives = 36/61 (59%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISG 62
           K++DFGLARAF G  +   T+ V+ T  Y APE     K+ S   D++S G +  E+++ 
Sbjct: 140 KLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197

Query: 63  K 63
           +
Sbjct: 198 R 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 38.8 bits (90), Expect = 9e-05
 Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D G+AR         +T  +IGT  YM+PE  S+  ++ KSDV++ G  + E+ + K
Sbjct: 142 KVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 38.8 bits (90), Expect = 9e-05
 Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 3/60 (5%)

Query: 5   ISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY--ASDGKFSVKSDVFSFGILLLEIISG 62
           ++DFGL++ F  DE+E       GT  YMAP+     DG      D +S G+L+ E+++G
Sbjct: 146 LTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.9 bits (90), Expect = 9e-05
 Identities = 26/75 (34%), Positives = 42/75 (56%), Gaps = 6/75 (8%)

Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFG++R  +  D   + G+T   I    +M PE     KF+ +SDV+S G++L EI 
Sbjct: 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIR---WMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Query: 61  SGKKNRGFYHSDNKL 75
           +  K   +  S+N++
Sbjct: 217 TYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 38.9 bits (90), Expect = 1e-04
 Identities = 20/60 (33%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG   A    E+      ++GT  +MAPE  S   +  + D++S GI+++E++ G+
Sbjct: 156 KLSDFGFC-AQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 38.6 bits (90), Expect = 1e-04
 Identities = 20/62 (32%), Positives = 35/62 (56%), Gaps = 6/62 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNR--VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFG    F     +    R  ++GT  +MAPE  S   +  + D++S GI+++E++ 
Sbjct: 155 KLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210

Query: 62  GK 63
           G+
Sbjct: 211 GE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 1e-04
 Identities = 20/61 (32%), Positives = 34/61 (55%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-----SDGKFSVKSDVFSFGILLLE 58
           K++DFG++ A     ++   +  IGT  +MAPE        D  +  K+D++S GI L+E
Sbjct: 143 KLADFGVS-AKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200

Query: 59  I 59
           +
Sbjct: 201 L 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 38.7 bits (90), Expect = 1e-04
 Identities = 23/71 (32%), Positives = 35/71 (49%), Gaps = 15/71 (21%)

Query: 2   NPKISDFGLARAFGGDEIEGNT----NRVIGTYGYMAPEYA----SDGKFS-VKSDVFSF 52
           N KI+DFG++R      I   T    N  +GT  YM+PE      + G +     D++S 
Sbjct: 206 NVKIADFGVSR------ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259

Query: 53  GILLLEIISGK 63
           G+ +LE   G+
Sbjct: 260 GVSILEFYLGR 270

Length = 353

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 38.4 bits (89), Expect = 1e-04
 Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 2/59 (3%)

Query: 5   ISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEIISG 62
           ++DFGL++ F  +E E  T    GT  YMAPE     G      D +S GIL+ E+++G
Sbjct: 146 LTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 38.5 bits (90), Expect = 1e-04
 Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 7/88 (7%)

Query: 4   KISDFGLAR--AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVK---SDVFSFGILLLE 58
           K+ DFG A         +      + GT  YMAPE  + GK       +D++S G ++LE
Sbjct: 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE 198

Query: 59  IISGKKNRGFYHSDNKLNLIGHVSKMHT 86
           + +GK  R +   DN+  ++ HV   H 
Sbjct: 199 MATGK--RPWSELDNEFQIMFHVGAGHK 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 38.2 bits (89), Expect = 1e-04
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGL++     + E       GT  YMAPE  +    +  +D +SFG+L+ E+++G
Sbjct: 138 KLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 38.2 bits (90), Expect = 1e-04
 Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 19/69 (27%)

Query: 4   KISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGI 54
           K++DFGLARAFG   I     T+ V+ T  Y APE       Y++    +V  D++S G 
Sbjct: 138 KLADFGLARAFG---IPLRTYTHEVV-TLWYRAPEILLGSKHYST----AV--DIWSVGC 187

Query: 55  LLLEIISGK 63
           +  E+I+GK
Sbjct: 188 IFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 38.2 bits (89), Expect = 1e-04
 Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 19/70 (27%)

Query: 4   KISDFGLARAFGGDEIEGN-TNRV-----IGTYGYMAPEYAS-DGK---FSVKSDVFSFG 53
           K+ DFG         I G   + V      G   YMAPE  + +     + VKSDV+S G
Sbjct: 144 KLCDFG---------ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLG 194

Query: 54  ILLLEIISGK 63
           I ++E+ +G+
Sbjct: 195 ITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 38.3 bits (90), Expect = 1e-04
 Identities = 23/62 (37%), Positives = 36/62 (58%), Gaps = 11/62 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILLLEII 60
           KI+DFG A+      ++G T  + GT  Y+APE       GK +V  D ++ GIL+ E++
Sbjct: 141 KITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK-AV--DWWALGILIYEML 192

Query: 61  SG 62
           +G
Sbjct: 193 AG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 5/59 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGL++      I    N V+G+  YMAPE      +    D +S G +L E + G
Sbjct: 141 KLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 38.1 bits (88), Expect = 2e-04
 Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D   G  N  IGT  +MAPE  +     D  +  +SD++S GI  +E
Sbjct: 161 KLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218

Query: 59  IISG 62
           +  G
Sbjct: 219 MAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 38.1 bits (88), Expect = 2e-04
 Identities = 21/60 (35%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG   A    E+      ++GT  +MAPE  S   +  + D++S GI+++E+I G+
Sbjct: 158 KLSDFGFC-AQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 38.1 bits (89), Expect = 2e-04
 Identities = 22/67 (32%), Positives = 37/67 (55%), Gaps = 9/67 (13%)

Query: 2   NPKISDFGLARAFGGDEIEGNTN-RVIGTYGYMAPEY----ASDGKFSVKSDVFSFGILL 56
           N K+ DFG++    G  ++     R  G   YMAPE       + K+ +++DV+S GI L
Sbjct: 153 NVKLCDFGIS----GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208

Query: 57  LEIISGK 63
           +E+ +G+
Sbjct: 209 VELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 38.1 bits (88), Expect = 2e-04
 Identities = 20/61 (32%), Positives = 36/61 (59%), Gaps = 4/61 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFG+ +      ++G T R   GT  Y+APE  +   +    D +++G+LL E+++G
Sbjct: 141 KIADFGMCKE---HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Query: 63  K 63
           +
Sbjct: 198 Q 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 38.2 bits (89), Expect = 2e-04
 Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 17/75 (22%)

Query: 4   KISDFGLARAFGGDEIEGN-------------TNRVIGTYGYMAPE--YASDGKFSVKSD 48
           KI+DFGLAR +G                    T++V+ T  Y APE    ++ K+    D
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVD 216

Query: 49  VFSFGILLLEIISGK 63
           ++S G +  E+++GK
Sbjct: 217 MWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 37.9 bits (88), Expect = 2e-04
 Identities = 13/32 (40%), Positives = 23/32 (71%)

Query: 32  YMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           Y+APE       + KSD++ FG++L+E+++GK
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGK 875

Length = 968

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 37.7 bits (87), Expect = 2e-04
 Identities = 20/58 (34%), Positives = 34/58 (58%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLA+  G DE E +         +MA E      ++ +SDV+S+G+ + E+++
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 37.6 bits (87), Expect = 2e-04
 Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 3/62 (4%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N ++SD GLA      +      +  GT GYMAPE   +  +S   D F+ G  + E+++
Sbjct: 133 NCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA 189

Query: 62  GK 63
           G+
Sbjct: 190 GR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 37.4 bits (87), Expect = 2e-04
 Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 6/74 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           K++DFGLARAF G  +   T+ V+ T  Y APE      ++S   D++S G +  E+ + 
Sbjct: 141 KLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT- 197

Query: 63  KKNRGFYHSDNKLN 76
              +  +H D++++
Sbjct: 198 --KKPLFHGDSEID 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 37.5 bits (87), Expect = 3e-04
 Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 2   NPKISDFGLARAFGG----DEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           + K+ DFG+     G    D      T  V+GT  Y APE       +  SD++++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 57  LEIISGK 63
           LE ++G+
Sbjct: 180 LECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 37.2 bits (86), Expect = 3e-04
 Identities = 21/56 (37%), Positives = 29/56 (51%), Gaps = 2/56 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFG++R   G      T    GT  YM+PE      +  KSD++S G +L E+
Sbjct: 145 KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 37.5 bits (87), Expect = 3e-04
 Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 1/63 (1%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNR-VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           N K+ DFG ++        G   + V GT  +M+PE  S   +  K+DV+S G  ++E++
Sbjct: 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201

Query: 61  SGK 63
           + K
Sbjct: 202 TEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 37.3 bits (87), Expect = 3e-04
 Identities = 19/36 (52%), Positives = 24/36 (66%), Gaps = 5/36 (13%)

Query: 32  YMAPE----YASDGKFSVKSDVFSFGILLLEIISGK 63
           YMAPE     A DG + V+SDV+S GI L E+ +GK
Sbjct: 173 YMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 37.2 bits (86), Expect = 3e-04
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 7/62 (11%)

Query: 4   KISDFGLARAFGGDE----IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFGL +A   D+    ++ + +  +  Y   APE     KF + SDV+SFG+ L E+
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWY---APECLIQSKFYIASDVWSFGVTLYEL 205

Query: 60  IS 61
           ++
Sbjct: 206 LT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 37.4 bits (87), Expect = 3e-04
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 6/62 (9%)

Query: 4   KISDFGLARA--FGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFG+ +   FGG      T    GT  Y+APE  +   +    D ++FG+LL E+++
Sbjct: 141 KIADFGMCKENIFGGK----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196

Query: 62  GK 63
           G+
Sbjct: 197 GQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 37.2 bits (87), Expect = 4e-04
 Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 8/78 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNR---VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K++DFG++      ++    ++    +GT  +MAPE      +  K+D++S GI  +E+ 
Sbjct: 138 KLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192

Query: 61  SGKKNRGFYHSDNKLNLI 78
            G+      H    L LI
Sbjct: 193 KGEPPLSDLHPMRVLFLI 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 37.4 bits (86), Expect = 4e-04
 Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 7/82 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA--SDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL++  G   IE   +  +GT  Y +PE        +  KSD+++ G ++ E+ S
Sbjct: 182 KIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 62  GKKNRGFYHSDNKLNLIGHVSK 83
           GK    F+ ++N   LI  + +
Sbjct: 239 GKTP--FHKANNFSQLISELKR 258

Length = 1021

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 36.9 bits (85), Expect = 4e-04
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 13/63 (20%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGL+R   G E+      V  T G     +MA E  +   ++  SDV+S+G+LL E
Sbjct: 164 KIADFGLSR---GQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Query: 59  IIS 61
           I+S
Sbjct: 216 IVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 36.9 bits (85), Expect = 5e-04
 Identities = 17/58 (29%), Positives = 33/58 (56%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG ++ +         +   GT  Y+APE     ++S K+D++S G++L E+++
Sbjct: 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 36.5 bits (84), Expect = 5e-04
 Identities = 20/60 (33%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFG+ +    D +   T    GT  Y+APE  +   +    D ++FG+LL E+++G+
Sbjct: 141 KIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 36.5 bits (84), Expect = 6e-04
 Identities = 21/71 (29%), Positives = 35/71 (49%), Gaps = 4/71 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGL +   G           GT  Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 135 KITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Query: 64  KNRGFYHSDNK 74
               FY+ D++
Sbjct: 193 --LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 36.6 bits (84), Expect = 6e-04
 Identities = 21/63 (33%), Positives = 35/63 (55%), Gaps = 1/63 (1%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNR-VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           N K+ DFG ++      + G   R V GT  +M+PE  S   +  K+DV+S G  ++E++
Sbjct: 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203

Query: 61  SGK 63
           + K
Sbjct: 204 TEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 36.0 bits (83), Expect = 8e-04
 Identities = 21/64 (32%), Positives = 35/64 (54%), Gaps = 4/64 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVI----GTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           K+ DFG AR      + G  + ++    GT  +MAPE  ++  +  KSD++S G  + E+
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201

Query: 60  ISGK 63
            +GK
Sbjct: 202 ATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 36.0 bits (83), Expect = 8e-04
 Identities = 22/66 (33%), Positives = 35/66 (53%), Gaps = 10/66 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG------KFSVKSDVFSFGILLL 57
           K+ DFG++    G+ +       IG   YMAPE    G       ++V+SDV+S G+ +L
Sbjct: 143 KLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198

Query: 58  EIISGK 63
           E+  G+
Sbjct: 199 EMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 36.0 bits (84), Expect = 0.001
 Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 10/84 (11%)

Query: 4   KISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    DE E    T  V+ T  Y APE   S  +++   D++S G +  E++
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Query: 61  SGK---KNRGFYHSDNKLNLIGHV 81
           + K     R +     +LNLI  V
Sbjct: 202 TRKPLFPGRDYID---QLNLIVEV 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 35.6 bits (83), Expect = 0.001
 Identities = 21/62 (33%), Positives = 36/62 (58%), Gaps = 5/62 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR+FG    +  T++V+ T  Y APE  + +   + V  D++S G +  E++ 
Sbjct: 142 KLADFGLARSFGSPNRK-MTHQVV-TRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLL 198

Query: 62  GK 63
             
Sbjct: 199 RV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 35.6 bits (82), Expect = 0.001
 Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG+AR          T   IGT  Y++PE   +  ++ KSD+++ G +L E+ + K
Sbjct: 141 KLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 35.7 bits (82), Expect = 0.001
 Identities = 21/63 (33%), Positives = 36/63 (57%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M  K+ DFG+AR    D +E      +GT  Y++PE   +  ++ K+D++S G +L E+ 
Sbjct: 139 MVAKLGDFGIARQLN-DSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196

Query: 61  SGK 63
           + K
Sbjct: 197 TLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 35.3 bits (82), Expect = 0.001
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLAR + G  ++  T  V+ T  Y APE      ++S   D++S G +  E+++ 
Sbjct: 146 KICDFGLAREY-GSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Query: 63  K 63
           K
Sbjct: 204 K 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 35.6 bits (82), Expect = 0.001
 Identities = 23/73 (31%), Positives = 39/73 (53%), Gaps = 6/73 (8%)

Query: 5   ISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKK 64
           I+DFGLA+       E     V+GT  Y  PE   +  +  K+DV++FG +L ++ + + 
Sbjct: 155 ITDFGLAKQKQP---ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211

Query: 65  NRGFYHSDNKLNL 77
               ++S N L+L
Sbjct: 212 P---FYSTNMLSL 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 35.4 bits (81), Expect = 0.002
 Identities = 21/61 (34%), Positives = 37/61 (60%), Gaps = 4/61 (6%)

Query: 1   MNPKISDFGLARA-FGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           MN  ++DFGL++  + GD   +G   ++     ++A E  +D  ++ KSDV+SFG+ + E
Sbjct: 149 MNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWE 206

Query: 59  I 59
           I
Sbjct: 207 I 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 35.3 bits (81), Expect = 0.002
 Identities = 17/58 (29%), Positives = 34/58 (58%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           +I+DFG+A     D+ +   +       +MA E    G+++ +SDV+S+G+ + E++S
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 35.3 bits (81), Expect = 0.002
 Identities = 18/63 (28%), Positives = 38/63 (60%), Gaps = 4/63 (6%)

Query: 1   MNPKISDFGLARA-FGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           M   ++DFGL++  + GD   +G  +++     ++A E  +D  ++  SDV++FG+ + E
Sbjct: 150 MTVCVADFGLSKKIYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWE 207

Query: 59  IIS 61
           I++
Sbjct: 208 IMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 35.3 bits (82), Expect = 0.002
 Identities = 29/84 (34%), Positives = 43/84 (51%), Gaps = 16/84 (19%)

Query: 4   KISDFGLARAFGGDEIEGNTNRV---IGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEI 59
           KI DFGLAR    D    +T  +   + T  Y APE   + K   K+ D++S G +L E+
Sbjct: 146 KICDFGLARI--ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203

Query: 60  ISGK-----KNRGFYHSDNKLNLI 78
           +S +     K+   Y   ++LNLI
Sbjct: 204 LSNRPLFPGKD---YL--HQLNLI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 35.4 bits (81), Expect = 0.002
 Identities = 18/78 (23%), Positives = 37/78 (47%), Gaps = 6/78 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFGLAR +     +     V+ T  Y APE      ++   D++S G +  E+    
Sbjct: 150 KLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--- 203

Query: 64  KNRGFYHSDNKLNLIGHV 81
           + +  +   + ++ +G +
Sbjct: 204 RRKPLFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 35.0 bits (80), Expect = 0.002
 Identities = 23/72 (31%), Positives = 38/72 (52%), Gaps = 6/72 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFGL +    D   G T +   GT  Y+APE   D  +    D +  G+++ E++ G
Sbjct: 136 KITDFGLCKEGIKD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Query: 63  KKNRGFYHSDNK 74
           +    FY+ D++
Sbjct: 193 R--LPFYNQDHE 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 35.1 bits (81), Expect = 0.002
 Identities = 11/37 (29%), Positives = 24/37 (64%)

Query: 25  RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           +++GT  YMAPE       S  +D+++ G++L ++++
Sbjct: 190 KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 34.9 bits (80), Expect = 0.002
 Identities = 14/30 (46%), Positives = 20/30 (66%)

Query: 32  YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           + APE      FS  SDV+SFGI++ E++S
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 35.0 bits (81), Expect = 0.002
 Identities = 17/36 (47%), Positives = 21/36 (58%), Gaps = 4/36 (11%)

Query: 4   KISDFGLARAFGGDEIEGN---TNRVIGTYGYMAPE 36
           K++DFGLARAF   +       TNRV+ T  Y  PE
Sbjct: 159 KLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 34.7 bits (79), Expect = 0.003
 Identities = 22/71 (30%), Positives = 36/71 (50%), Gaps = 4/71 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGL +    D     T    GT  Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 135 KITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Query: 64  KNRGFYHSDNK 74
               FY+ D++
Sbjct: 193 --LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 34.4 bits (79), Expect = 0.003
 Identities = 18/59 (30%), Positives = 36/59 (61%), Gaps = 4/59 (6%)

Query: 5   ISDFGLARA-FGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           ++DFGL++  + GD   +G   ++     ++A E  +D  ++ KSDV++FG+ + EI +
Sbjct: 154 VADFGLSKKIYSGDYYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 34.4 bits (79), Expect = 0.003
 Identities = 22/59 (37%), Positives = 32/59 (54%), Gaps = 9/59 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--YASD-GKFSVKSDVFSFGILLLEI 59
           K++DFG A       +    N  +GT  +MAPE   A D G++  K DV+S GI  +E+
Sbjct: 155 KLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 34.4 bits (79), Expect = 0.003
 Identities = 24/74 (32%), Positives = 38/74 (51%), Gaps = 7/74 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFGL +       +G T +   GT  Y+APE   D  +    D +  G+++ E++ G
Sbjct: 135 KITDFGLCKE---GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Query: 63  KKNRGFYHSD-NKL 75
           +    FY+ D  KL
Sbjct: 192 R--LPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 34.3 bits (79), Expect = 0.003
 Identities = 20/64 (31%), Positives = 34/64 (53%), Gaps = 10/64 (15%)

Query: 4   KISDFGLAR---AFGGDEIEGNTNRVIGTYGYMAPEY-ASDGKFSVKSDVFSFGILLLEI 59
           K++DFG+A+    F             G+  +MAPE  A  G + + +D++S G  +LE+
Sbjct: 142 KLADFGMAKQVVEFSF------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Query: 60  ISGK 63
            +GK
Sbjct: 196 ATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 34.3 bits (78), Expect = 0.004
 Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY---ASDGKFSVKSDVFSFGILLLEII 60
           K++DFG A       I    N  +GT  +MAPE      +G++  K DV+S GI  +E+ 
Sbjct: 165 KLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218

Query: 61  SGK 63
             K
Sbjct: 219 ERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 34.2 bits (78), Expect = 0.004
 Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY---ASDGKFSVKSDVFSFGILLLEII 60
           K++DFG A            N  +GT  +MAPE      +G++  K DV+S GI  +E+ 
Sbjct: 161 KLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214

Query: 61  SGK 63
             K
Sbjct: 215 ERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 34.3 bits (79), Expect = 0.004
 Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 3/61 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEIISG 62
           KI+DFGLAR + G   +  T +V+ T  Y APE          + D+++ G +L E+++ 
Sbjct: 148 KIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Query: 63  K 63
           K
Sbjct: 206 K 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	92
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.69
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.68
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.68
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.67
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.66
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.65
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.63
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.62
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.62
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.62
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.62
KOG0578	550	consensus p21-activated serine/threonine protein k	99.61
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.61
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.59
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.57
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.56
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.55
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.55
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.55
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.55
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.54
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.54
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.51
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.5
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.5
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.47
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.45
PTZ00284	467	protein kinase; Provisional	99.43
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.42
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.41
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.4
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.4
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.39
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.38
PTZ00283	496	serine/threonine protein kinase; Provisional	99.38
PHA03207	392	serine/threonine kinase US3; Provisional	99.37
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.37
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.35
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.35
KOG0198	313	consensus MEKK and related serine/threonine protei	99.34
PTZ00267	478	NIMA-related protein kinase; Provisional	99.34
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.34
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.33
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.33
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.33
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.33
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.33
KOG0589	426	consensus Serine/threonine protein kinase [General	99.32
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.32
PTZ00036	440	glycogen synthase kinase; Provisional	99.32
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.32
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.32
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.31
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.3
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.3
PHA02882	294	putative serine/threonine kinase; Provisional	99.3
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.3
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.29
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.29
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.29
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.29
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.29
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.29
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.29
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.28
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.28
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.28
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.28
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.28
KOG0605	550	consensus NDR and related serine/threonine kinases	99.27
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.27
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.27
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.27
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.26
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.26
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.26
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.26
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.26
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.25
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.25
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.25
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.25
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.25
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.25
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.25
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.25
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.24
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.24
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.24
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.23
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.23
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.23
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.23
PHA02988	283	hypothetical protein; Provisional	99.23
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.23
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.23
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.23
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.22
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.22
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.22
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.22
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.22
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.22
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.21
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.21
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.21
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.21
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.21
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.21
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.21
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.21
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.2
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.2
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.2
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.2
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.19
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.19
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.19
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.19
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.19
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.18
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.18
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.18
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.17
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.17
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.17
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.16
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.16
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.16
PHA03212	391	serine/threonine kinase US3; Provisional	99.15
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.15
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.15
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.15
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.15
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.15
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.14
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.14
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.14
PHA03210	501	serine/threonine kinase US3; Provisional	99.13
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.13
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.12
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.12
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.12
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.12
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.11
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.11
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.11
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.11
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.11
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.11
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.11
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.11
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.1
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.1
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.1
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.1
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.09
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.09
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.09
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.09
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.08
PHA03211	461	serine/threonine kinase US3; Provisional	99.08
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.08
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.08
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.08
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.08
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.07
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.07
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.07
KOG0610	459	consensus Putative serine/threonine protein kinase	99.07
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.07
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.06
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.06
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.06
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.06
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.06
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.05
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.05
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.04
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.04
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.04
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.04
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.04
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.03
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.03
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.03
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.03
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.03
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.03
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.03
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.03
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.02
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.02
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.02
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.02
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.02
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.02
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.02
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.01
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.01
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.01
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.01
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.01
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	98.99
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	98.99
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	98.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	98.98
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	98.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	98.98
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	98.98
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	98.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	98.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.98
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	98.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	98.98
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	98.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	98.98
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	98.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	98.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	98.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	98.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	98.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	98.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	98.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	98.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	98.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	98.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	98.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	98.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	98.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	98.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	98.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	98.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	98.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	98.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	98.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	98.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	98.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	98.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	98.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	98.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	98.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	98.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	98.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	98.95
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	98.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	98.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	98.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	98.94
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	98.94
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	98.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	98.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	98.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	98.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	98.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	98.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	98.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	98.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	98.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	98.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	98.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	98.93
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	98.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	98.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	98.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	98.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	98.92
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	98.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	98.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	98.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	98.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	98.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	98.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	98.92
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	98.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	98.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	98.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	98.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	98.91
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	98.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	98.91
PHA03209	357	serine/threonine kinase US3; Provisional	98.91
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	98.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	98.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	98.9
PLN00009	294	cyclin-dependent kinase A; Provisional	98.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	98.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	98.9
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	98.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	98.9
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	98.9
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	98.9
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	98.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	98.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	98.89
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	98.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	98.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	98.88
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	98.88
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	98.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	98.88
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	98.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	98.88
PLN00181	793	protein SPA1-RELATED; Provisional	98.87
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	98.87
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	98.87
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	98.87
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	98.87
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	98.87
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	98.87
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	98.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	98.86
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	98.86
KOG0584	632	consensus Serine/threonine protein kinase [General	98.86
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	98.86
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	98.86
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	98.86
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	98.86
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	98.85
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	98.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	98.85
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	98.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	98.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	98.85
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	98.84
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	98.84
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	98.84
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	98.84
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	98.84
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	98.84
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	98.84
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	98.83
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	98.83
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	98.83
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	98.83
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	98.83
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	98.83
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	98.82
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	98.82
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	98.82
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	98.82
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	98.82
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	98.82
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	98.81
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	98.81
PTZ00024	335	cyclin-dependent protein kinase; Provisional	98.81
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	98.81
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	98.81
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	98.81
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	98.8
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	98.8
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	98.8
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	98.8
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	98.8
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	98.79
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	98.79
KOG0586	596	consensus Serine/threonine protein kinase [General	98.79
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	98.79
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	98.79
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	98.78
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	98.76
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	98.76
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	98.76
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	98.75
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	98.75
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	98.74
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	98.74
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	98.73
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	98.72
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	98.7
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	98.7
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	98.7
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	98.69
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	98.68
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	98.67
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	98.66
KOG0607	463	consensus MAP kinase-interacting kinase and relate	98.66
KOG1989	738	consensus ARK protein kinase family [Signal transd	98.64
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	98.63
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	98.62
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	98.6
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	98.59
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	98.59
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	98.58
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	98.58
KOG3653	534	consensus Transforming growth factor beta/activin	98.56
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	98.56
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	98.54
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	98.48
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	98.47
KOG1027	903	consensus Serine/threonine protein kinase and endo	98.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.4
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.19
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	98.15
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.11
KOG1152	772	consensus Signal transduction serine/threonine kin	98.09
PLN03224	507	probable serine/threonine protein kinase; Provisio	98.03
KOG0590	601	consensus Checkpoint kinase and related serine/thr	97.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	97.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	97.93
KOG2052	513	consensus Activin A type IB receptor, serine/threo	97.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	97.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.64
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	97.29
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	97.25
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	97.24
KOG1167	418	consensus Serine/threonine protein kinase of the C	97.16
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	97.12
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	96.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	96.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	96.43
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	96.24
KOG0606	1205	consensus Microtubule-associated serine/threonine	95.31
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	93.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	91.58
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	90.47
COG4248	637	Uncharacterized protein with protein kinase and he	88.31
PRK09188	365	serine/threonine protein kinase; Provisional	85.09

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.69  E-value=8.5e-18  Score=97.48  Aligned_cols=73  Identities=29%  Similarity=0.430  Sum_probs=59.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++.+....   ...+.+|++.||+||++....|..++|+|++|+++|++++|++||......+.+.+
T Consensus       153 ~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  153 VLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             eEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            47999999999875332   23457999999999999999999999999999999999999999765555444433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=5.3e-17  Score=97.76  Aligned_cols=76  Identities=30%  Similarity=0.470  Sum_probs=62.1

Q ss_pred             CceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      +++||+|||++......  .....+.+|++-|.+||++...+++..+|+||+||++|.++.|+|||+...-+++...+
T Consensus       155 ~~VKIgDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I  230 (592)
T KOG0575|consen  155 MNVKIGDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI  230 (592)
T ss_pred             CcEEecccceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence            47899999999876532  23455689999999999998888899999999999999999999998777555555444

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=5.9e-17  Score=98.74  Aligned_cols=75  Identities=27%  Similarity=0.451  Sum_probs=62.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      ++||+|||+++..-..  ....++++|++-|++||++....|+...|.|++|+++++|+.|+.||++.++++.+.-|
T Consensus       506 h~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI  580 (694)
T KOG0694|consen  506 HVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI  580 (694)
T ss_pred             cEEecccccccccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            6899999999864322  12466799999999999999999999999999999999999999998877776655433

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.67  E-value=4.6e-17  Score=98.39  Aligned_cols=80  Identities=23%  Similarity=0.212  Sum_probs=69.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      .+||+|||.++.....     ....+.+..|.+||++.+.+|+.+.|+||+||++.|+.+|.|.|++..+.+++.++..+
T Consensus       329 ~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV  403 (586)
T ss_pred             ceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence            5799999998864322     22578899999999999999999999999999999999999999999999999888887


Q ss_pred             hhhcc
Q 034502           82 SKMHT   86 (92)
Q Consensus        82 ~~~~~   86 (92)
                      ..++.
T Consensus       404 lG~Pp  408 (586)
T KOG0667|consen  404 LGLPP  408 (586)
T ss_pred             hCCCC
Confidence            76554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=1.1e-16  Score=89.97  Aligned_cols=78  Identities=29%  Similarity=0.415  Sum_probs=63.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      .+|++|||+++.+....  .-..+.+|++.|++||.+...+|+.++|+|++||+++||..=++||.+.   +.+.+-.+|
T Consensus       166 vvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI  240 (375)
T KOG0591|consen  166 VVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKI  240 (375)
T ss_pred             ceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHH
Confidence            47999999999775432  2345579999999999999999999999999999999999999997666   455555555


Q ss_pred             hhh
Q 034502           82 SKM   84 (92)
Q Consensus        82 ~~~   84 (92)
                      .++
T Consensus       241 ~qg  243 (375)
T KOG0591|consen  241 EQG  243 (375)
T ss_pred             HcC
Confidence            554

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.65  E-value=1.8e-16  Score=90.91  Aligned_cols=70  Identities=33%  Similarity=0.429  Sum_probs=57.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      +++++|||+++.....  .....+++||+.|++||++...+|+...|.|++|+++++|++|.+||...+...
T Consensus       163 Hi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~  232 (357)
T KOG0598|consen  163 HIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK  232 (357)
T ss_pred             cEEEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence            6899999999854322  223455899999999999999999999999999999999999999966555433

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=4.6e-16  Score=91.10  Aligned_cols=75  Identities=29%  Similarity=0.482  Sum_probs=62.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||++..+.....  ....+.|+++|++||++.+..|+.++|+|++|+..+|+.+|.||+...+++.-+.++
T Consensus       149 ~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI  223 (467)
T KOG0201|consen  149 DVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI  223 (467)
T ss_pred             cEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence            579999999877654322  235589999999999999889999999999999999999999999988876554433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=4.8e-16  Score=92.45  Aligned_cols=86  Identities=26%  Similarity=0.262  Sum_probs=67.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||+++........ .-+..+-+.+|.+||.+.+.. |+...|+||.||++.|++.|++.+++..+.+++.+|-+
T Consensus       256 ~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk  334 (560)
T KOG0600|consen  256 VLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK  334 (560)
T ss_pred             CEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence            4799999999976543222 122345578999999988655 89999999999999999999999999999888888877


Q ss_pred             HhhhcccC
Q 034502           81 VSKMHTTF   88 (92)
Q Consensus        81 ~~~~~~~~   88 (92)
                      +-....+.
T Consensus       335 lcGSP~e~  342 (560)
T KOG0600|consen  335 LCGSPTED  342 (560)
T ss_pred             HhCCCChh
Confidence            65544443

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=5.8e-16  Score=88.72  Aligned_cols=83  Identities=29%  Similarity=0.351  Sum_probs=64.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||+++...........+..+.|.+|.+||.+.. ..|+...|+||.||++.|+++|++.|.+.+..+++.++..
T Consensus       163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~  242 (359)
T KOG0660|consen  163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE  242 (359)
T ss_pred             CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence            368999999997643211112244677899999998754 4588999999999999999999999999998888877766


Q ss_pred             Hhhh
Q 034502           81 VSKM   84 (92)
Q Consensus        81 ~~~~   84 (92)
                      +...
T Consensus       243 ~lGt  246 (359)
T KOG0660|consen  243 LLGT  246 (359)
T ss_pred             hcCC
Confidence            5443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.3e-15  Score=93.11  Aligned_cols=77  Identities=32%  Similarity=0.455  Sum_probs=61.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||++....+.   ....+.||++.|.+||++.+.+|. .++|+|++|++++.+++|+.|   |+.+++..++.+
T Consensus       150 nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP---FdDdNir~LLlK  223 (786)
T KOG0588|consen  150 NIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP---FDDDNIRVLLLK  223 (786)
T ss_pred             CEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC---CCCccHHHHHHH
Confidence            4799999999764433   223457899999999999988876 678999999999999999999   456677777777


Q ss_pred             Hhhh
Q 034502           81 VSKM   84 (92)
Q Consensus        81 ~~~~   84 (92)
                      |++.
T Consensus       224 V~~G  227 (786)
T KOG0588|consen  224 VQRG  227 (786)
T ss_pred             HHcC
Confidence            6653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.62  E-value=1.4e-15  Score=85.88  Aligned_cols=72  Identities=28%  Similarity=0.423  Sum_probs=60.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      ++|+.|||+++....     ...+.+|++.|++||++...+++...|.|++|++.+||+.|.+||....+..+.++|
T Consensus       182 ~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI  253 (355)
T KOG0616|consen  182 HIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI  253 (355)
T ss_pred             cEEEEeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence            579999999997533     245578999999999999999999999999999999999999997776664444433

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1e-15  Score=91.75  Aligned_cols=67  Identities=25%  Similarity=0.497  Sum_probs=56.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|+.|||++..+.....  ...+.+|++.|++||++....|+++.|+||+|++.+||+.|+|||-+.+
T Consensus       407 ~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~  473 (550)
T KOG0578|consen  407 SVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN  473 (550)
T ss_pred             cEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC
Confidence            479999999987755432  3445789999999999998899999999999999999999999965533

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.5e-15  Score=89.57  Aligned_cols=73  Identities=27%  Similarity=0.396  Sum_probs=60.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      ++|++|||+++.--  .......+++|++-|++||++.+.+|+.+.|.|++|++++|++.|++||.+-++++.++
T Consensus       488 HiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~  560 (683)
T KOG0696|consen  488 HIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ  560 (683)
T ss_pred             ceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            68999999998521  12234566899999999999999999999999999999999999999977766655543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.59  E-value=1.1e-15  Score=87.81  Aligned_cols=80  Identities=26%  Similarity=0.257  Sum_probs=65.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||.++.+.....   ..+...++.|.+||.+.+.. |+.+.|+||.||++.|++.|++.|++....+++..+.+
T Consensus       164 ~LKicDFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik  240 (364)
T KOG0658|consen  164 VLKICDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK  240 (364)
T ss_pred             eEEeccCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence            469999999998765433   23466788999999987655 89999999999999999999999999888788777766


Q ss_pred             Hhhh
Q 034502           81 VSKM   84 (92)
Q Consensus        81 ~~~~   84 (92)
                      +...
T Consensus       241 ~lG~  244 (364)
T KOG0658|consen  241 VLGT  244 (364)
T ss_pred             HhCC
Confidence            5443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.57  E-value=2.4e-15  Score=91.14  Aligned_cols=77  Identities=31%  Similarity=0.528  Sum_probs=61.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      ++|++|||+++.+....  ...++..|++.|++||.+....|+..+|.|++||++||++.|+||   |...++.++...|
T Consensus       138 ~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PP---F~a~si~~Lv~~I  212 (808)
T KOG0597|consen  138 TLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPP---FYARSITQLVKSI  212 (808)
T ss_pred             ceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCC---chHHHHHHHHHHH
Confidence            57999999999765322  224457899999999999999999999999999999999999999   4455566666555


Q ss_pred             hh
Q 034502           82 SK   83 (92)
Q Consensus        82 ~~   83 (92)
                      .+
T Consensus       213 ~~  214 (808)
T KOG0597|consen  213 LK  214 (808)
T ss_pred             hc
Confidence            43

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.56  E-value=3.9e-15  Score=85.63  Aligned_cols=76  Identities=33%  Similarity=0.482  Sum_probs=60.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC--CCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY--HSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~--~~~~~~~~~~   79 (92)
                      .+|++|||+++.+..+    ...+++||..|++||.+....|+.+.|+||+|..++|+..|+.|+...  ...+.+.++.
T Consensus       217 eVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~  292 (364)
T KOG0581|consen  217 EVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC  292 (364)
T ss_pred             CEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH
Confidence            5899999999876543    245588999999999999999999999999999999999999998764  2234444444


Q ss_pred             HH
Q 034502           80 HV   81 (92)
Q Consensus        80 ~~   81 (92)
                      .|
T Consensus       293 ~I  294 (364)
T KOG0581|consen  293 AI  294 (364)
T ss_pred             HH
Confidence            43

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.55  E-value=7.5e-15  Score=88.10  Aligned_cols=81  Identities=22%  Similarity=0.381  Sum_probs=63.4

Q ss_pred             CceEEeeeeceeeeCCCccc---------ccc--cccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            1 MNPKISDFGLARAFGGDEIE---------GNT--NRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~---------~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ++++|.|||.++.+.+....         ...  .+++|+-.|.+||++.....+...|+|++||++++|+.|++||...
T Consensus       211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            47899999999977543211         111  4578999999999998888889999999999999999999997777


Q ss_pred             CCcchhhHHHHH
Q 034502           70 HSDNKLNLIGHV   81 (92)
Q Consensus        70 ~~~~~~~~~~~~   81 (92)
                      ++..+++++..+
T Consensus       291 NeyliFqkI~~l  302 (604)
T KOG0592|consen  291 NEYLIFQKIQAL  302 (604)
T ss_pred             cHHHHHHHHHHh
Confidence            666666555443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=5.1e-15  Score=88.85  Aligned_cols=75  Identities=29%  Similarity=0.428  Sum_probs=65.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      +|+.|||+++.+...   .+..+++|++.|.+||++...++....|.|++|++++|+++|.|||+..++..+.+++-+
T Consensus       559 ~KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk  633 (732)
T KOG0614|consen  559 LKLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK  633 (732)
T ss_pred             eEEeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence            689999999987543   345678999999999999999999999999999999999999999999999887766543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.55  E-value=2.2e-15  Score=89.50  Aligned_cols=84  Identities=38%  Similarity=0.521  Sum_probs=60.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+||+|||+++............ ..-+..|++||.+....|+.++|+||+|++++|+++ |+.||......+..+.+++
T Consensus       341 ~vKIsDFGLAr~~~d~~Y~~~~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~  419 (468)
T KOG0197|consen  341 VVKISDFGLARLIGDDEYTASEG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER  419 (468)
T ss_pred             eEEEcccccccccCCCceeecCC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence            47999999999543332222221 122457999999999999999999999999999985 8888777766665555555


Q ss_pred             Hhhhcc
Q 034502           81 VSKMHT   86 (92)
Q Consensus        81 ~~~~~~   86 (92)
                      =.++.+
T Consensus       420 GyRlp~  425 (468)
T KOG0197|consen  420 GYRLPR  425 (468)
T ss_pred             cCcCCC
Confidence            444443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.55  E-value=4.1e-15  Score=84.44  Aligned_cols=78  Identities=24%  Similarity=0.369  Sum_probs=62.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      +|++|||+++.+..+..  .-+-++.+.+|.+||.+.+ ..|+.+.|+|++||++.|+++|++.|++.-.-+++..+...
T Consensus       140 vKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~kt  217 (396)
T KOG0593|consen  140 VKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKT  217 (396)
T ss_pred             EEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHH
Confidence            69999999997652211  1223678899999999887 56999999999999999999999999888877777766654


Q ss_pred             h
Q 034502           82 S   82 (92)
Q Consensus        82 ~   82 (92)
                      .
T Consensus       218 L  218 (396)
T KOG0593|consen  218 L  218 (396)
T ss_pred             H
Confidence            3

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.54  E-value=1.2e-14  Score=83.42  Aligned_cols=81  Identities=28%  Similarity=0.343  Sum_probs=64.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||+++....+.  ..-+..+-+.+|.+||.+.+.. |+...|+||+||++.|++.++|.|++.-+.+++.++..
T Consensus       215 ~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~  292 (419)
T KOG0663|consen  215 ILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK  292 (419)
T ss_pred             cEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence            36999999999876442  2223345577899999988765 88999999999999999999999988888888777766


Q ss_pred             Hhhh
Q 034502           81 VSKM   84 (92)
Q Consensus        81 ~~~~   84 (92)
                      +..-
T Consensus       293 llGt  296 (419)
T KOG0663|consen  293 LLGT  296 (419)
T ss_pred             HhCC
Confidence            5443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=9.6e-15  Score=84.00  Aligned_cols=75  Identities=27%  Similarity=0.424  Sum_probs=63.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      ++|+.|||+++.--.  ......+++|++.|++||++-...|+...|.|.+|++++||+.|+.||...+++..++++
T Consensus       306 HIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  306 HIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             ceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            689999999985321  222345689999999999998888999999999999999999999999998888777655

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.51  E-value=3.5e-14  Score=79.27  Aligned_cols=84  Identities=25%  Similarity=0.257  Sum_probs=63.6

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      +|++|||+++.+..+...  ....+-+.+|.+||.+.+.. |+...|+|+.||++.|++-|.|.|++...-+++..+-++
T Consensus       140 lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~  217 (318)
T KOG0659|consen  140 LKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA  217 (318)
T ss_pred             EEeecccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence            699999999987654322  22235678999999887654 889999999999999999999998877766666666665


Q ss_pred             hhhcccC
Q 034502           82 SKMHTTF   88 (92)
Q Consensus        82 ~~~~~~~   88 (92)
                      ..-..+.
T Consensus       218 LGTP~~~  224 (318)
T KOG0659|consen  218 LGTPTPD  224 (318)
T ss_pred             cCCCCcc
Confidence            5544443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4e-14  Score=84.05  Aligned_cols=83  Identities=24%  Similarity=0.233  Sum_probs=66.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||++|......+   -+.++.+++|.+||++... .|+.+.|+|++||+++|+.+=++.|++..+-+++.++-.
T Consensus       148 ~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  148 VIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             eeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            479999999998754322   2336778999999987654 488999999999999999999999999998888888877


Q ss_pred             Hhhhccc
Q 034502           81 VSKMHTT   87 (92)
Q Consensus        81 ~~~~~~~   87 (92)
                      |..-..+
T Consensus       225 VLGtP~~  231 (538)
T KOG0661|consen  225 VLGTPDK  231 (538)
T ss_pred             HhCCCcc
Confidence            6554443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.50  E-value=5.3e-14  Score=82.38  Aligned_cols=68  Identities=38%  Similarity=0.578  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc--CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS--DGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++||+|||+++......  .......|+..|++||++.  ...|+.+.|+||+|+++||+++|+.||+....
T Consensus       182 ~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  182 TLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             EEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            68999999998654321  1222357889999999998  56899999999999999999999999877764

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.47  E-value=1.6e-14  Score=89.75  Aligned_cols=80  Identities=34%  Similarity=0.469  Sum_probs=61.2

Q ss_pred             CceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 034502            1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~   79 (92)
                      +.|||+|||+++-.-..+.........-+..|++||.+.+..|+..+|+|++|+++||+++ |+.||.+...++..+.+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            3589999999985543333322222233567999999999999999999999999999985 889998888777666654


Q ss_pred             H
Q 034502           80 H   80 (92)
Q Consensus        80 ~   80 (92)
                      .
T Consensus       720 ~  720 (774)
T KOG1026|consen  720 A  720 (774)
T ss_pred             c
Confidence            4

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.1e-13  Score=83.65  Aligned_cols=69  Identities=36%  Similarity=0.519  Sum_probs=53.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-----------CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-----------FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-----------~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+..+..+.......+.+|+..|++||.+....           .+++.|+||+||++|+|+.|++||+.+.
T Consensus       497 ~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  497 RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence            36899999998776554433444578999999999775332           3467899999999999999999987665

>PTZ00284 protein kinase; Provisional

Probab=99.43  E-value=3.1e-13  Score=81.44  Aligned_cols=70  Identities=20%  Similarity=0.285  Sum_probs=54.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+|++|||.+.....     ......++..|++||++....++.+.|+|++||+++++++|++||......+.+.
T Consensus       286 ~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        286 RVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             eEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            379999998753211     1223578889999999988888999999999999999999999987665444333

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.42  E-value=2.7e-13  Score=77.59  Aligned_cols=79  Identities=27%  Similarity=0.283  Sum_probs=59.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||+++...-+.  ..-.+.+.+.+|.+||++.+. .|+...|+|++||++.|++++++.|.+..+.+++..+-.
T Consensus       158 ~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~  235 (323)
T KOG0594|consen  158 VLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR  235 (323)
T ss_pred             cEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence            47999999998554222  223345677889999998876 588999999999999999999999877776555555544


Q ss_pred             Hh
Q 034502           81 VS   82 (92)
Q Consensus        81 ~~   82 (92)
                      +.
T Consensus       236 ~l  237 (323)
T KOG0594|consen  236 LL  237 (323)
T ss_pred             Hc
Confidence            43

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.41  E-value=4.8e-14  Score=85.90  Aligned_cols=69  Identities=32%  Similarity=0.498  Sum_probs=57.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+||+|||.++.....   .....+.|+..|++||++...+.+.+.|+|++|+++|||++|.-||...+..-
T Consensus       250 ~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA  318 (904)
T KOG4721|consen  250 VVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA  318 (904)
T ss_pred             eEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence            3799999998865321   22445889999999999999999999999999999999999999987776543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=5.7e-13  Score=78.40  Aligned_cols=67  Identities=33%  Similarity=0.500  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FS-VKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~-~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||++.....  ........+|++.|++||++.... |. .++|+||+|++++.++.|+-||...+
T Consensus       159 ~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~  227 (370)
T KOG0583|consen  159 NLKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN  227 (370)
T ss_pred             CEEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence            689999999986521  112344578999999999998877 76 67899999999999999999976633

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.40  E-value=1.4e-12  Score=72.74  Aligned_cols=64  Identities=28%  Similarity=0.449  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      -+|++|||++.......   ......|++.|++||+++..+|+.+.|+|++|++++-++.|.+||.+
T Consensus       151 ~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  151 AVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             ceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            47999999998765221   12336789999999999999999999999999999999999999655

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.39  E-value=2.8e-13  Score=86.70  Aligned_cols=74  Identities=38%  Similarity=0.502  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++-+-............-+..|++||.+....|+.+.|+|++|+++||+++ |..||......+..
T Consensus       840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~  914 (1025)
T KOG1095|consen  840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL  914 (1025)
T ss_pred             cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence            589999999984332222222222233567999999998899999999999999999996 88898777755443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.38  E-value=5.4e-14  Score=81.52  Aligned_cols=77  Identities=25%  Similarity=0.316  Sum_probs=61.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      .++++|||.+..-..     .....+.+..|.+||++.+.+++.+.|+||+||++.|+.+|...|+.-+..+-+...+.|
T Consensus       250 ~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI  324 (415)
T KOG0671|consen  250 AIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI  324 (415)
T ss_pred             ceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence            579999999875322     234467788999999999999999999999999999999999998776654555555555


Q ss_pred             hh
Q 034502           82 SK   83 (92)
Q Consensus        82 ~~   83 (92)
                      .+
T Consensus       325 lG  326 (415)
T KOG0671|consen  325 LG  326 (415)
T ss_pred             hC
Confidence            44

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.38  E-value=1.1e-12  Score=79.69  Aligned_cols=69  Identities=29%  Similarity=0.441  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++...............|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~  249 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN  249 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            479999999876543221222334568889999999988888899999999999999999999976543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.37  E-value=3.1e-12  Score=75.73  Aligned_cols=72  Identities=21%  Similarity=0.242  Sum_probs=54.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .++++|||+++...............|+..|++||.+....++.+.|+|++|++++++++|+.||.......
T Consensus       223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~  294 (392)
T PHA03207        223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS  294 (392)
T ss_pred             CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC
Confidence            478999999875543222112223567889999999988888899999999999999999999986655443

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.37  E-value=9.2e-13  Score=76.07  Aligned_cols=68  Identities=29%  Similarity=0.437  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       139 ~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~  206 (323)
T cd05616         139 HIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  206 (323)
T ss_pred             cEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence            47899999987532111  112235678899999999888888999999999999999999999876543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=4.9e-14  Score=82.50  Aligned_cols=69  Identities=32%  Similarity=0.424  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS---VKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~---~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++.....   ....+.+|++.|.+||++......   .+.|+||+||+++-.++|.+||+..-...
T Consensus       317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            4799999999876421   123457999999999998765533   36799999999999999999987655544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=2.1e-12  Score=75.86  Aligned_cols=86  Identities=41%  Similarity=0.697  Sum_probs=63.0

Q ss_pred             CceEEeeeeceeeeCCCccccccccc-ccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 034502            1 MNPKISDFGLARAFGGDEIEGNTNRV-IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~   79 (92)
                      |..|++|||+++......  ...... .|+..|++||+......+.+.|+||+|+++.|+++|+++.....+.....+..
T Consensus       214 ~~aKlsDFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CCEEccCccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            467999999996543201  111112 68889999999887778899999999999999999998876554445555777


Q ss_pred             HHhhhcccC
Q 034502           80 HVSKMHTTF   88 (92)
Q Consensus        80 ~~~~~~~~~   88 (92)
                      |++..+.+.
T Consensus       292 w~~~~~~~~  300 (361)
T KOG1187|consen  292 WAKPLLEEG  300 (361)
T ss_pred             HHHHHHHCc
Confidence            776666543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.34  E-value=1.5e-13  Score=78.98  Aligned_cols=68  Identities=32%  Similarity=0.561  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCC-CcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGG-DEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||.++.... ...........|++.|++||++.... ....+|+|++||++.||++|++|+..+
T Consensus       156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            579999998876542 11112233468899999999997532 224889999999999999999998875

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.34  E-value=3.2e-12  Score=77.40  Aligned_cols=69  Identities=25%  Similarity=0.403  Sum_probs=53.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++..............+|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       207 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            478999999986543221112334568889999999887778889999999999999999999975443

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.34  E-value=2.4e-12  Score=74.21  Aligned_cols=67  Identities=33%  Similarity=0.523  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       134 ~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         134 HIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             CEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence            47899999987542211  12233567889999999887778889999999999999999999986554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.33  E-value=4.3e-12  Score=71.99  Aligned_cols=71  Identities=24%  Similarity=0.316  Sum_probs=53.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...... ........++..|++||.+....++.+.|+|++|++++++++|++||......+
T Consensus       138 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~  208 (287)
T cd07848         138 VLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID  208 (287)
T ss_pred             cEEEeeccCcccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            46899999987653211 111222457788999999877778888999999999999999999987654433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.33  E-value=4e-12  Score=72.23  Aligned_cols=69  Identities=26%  Similarity=0.332  Sum_probs=53.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++.....   .......++..|++||.+....++.+.|+|++|++++++++|++||......+
T Consensus       148 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~  216 (290)
T cd07862         148 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD  216 (290)
T ss_pred             CEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence            4789999998764322   11223457788999999877778889999999999999999999977655433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.5e-12  Score=76.57  Aligned_cols=68  Identities=34%  Similarity=0.512  Sum_probs=56.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      +++|+|+|++..+.....   ....+|+..|++||++....|+...|.|++||++++|+.|+.||.-..+.
T Consensus       325 hvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK  392 (591)
T KOG0986|consen  325 HVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK  392 (591)
T ss_pred             CeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence            689999999987754332   22247999999999998888999999999999999999999998655544

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.33  E-value=1.2e-13  Score=78.89  Aligned_cols=68  Identities=32%  Similarity=0.513  Sum_probs=57.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .|++|||++..+....  ....+.+|+++|++||++..-+|...+|+||+|+...|+..|+|||+..++.
T Consensus       168 AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM  235 (502)
T KOG0574|consen  168 AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM  235 (502)
T ss_pred             hhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence            4789999997665432  2344579999999999998888999999999999999999999999887765

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.33  E-value=2.7e-12  Score=75.23  Aligned_cols=46  Identities=24%  Similarity=0.392  Sum_probs=40.4

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       196 ~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~  241 (363)
T cd05628         196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP  241 (363)
T ss_pred             ccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence            4688899999999888888999999999999999999999865443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.32  E-value=9.8e-13  Score=77.93  Aligned_cols=74  Identities=31%  Similarity=0.428  Sum_probs=60.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|+.|||+++.+....  ....+.+|++.|++||.+...+|+.+.|+|++||.++|+.+=+++|...+......+
T Consensus       144 ~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k  217 (426)
T KOG0589|consen  144 KVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK  217 (426)
T ss_pred             ceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH
Confidence            36899999999876543  134557899999999999999999999999999999999999999766665544333

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.32  E-value=3.9e-12  Score=73.50  Aligned_cols=67  Identities=28%  Similarity=0.420  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....  ........|+..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       139 ~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         139 HIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             CEEEeecCcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            4789999988643211  111233567889999999987778889999999999999999999976544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.32  E-value=3.5e-12  Score=76.55  Aligned_cols=69  Identities=25%  Similarity=0.333  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++......   ......+++.|++||.+... .++.+.|+||+|++++++++|.+||......+
T Consensus       209 ~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  278 (440)
T PTZ00036        209 TLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD  278 (440)
T ss_pred             ceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            47999999997553221   12234678889999987654 57888999999999999999999986655433

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.32  E-value=6.1e-12  Score=74.35  Aligned_cols=70  Identities=27%  Similarity=0.366  Sum_probs=57.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||++.....   .......+|++.|++||++....|+...|+|++|++++.++.|.+||........
T Consensus       177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~  246 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI  246 (382)
T ss_pred             cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence            579999999987654   2234457899999999999888999999999999999999999999766654443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.32  E-value=9.3e-12  Score=70.79  Aligned_cols=67  Identities=33%  Similarity=0.542  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++.......   ......|+..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       140 ~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         140 HIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             CEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence            47899999987643211   11224678889999999877888999999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.31  E-value=4e-12  Score=73.49  Aligned_cols=68  Identities=26%  Similarity=0.404  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       139 ~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~  206 (324)
T cd05589         139 FVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE  206 (324)
T ss_pred             cEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence            47899999876432211  112335678899999998877788889999999999999999999865543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=4.1e-12  Score=77.10  Aligned_cols=70  Identities=23%  Similarity=0.453  Sum_probs=57.6

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      +|+.|||++-.+.+.   ....+.+|+..|-+||++.+..|. +..|+|++|++++-+..|++||+.-+..+.+
T Consensus       158 VKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL  228 (864)
T KOG4717|consen  158 VKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL  228 (864)
T ss_pred             eEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence            689999998776543   234557899999999999988887 6789999999999999999998877655554

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.30  E-value=6.2e-12  Score=72.83  Aligned_cols=66  Identities=24%  Similarity=0.520  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       134 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~  199 (327)
T cd05617         134 HIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII  199 (327)
T ss_pred             CEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence            47899999887432111  1123356788999999988778888999999999999999999998643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.30  E-value=1.2e-11  Score=70.70  Aligned_cols=70  Identities=19%  Similarity=0.148  Sum_probs=52.8

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++........     .......|+..|++|+......++.+.|+||+|++++++++|+.||.....
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            4689999998765321100     111123578889999998877788999999999999999999999877643

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.30  E-value=2.5e-12  Score=74.50  Aligned_cols=65  Identities=29%  Similarity=0.477  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++....     ......|++.|++||.+....++.+.|+|++|++++++++|++||.....
T Consensus       139 ~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  203 (333)
T cd05600         139 HIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP  203 (333)
T ss_pred             CEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence            478999999875422     12235678889999998877888999999999999999999999865543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.29  E-value=4.8e-12  Score=73.09  Aligned_cols=68  Identities=25%  Similarity=0.389  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       134 ~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~  201 (320)
T cd05590         134 HCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE  201 (320)
T ss_pred             cEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence            47899999887532111  112235678899999998877788899999999999999999999865543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.29  E-value=7.3e-12  Score=72.29  Aligned_cols=68  Identities=31%  Similarity=0.456  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       134 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~  201 (316)
T cd05619         134 HIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE  201 (316)
T ss_pred             CEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence            47899999887532111  112234678889999998877788999999999999999999999765543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.29  E-value=6.5e-12  Score=72.65  Aligned_cols=68  Identities=28%  Similarity=0.447  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|++||.....
T Consensus       139 ~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~  206 (323)
T cd05615         139 HIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE  206 (323)
T ss_pred             CEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence            47899999887532211  112234578889999998877788899999999999999999999866543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.29  E-value=2.3e-12  Score=74.45  Aligned_cols=67  Identities=27%  Similarity=0.440  Sum_probs=51.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....  ........|++.|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       133 ~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         133 HIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             CEEEeeCCCCcccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence            4789999998743211  111223568889999999987788899999999999999999999975543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.29  E-value=3.5e-12  Score=73.63  Aligned_cols=68  Identities=24%  Similarity=0.395  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       134 ~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~  201 (321)
T cd05591         134 HCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE  201 (321)
T ss_pred             CEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence            47899999887532211  112234678889999998877788899999999999999999999865543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.29  E-value=1.1e-11  Score=71.29  Aligned_cols=69  Identities=23%  Similarity=0.399  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....... ........++..|++||.+... .++.+.|+||+|++++++++|++||....
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            479999999976532211 1112234677889999988654 47788999999999999999999986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.29  E-value=7.3e-12  Score=70.90  Aligned_cols=63  Identities=32%  Similarity=0.523  Sum_probs=50.8

Q ss_pred             CceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC------CCCccchhHHHHHHHHHHHhCCCCC
Q 034502            1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG------KFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~------~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      +.++++|||+++.+.+.   .+.+..+|++.|++||.+.+.      +|+...|.|++|++++.++.|.+||
T Consensus       160 ~~i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  160 MNIKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             cceEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            36799999999876543   234557999999999988653      3556689999999999999999993

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.28  E-value=3.9e-12  Score=68.29  Aligned_cols=86  Identities=28%  Similarity=0.318  Sum_probs=67.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHH-hCCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEII-SGKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~-~g~~~~~~~~~~~~~~~~~   79 (92)
                      ++|++|||+++.++.+.  .+-+..+-+.+|.+|.++.+.. |+...|+||.||++.|+. .|+|.|++.+-++++..+-
T Consensus       139 elkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif  216 (292)
T KOG0662|consen  139 ELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_pred             cEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence            57999999999775432  2333345577899999987766 788899999999999998 5888988888888888888


Q ss_pred             HHhhhcccCC
Q 034502           80 HVSKMHTTFS   89 (92)
Q Consensus        80 ~~~~~~~~~~   89 (92)
                      ++.....+.+
T Consensus       217 ~~lg~p~ed~  226 (292)
T KOG0662|consen  217 RLLGTPTEDQ  226 (292)
T ss_pred             HHhCCCcccc
Confidence            8777766654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=3.4e-12  Score=75.54  Aligned_cols=70  Identities=24%  Similarity=0.389  Sum_probs=57.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      ++|++|||++-.+..   .....+++|++.|..||++.+.+|. +..|.|++|+++|.+..|..||.+++.+..
T Consensus       191 NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l  261 (668)
T KOG0611|consen  191 NIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL  261 (668)
T ss_pred             Ceeeeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence            479999999865432   2335568999999999999888876 668999999999999999999988886543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.28  E-value=6.9e-12  Score=72.52  Aligned_cols=67  Identities=27%  Similarity=0.397  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       138 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         138 HVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             CEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence            47899999987532211  11223467888999999887778888999999999999999999976544

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.28  E-value=1.4e-11  Score=71.51  Aligned_cols=69  Identities=38%  Similarity=0.435  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||....
T Consensus       212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            478999999875432111111122334567999999877778899999999999999996 999987644

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.28  E-value=8.3e-12  Score=71.21  Aligned_cols=64  Identities=28%  Similarity=0.405  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....     .....|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       139 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         139 HIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             CEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4789999998754321     122457888999999887778889999999999999999999976544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.27  E-value=6.3e-12  Score=75.62  Aligned_cols=61  Identities=20%  Similarity=0.280  Sum_probs=55.0

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHhhhcc
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVSKMHT   86 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~   86 (92)
                      .+|+|-|++||++.+.+|+...|.||+||+++|++.|.|||...+.+.+...+.+....+.
T Consensus       348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~  408 (550)
T KOG0605|consen  348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK  408 (550)
T ss_pred             ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc
Confidence            5789999999999999999999999999999999999999999998888888877766554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.27  E-value=5.6e-12  Score=73.07  Aligned_cols=67  Identities=27%  Similarity=0.436  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....  ........|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       133 ~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~  199 (328)
T cd05593         133 HIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (328)
T ss_pred             cEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence            4789999998753221  111223567889999999887778889999999999999999999976544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.27  E-value=4.5e-12  Score=73.28  Aligned_cols=67  Identities=25%  Similarity=0.380  Sum_probs=51.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|++||....
T Consensus       134 ~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         134 HIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             CEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            47899999986432211  11233568889999999988788889999999999999999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.27  E-value=4.5e-12  Score=73.89  Aligned_cols=64  Identities=28%  Similarity=0.394  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....     .....|++.|++||++....++.+.|+|++|++++++++|++||....
T Consensus       169 ~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        169 FIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            4789999998764321     223567888999999877778888999999999999999999976543

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.26  E-value=5.8e-12  Score=74.17  Aligned_cols=68  Identities=22%  Similarity=0.410  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK----FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....... .......|++.|++||.+....    ++.++|+|++|++++++++|+.||....
T Consensus       180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            478999999876532211 1122356888999999886432    6678999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.26  E-value=6.2e-12  Score=72.37  Aligned_cols=66  Identities=29%  Similarity=0.426  Sum_probs=51.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       131 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         131 HIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             cEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence            47899999987432211  1122356788999999998878888999999999999999999997543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.26  E-value=1.2e-11  Score=71.54  Aligned_cols=67  Identities=27%  Similarity=0.440  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       133 ~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         133 HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             CEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence            47899999886432111  11223467888999999887778889999999999999999999976544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.26  E-value=1.2e-11  Score=72.52  Aligned_cols=67  Identities=30%  Similarity=0.297  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       164 ~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  230 (364)
T cd07875         164 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  230 (364)
T ss_pred             cEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            47899999987543211   12234677889999999888888899999999999999999999866543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.26  E-value=1.2e-11  Score=71.44  Aligned_cols=67  Identities=30%  Similarity=0.455  Sum_probs=51.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       134 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~  200 (316)
T cd05620         134 HIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD  200 (316)
T ss_pred             CEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            47899999886432111  11233567889999999988788889999999999999999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.25  E-value=6.1e-12  Score=74.06  Aligned_cols=68  Identities=22%  Similarity=0.385  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK----FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++...... ........|++.|++||.+....    ++.+.|+|++|++++++++|++||....
T Consensus       180 ~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         180 HLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             CEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            57999999987653221 11122356888999999886432    6678999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.25  E-value=1.9e-11  Score=70.25  Aligned_cols=69  Identities=23%  Similarity=0.410  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++........ .......++..|++||.+... .++.+.|+||+|++++++++|++||....
T Consensus       150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            4789999999765332111 112234567789999988653 46788999999999999999999986544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=1.5e-11  Score=68.95  Aligned_cols=80  Identities=24%  Similarity=0.352  Sum_probs=59.0

Q ss_pred             eEEeeeeceeeeCCCccccccc--ccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTN--RVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~--~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~   79 (92)
                      +|++|||+++.+..+......+  ..+-+.+|.+||.+.+.. |+++.|+|..||++.++.++.+.+++..++..+..+.
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence            6899999998765432222111  123356899999887654 8899999999999999999999988877776666665


Q ss_pred             HHh
Q 034502           80 HVS   82 (92)
Q Consensus        80 ~~~   82 (92)
                      .+-
T Consensus       243 ~Lc  245 (376)
T KOG0669|consen  243 QLC  245 (376)
T ss_pred             HHh
Confidence            543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.25  E-value=2.6e-11  Score=70.97  Aligned_cols=67  Identities=27%  Similarity=0.269  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       161 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~  227 (359)
T cd07876         161 TLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH  227 (359)
T ss_pred             CEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            47899999987532211   12224567889999999887888899999999999999999999876653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.25  E-value=5.3e-12  Score=74.40  Aligned_cols=46  Identities=26%  Similarity=0.428  Sum_probs=40.3

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ..|++.|++||++....++.+.|+|++|++++++++|++||.....
T Consensus       208 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         208 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             cccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence            4678889999999888888999999999999999999999865543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.6e-11  Score=71.45  Aligned_cols=66  Identities=24%  Similarity=0.518  Sum_probs=55.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ++|+.|+|+++.-..+  ....++++|++.|.+||++.+..|+...|.|++|++++||+.|+.||.-.
T Consensus       389 hikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  389 HIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             ceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            5799999999854332  22356689999999999999999999999999999999999999998543

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=7.1e-13  Score=82.63  Aligned_cols=65  Identities=34%  Similarity=0.552  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC--CCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG--KFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||.++.+-+-  .-+..++.|+..|++||++...  +|+..+|+||+||.+.||.+|+|||-.
T Consensus       714 vlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E  780 (1226)
T KOG4279|consen  714 VLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE  780 (1226)
T ss_pred             eEEecccccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence            3699999998866432  2235568899999999998754  488899999999999999999999643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.25  E-value=2.4e-11  Score=69.21  Aligned_cols=69  Identities=25%  Similarity=0.322  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++......  .......++..|++||.+.. ..++.+.|+|++|++++++++|++||......
T Consensus       141 ~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~  210 (288)
T cd07871         141 ELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK  210 (288)
T ss_pred             CEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            47899999987543221  11222456778999998764 44778899999999999999999997655433

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.24  E-value=1.8e-11  Score=70.92  Aligned_cols=70  Identities=30%  Similarity=0.357  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++....... ........++..|++||++..  ..++.+.|+|++|++++++++|++||.....
T Consensus       141 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~  213 (338)
T cd07859         141 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV  213 (338)
T ss_pred             cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence            478999999875422111 111122467888999998754  4577889999999999999999999866543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.24  E-value=1.4e-11  Score=71.09  Aligned_cols=67  Identities=28%  Similarity=0.380  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       134 ~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~  200 (318)
T cd05570         134 HIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD  200 (318)
T ss_pred             cEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence            47899999886432111  11223467888999999988888899999999999999999999976544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.24  E-value=1.8e-11  Score=69.29  Aligned_cols=71  Identities=34%  Similarity=0.512  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||......
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            468999999875432211111222344567999998877778889999999999999997 98887665543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.23  E-value=6.9e-12  Score=72.48  Aligned_cols=67  Identities=24%  Similarity=0.328  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       134 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         134 HVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             cEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            47899999886432211  11223467888999999887778889999999999999999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.23  E-value=7e-12  Score=72.38  Aligned_cols=67  Identities=25%  Similarity=0.348  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....  ........+++.|++||.+....++.+.|+|++|++++++++|++||...+
T Consensus       134 ~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         134 HVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             CEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            4789999988643221  112233567888999999887778889999999999999999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.23  E-value=1.2e-11  Score=69.99  Aligned_cols=68  Identities=32%  Similarity=0.559  Sum_probs=53.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||.+..+..+.   -.+...|.+.|++||.+..   ..|...+|+||+|+.+.|+.+|+.||.+.+.+
T Consensus       230 niKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td  300 (391)
T KOG0983|consen  230 NIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD  300 (391)
T ss_pred             CEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence            57999999987765432   2333567889999998753   34778899999999999999999998886643

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.23  E-value=9.3e-12  Score=73.43  Aligned_cols=46  Identities=26%  Similarity=0.432  Sum_probs=40.3

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ..|+..|++||.+....++.+.|+|++|++++++++|++||.....
T Consensus       208 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             ccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence            4688899999998877788899999999999999999999865543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA02988 hypothetical protein; Provisional

Probab=99.23  E-value=1.1e-11  Score=70.52  Aligned_cols=65  Identities=23%  Similarity=0.417  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....     .....++..|++||.+..  ..++.+.|+||+|++++++++|+.||.....
T Consensus       161 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~  227 (283)
T PHA02988        161 KLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT  227 (283)
T ss_pred             cEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence            4789999988754221     112356778999998864  5678899999999999999999999876543

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.23  E-value=1.2e-12  Score=85.16  Aligned_cols=73  Identities=27%  Similarity=0.438  Sum_probs=57.9

Q ss_pred             eEEeeeeceeeeCCCcc--cccccccccCCCccCCccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            3 PKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDG---KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      +|++|||.+..+.++..  .+......|++-|++||++...   +...++|+||+||+..||++|++|++.++.+...
T Consensus      1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI 1450 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI 1450 (1509)
T ss_pred             EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH
Confidence            68999999988765421  1223346899999999998643   3557899999999999999999999999977654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.1e-11  Score=74.35  Aligned_cols=66  Identities=24%  Similarity=0.253  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+||+|||-+++...+     -+.-+++..|.+||++.+.+|+..+|+||++|+.+|+.+|--.|+.-..+
T Consensus       392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~  457 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGE  457 (590)
T ss_pred             eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence            5799999999875332     22246788899999999999999999999999999999998777544443

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=3.9e-12  Score=78.12  Aligned_cols=69  Identities=32%  Similarity=0.429  Sum_probs=54.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      -+|++|||.+....      ...+++|+++|++||++.   ...|..+.|+||+|+.+.++...+||+=+.+.++-+.
T Consensus       164 ~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY  235 (948)
T KOG0577|consen  164 LVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  235 (948)
T ss_pred             eeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence            36899999886432      234589999999999875   3568899999999999999999999965555444443

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.22  E-value=3.3e-11  Score=68.39  Aligned_cols=67  Identities=27%  Similarity=0.364  Sum_probs=51.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+....++.+.|+|++|++++++++|++||.....
T Consensus       146 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~  212 (288)
T cd07863         146 QVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  212 (288)
T ss_pred             CEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence            46899999887543221   11224567789999998877788999999999999999999999765443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.22  E-value=2.9e-11  Score=70.10  Aligned_cols=63  Identities=30%  Similarity=0.409  Sum_probs=51.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++.....     .....|++.|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       156 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        156 HVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             CEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence            4789999998764321     12346788899999998777888999999999999999999997543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.22  E-value=3.1e-11  Score=70.56  Aligned_cols=66  Identities=29%  Similarity=0.276  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       157 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         157 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             CEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            47899999987543221   1223467788999999887778889999999999999999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.22  E-value=3.2e-11  Score=69.98  Aligned_cols=65  Identities=23%  Similarity=0.489  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||..
T Consensus       134 ~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         134 HIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             CEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence            47899999886422111  112235678889999999887788899999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.22  E-value=2.6e-11  Score=70.37  Aligned_cols=66  Identities=30%  Similarity=0.506  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++.....    ......++..|++||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       142 ~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~  207 (331)
T cd06649         142 EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA  207 (331)
T ss_pred             cEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4789999988754321    12234678889999998877788999999999999999999999865443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.22  E-value=6e-12  Score=72.77  Aligned_cols=67  Identities=24%  Similarity=0.352  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|++||...+
T Consensus       134 ~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         134 HVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             CEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            47899999986432111  11223567888999999988788889999999999999999999976544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.21  E-value=3.8e-11  Score=68.08  Aligned_cols=70  Identities=26%  Similarity=0.343  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.|+.....
T Consensus       147 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~  217 (279)
T cd05111         147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP  217 (279)
T ss_pred             cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            468999999876532211111122344567999999877778889999999999999997 9989766543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.21  E-value=2.3e-11  Score=68.93  Aligned_cols=70  Identities=34%  Similarity=0.500  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..|+.....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            478999998875432211111112334567999999877778888999999999999997 8888765544

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=1.3e-11  Score=76.57  Aligned_cols=75  Identities=27%  Similarity=0.401  Sum_probs=56.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .++++|||++......  .....+++|+++|++||++.     ..+|..++|+||+|+.+.+|..+.||......+-.+.
T Consensus       168 dirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll  245 (1187)
T KOG0579|consen  168 DIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL  245 (1187)
T ss_pred             cEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence            4689999987653321  22345689999999999764     4568889999999999999999999977776654443


Q ss_pred             HH
Q 034502           77 LI   78 (92)
Q Consensus        77 ~~   78 (92)
                      ++
T Consensus       246 Ki  247 (1187)
T KOG0579|consen  246 KI  247 (1187)
T ss_pred             HH
Confidence            33

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.21  E-value=8.9e-11  Score=66.65  Aligned_cols=67  Identities=31%  Similarity=0.496  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........  ......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       135 ~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         135 NVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             CEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999999876533211  1222457788999999988888889999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.21  E-value=1.8e-11  Score=71.00  Aligned_cols=64  Identities=23%  Similarity=0.492  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||.
T Consensus       134 ~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         134 HIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             CEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            47899999986432111  11223567889999999988788889999999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.21  E-value=2.2e-11  Score=70.60  Aligned_cols=68  Identities=31%  Similarity=0.493  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....... .......|+..|++||.+.... ++.+.|+|++|++++++++|+.||....
T Consensus       143 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  211 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG  211 (332)
T ss_pred             CEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence            478999999875432211 1122356788999999986543 6778999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.21  E-value=5.5e-11  Score=70.16  Aligned_cols=70  Identities=40%  Similarity=0.449  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       250 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~  320 (374)
T cd05106         250 VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV  320 (374)
T ss_pred             eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence            468999999875432211111111223456999999877778899999999999999997 9999866543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=2.8e-11  Score=71.89  Aligned_cols=73  Identities=27%  Similarity=0.426  Sum_probs=55.4

Q ss_pred             ceEEeeeeceeeeCCCcccc-cc-cccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEG-NT-NRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~-~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+.-.+..+.... .. .++.|++.|++||++..  .+|+.++|+|++|+...|+.+|..||....+..-
T Consensus       164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv  240 (516)
T KOG0582|consen  164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV  240 (516)
T ss_pred             cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH
Confidence            57999999876554321111 11 44688999999999543  4588999999999999999999999888886553

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.20  E-value=3.1e-12  Score=73.97  Aligned_cols=68  Identities=26%  Similarity=0.425  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       134 ~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~  201 (325)
T cd05594         134 HIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  201 (325)
T ss_pred             CEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence            47899999987532211  112234678899999998877788999999999999999999999865543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.20  E-value=1.6e-11  Score=70.13  Aligned_cols=69  Identities=25%  Similarity=0.341  Sum_probs=55.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++.-..+   ....+.+.++.|.+||++....|....|+||+|+++|-++.|.|||...++..
T Consensus       202 ~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a  270 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_pred             ceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence            4699999999864321   22334577899999999988889999999999999999999999988777643

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.20  E-value=4.6e-12  Score=74.18  Aligned_cols=47  Identities=23%  Similarity=0.391  Sum_probs=40.8

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++.|++||++....++.+.|+|++|++++++++|++||......
T Consensus       196 ~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~  242 (360)
T cd05627         196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ  242 (360)
T ss_pred             cCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH
Confidence            46788999999998888889999999999999999999998655543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.20  E-value=5.7e-11  Score=69.88  Aligned_cols=72  Identities=26%  Similarity=0.325  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++....... .......++..|++||.+... .++.+.|+|++|++++++++|+.||......+.
T Consensus       141 ~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  213 (372)
T cd07853         141 VLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ  213 (372)
T ss_pred             CEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH
Confidence            478999999875432211 111223567789999987654 367889999999999999999999876654433

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.19  E-value=6.2e-11  Score=67.90  Aligned_cols=67  Identities=25%  Similarity=0.347  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......++..|++||.+... .++.+.|+||+|++++++++|++||....
T Consensus       141 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         141 ELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             CEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            47899999987542211  112224567889999987643 46778899999999999999999987543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.19  E-value=1.8e-11  Score=71.67  Aligned_cols=45  Identities=24%  Similarity=0.434  Sum_probs=39.4

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++.|++||++....++.+.|+|++|++++++++|.+||....
T Consensus       199 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~  243 (364)
T cd05599         199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN  243 (364)
T ss_pred             cccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence            357889999999887788899999999999999999999976544

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.19  E-value=2.8e-11  Score=71.24  Aligned_cols=68  Identities=22%  Similarity=0.409  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG----KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++........ .......|++.|++||.+...    .++.+.|+|++|++++++++|++||....
T Consensus       180 ~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         180 HLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             CEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            478999999876532211 112234678899999987543    26678999999999999999999976544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.19  E-value=9.3e-12  Score=71.46  Aligned_cols=70  Identities=26%  Similarity=0.324  Sum_probs=54.4

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|+|+++.+..+.... .....+-+.+|.+||.+.+.. |+...|+|++||++.|+++-+|.|...+.
T Consensus       174 ~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  174 RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            47999999999776442211 233456678899999988765 78889999999999999999998766544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.19  E-value=6.1e-11  Score=69.08  Aligned_cols=69  Identities=38%  Similarity=0.435  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++.+.............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~  280 (337)
T cd05054         211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ  280 (337)
T ss_pred             cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence            468999999875432111111222334567999999888888899999999999999997 999986544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.18  E-value=2.2e-11  Score=70.67  Aligned_cols=67  Identities=24%  Similarity=0.433  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++...... ........|++.|++||++.     ...++.+.|+|++|++++++++|+.||...
T Consensus       140 ~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         140 HIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             CEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            47899999987543211 11122346788999999875     234678899999999999999999997544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.18  E-value=9.4e-11  Score=62.39  Aligned_cols=55  Identities=22%  Similarity=0.207  Sum_probs=44.0

Q ss_pred             eeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            8 FGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         8 fg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ||.++.....       ...+++.|++||++....++.+.|+||+|++++++++|+.||...
T Consensus        53 fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       53 DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             ccceEeeccc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            7877654221       124678899999998888889999999999999999999997543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.18  E-value=1.3e-11  Score=72.73  Aligned_cols=46  Identities=26%  Similarity=0.387  Sum_probs=39.8

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ..|++.|++||.+....++.+.|+|++|++++++++|++||.....
T Consensus       208 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         208 TVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             cCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence            3578889999998877788999999999999999999999765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.17  E-value=9.6e-11  Score=68.19  Aligned_cols=64  Identities=28%  Similarity=0.410  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....     .....++..|++||.+.. ..++.+.|+|++|++++++++|+.||...+
T Consensus       156 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  220 (343)
T cd07878         156 ELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND  220 (343)
T ss_pred             CEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            4789999998764321     122467888999998765 357788999999999999999999976544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.17  E-value=1.2e-10  Score=66.30  Aligned_cols=67  Identities=33%  Similarity=0.550  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++.......   ......++..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       140 ~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~  206 (285)
T cd05605         140 HIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE  206 (285)
T ss_pred             CEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence            47899999987643211   11223567889999998777788889999999999999999999876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.17  E-value=1.6e-10  Score=65.50  Aligned_cols=67  Identities=30%  Similarity=0.489  Sum_probs=51.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++.......   ......++..|++||......++.+.|+|++|++++++++|+.||.....
T Consensus       133 ~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~  199 (277)
T cd05607         133 NCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE  199 (277)
T ss_pred             CEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            46899999887553221   11223567789999998777788899999999999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.16  E-value=2.1e-11  Score=70.80  Aligned_cols=68  Identities=24%  Similarity=0.435  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....... .......|+..|++||.+..     ..++.+.|+|++|++++++++|+.||....
T Consensus       140 ~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         140 HIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            478999999876543211 11222467889999998754     346678999999999999999999975443

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.16  E-value=7.9e-11  Score=66.69  Aligned_cols=69  Identities=33%  Similarity=0.446  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |.+|+....
T Consensus       147 ~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  216 (279)
T cd05109         147 HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP  216 (279)
T ss_pred             cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            478999999886542211111111123456899999877778888999999999999987 888876544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=6.7e-11  Score=65.57  Aligned_cols=73  Identities=23%  Similarity=0.345  Sum_probs=57.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||-+-..    +.....+.+|+.-|++||.+....++...|+|++|++++|++.|.+||+.-...+....+
T Consensus       162 ~lkiAdfGwsV~~----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI  234 (281)
T KOG0580|consen  162 ELKIADFGWSVHA----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI  234 (281)
T ss_pred             CeeccCCCceeec----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH
Confidence            3689999976542    122344578999999999999888999999999999999999999997766644444433

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.15  E-value=8.6e-11  Score=69.75  Aligned_cols=64  Identities=23%  Similarity=0.280  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++...... ........|++.|++||++....++.+.|+|++|++++++++|+.|+
T Consensus       220 ~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        220 DVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             CEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            47899999986432111 11122346788999999988778889999999999999999999764

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.15  E-value=9.7e-11  Score=66.20  Aligned_cols=69  Identities=32%  Similarity=0.436  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            468999998875422111111122234567999999887788888999999999999998 998865443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.15  E-value=1.7e-11  Score=71.33  Aligned_cols=45  Identities=27%  Similarity=0.443  Sum_probs=39.8

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ..|+..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            467888999999988888899999999999999999999976554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.15  E-value=1.6e-12  Score=78.94  Aligned_cols=80  Identities=26%  Similarity=0.412  Sum_probs=62.1

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHh
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHVS   82 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~~   82 (92)
                      +|++|||+++.++...   -..+.+|++.|++||++...+|....|+||.|++.|..++|..||...  +++-..++++.
T Consensus       706 vKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAa  780 (888)
T KOG4236|consen  706 VKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAA  780 (888)
T ss_pred             eeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccc
Confidence            6999999999875321   234578999999999999999999999999999999999999885433  34555566655


Q ss_pred             hhccc
Q 034502           83 KMHTT   87 (92)
Q Consensus        83 ~~~~~   87 (92)
                      -|.++
T Consensus       781 FMyPp  785 (888)
T KOG4236|consen  781 FMYPP  785 (888)
T ss_pred             cccCC
Confidence            55443

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.15  E-value=9.1e-12  Score=73.27  Aligned_cols=46  Identities=26%  Similarity=0.420  Sum_probs=40.4

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ..|++.|++||++....++.+.|+|++|++++++++|+.||.....
T Consensus       204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  249 (376)
T cd05598         204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  249 (376)
T ss_pred             cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence            4678899999999888888999999999999999999999866554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.15  E-value=1.4e-10  Score=66.60  Aligned_cols=71  Identities=24%  Similarity=0.355  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++......  .......++..|.+||.+.. ..++.+.|+|++|++++++++|++||......+.
T Consensus       142 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  213 (309)
T cd07872         142 ELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE  213 (309)
T ss_pred             CEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            47899999987543221  11122355778999998754 3467889999999999999999999876554433

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.14  E-value=8.6e-11  Score=67.72  Aligned_cols=69  Identities=32%  Similarity=0.448  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++................+..|++||.+....++.+.|+|++|++++++++ |+.|+....
T Consensus       147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~  216 (316)
T cd05108         147 HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  216 (316)
T ss_pred             cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            478999999986542211111111223456899999877778889999999999999987 898876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.14  E-value=9.4e-11  Score=66.72  Aligned_cols=69  Identities=30%  Similarity=0.428  Sum_probs=49.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++...............++..|++||.+....++.+.|+|++|++++++++ |++||....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            468999998875432211111112234557999999877778889999999999999998 888875544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.14  E-value=8.2e-11  Score=68.31  Aligned_cols=67  Identities=24%  Similarity=0.439  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||++..+..... .......|++.|++||++..     ..++.+.|+|++|++++++++|+.||...
T Consensus       140 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         140 HIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            478999999875432211 11122457888999998752     33567899999999999999999997543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.13  E-value=4.2e-10  Score=68.72  Aligned_cols=63  Identities=24%  Similarity=0.391  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .+||+|||+++.+..... .......|+..|++||.+....++.+.|+|++|++++++++|..+
T Consensus       305 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        305 KIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            478999999976543211 112234678899999999888888999999999999999988743

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.13  E-value=1.7e-10  Score=64.92  Aligned_cols=69  Identities=23%  Similarity=0.335  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++................+..|++||......++.+.|+|++|++++++++ |.+||....
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~  220 (273)
T cd05035         151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE  220 (273)
T ss_pred             eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            468999999876533211111111223456889998876778889999999999999998 888876544

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.12  E-value=2.8e-10  Score=64.77  Aligned_cols=66  Identities=32%  Similarity=0.548  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       140 ~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         140 HIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             CEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            47899999886543211   1122457788999999877778888999999999999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.12  E-value=7.8e-11  Score=73.19  Aligned_cols=81  Identities=32%  Similarity=0.472  Sum_probs=60.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~~~   81 (92)
                      +|++|||+++.+.......... ..-+..|++||.+-++.|+.+.|+|++|+++||..+ |-.||.+.+......++++=
T Consensus       404 VKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg  482 (1157)
T KOG4278|consen  404 VKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG  482 (1157)
T ss_pred             EEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc
Confidence            6999999999886654322221 122457999999999999999999999999999985 66798888765555555543


Q ss_pred             hhh
Q 034502           82 SKM   84 (92)
Q Consensus        82 ~~~   84 (92)
                      .+|
T Consensus       483 yRM  485 (1157)
T KOG4278|consen  483 YRM  485 (1157)
T ss_pred             ccc
Confidence            333

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.12  E-value=1.5e-10  Score=65.71  Aligned_cols=69  Identities=35%  Similarity=0.490  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            478999999875432211111122334456899998877778889999999999999998 888875543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.12  E-value=9.5e-11  Score=71.78  Aligned_cols=72  Identities=35%  Similarity=0.513  Sum_probs=50.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      +|||.|||++..-..-..........+...|++||++.   ..+|+...|+|++|++.||+++|.-||..-..+.
T Consensus       526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq  600 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ  600 (678)
T ss_pred             cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence            58999999986322100000011134566799999886   3458899999999999999999999988444433

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.11  E-value=1.6e-10  Score=65.10  Aligned_cols=69  Identities=26%  Similarity=0.361  Sum_probs=49.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  219 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE  219 (272)
T ss_pred             CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            478999999876532211111112234556889998877778889999999999999998 788876543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.11  E-value=1e-10  Score=72.77  Aligned_cols=69  Identities=39%  Similarity=0.456  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++......... ......-+..|++||.+....|+.+.|+||+|+++||+++ |..||.+..
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            46999999998543322221 1111012446999999988889999999999999999985 788987744

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.11  E-value=4.2e-10  Score=64.09  Aligned_cols=66  Identities=32%  Similarity=0.547  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       140 ~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         140 HIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            46899999886543211   1112357788999999887778889999999999999999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.11  E-value=3.8e-10  Score=64.00  Aligned_cols=64  Identities=31%  Similarity=0.535  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++......    ......++..|++||......++.+.|+|++|++++++++|+.||...
T Consensus       133 ~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         133 QVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             CEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence            4789999988754321    122246777899999987777888999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.11  E-value=2e-10  Score=65.18  Aligned_cols=69  Identities=32%  Similarity=0.475  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |++||....
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            478999998875432111111111233567899998877778888999999999999998 888875433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.11  E-value=1.4e-10  Score=66.14  Aligned_cols=68  Identities=32%  Similarity=0.458  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.||...
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998865432211111222344567999999887778888999999999999998 99886443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.11  E-value=3.5e-10  Score=63.37  Aligned_cols=68  Identities=29%  Similarity=0.453  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCccccc-ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++.......... .....++..|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence            478999998875432111110 01234567899999988777888899999999999999999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.11  E-value=3.4e-10  Score=63.94  Aligned_cols=67  Identities=28%  Similarity=0.497  Sum_probs=51.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++.......  ......++..|++||......++.+.|+|++|++++++++|++||...+
T Consensus       136 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         136 DVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             CEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence            468899999876643211  1223456677999999877778889999999999999999999976544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.10  E-value=5.5e-10  Score=65.38  Aligned_cols=65  Identities=32%  Similarity=0.515  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----KFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++.......  ......|+..|++||.+...     ..+.+.|+|++|++++++++|+.||..
T Consensus       206 ~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        206 NVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             CEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            478999999876532211  11234678889999987432     123578999999999999999999863

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.10  E-value=1.1e-10  Score=72.40  Aligned_cols=66  Identities=29%  Similarity=0.513  Sum_probs=54.3

Q ss_pred             EEeeeeceeeeCCCcccccccccccCCCccCCcccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            4 KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         4 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      |++|||.++.+...   ....+.+|+..|+.|+..- +..|+...|.||+|+.+|+..+|..||..+...
T Consensus       164 KLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  164 KLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             eeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            89999999976432   2345678999999999886 467889999999999999999999998665544

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.10  E-value=8.6e-11  Score=73.47  Aligned_cols=78  Identities=31%  Similarity=0.405  Sum_probs=57.7

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~   79 (92)
                      .+||+|||+.+.+......- ......-+..|.+||.+....|+.+.|+|.+|+.+|||++ |+.|+-+...-.+++.++
T Consensus       250 tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD  329 (1039)
T KOG0199|consen  250 TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID  329 (1039)
T ss_pred             eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence            47999999998775432211 1111122446899999999999999999999999999995 778988887766665554

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.10  E-value=1.5e-10  Score=65.52  Aligned_cols=70  Identities=30%  Similarity=0.465  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||.....
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~  227 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN  227 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            478999998865432211111111233556999999877778888999999999999998 6788765443

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.09  E-value=4.4e-10  Score=66.37  Aligned_cols=69  Identities=36%  Similarity=0.430  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~  321 (375)
T cd05104         252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP  321 (375)
T ss_pred             cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence            368999999875432211111111223456999999887788899999999999999997 888875543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.09  E-value=1.6e-10  Score=65.43  Aligned_cols=69  Identities=38%  Similarity=0.508  Sum_probs=48.3

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      +|++|||+++................+..|++||.+....++.+.|+|++|++++++++ |..||.....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~  227 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN  227 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            68999998875432111111111223456899999877778899999999999999996 8888765443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.09  E-value=2e-10  Score=66.79  Aligned_cols=65  Identities=31%  Similarity=0.506  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++......    ......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       142 ~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         142 EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             CEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            4789999988644221    1122457778999999887778888999999999999999999976544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.09  E-value=2.4e-10  Score=64.26  Aligned_cols=68  Identities=38%  Similarity=0.575  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||+++................+..|++||.+....++.+.|+|++|++++++++ |+.||...
T Consensus       149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            478999998875432211111111233456899999877778889999999999999997 88887543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.08  E-value=1.7e-10  Score=65.11  Aligned_cols=69  Identities=32%  Similarity=0.493  Sum_probs=49.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++...............++..|.+||......++.+.|+|++|++++++++ |+.||....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            468999998875432211111122334567899998877778888999999999999998 888875544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.08  E-value=4.6e-10  Score=68.01  Aligned_cols=64  Identities=22%  Similarity=0.288  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .++|+|||+++...............|+..|++||++....++.+.|+|++|+++++++.|..+
T Consensus       298 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~  361 (461)
T PHA03211        298 DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS  361 (461)
T ss_pred             CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCC
Confidence            4789999998765322111112234678899999999887888899999999999999987654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.08  E-value=1.1e-11  Score=77.80  Aligned_cols=72  Identities=31%  Similarity=0.457  Sum_probs=52.7

Q ss_pred             ceEEeeeeceeeeCCCccccccccc--ccCCCccCCccccCCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRV--IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII-SGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~-~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++.+.... ..-..+.  .-+..|++||.+...+|+...|+||+|+++||++ .|.+||=...+++.
T Consensus       769 vCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  769 VCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             EEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence            47999999999764322 1111111  1235799999999999999999999999999987 58899765555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.08  E-value=2.8e-10  Score=69.77  Aligned_cols=66  Identities=21%  Similarity=0.362  Sum_probs=53.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      +++++|||.++.....     ..+.+-+..|.+||++....++...|+||+|+++++|++|+.||+.-..+
T Consensus       454 ~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  454 HLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             cEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence            4799999999865432     11234466789999998888999999999999999999999998766655

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.08  E-value=3.6e-10  Score=64.76  Aligned_cols=69  Identities=32%  Similarity=0.456  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS--GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~--g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++  +..|+....
T Consensus       176 ~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            478999999875432211111122334567999998877778889999999999999986  455665443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.08  E-value=2.7e-10  Score=63.83  Aligned_cols=70  Identities=41%  Similarity=0.525  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||.++........ .......++..|++||......++.+.|+|++|++++++++ |++||.....
T Consensus       133 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  204 (257)
T cd05116         133 YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG  204 (257)
T ss_pred             eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            3689999998765322111 01111223457899998876667788999999999999997 9999865543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.07  E-value=2e-10  Score=65.02  Aligned_cols=68  Identities=28%  Similarity=0.328  Sum_probs=48.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||+++.+.............++..|++||......++.+.|+|++|++++++++ |+.||...
T Consensus       155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            468999999875532211111111234456899998877778888999999999999998 99987543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.07  E-value=2.7e-10  Score=65.31  Aligned_cols=69  Identities=38%  Similarity=0.504  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.|+....
T Consensus       147 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~  216 (303)
T cd05110         147 HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP  216 (303)
T ss_pred             ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            468999999876532211111111233457899998877778888999999999999987 888875543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.07  E-value=2.1e-11  Score=68.71  Aligned_cols=66  Identities=29%  Similarity=0.470  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+..+..+..   .+.-.|...|++||.+..  .+|..++|+||+|+.++|+.+|+.||...+
T Consensus       206 ~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  206 DVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             CEeeecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence            479999999876543321   223467788999998753  347888999999999999999999976665

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.07  E-value=2.2e-10  Score=67.56  Aligned_cols=53  Identities=28%  Similarity=0.457  Sum_probs=46.9

Q ss_pred             ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502           23 TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus        23 ~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      ..+++|+..|++||++.+.+++...|.|++|+.+|||+.|..||.+...+.++
T Consensus       292 SnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl  344 (459)
T KOG0610|consen  292 SNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL  344 (459)
T ss_pred             ccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence            45578999999999999999999999999999999999999998777766554

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.07  E-value=1.9e-11  Score=70.48  Aligned_cols=67  Identities=30%  Similarity=0.472  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......|+..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       136 ~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         136 HIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             cEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            47899999887543211  11223567888999999887778888999999999999999999976544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.06  E-value=9.4e-10  Score=62.39  Aligned_cols=69  Identities=25%  Similarity=0.362  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++........ .......++..|++||..... .++.+.|+|++|++++++++|++|+.....
T Consensus       138 ~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         138 VLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             CEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            478999999876543221 112224566789999998776 677889999999999999999999875543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.06  E-value=2.6e-11  Score=70.21  Aligned_cols=68  Identities=29%  Similarity=0.517  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS------DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++......... ......+++.|++||.+.      ...++.+.|+|++|++++++++|+.||....
T Consensus       140 ~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         140 HIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             CEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            4789999998765422111 122245788899999875      3346678999999999999999999975443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.06  E-value=3.1e-10  Score=73.47  Aligned_cols=65  Identities=31%  Similarity=0.510  Sum_probs=49.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      +||+|||++.......   ......+++.|++||++..  ..++.+.|+|++|++++++++|+.||....
T Consensus       181 VKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        181 AKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             eEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence            6899999987543211   1223467889999998753  346788999999999999999999976433

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.06  E-value=1.1e-10  Score=72.30  Aligned_cols=78  Identities=29%  Similarity=0.403  Sum_probs=60.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII-SGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~-~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++|||+++.+....... .+...-+..|++||.+....|+...|+|-+|+.+||.+ -|..||++.+..+..-.+++
T Consensus       529 CVKLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn  607 (974)
T KOG4257|consen  529 CVKLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN  607 (974)
T ss_pred             eeeecccchhhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC
Confidence            57999999999875443222 22334456799999999999999999999999999976 69999999888776544443

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.06  E-value=4.6e-10  Score=62.65  Aligned_cols=67  Identities=33%  Similarity=0.562  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++.......  ......++..|++||+.....++.+.|+|++|++++++++|+.||....
T Consensus       139 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         139 NVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             CEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            468899998876543211  1222456778999999877778888999999999999999999976544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.05  E-value=4e-10  Score=64.93  Aligned_cols=69  Identities=36%  Similarity=0.422  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||....
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            478999999875432111111111223346899998877778888999999999999998 788875544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.05  E-value=1.7e-10  Score=63.17  Aligned_cols=66  Identities=32%  Similarity=0.426  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+..+..+...   +.-.|...|++||.+.    ...|+.++|+||+|+.+.|+..++.||+.-.
T Consensus       187 qVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  187 QVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             cEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            4799999999877544221   1124566799999764    3468899999999999999999999976544

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.04  E-value=1.6e-09  Score=61.51  Aligned_cols=65  Identities=34%  Similarity=0.606  Sum_probs=49.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++..+....    .....++..|++||..... .++.+.|+|++|++++++++|+.||....
T Consensus       135 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         135 HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             CEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence            46899999886543211    1224577889999987643 47788999999999999999999986553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.04  E-value=3.3e-11  Score=69.83  Aligned_cols=67  Identities=31%  Similarity=0.450  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......|+..|++||.+... .++.+.|+|++|++++++++|+.||....
T Consensus       134 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~  201 (330)
T cd05586         134 HIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED  201 (330)
T ss_pred             CEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence            47899999886432111  112235678889999987644 36788999999999999999999975543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.04  E-value=4.6e-10  Score=63.93  Aligned_cols=70  Identities=33%  Similarity=0.399  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||.....
T Consensus       165 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            468999999875432211111111233456899998777777888999999999999998 8888765543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.04  E-value=1e-09  Score=65.48  Aligned_cols=68  Identities=38%  Similarity=0.440  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||...
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            468999999875432211111122344567999999877778889999999999999986 88887554

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.04  E-value=4.8e-10  Score=63.50  Aligned_cols=71  Identities=31%  Similarity=0.381  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||.++...............++..|++||......++.+.|+|++|++++++++ |+.|+.....+
T Consensus       147 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  218 (279)
T cd05057         147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV  218 (279)
T ss_pred             eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            468999999876542211111111122346899998876777888999999999999998 99997665543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.03  E-value=2.3e-10  Score=67.61  Aligned_cols=78  Identities=23%  Similarity=0.295  Sum_probs=58.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~   79 (92)
                      .+|++|-.+++-+.+.+..........+..|+++|.+....|+..+|+|++|+++||+++ |+.||...++.+-..++.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            468888888775555444433444445567999999988889999999999999999985 889988777655444443

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.03  E-value=6.1e-10  Score=62.75  Aligned_cols=66  Identities=32%  Similarity=0.487  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......  .......++..|++||.+..     ..++.+.|+|++|++++++++|+.|+...
T Consensus       149 ~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         149 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             CEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            46899999987543211  12223456778999998752     24667899999999999999999997543

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.03  E-value=7.7e-10  Score=63.36  Aligned_cols=67  Identities=25%  Similarity=0.486  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........  ......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       153 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         153 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             CEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998765432211  1122346678999999877778888999999999999999999975543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.03  E-value=8.3e-10  Score=63.39  Aligned_cols=69  Identities=36%  Similarity=0.412  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            368899999875432211111111234557999998877778888999999999999997 898876544

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.03  E-value=5e-10  Score=64.15  Aligned_cols=66  Identities=29%  Similarity=0.502  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|+.||...
T Consensus       155 ~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  220 (297)
T cd06659         155 RVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD  220 (297)
T ss_pred             cEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46899999886443221  1122345677899999987777888899999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.03  E-value=7.9e-10  Score=64.69  Aligned_cols=66  Identities=30%  Similarity=0.307  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||...+
T Consensus       156 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         156 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            47899999987643221   1122346678999999887788899999999999999999999976554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.03  E-value=6.5e-10  Score=63.74  Aligned_cols=69  Identities=35%  Similarity=0.422  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |..|+....
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            368999999876532211111111233456999998877778888999999999999997 777765443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.03  E-value=1.2e-09  Score=61.07  Aligned_cols=67  Identities=30%  Similarity=0.428  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|+.||...+
T Consensus       140 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  206 (257)
T cd08223         140 IIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD  206 (257)
T ss_pred             cEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            46899999987653221  11223456778999999877777888999999999999999999876443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.02  E-value=7e-10  Score=62.54  Aligned_cols=72  Identities=19%  Similarity=0.369  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-------KFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-------~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      +++++|||+++...............++..|++||.+...       .++.+.|+|++|++++++++ |+.||......+
T Consensus       138 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  217 (269)
T cd05087         138 TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ  217 (269)
T ss_pred             cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence            4789999988643221111111123455678999987432       24678999999999999996 999987655433

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.02  E-value=7.3e-10  Score=63.45  Aligned_cols=68  Identities=24%  Similarity=0.316  Sum_probs=48.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++.......  .......++..|++||.+... .++.+.|+|++|++++++++|++||...+.
T Consensus       142 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~  210 (301)
T cd07873         142 ELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV  210 (301)
T ss_pred             cEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            47899999886532211  111223456789999987543 366789999999999999999999876544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.02  E-value=8.2e-10  Score=62.17  Aligned_cols=69  Identities=29%  Similarity=0.452  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++........ .......++..|++||.+....++...|+|++|++++++++|+.||...+
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~  213 (266)
T cd06651         144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE  213 (266)
T ss_pred             CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence            4789999988754321110 11112345667999999877778888999999999999999999976543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.02  E-value=3.4e-10  Score=69.61  Aligned_cols=85  Identities=24%  Similarity=0.362  Sum_probs=61.7

Q ss_pred             CceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHH--hCCCCCCCCCCcchhhHH
Q 034502            1 MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII--SGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         1 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~--~g~~~~~~~~~~~~~~~~   78 (92)
                      +++|++|||+++.+-...........+-+..|+++|.+...+|+.+.|+|++|+.+||++  ..+.||+...   .++..
T Consensus       674 ~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vv  750 (807)
T KOG1094|consen  674 FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVV  750 (807)
T ss_pred             ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHH
Confidence            578999999998654333333444556677899999999999999999999999999986  4677865444   34455


Q ss_pred             HHHhhhcccC
Q 034502           79 GHVSKMHTTF   88 (92)
Q Consensus        79 ~~~~~~~~~~   88 (92)
                      ++.-.+.+..
T Consensus       751 en~~~~~~~~  760 (807)
T KOG1094|consen  751 ENAGEFFRDQ  760 (807)
T ss_pred             HhhhhhcCCC
Confidence            5555554443

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.02  E-value=1.2e-09  Score=61.85  Aligned_cols=68  Identities=26%  Similarity=0.268  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++.......   .....++..|++||.... ..++.+.|+|++|++++++++|++||...+..
T Consensus       137 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~  205 (282)
T cd07831         137 ILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL  205 (282)
T ss_pred             CeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence            478999999875532211   112346678999997644 33577899999999999999999998665543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.02  E-value=5.2e-10  Score=63.05  Aligned_cols=70  Identities=21%  Similarity=0.351  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||.++...............++..|++||......++.+.|+|++|++++++++ |++|+...+.
T Consensus       151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~  221 (273)
T cd05074         151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN  221 (273)
T ss_pred             CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence            478999998875432111111111233456788998777777888999999999999998 8888765544

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.02  E-value=8.5e-10  Score=71.10  Aligned_cols=69  Identities=23%  Similarity=0.275  Sum_probs=51.4

Q ss_pred             ceEEeeeeceeeeCCCcc----------------cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEI----------------EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .++++|||+++.......                ........|++.|++||.+....++.+.|+|++|++++++++|+.|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            468999999876521100                0001124578899999998887888899999999999999999999


Q ss_pred             CCCCC
Q 034502           66 RGFYH   70 (92)
Q Consensus        66 ~~~~~   70 (92)
                      |....
T Consensus       231 F~~~~  235 (932)
T PRK13184        231 YRRKK  235 (932)
T ss_pred             CCCcc
Confidence            86543

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.01  E-value=8.6e-10  Score=63.13  Aligned_cols=67  Identities=27%  Similarity=0.491  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........  ......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       154 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         154 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             CEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998765432111  1122356678999998877777889999999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.01  E-value=8.1e-10  Score=61.64  Aligned_cols=69  Identities=41%  Similarity=0.518  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.+................++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  212 (262)
T cd00192         143 VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS  212 (262)
T ss_pred             cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence            468999998876543211111222345667999998877778888999999999999998 588876654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.01  E-value=1.4e-09  Score=61.42  Aligned_cols=62  Identities=26%  Similarity=0.449  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.++.....      ....++..|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            4789999988754322      1234677899999987777888899999999999999999998643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.01  E-value=2.2e-11  Score=73.87  Aligned_cols=77  Identities=25%  Similarity=0.238  Sum_probs=60.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGHV   81 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~~   81 (92)
                      .+|+||||.+......  .  .+.++-+.+|.+||++.+..|....|+||.||.+||+.+|+-.|++...++-+.+.-.+
T Consensus       575 iLKLCDfGSA~~~~en--e--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  575 ILKLCDFGSASFASEN--E--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeeccCccccccccc--c--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            3689999988654221  1  22245567899999999999999999999999999999999999999887766555444


Q ss_pred             h
Q 034502           82 S   82 (92)
Q Consensus        82 ~   82 (92)
                      +
T Consensus       651 K  651 (752)
T KOG0670|consen  651 K  651 (752)
T ss_pred             c
Confidence            3

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.01  E-value=1.1e-09  Score=61.61  Aligned_cols=68  Identities=26%  Similarity=0.431  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.++....... ........++..|++||......++...|+|++|++++++++|+.||...
T Consensus       144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            468999998875432111 01112234667899999887777788899999999999999999997644

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.00  E-value=5.6e-10  Score=63.45  Aligned_cols=66  Identities=35%  Similarity=0.532  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG---KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++.......   .....++..|++||.+...   .++.++|+|++|++++++++|+.||....
T Consensus       146 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         146 NIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             cEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            368999998865432211   1223466779999988655   57788999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.00  E-value=9.2e-10  Score=62.95  Aligned_cols=66  Identities=29%  Similarity=0.466  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++........  ......++..|++||......++.+.|+|++|++++++++|+.||...
T Consensus       156 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  221 (292)
T cd06658         156 RIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE  221 (292)
T ss_pred             CEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            478999998765432211  112245677899999987777888899999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.00  E-value=7.3e-10  Score=63.64  Aligned_cols=69  Identities=36%  Similarity=0.411  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++...............++..|++||......++.+.|+|++|++++++++ |.+||....
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            468999998865432111111111123356899998877778888999999999999997 888865433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=3.2e-10  Score=73.53  Aligned_cols=65  Identities=25%  Similarity=0.500  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      ++|++|||.+-.+.... .......+|+|-|.+||++..     ..|++..|.||+|+.+|||+.|..||.
T Consensus       213 HikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             cEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            68999999886664221 122344689999999998752     347788999999999999999999953

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.00  E-value=1.3e-09  Score=61.71  Aligned_cols=70  Identities=24%  Similarity=0.377  Sum_probs=50.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .++++|||++........  ......++..|++||.... ..++.+.|+|++|++++++++|++||......+
T Consensus       138 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~  208 (286)
T cd07847         138 QIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD  208 (286)
T ss_pred             cEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence            468999999876533211  1122345667899998754 346778999999999999999999987665433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=98.99  E-value=5.6e-10  Score=63.59  Aligned_cols=69  Identities=36%  Similarity=0.416  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |..|+....
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            368999998875432211111111223456899998877778888999999999999987 888865543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=98.99  E-value=1.8e-09  Score=60.72  Aligned_cols=65  Identities=26%  Similarity=0.405  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||++.......  .......++..|++||.+.   ...++.+.|+||+|++++++++|++|+..
T Consensus       144 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         144 HVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             CEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            46899999887553221  1122345778899999864   33467789999999999999999988644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=98.98  E-value=1.4e-09  Score=63.31  Aligned_cols=68  Identities=28%  Similarity=0.341  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......++..|++||.+.. ..++.+.|+|++|++++++++|++||...+.
T Consensus       146 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  214 (337)
T cd07858         146 DLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY  214 (337)
T ss_pred             CEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence            47899999887543221  11222456678999998754 3477889999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=98.98  E-value=1.9e-09  Score=61.70  Aligned_cols=72  Identities=22%  Similarity=0.286  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||.+.........  .......++..|++||...... ++.+.|+|++|++++++++|++|+.......
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~  231 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH  231 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            4689999988755322111  1111234566799999875443 5678999999999999999999976655433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=98.98  E-value=1.5e-09  Score=61.46  Aligned_cols=67  Identities=30%  Similarity=0.527  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|++|+....
T Consensus       139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~  205 (277)
T cd06640         139 DVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH  205 (277)
T ss_pred             CEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            36889999887653321  11222345667899999877777888999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=98.98  E-value=1.1e-09  Score=62.41  Aligned_cols=68  Identities=32%  Similarity=0.489  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |..|+...
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998875432211111111234556899998877778888999999999999997 67786543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=98.98  E-value=6.2e-11  Score=71.43  Aligned_cols=71  Identities=37%  Similarity=0.409  Sum_probs=51.7

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKL   75 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~   75 (92)
                      +|++|||+++.....  ........-+..|++||.+....|+.+.|+|++|+++||+++ |..||.+.......
T Consensus       301 vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~  372 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK  372 (474)
T ss_pred             EEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH
Confidence            599999998753211  111111123567999999988889999999999999999986 88897776654433

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=98.98  E-value=1.1e-09  Score=61.27  Aligned_cols=67  Identities=27%  Similarity=0.404  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC---CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG---KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+.......  .......++..|++||.....   .++.+.|+|++|++++++++|++|+....
T Consensus       139 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         139 DVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             CEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            46899999876543211  111223566779999987655   67778999999999999999999975543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=98.98  E-value=2.1e-09  Score=62.50  Aligned_cols=69  Identities=29%  Similarity=0.371  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......... .......++..|++||.+.. ..++.+.|+|++|++++++++|++||...+
T Consensus       144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~  214 (336)
T cd07849         144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD  214 (336)
T ss_pred             CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4789999988754322111 11122456778999998654 447788999999999999999999986544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.98  E-value=4.9e-10  Score=70.48  Aligned_cols=46  Identities=26%  Similarity=0.419  Sum_probs=40.5

Q ss_pred             ccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502           25 RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus        25 ~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ..+|++.|++||++....++.+.|+|++||+++++++|++||....
T Consensus       539 ~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~  584 (669)
T cd05610         539 RILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDET  584 (669)
T ss_pred             ceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            3578999999999988888899999999999999999999975543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=98.98  E-value=1.7e-09  Score=60.88  Aligned_cols=65  Identities=28%  Similarity=0.441  Sum_probs=50.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.+.......   ......++..|++||......++.+.|+|++|++++++++|++||...
T Consensus       152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~  216 (269)
T cd08528         152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST  216 (269)
T ss_pred             cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence            46899999987543221   222345677899999987777888999999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=98.98  E-value=1.7e-09  Score=60.32  Aligned_cols=69  Identities=33%  Similarity=0.420  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++................+..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       131 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~  200 (251)
T cd05041         131 VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS  200 (251)
T ss_pred             cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence            468999998865431111111111122345899998877778888999999999999998 777875544

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=98.98  E-value=1.2e-09  Score=60.91  Aligned_cols=67  Identities=33%  Similarity=0.518  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........  ......++..|++||......++.+.|+|++|++++++++|++|+....
T Consensus       137 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~  203 (256)
T cd06612         137 QAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH  203 (256)
T ss_pred             cEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            468999998875432211  1222346678999999877778888999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=98.98  E-value=1.1e-09  Score=63.70  Aligned_cols=69  Identities=36%  Similarity=0.419  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            468999999875432111111111223346899999877778888999999999999997 788865543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=98.98  E-value=2.9e-09  Score=60.52  Aligned_cols=66  Identities=32%  Similarity=0.566  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++.......    .....++..|++||.... ..++.+.|+|++|++++++++|..||.....
T Consensus       135 ~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  201 (279)
T cd05633         135 HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (279)
T ss_pred             CEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence            46899999886542211    122357788999998753 4467889999999999999999999865443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=98.98  E-value=2.8e-09  Score=60.76  Aligned_cols=67  Identities=33%  Similarity=0.454  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh--CCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS--GKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~--g~~~~~~   68 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++  +..|+..
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            468999999875432211111222344567999998877678889999999999999987  5566543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=98.97  E-value=1.1e-09  Score=61.49  Aligned_cols=68  Identities=41%  Similarity=0.550  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++......... ......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       141 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  209 (261)
T cd05072         141 MCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS  209 (261)
T ss_pred             cEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence            3688999998765322111 1111233456899998877777888999999999999998 888876543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=98.97  E-value=1.6e-09  Score=62.31  Aligned_cols=65  Identities=29%  Similarity=0.505  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......    ......++..|++||......++.+.|+|++|++++++++|+.|+...+
T Consensus       138 ~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         138 EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             cEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence            4689999987654221    1223456778999998876677888999999999999999999975443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=98.97  E-value=1.6e-09  Score=60.94  Aligned_cols=68  Identities=28%  Similarity=0.415  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++........ .......++..|++||......++.+.|+|++|++++++++|++||...
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            4688999988754321110 1112245677899999987777788899999999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=98.97  E-value=2.3e-09  Score=60.20  Aligned_cols=68  Identities=41%  Similarity=0.529  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++......... ......+..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         141 ICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             CEEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            46899999987654221110 111112346899998877778889999999999999998 888876544

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=98.97  E-value=3.6e-09  Score=60.11  Aligned_cols=66  Identities=32%  Similarity=0.505  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC------CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK------FSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~------~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+.......    .....++..|++||.+....      ++.+.|+|++|++++++++|+.||.....
T Consensus       141 ~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  212 (286)
T cd06622         141 QVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY  212 (286)
T ss_pred             CEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence            46899999886542211    12234566799999874432      36778999999999999999999865433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=98.97  E-value=2e-09  Score=61.33  Aligned_cols=64  Identities=31%  Similarity=0.457  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++.....     .....++..|++||.......+.+.|+|++|++++++++|+.||....
T Consensus       139 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         139 YIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             CEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            4689999988764322     222456778999998876667788999999999999999999976544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=98.97  E-value=1.3e-09  Score=61.02  Aligned_cols=68  Identities=32%  Similarity=0.472  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||+++........ .......++..|++||......++.+.|+|++|++++++++ |+.|+...
T Consensus       135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            4689999988765321110 01112334567999998877778888999999999999998 99997543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=98.97  E-value=1.4e-09  Score=61.70  Aligned_cols=67  Identities=30%  Similarity=0.433  Sum_probs=47.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||.+.     ...++.+.|+|++|++++++++|++||....
T Consensus       141 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  212 (282)
T cd06643         141 DIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN  212 (282)
T ss_pred             CEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence            46899999886543211  1122345677899999873     2335668999999999999999999976554

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=98.97  E-value=2e-09  Score=61.37  Aligned_cols=67  Identities=28%  Similarity=0.419  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+.......  .......++..|++||.+.     ...++.+.|+|++|++++++++|.+|+....
T Consensus       148 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  219 (292)
T cd06644         148 DIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  219 (292)
T ss_pred             CEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence            46899999876432211  1112245667899999874     2335677999999999999999999976543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=98.97  E-value=1.8e-09  Score=60.51  Aligned_cols=70  Identities=41%  Similarity=0.549  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCccccc-ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||.++.......... .....++..|.+||......++.+.|+|++|++++++++ |++||.....
T Consensus       133 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~  204 (257)
T cd05060         133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG  204 (257)
T ss_pred             cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence            468999998875532211110 111112346899998877778889999999999999997 9999765543

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=98.97  E-value=1.8e-09  Score=61.82  Aligned_cols=66  Identities=26%  Similarity=0.488  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++........  ......++..|.+||......++.+.|+|++|++++++++|+.||...
T Consensus       153 ~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         153 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             CEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            468999998875432211  112235667899999987777888899999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=98.96  E-value=2e-09  Score=60.97  Aligned_cols=66  Identities=27%  Similarity=0.370  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........   .....++..|.+||......++.+.|+|++|++++++++|++|+....
T Consensus       145 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         145 QVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             CEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            478999998876532211   112345667899999877778888999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=98.96  E-value=1.7e-09  Score=63.11  Aligned_cols=64  Identities=30%  Similarity=0.396  Sum_probs=47.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++.....     .....++..|++||.+.. ..++.+.|+|++|++++++++|+.||...+
T Consensus       155 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~  219 (342)
T cd07879         155 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  219 (342)
T ss_pred             CEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4789999988643211     112345667899998765 346788999999999999999999986544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=98.96  E-value=5.1e-10  Score=71.13  Aligned_cols=78  Identities=31%  Similarity=0.412  Sum_probs=57.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~~~~~~   79 (92)
                      ++|+.|||+++.+......-......-.+.|++-|.+....|+++.|+|++|+..||+++ |+.||.+..-+++..+++
T Consensus       836 hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle  914 (1177)
T KOG1025|consen  836 HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE  914 (1177)
T ss_pred             eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence            478999999987654433222222223456888888888899999999999999999996 888987776655544443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=98.96  E-value=2.2e-09  Score=61.46  Aligned_cols=73  Identities=22%  Similarity=0.354  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccc---------cccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG---------NTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++.........         ......++..|++||..... .++.+.|+|++|++++++++|++||.....
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            46899999887543211100         01112445678999986543 367789999999999999999999765554


Q ss_pred             cch
Q 034502           72 DNK   74 (92)
Q Consensus        72 ~~~   74 (92)
                      .+.
T Consensus       233 ~~~  235 (311)
T cd07866         233 IDQ  235 (311)
T ss_pred             HHH
Confidence            433

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=98.96  E-value=2.1e-09  Score=60.27  Aligned_cols=68  Identities=40%  Similarity=0.558  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.+......... ......++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       140 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         140 VCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             eEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            3688999998765322111 1111233456899998877777888999999999999998 888876544

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=1.7e-10  Score=65.64  Aligned_cols=77  Identities=27%  Similarity=0.355  Sum_probs=54.0

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      +|++|||+++........ .....+-+..|.+||.+.+.. |+...|+||.||++.|++..+-.|+--.+-..++++..
T Consensus       195 LKICDFGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd  272 (449)
T KOG0664|consen  195 LKICDFGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID  272 (449)
T ss_pred             EEecccccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence            589999999865433211 112234456799999987654 88889999999999999988777655555455555544

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=98.96  E-value=2.1e-09  Score=60.40  Aligned_cols=69  Identities=29%  Similarity=0.554  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcc----cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI----EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++.......    ........++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  216 (267)
T cd06628         144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT  216 (267)
T ss_pred             CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence            468999998875532110    001112345677999998877777888999999999999999999976543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=98.96  E-value=1.6e-09  Score=60.71  Aligned_cols=68  Identities=34%  Similarity=0.448  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++........ ......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       138 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         138 VVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             eEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            4688999987654221111 1111223446899999877778889999999999999998 888875544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=98.96  E-value=2.8e-09  Score=61.27  Aligned_cols=69  Identities=28%  Similarity=0.335  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .++++|||++........  .......+..|++||.+.. ..++.+.|+|++|++++++++|++||......
T Consensus       146 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~  215 (309)
T cd07845         146 CLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI  215 (309)
T ss_pred             CEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            468999999876543211  1111233567899998754 34678899999999999999999997655433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=98.95  E-value=3e-09  Score=61.90  Aligned_cols=70  Identities=29%  Similarity=0.347  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCccc---ccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE---GNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||.+.........   .......++..|++||.+.. ..++.+.|+|++|++++++++|++||.....
T Consensus       145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~  218 (337)
T cd07852         145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST  218 (337)
T ss_pred             cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence            4789999988754322110   11122456778999997654 3466789999999999999999999865443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=98.95  E-value=2.9e-09  Score=60.36  Aligned_cols=67  Identities=31%  Similarity=0.369  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||.+... .++.+.|+|++|++++++++|++||....
T Consensus       139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         139 VIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             cEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            46899999987543221  111223456779999987543 36778999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=98.95  E-value=3.2e-09  Score=61.48  Aligned_cols=71  Identities=30%  Similarity=0.366  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .++++|||.+........ ........++..|++||.+... .++.+.|+|++|++++++++|++||......
T Consensus       141 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~  213 (330)
T cd07834         141 DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI  213 (330)
T ss_pred             CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence            478999999876543211 0112224566789999998766 6778899999999999999999998666543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=98.95  E-value=3.1e-10  Score=63.85  Aligned_cols=70  Identities=40%  Similarity=0.621  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+.....................|.+||.+....++.+.|+|++|++++|+++ |+.|+.....
T Consensus       141 ~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  141 QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            468999998876522211111222334557899999877778899999999999999999 6788766643

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=98.95  E-value=1.8e-09  Score=60.60  Aligned_cols=70  Identities=37%  Similarity=0.500  Sum_probs=47.5

Q ss_pred             ceEEeeeeceeeeCCCccccccc-ccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTN-RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++............ ...++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       133 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  204 (257)
T cd05115         133 YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG  204 (257)
T ss_pred             cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            46899999886443211110111 1122356899998877677888999999999999996 9999765443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=98.95  E-value=1.7e-09  Score=61.27  Aligned_cols=66  Identities=29%  Similarity=0.511  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|+.|+...
T Consensus       139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06642         139 DVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL  204 (277)
T ss_pred             CEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence            36889999886543221  1122234667799999987777888899999999999999999997544

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=98.95  E-value=4e-09  Score=59.95  Aligned_cols=65  Identities=37%  Similarity=0.625  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......    ......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       142 ~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         142 QIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             cEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            3688999987643211    1122456778999999877777888999999999999999999986544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=98.95  E-value=4.3e-09  Score=59.71  Aligned_cols=63  Identities=30%  Similarity=0.432  Sum_probs=45.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .++++|||+++......  .......++..|++||.+.... ++.+.|+|++|++++++++|..|+
T Consensus       137 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~  200 (284)
T cd07839         137 ELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  200 (284)
T ss_pred             cEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence            47899999887543221  1112234567899999875543 678899999999999999988774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=98.94  E-value=2.7e-09  Score=60.80  Aligned_cols=67  Identities=28%  Similarity=0.447  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........  ......++..|++||.+...     .++.+.|+|++|++++++++|++|+...+
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            368999998775432111  11223566779999986432     25678999999999999999999976544

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=98.94  E-value=1.6e-09  Score=60.46  Aligned_cols=69  Identities=35%  Similarity=0.424  Sum_probs=46.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++.................+..|++||.+....++.+.|+|++|++++++++ |..|+....
T Consensus       132 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~  201 (252)
T cd05084         132 VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS  201 (252)
T ss_pred             cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            368999998764322111000111112345899998877778888999999999999997 888865443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=98.94  E-value=3.5e-09  Score=59.23  Aligned_cols=65  Identities=31%  Similarity=0.562  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||.+........  ......++..|.+||......++.+.|+|++|++++++++|..||..
T Consensus       139 ~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         139 LIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             CEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence            468999998876533221  12234567789999988776677889999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=98.94  E-value=3.8e-09  Score=63.10  Aligned_cols=69  Identities=36%  Similarity=0.430  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||....
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            468999999875422111111112345567999998877778888999999999999997 788875543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=98.94  E-value=2.9e-09  Score=60.83  Aligned_cols=69  Identities=29%  Similarity=0.441  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS--GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~--g~~~~~~~~   70 (92)
                      .+|++|||++................++..|++||......++.+.|+|++|++++++++  +..||....
T Consensus       167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            478999998875432111111122234567999998877778889999999999999987  455655443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=98.94  E-value=2e-09  Score=61.27  Aligned_cols=65  Identities=28%  Similarity=0.483  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+........  ......++..|++||......++.+.|+|++|++++++++|+.||..
T Consensus       153 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         153 RVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             cEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            468899997764332111  11224567789999998777788889999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=98.94  E-value=1.8e-09  Score=60.83  Aligned_cols=69  Identities=20%  Similarity=0.268  Sum_probs=44.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-------GKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||++................++..|++||....       ..++.+.|+|++|++++++++ |..||....
T Consensus       138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (269)
T cd05042         138 SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS  214 (269)
T ss_pred             cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            468999998764322111111111233456899997642       235678999999999999998 777876544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=98.94  E-value=7.7e-10  Score=61.86  Aligned_cols=67  Identities=28%  Similarity=0.384  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........  ......++..|++||......++.+.|+|++|++++++++|+.||...+
T Consensus       138 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  204 (255)
T cd08219         138 KVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS  204 (255)
T ss_pred             cEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence            468899998875532211  1122456778999999877778888999999999999999999976443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=98.94  E-value=3.2e-09  Score=59.40  Aligned_cols=67  Identities=33%  Similarity=0.484  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+........  ......++..|++||......++.+.|+|++|++++++++|+.|+...+
T Consensus       148 ~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         148 NVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             CEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            478999998876533211  1222456778999999877777888999999999999999999976554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=98.94  E-value=5.3e-09  Score=58.59  Aligned_cols=67  Identities=31%  Similarity=0.457  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+.........  .....++..|++||......++.+.|+|++|++++++++|+.|+....
T Consensus       138 ~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         138 EVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             CEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            4688999988765432211  112345677899999877777888999999999999999999976664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=98.94  E-value=1.6e-09  Score=60.75  Aligned_cols=69  Identities=29%  Similarity=0.505  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccc--cccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG--NTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++..........  ......++..|++||.+... .++.+.|+|++|++++++++|+.||....
T Consensus       140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~  211 (267)
T cd06610         140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP  211 (267)
T ss_pred             CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence            46889999876543221110  11223566779999987665 57788999999999999999999976544

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=98.93  E-value=5e-09  Score=58.83  Aligned_cols=66  Identities=32%  Similarity=0.523  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       131 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         131 YVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             CEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            46899999887553221   1222456778999998877777888999999999999999999987665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=98.93  E-value=2.3e-09  Score=60.36  Aligned_cols=67  Identities=36%  Similarity=0.461  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~   68 (92)
                      .++++|||+++...............++..|++||......++.+.|+|++|++++++++ |..||..
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence            468999999876532111111111223456899998877778889999999999999987 8888644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=98.93  E-value=2.4e-09  Score=60.24  Aligned_cols=68  Identities=37%  Similarity=0.510  Sum_probs=47.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||++......... .......+..|++||......++.+.|+|++|++++++++ |..|+...+
T Consensus       142 ~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  210 (263)
T cd05052         142 LVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  210 (263)
T ss_pred             cEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            4689999988754322111 0111122346899998877778888999999999999998 888876543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=98.93  E-value=4e-09  Score=59.49  Aligned_cols=69  Identities=29%  Similarity=0.409  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++........ ......++..|++||......++.+.|+|++|++++++++ |..||.....
T Consensus       145 ~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~  214 (270)
T cd05056         145 CVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN  214 (270)
T ss_pred             CeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            4689999988765332111 1111223456899998877778888999999999999885 9999765543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=98.93  E-value=2.4e-09  Score=60.69  Aligned_cols=66  Identities=30%  Similarity=0.485  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......  .......++..|++||.+..     ..++.+.|+|++|++++++++|+.||...
T Consensus       159 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         159 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             CEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            46899999876542211  11222456778999998752     34667799999999999999999997544

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=98.93  E-value=2.1e-09  Score=61.19  Aligned_cols=68  Identities=28%  Similarity=0.407  Sum_probs=46.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||+++................+..|++||......++.+.|+|++|++++++++ |..||...
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998875432211111111223456899998877778889999999999999997 77776443

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=98.92  E-value=4.1e-09  Score=61.22  Aligned_cols=69  Identities=33%  Similarity=0.424  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++........  .......++..|++||.... ..++.+.|+|++|++++++++|++||....
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            4789999998754321110  01122456778999998754 346788999999999999999999976654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=98.92  E-value=2.5e-09  Score=59.74  Aligned_cols=66  Identities=36%  Similarity=0.564  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.+......  ........++..|.+||... ....+.+.|+|++|++++++++|..|+...
T Consensus       136 ~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  136 EVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             EEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3588999988753211  11222345677899999987 666788999999999999999999997766

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=98.92  E-value=2.7e-09  Score=61.00  Aligned_cols=68  Identities=29%  Similarity=0.435  Sum_probs=46.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh--CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS--GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~--g~~~~~~~   69 (92)
                      .++++|||+++...............++..|++||......++.+.|+||+|++++++++  +..|+...
T Consensus       168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            468999998875432211111112233456889988766778889999999999999997  66676543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=98.92  E-value=2.6e-09  Score=61.34  Aligned_cols=71  Identities=24%  Similarity=0.319  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++....... ........++..|++||..... .++.+.|+|++|++++++++|++||......
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~  222 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK  222 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence            468999998875432211 1111223456779999987543 4678899999999999999999998765543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=98.92  E-value=5.8e-09  Score=59.18  Aligned_cols=67  Identities=25%  Similarity=0.366  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||..... .++.+.|+|++|++++++++|++||....
T Consensus       138 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         138 VVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             cEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            46899999887543221  111223466778999987543 35677999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=98.92  E-value=7e-09  Score=58.67  Aligned_cols=68  Identities=29%  Similarity=0.386  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+.......  .......+...|.+||.+... .++.+.|+|++|++++++++|++||...+.
T Consensus       136 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~  204 (283)
T cd05118         136 VLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE  204 (283)
T ss_pred             cEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            46899999887654322  111223456678999987655 577889999999999999999999765543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=98.92  E-value=3.2e-09  Score=59.72  Aligned_cols=66  Identities=27%  Similarity=0.412  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++.......  ......++..|++||.+.   ...++.+.|+|++|++++++++|+.|+...
T Consensus       144 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~  212 (267)
T cd06646         144 DVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL  212 (267)
T ss_pred             CEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            478999999876532211  112245667899999874   233567889999999999999999887433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=98.92  E-value=1.2e-09  Score=62.79  Aligned_cols=67  Identities=30%  Similarity=0.266  Sum_probs=52.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|+.|||+++.....   ...+-.+.+..|.+||++.+..+....|+|+.||++.|+..|.-.|.+.+.
T Consensus       156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~  222 (369)
T KOG0665|consen  156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH  222 (369)
T ss_pred             heeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH
Confidence            3689999999754322   122235667889999999888899999999999999999999998775554

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=98.92  E-value=5.9e-09  Score=58.61  Aligned_cols=69  Identities=25%  Similarity=0.444  Sum_probs=50.0

Q ss_pred             eEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++++|||.+.........  .......++..|.+||......++.+.|+|++|++++++++|..||.....
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            689999988755322110  011223566789999988776778889999999999999999999765443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=1e-09  Score=68.43  Aligned_cols=55  Identities=22%  Similarity=0.346  Sum_probs=47.0

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIGH   80 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~~   80 (92)
                      .+|++.|++||++...+++...|.|+.|+++++|+-|++||......+...++.+
T Consensus       831 lvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n  885 (1034)
T KOG0608|consen  831 LVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN  885 (1034)
T ss_pred             hcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee
Confidence            5788899999999888899999999999999999999999877776666555544

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=98.91  E-value=4.1e-09  Score=59.71  Aligned_cols=67  Identities=34%  Similarity=0.526  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+.......   ......++..|++||......++.+.|+|++|++++++++|+.||.....
T Consensus       133 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         133 NVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             CEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            46899999876542211   11223456679999998776778889999999999999999999866543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=98.91  E-value=2.8e-09  Score=59.93  Aligned_cols=69  Identities=29%  Similarity=0.407  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcc----cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI----EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........    ........++..|++||......++.+.|+|++|++++++++|+.||...+
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence            468899998764321100    011122456778999999877778888999999999999999999986544

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=98.91  E-value=3.2e-09  Score=59.68  Aligned_cols=66  Identities=30%  Similarity=0.456  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.+........  ......++..|++||......++.+.|+|++|++++++++|..||...
T Consensus       144 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         144 VVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            468899998765432211  112235677899999987777888899999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=98.91  E-value=4.4e-09  Score=60.18  Aligned_cols=66  Identities=26%  Similarity=0.488  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++........  ......++..|++||......++.+.|+|++|++++++++|+.||...
T Consensus       153 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         153 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             CEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            468999998765432211  122235667799999887777788899999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=98.91  E-value=4.7e-09  Score=58.91  Aligned_cols=66  Identities=30%  Similarity=0.456  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.++.+.....  ......++..|.+||......++.+.|+|++|++++++++|+.|+...
T Consensus       144 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         144 VVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            368899998875432211  122245667799999887777888899999999999999999987443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=98.91  E-value=4.1e-09  Score=61.59  Aligned_cols=65  Identities=28%  Similarity=0.407  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++.....     .....++..|++||.... ..++.+.|+|++|++++++++|++||.....
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  223 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  223 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4789999988653221     112355677999998755 3467789999999999999999999765443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=98.91  E-value=2.5e-09  Score=61.17  Aligned_cols=66  Identities=35%  Similarity=0.375  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||++......   ........+..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       157 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         157 ASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             eEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            4689999987532111   01111122346899998877778889999999999999997 988875543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=98.91  E-value=8.6e-09  Score=60.59  Aligned_cols=63  Identities=27%  Similarity=0.280  Sum_probs=46.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK-KNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~-~~~~   67 (92)
                      .++++|||+++.....   .......|+..|++||.+....++.+.|+|++|+++++++++. ++|.
T Consensus       195 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        195 QVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             CEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence            4689999988643211   1112245788899999988878889999999999999999754 4433

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=98.91  E-value=3.7e-09  Score=59.49  Aligned_cols=68  Identities=38%  Similarity=0.520  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++........ ......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~  208 (262)
T cd05071         140 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  208 (262)
T ss_pred             cEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            3689999988755322111 1111234456899998877778888999999999999998 787875443

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=98.90  E-value=2.9e-09  Score=59.65  Aligned_cols=64  Identities=41%  Similarity=0.530  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++......     .....+..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~  204 (256)
T cd05082         140 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             cEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            46899999887543211     11233456899998877778888999999999999997 888875443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=98.90  E-value=5.6e-09  Score=59.79  Aligned_cols=66  Identities=27%  Similarity=0.464  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|++||...
T Consensus       154 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         154 RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             CEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46889999876543211  1122245677899999887667788899999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=98.90  E-value=3.8e-09  Score=60.24  Aligned_cols=66  Identities=32%  Similarity=0.393  Sum_probs=47.3

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      +|++|||++........  ......++..|++||.+... .++.+.|+|++|++++++++|++||....
T Consensus       142 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        142 LKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             EEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            68999998865432211  11123456678999987543 46778999999999999999999976544

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=98.90  E-value=3.6e-09  Score=59.82  Aligned_cols=67  Identities=30%  Similarity=0.558  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||..... .++.+.|+|++|++++++++|++||....
T Consensus       139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~  206 (277)
T cd06917         139 NVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD  206 (277)
T ss_pred             CEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            46899999887654322  112234567789999987543 35778999999999999999999976544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=98.90  E-value=2.6e-09  Score=59.96  Aligned_cols=69  Identities=36%  Similarity=0.483  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||.++........ ......++..|++||......++.+.|+|++|++++++++ |+.|+.....
T Consensus       138 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~  207 (256)
T cd05113         138 CVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN  207 (256)
T ss_pred             CEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            4789999988754322111 1111123456899998877777888999999999999998 8888765543

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=98.90  E-value=6e-09  Score=59.37  Aligned_cols=67  Identities=24%  Similarity=0.345  Sum_probs=47.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......++..|++||..... .++.+.|+|++|++++++++|+.||....
T Consensus       141 ~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         141 ELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             cEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            46899999886532211  111223456789999987543 46778899999999999999999976543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=98.90  E-value=4e-09  Score=59.21  Aligned_cols=68  Identities=40%  Similarity=0.561  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.+......... ......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~  208 (260)
T cd05073         140 VCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS  208 (260)
T ss_pred             cEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence            4689999988754322111 1111233456899999877777888999999999999998 888876543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=98.90  E-value=6.5e-09  Score=60.74  Aligned_cols=69  Identities=38%  Similarity=0.447  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||++................++..|++||......++.+.|+|++|++++++++ |..|+....
T Consensus       217 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence            478999998875422111111111233456899998877778888999999999999996 888876543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=98.90  E-value=4.7e-09  Score=59.78  Aligned_cols=67  Identities=24%  Similarity=0.318  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++.......  ......++..|++||.... ..++.+.|+|++|++++++++|++||....
T Consensus       141 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         141 ELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             CEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            468999998764321111  1111234567899998754 346778999999999999999999986554

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=98.89  E-value=6.1e-09  Score=59.82  Aligned_cols=44  Identities=27%  Similarity=0.308  Sum_probs=37.3

Q ss_pred             ccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502           27 IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus        27 ~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++..|++||.+....++.+.|+|++|++++++++|+.||.+..
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~  220 (305)
T cd05609         177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  220 (305)
T ss_pred             ccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            45667999999877778889999999999999999999976443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=98.89  E-value=6.7e-09  Score=58.24  Aligned_cols=63  Identities=29%  Similarity=0.356  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++....      .....++..|++||......++.+.|+|++|++++++++|..||....
T Consensus       135 ~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  197 (260)
T cd05611         135 HLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET  197 (260)
T ss_pred             cEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            468999998764321      112346677899998876667788999999999999999999975543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=98.89  E-value=9e-09  Score=57.47  Aligned_cols=65  Identities=29%  Similarity=0.528  Sum_probs=49.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++++|||.+.......   ......++..|++||......++.+.|+|++|++++++++|+.||...+
T Consensus       141 ~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         141 VKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             EEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence            5889999887653221   1122456778999999877777888999999999999999999975543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=98.89  E-value=7.5e-09  Score=58.68  Aligned_cols=68  Identities=28%  Similarity=0.395  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........ .......++..|++||...... ++.+.|+|++|++++++++|+++|....
T Consensus       137 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  205 (286)
T cd07832         137 VLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN  205 (286)
T ss_pred             cEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence            368899998875532211 1122245677899999875433 5788999999999999999988875544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=98.89  E-value=6.4e-09  Score=57.66  Aligned_cols=65  Identities=31%  Similarity=0.526  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+++.|||.+........   .....++..|.+||......++.+.|+|++|++++++++|+.|+...
T Consensus       136 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         136 EVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             eEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            468999998765433211   12345677899999987666778899999999999999999997655

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=98.88  E-value=5.2e-09  Score=58.65  Aligned_cols=68  Identities=37%  Similarity=0.515  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||.++........ ......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       138 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         138 VVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             cEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence            4689999988754321111 0101112335899998877778888999999999999998 788876543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=98.88  E-value=4.3e-09  Score=59.05  Aligned_cols=66  Identities=36%  Similarity=0.477  Sum_probs=45.1

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhC-CCCCC
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG-KKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g-~~~~~   67 (92)
                      .+|++|||+++.......  ........++..|++||......++.+.|+|++|++++++++| .+|+.
T Consensus       136 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  204 (262)
T cd05058         136 TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  204 (262)
T ss_pred             cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence            468999998875422110  0001112345578999988777788899999999999999985 55654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=98.88  E-value=5.6e-09  Score=58.32  Aligned_cols=66  Identities=26%  Similarity=0.421  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++.......   ......++..|++||...... ++.+.|+|++|++++++++|++||....
T Consensus       140 ~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         140 VVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             CEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            46899999887543221   122245667789999876555 7788999999999999999999976554

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=98.88  E-value=7.9e-09  Score=60.09  Aligned_cols=69  Identities=23%  Similarity=0.368  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccc--cccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG--NTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.........  ......++..|.+||.+.. ..++.+.|+|++|++++++++|++||....
T Consensus       145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~  216 (334)
T cd07855         145 ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN  216 (334)
T ss_pred             cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence            46899999987653221110  0112356778999998754 346788999999999999999999976544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=98.88  E-value=4.2e-09  Score=63.44  Aligned_cols=66  Identities=29%  Similarity=0.530  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcc---cccccccccCCCccCCccccCCC---C-CccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI---EGNTNRVIGTYGYMAPEYASDGK---F-SVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~p~~~~~~~---~-~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      ++|++|||++........   ........|++.+++||.+....   + +.+.|+|++|+.+|.++-|+-||-
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            589999999875522111   11223368999999999987622   2 356899999999999999999843

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=98.88  E-value=4.8e-09  Score=58.89  Aligned_cols=68  Identities=40%  Similarity=0.547  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++......... .....++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  208 (260)
T cd05069         140 VCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV  208 (260)
T ss_pred             eEEECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            46889999887543221111 111233456899998877777888999999999999998 888876543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PLN00181 protein SPA1-RELATED; Provisional

Probab=98.87  E-value=2.3e-09  Score=68.58  Aligned_cols=41  Identities=27%  Similarity=0.463  Sum_probs=36.3

Q ss_pred             ccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502           27 IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus        27 ~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+++.|++||.+....++.+.|+|++||+++|+++|.+|+.
T Consensus       176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            56778999999888888999999999999999999888754

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=98.87  E-value=6e-09  Score=58.07  Aligned_cols=68  Identities=34%  Similarity=0.402  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++........ .......++..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       131 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         131 VLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             eEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            368999998865332111 11111223456899998877777888999999999999997 888875543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=98.87  E-value=7.4e-09  Score=58.10  Aligned_cols=68  Identities=40%  Similarity=0.544  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++......... ......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         140 CCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             CEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            4688999988765321111 1111234457899998877777888999999999999998 999976443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=7.6e-10  Score=66.59  Aligned_cols=69  Identities=36%  Similarity=0.597  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccc-----cccccccCCCccCCccccCC----CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-----NTNRVIGTYGYMAPEYASDG----KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~p~~~~~~----~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|+.|||+++.+.......     ...-..|+.+|++||.....    ..+.+.|+|++|++++..+.|+.||....
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            47999999999775432211     12235778899999976543    35678999999999999999999965433

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=98.87  E-value=5.3e-09  Score=58.88  Aligned_cols=69  Identities=35%  Similarity=0.457  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCccccc-ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++........... ......+..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~  215 (268)
T cd05063         145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS  215 (268)
T ss_pred             cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence            468999998875432111100 001112335899998877777888999999999999987 998975443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=98.87  E-value=9.4e-09  Score=58.32  Aligned_cols=67  Identities=31%  Similarity=0.411  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||...... ++.+.|+|++|++++++++|+.||....
T Consensus       138 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         138 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             CEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            46899999876543211  1112234566789999875544 4677999999999999999999976544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=98.87  E-value=4.8e-09  Score=58.98  Aligned_cols=65  Identities=31%  Similarity=0.475  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+.......  .......++..|++||......++.+.|+|++|++++++++|+.|+..
T Consensus       144 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         144 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            46889999887653221  111123566779999988777778889999999999999999998744

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=98.86  E-value=4.4e-09  Score=58.94  Aligned_cols=68  Identities=43%  Similarity=0.589  Sum_probs=47.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++......... ......+..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       141 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         141 VCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             CEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            46889999887553211111 111123456899998877778888999999999999998 898875543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=98.86  E-value=7.2e-09  Score=58.46  Aligned_cols=67  Identities=28%  Similarity=0.423  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||+++...............++..|++||......  ++.+.|+|++|++++++++|+.|+..
T Consensus       146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            46889999886543211111122234567789999876543  67789999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=98.86  E-value=5.5e-09  Score=58.79  Aligned_cols=67  Identities=34%  Similarity=0.538  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+.......  .......++..|++||.+..     ..++.+.|+|++|++++++++|++||....
T Consensus       151 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  222 (275)
T cd06608         151 EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH  222 (275)
T ss_pred             eEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence            36889999876543221  11222456778999997643     235567899999999999999999986543

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=1.5e-09  Score=66.67  Aligned_cols=65  Identities=31%  Similarity=0.520  Sum_probs=53.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+||+|+|++.....+.    ..+.+|+|.+|+||.-- ..|....|+|+||..+.||.++.-||....+
T Consensus       184 ~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n  248 (632)
T KOG0584|consen  184 EVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN  248 (632)
T ss_pred             ceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence            57999999998654322    22378999999999853 6688999999999999999999999888774

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=98.86  E-value=1.4e-08  Score=57.85  Aligned_cols=64  Identities=31%  Similarity=0.441  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......    .....++..|++||......++.+.|+|++|++++++++|+.|+...
T Consensus       143 ~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         143 QVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             eEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            36889999876543211    11234566789999887777888899999999999999999997655

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=98.86  E-value=1.1e-08  Score=57.86  Aligned_cols=69  Identities=26%  Similarity=0.360  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+........ .......++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       138 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         138 VLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             CEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            468999998876543211 01112344567899997654 3467889999999999999999999765553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=98.86  E-value=1.1e-08  Score=58.09  Aligned_cols=67  Identities=30%  Similarity=0.406  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++......  .......++..|++||.+... .++.+.|+|++|++++++++|++||....
T Consensus       137 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         137 ALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             cEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            46899999886542211  111122446678999987543 36778999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.86  E-value=6.3e-09  Score=59.09  Aligned_cols=68  Identities=31%  Similarity=0.339  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCccccc-ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++.......... .....++..|++||......++.+.|+|++|++++++++|..|+...
T Consensus       145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            468999999875432111000 11123344688999887777788899999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=98.85  E-value=3.6e-09  Score=59.67  Aligned_cols=68  Identities=29%  Similarity=0.274  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||......... ........++..|++||......++.+.|+|++|++++++++ |++||....
T Consensus       145 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~  213 (266)
T cd05064         145 VCKISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS  213 (266)
T ss_pred             cEEECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence            46788998765322111 011111223457899998877778889999999999999775 999976544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=98.85  E-value=6.3e-09  Score=58.05  Aligned_cols=66  Identities=32%  Similarity=0.412  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++......    .....++..|.+||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       141 ~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  206 (256)
T cd08530         141 LVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM  206 (256)
T ss_pred             cEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            46899999887543321    1123466789999998777778889999999999999999999765543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=98.85  E-value=9.9e-09  Score=58.16  Aligned_cols=67  Identities=30%  Similarity=0.526  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|..|+....
T Consensus       139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  205 (277)
T cd06641         139 EVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH  205 (277)
T ss_pred             CEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence            46889999887543221  11222356667899998876667788999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=98.85  E-value=5.2e-09  Score=58.66  Aligned_cols=67  Identities=43%  Similarity=0.580  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||.+.........  .....++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       142 ~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         142 VCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             eEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence            4688999988654322111  111223456899998877778888999999999999998 888876544

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=98.85  E-value=1.1e-08  Score=58.90  Aligned_cols=62  Identities=34%  Similarity=0.468  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.....      .....++..|++||.+.   ...++.+.|+|++|++++++++|++|+...
T Consensus       153 ~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~  217 (307)
T cd06607         153 TVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (307)
T ss_pred             CEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence            468999998765321      11235667899999864   244677899999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=98.85  E-value=6.1e-09  Score=58.25  Aligned_cols=65  Identities=29%  Similarity=0.484  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+.......  .......++..|.+||......++.+.|+|++|++++++++|+.|+..
T Consensus       139 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         139 TIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             CEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence            46899999887543211  111223466779999998777777889999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=98.84  E-value=9.1e-09  Score=58.43  Aligned_cols=67  Identities=28%  Similarity=0.446  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++......  .......++..|++||.+..     ..++.+.|+|++|++++++++|+.|+....
T Consensus       162 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~  233 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH  233 (286)
T ss_pred             CEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence            36899999987653221  11222457778999998642     336778999999999999999999976543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=98.84  E-value=1.2e-08  Score=58.18  Aligned_cols=69  Identities=30%  Similarity=0.375  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .++++|||+++.......  ......++..|++||.+.... ++.+.|+|++|++++++++|.+||......
T Consensus       144 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~  213 (293)
T cd07843         144 ILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI  213 (293)
T ss_pred             cEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            468999998876543211  112234566799999876443 567899999999999999999997665543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=98.84  E-value=1.1e-08  Score=57.79  Aligned_cols=69  Identities=16%  Similarity=0.331  Sum_probs=43.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-------GKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||++................++..|++||....       ..++.+.|+|++|++++++++ +..||....
T Consensus       137 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  213 (268)
T cd05086         137 TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS  213 (268)
T ss_pred             cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence            468999998753211111111122355677899998642       224567899999999999986 566765443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=98.84  E-value=1.2e-08  Score=58.98  Aligned_cols=62  Identities=34%  Similarity=0.458  Sum_probs=46.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.....      .....++..|++||.+.   ...++.+.|+|++|++++++++|++|+...
T Consensus       163 ~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         163 QVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             CEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            468899998764321      11235677899999863   334677899999999999999999986544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=98.84  E-value=9.1e-09  Score=58.30  Aligned_cols=64  Identities=31%  Similarity=0.480  Sum_probs=46.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD----GKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||++.......   ......++..|++||.+..    ..++.+.|+|++|++++++++|+.|+..
T Consensus       142 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         142 QVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             CEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            47899999987543211   1112345677899997653    3456789999999999999999999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=98.84  E-value=7.1e-09  Score=58.01  Aligned_cols=65  Identities=38%  Similarity=0.480  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||.++......     .....+..|++||......++.+.|+|++|++++++++ |++||.....
T Consensus       138 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  203 (254)
T cd05083         138 VAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL  203 (254)
T ss_pred             cEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence            46899999886532111     11223456899998877778888999999999999997 8888765443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=98.84  E-value=9.1e-09  Score=59.28  Aligned_cols=45  Identities=31%  Similarity=0.447  Sum_probs=38.3

Q ss_pred             ccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           27 IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        27 ~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .|+..|++||......++.+.|+|++|++++++++|+.||.....
T Consensus       193 ~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            566779999998777778889999999999999999999765543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=98.83  E-value=8.6e-09  Score=60.20  Aligned_cols=65  Identities=29%  Similarity=0.410  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++......     .....++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~  221 (343)
T cd07851         156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH  221 (343)
T ss_pred             CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            4689999988754221     122345667899998754 3466789999999999999999999765543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=98.83  E-value=1.2e-08  Score=57.01  Aligned_cols=69  Identities=29%  Similarity=0.365  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcc------cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI------EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++........      ........+...|++||.......+.+.|+|++|++++++++|+.||....
T Consensus       131 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998764322110      001122345667899998877767788999999999999999999975444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=98.83  E-value=7.3e-09  Score=58.69  Aligned_cols=67  Identities=28%  Similarity=0.471  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|.+||.+.     ...++.+.|+|++|++++++++|++||...+
T Consensus       141 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~  212 (280)
T cd06611         141 DVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN  212 (280)
T ss_pred             CEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence            36789999775432211  1122245677789999864     2335667999999999999999999976544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=98.83  E-value=1.1e-08  Score=59.52  Aligned_cols=65  Identities=32%  Similarity=0.422  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+......     .....++..|++||.+.. ..++.+.|+|++|++++++++|++||.....
T Consensus       146 ~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~  211 (328)
T cd07856         146 DLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH  211 (328)
T ss_pred             CEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4689999988643211     122345667899998654 4577889999999999999999999866543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=98.83  E-value=1.5e-08  Score=57.82  Aligned_cols=67  Identities=28%  Similarity=0.279  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++......  .......+++.|++||.+.. ..++.+.|+|++|++++++++|.+||....
T Consensus       149 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  216 (295)
T cd07837         149 LLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS  216 (295)
T ss_pred             eEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            46899999887543211  11112245667899998754 346788999999999999999999976543

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=98.83  E-value=2.6e-08  Score=56.77  Aligned_cols=66  Identities=30%  Similarity=0.552  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC--CCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG--KFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||++....... ........++..|++||.....  .++.+.|+|++|++++++++|+.|+..
T Consensus       143 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         143 HVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             CEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            47899999887543211 1112224567789999987542  356778999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=98.82  E-value=1.2e-08  Score=59.60  Aligned_cols=68  Identities=25%  Similarity=0.322  Sum_probs=47.1

Q ss_pred             eEEeeeeceeeeCCCcccc-cccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++++|||.++......... ......++..|++||.+.. ..++.+.|+|++|++++++++|+.||....
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            5889999887543221110 0111245667899997654 346778999999999999999999976544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=98.82  E-value=1.7e-08  Score=56.14  Aligned_cols=69  Identities=30%  Similarity=0.457  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+................++..|.+||.......+.+.|+|++|++++++++|+.|+....
T Consensus       139 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            468899998876543221001122456677999998877767888999999999999999999986655

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=98.82  E-value=5.1e-09  Score=59.13  Aligned_cols=65  Identities=32%  Similarity=0.357  Sum_probs=45.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||++......   ........+..|++||......++.+.|+|++|++++++++ |..||...
T Consensus       150 ~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         150 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             eEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            4689999987532110   00111122446899998877778888999999999999996 88887543

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=98.82  E-value=2.1e-09  Score=68.27  Aligned_cols=70  Identities=30%  Similarity=0.474  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----KFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|+.|||++..+...  .....+.+|++.|++||++.+.     .|...+|+|++|+...|+..|.+|+...++.-
T Consensus       161 ~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             cEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            5799999998765432  2334557899999999988543     35577899999999999999999876655543

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=98.82  E-value=1.3e-08  Score=56.83  Aligned_cols=67  Identities=43%  Similarity=0.574  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||.++......... .....++..|++||......++.+.|+|++|++++++++ |.+|+...
T Consensus       141 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      141 VVKISDFGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             eEEEcccCCceecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            46899999887654321111 101224567899998876677888999999999999997 77886543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=98.82  E-value=1.5e-08  Score=57.41  Aligned_cols=69  Identities=30%  Similarity=0.458  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .++++|||++.......  .......++..|++||..... .++.+.|+|++|++++++++|++||......
T Consensus       138 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~  207 (284)
T cd07836         138 ELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE  207 (284)
T ss_pred             cEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            46889999886442211  111123456678999987543 3577899999999999999999997665543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=98.81  E-value=7.2e-09  Score=58.42  Aligned_cols=69  Identities=33%  Similarity=0.521  Sum_probs=46.1

Q ss_pred             ceEEeeeeceeeeCCCccccccccccc---CCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...............+   +..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence            468899998765432111100000111   235899999877778888999999999999885 888875443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=98.81  E-value=9.8e-09  Score=57.41  Aligned_cols=68  Identities=35%  Similarity=0.462  Sum_probs=47.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.+........ ........+..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       138 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         138 VVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             eEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            368899998865432111 11111223456899998877777888999999999999997 888865443

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=98.81  E-value=2.3e-08  Score=58.10  Aligned_cols=71  Identities=28%  Similarity=0.374  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcc------------cccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI------------EGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.++.......            ........++..|.+||.+.... ++.+.|+|++|++++++++|++||..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            468899998875531100            00011123456789999876433 57789999999999999999999766


Q ss_pred             CCCc
Q 034502           69 YHSD   72 (92)
Q Consensus        69 ~~~~   72 (92)
                      .+..
T Consensus       237 ~~~~  240 (335)
T PTZ00024        237 ENEI  240 (335)
T ss_pred             CCHH
Confidence            5543

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=98.81  E-value=2.5e-08  Score=55.95  Aligned_cols=69  Identities=30%  Similarity=0.497  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCccccc--ccccccCCCccCCccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPEYASDGK---FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~---~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++...........  .....++..|++||.+....   +..+.|+|++|++++++++|+.||...+
T Consensus       137 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~  210 (264)
T cd06626         137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD  210 (264)
T ss_pred             CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence            468999998876532211100  01134566799999886554   6778999999999999999999986553

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=98.81  E-value=2e-08  Score=57.47  Aligned_cols=68  Identities=28%  Similarity=0.373  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++........ .......++..|++||..... .++.+.|+|++|++++++++|++||....
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            468999998875432111 111112345678999976543 46778999999999999999999976433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=98.81  E-value=5.4e-09  Score=60.06  Aligned_cols=66  Identities=32%  Similarity=0.357  Sum_probs=46.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++......   .......+..|++||......++.+.|+|++|++++++++ |..||....
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  228 (303)
T cd05088         162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  228 (303)
T ss_pred             cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence            47899999875321100   1111122446899998876667888999999999999998 898875443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=98.80  E-value=2.2e-08  Score=56.64  Aligned_cols=67  Identities=34%  Similarity=0.419  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++.......  .......+..|++||..... .++.+.|+|++|++++++++|++||....
T Consensus       136 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         136 VLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             CEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence            468999998875432211  11123345668999987655 57788999999999999999999875544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=98.80  E-value=3e-08  Score=55.91  Aligned_cols=67  Identities=33%  Similarity=0.506  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........  ......++..|++||......  ++.+.|+|++|++++++++|++|+....
T Consensus       147 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         147 VVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             eEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            468999998765432111  111234667899999875433  6678999999999999999999976543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=98.80  E-value=2.7e-08  Score=56.66  Aligned_cols=66  Identities=30%  Similarity=0.525  Sum_probs=47.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||+++....... .......++..|.+||......  .+.+.|+|++|++++++++|+.||..
T Consensus       143 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             CEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            468999998875432211 1112234677899999875543  56788999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=98.80  E-value=1e-08  Score=58.27  Aligned_cols=67  Identities=30%  Similarity=0.493  Sum_probs=47.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|.+||......++.+.|+|++|++++++++|+.|+....
T Consensus       154 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         154 SVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             CEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            46788998765432211  11112345667899998877778888999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=98.80  E-value=1.5e-08  Score=57.95  Aligned_cols=64  Identities=31%  Similarity=0.552  Sum_probs=46.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC----CCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK----FSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+..+.....   .....++..|++||.+....    ++.+.|+|++|++++++++|+.||..
T Consensus       153 ~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         153 NVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             CEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            478999998865432111   11123556789999875432    56789999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=98.79  E-value=1.7e-08  Score=57.03  Aligned_cols=69  Identities=23%  Similarity=0.427  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCccc------------------ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC
Q 034502            2 NPKISDFGLARAFGGDEIE------------------GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK   63 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~------------------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~   63 (92)
                      .++++|||++.........                  .......++..|++||.......+.+.|+|++|++++++++|+
T Consensus       140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~  219 (280)
T cd05581         140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK  219 (280)
T ss_pred             CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence            4688999988754322110                  1112234566789999877666778899999999999999999


Q ss_pred             CCCCCCC
Q 034502           64 KNRGFYH   70 (92)
Q Consensus        64 ~~~~~~~   70 (92)
                      .|+....
T Consensus       220 ~p~~~~~  226 (280)
T cd05581         220 PPFRGSN  226 (280)
T ss_pred             CCCCCcc
Confidence            9976554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=98.79  E-value=5.5e-09  Score=58.63  Aligned_cols=64  Identities=33%  Similarity=0.550  Sum_probs=48.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||.+.......    .....++..|++||......++.+.|+|++|++++++++|+.|+...
T Consensus       139 ~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         139 QIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             CEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            36889999876442111    11145667799999987777888899999999999999999997554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.79  E-value=3.5e-09  Score=64.92  Aligned_cols=64  Identities=28%  Similarity=0.442  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+||+|||++..+...   ....+.+|++.|.+||+..+..|. +..|+|++|++++.++.|..||.+
T Consensus       193 nikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  193 NIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             ceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence            5899999998876422   234557899999999998777665 778999999999999999999653

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=98.79  E-value=1.5e-08  Score=58.31  Aligned_cols=63  Identities=33%  Similarity=0.450  Sum_probs=46.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......      ....++..|++||.+.   ...++.+.|+|++|++++++++|+.|+...+
T Consensus       153 ~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  218 (308)
T cd06634         153 LVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (308)
T ss_pred             cEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence            4689999988654321      1235667899999864   2346678999999999999999999875543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=98.79  E-value=3.4e-08  Score=55.98  Aligned_cols=69  Identities=25%  Similarity=0.291  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .++++|||.+........   .....++..|++||.... ..++.+.|+|++|++++++++|++||......+
T Consensus       137 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~  206 (283)
T cd07830         137 VVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID  206 (283)
T ss_pred             CEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence            468999998875432111   112346677899997743 346788999999999999999999976655433

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=98.78  E-value=2.4e-08  Score=55.97  Aligned_cols=67  Identities=33%  Similarity=0.441  Sum_probs=50.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+.......   ......++..|++||......++.+.|+|++|++++++++|+.||.....
T Consensus       138 ~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         138 HVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             CEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            46899999876543221   11223456678999998777778889999999999999999999776553

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=98.76  E-value=2.3e-08  Score=57.12  Aligned_cols=68  Identities=28%  Similarity=0.364  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++.......  ......++..|.+||.+.. ..++...|+|++|++++++++|.++|.....
T Consensus       140 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~  208 (298)
T cd07841         140 VLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD  208 (298)
T ss_pred             CEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence            468999998876533211  1112234567899998744 3467789999999999999999888655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=98.76  E-value=2.8e-08  Score=58.14  Aligned_cols=64  Identities=30%  Similarity=0.399  Sum_probs=47.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......     .....++..|++||.+.. ..++.+.|+|++|++++++++|++||...+
T Consensus       156 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  220 (343)
T cd07880         156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD  220 (343)
T ss_pred             CEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            4789999988653221     112345677899998764 346778999999999999999999976544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=98.76  E-value=2.7e-08  Score=55.83  Aligned_cols=64  Identities=31%  Similarity=0.402  Sum_probs=47.6

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      ++++|||+++.......  ......++..|.+||......++.+.|+|++|++++++++|..|+..
T Consensus       144 ~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         144 LKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             EeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            68899998875432211  12224466778999987766677889999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=98.75  E-value=2.2e-08  Score=55.97  Aligned_cols=65  Identities=28%  Similarity=0.460  Sum_probs=48.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ++++|||.+.......  .......++..|.+||......++.+.|+|++|++++++++|+.|+...
T Consensus       141 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         141 AKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             EEecccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            4789999876543221  1112235677799999887777788899999999999999999997543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=98.75  E-value=1.4e-08  Score=57.19  Aligned_cols=69  Identities=33%  Similarity=0.454  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.+.......... .......+..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~  214 (267)
T cd05066         144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS  214 (267)
T ss_pred             eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence            36889999887543211100 0111112346889998877778889999999999999886 998875544

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=98.74  E-value=3.7e-08  Score=56.91  Aligned_cols=62  Identities=34%  Similarity=0.458  Sum_probs=45.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.....      .....++..|++||.+.   ...++.+.|+|++|++++++++|.+|+...
T Consensus       159 ~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         159 QVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             CEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            468999998753211      11245677899999873   344677889999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=98.74  E-value=1e-07  Score=53.04  Aligned_cols=67  Identities=33%  Similarity=0.517  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||.......+.+.|+|++|++++++++|+.||...+
T Consensus       131 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         131 HIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             cEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            46889999876543221  11222455667999998876667788999999999999999999975444

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=98.73  E-value=3.4e-08  Score=55.30  Aligned_cols=64  Identities=42%  Similarity=0.521  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||.++......    . ....+..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       140 ~~~l~d~g~~~~~~~~~----~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  204 (256)
T cd05039         140 VAKVSDFGLAKEASQGQ----D-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  204 (256)
T ss_pred             CEEEccccccccccccc----c-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            36889999887542211    1 1223456899998877777888999999999999997 888875554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=98.72  E-value=3.4e-08  Score=55.03  Aligned_cols=67  Identities=27%  Similarity=0.450  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|+.|+....
T Consensus       141 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         141 LVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             cEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            36889999887543321  11222456777999998877777888999999999999999999975543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.70  E-value=4.2e-08  Score=55.35  Aligned_cols=61  Identities=26%  Similarity=0.359  Sum_probs=43.9

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCcccc-CCCCCccchhHHHHHHHHHHH-hCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-DGKFSVKSDVFSFGILLLEII-SGKKNRGFY   69 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~ws~g~~~~~~~-~g~~~~~~~   69 (92)
                      ++++|||++.....      .....++..|++||.+. ...++.+.|+|++|+++++++ .|+.|+...
T Consensus       151 ~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         151 IKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             eEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            67888887754321      11234567799999876 345778899999999999997 577776543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.70  E-value=4.9e-08  Score=54.60  Aligned_cols=62  Identities=29%  Similarity=0.445  Sum_probs=45.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC--CCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG--KFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .++++|||++.....      .....+...|++||.+...  .++.+.|+|++|++++++++ |..|+...
T Consensus       146 ~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         146 FIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             eEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            378999998875422      1113445678999988665  57788999999999999998 46666554

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=98.70  E-value=7e-08  Score=53.74  Aligned_cols=67  Identities=28%  Similarity=0.415  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.+........  ......++..|.+||.......+.+.|+|++|++++++++|+.|+....
T Consensus       137 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~  203 (254)
T cd06627         137 VVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN  203 (254)
T ss_pred             CEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence            468999998876543221  1122355677999998866667788999999999999999999976543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=98.69  E-value=5.2e-08  Score=54.46  Aligned_cols=78  Identities=22%  Similarity=0.281  Sum_probs=53.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCC-CCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKN-RGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~-~~~~~~~~~~~~~~   79 (92)
                      .++++|+|++....+...   -...+.+..+-.||.+.... |..+.|+||+||.+.+++-.+.| |.+-+..+++.+++
T Consensus       171 kLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa  247 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA  247 (338)
T ss_pred             eeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence            468999999976543321   12235567778888876544 77889999999999999877665 35555556666666


Q ss_pred             HHh
Q 034502           80 HVS   82 (92)
Q Consensus        80 ~~~   82 (92)
                      .+.
T Consensus       248 kVL  250 (338)
T KOG0668|consen  248 KVL  250 (338)
T ss_pred             HHh
Confidence            543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=98.68  E-value=5.6e-08  Score=54.10  Aligned_cols=61  Identities=20%  Similarity=0.250  Sum_probs=44.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .++++|||.+......     .....++..|++||......++.+.|+|++|++++++++|+.++.
T Consensus       123 ~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         123 HIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             CEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            3678899876543221     111234566899998876667888999999999999999987654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=98.67  E-value=1.7e-07  Score=51.20  Aligned_cols=66  Identities=32%  Similarity=0.443  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccc-cCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+....... ........+...|++||.. ....++.+.|+|++|++++++++|+.||..
T Consensus       136 ~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      136 LVKLADFGLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CEEEeeCceeeEecCcc-cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            46899999887654321 0011223456678999987 555567789999999999999999999744

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.66  E-value=5.2e-08  Score=54.73  Aligned_cols=62  Identities=27%  Similarity=0.389  Sum_probs=43.8

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCC-CCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGK-KNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~-~~~~~~~   70 (92)
                      ++++|||++.....      .....++..|++||.+... .++.+.|+|++|++++++++|. +|+....
T Consensus       147 ~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~  210 (258)
T cd05078         147 IKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD  210 (258)
T ss_pred             EEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence            57888887654321      1123456779999988653 3677899999999999999984 5654433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=98.66  E-value=5e-08  Score=56.78  Aligned_cols=71  Identities=23%  Similarity=0.319  Sum_probs=49.1

Q ss_pred             eEEeeeeceeeeCCCc-----ccccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            3 PKISDFGLARAFGGDE-----IEGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      +|++||-+...+....     ..-...+.+|+-.|++||++..     .-|....|.||+|+++|-|++|.+||.+....
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            6899987655332111     1111234577778999997632     23667789999999999999999999877654


Q ss_pred             c
Q 034502           73 N   73 (92)
Q Consensus        73 ~   73 (92)
                      +
T Consensus       298 d  298 (463)
T KOG0607|consen  298 D  298 (463)
T ss_pred             c
Confidence            3

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=98.64  E-value=3.1e-08  Score=62.63  Aligned_cols=68  Identities=24%  Similarity=0.189  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccc-------cccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-------NTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      +.||||||.+.-........       ..-....++.|.+||++.   ....+.+.|+|++||++|.+.....||+..
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            46899999876322111000       011134577899999874   344678999999999999999999997665

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=98.63  E-value=1.3e-07  Score=54.48  Aligned_cols=69  Identities=16%  Similarity=0.211  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcc-----cccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-----EGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++||+.+........     ........++..|++||.+..  ..++.+.|+|++|++++++++|+.||....
T Consensus       139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~  214 (314)
T cd08216         139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP  214 (314)
T ss_pred             ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            357888887754421110     001112334557899998754  346788999999999999999999976543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=98.62  E-value=8.4e-08  Score=59.71  Aligned_cols=63  Identities=21%  Similarity=0.208  Sum_probs=41.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC----------------------CCCccchhHHHHHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG----------------------KFSVKSDVFSFGILLLEI   59 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----------------------~~~~~~~~ws~g~~~~~~   59 (92)
                      .+|++|||+++.+..... .......+++.|++||.....                      .+..+.|+||+|++++++
T Consensus       294 ~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el  372 (566)
T PLN03225        294 SFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM  372 (566)
T ss_pred             cEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHH
Confidence            479999999975432211 112335677889999954322                      122345999999999999


Q ss_pred             HhCCCC
Q 034502           60 ISGKKN   65 (92)
Q Consensus        60 ~~g~~~   65 (92)
                      +.+..+
T Consensus       373 ~~~~~~  378 (566)
T PLN03225        373 AFPNLR  378 (566)
T ss_pred             HhCcCC
Confidence            876543

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=98.60  E-value=5.3e-08  Score=55.39  Aligned_cols=64  Identities=33%  Similarity=0.481  Sum_probs=44.7

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .++++|||+++........ .......++..|++||......++.+.|+|++|++++++++++.+
T Consensus       147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~  211 (284)
T cd05079         147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS  211 (284)
T ss_pred             CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence            4689999988754322110 011123345568999988777778889999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=98.59  E-value=1.8e-07  Score=51.46  Aligned_cols=64  Identities=34%  Similarity=0.537  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+.......   ......+...|.+||......++.+.|+|++|++++++++|..|+..
T Consensus       125 ~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      125 HVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             cEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            46789999887654321   11224566678999988766778899999999999999999999755

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=98.59  E-value=6.5e-08  Score=54.76  Aligned_cols=67  Identities=34%  Similarity=0.377  Sum_probs=46.3

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+......... .......++..|.+||......++...|+|++|++++++++|+.|+..
T Consensus       147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            4689999988765421110 001112233458899988777778889999999999999999987643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=98.58  E-value=5.1e-08  Score=54.78  Aligned_cols=68  Identities=21%  Similarity=0.181  Sum_probs=46.0

Q ss_pred             ceEEeeeeceeeeCCCcc-------cccccccccCCCccCCccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-------EGNTNRVIGTYGYMAPEYASDGK---FSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~~~~~---~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+.+.|||.+........       .........+..|.+||......   .+.+.|+||+||.+++++-|..||+..
T Consensus       167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~  244 (302)
T KOG2345|consen  167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI  244 (302)
T ss_pred             ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence            357889998765431100       00112234567899999875433   457899999999999999999887543

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=98.58  E-value=2e-07  Score=52.99  Aligned_cols=63  Identities=27%  Similarity=0.337  Sum_probs=43.9

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEII-SGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~-~g~~~~~~~~~   71 (92)
                      ++++|||++......      ....++..|++||.+.. ..++.+.|+|++|+++++++ .|+.|+.....
T Consensus       163 ~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         163 IKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             eeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            577888876532111      11245667899998754 44778899999999999984 78888765543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=98.56  E-value=2.2e-07  Score=56.14  Aligned_cols=63  Identities=35%  Similarity=0.531  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CC-----ccchhHHHHHHHHHHHhCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FS-----VKSDVFSFGILLLEIISGKK   64 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~-----~~~~~ws~g~~~~~~~~g~~   64 (92)
                      ++-++|||++..+............+|+..|++||++-+.- +.     .+.|+|++|.++||+.++-.
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            45689999998877554444444578999999999885432 22     34799999999999998643

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=98.56  E-value=1.1e-07  Score=54.08  Aligned_cols=64  Identities=34%  Similarity=0.486  Sum_probs=43.7

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .++++|||+++......... ......++..|.+||......++.+.|+|++|+++++++++..+
T Consensus       146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~  210 (284)
T cd05081         146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK  210 (284)
T ss_pred             eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence            46899999987543221110 01111223358899988777788889999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=98.54  E-value=2.2e-07  Score=54.02  Aligned_cols=43  Identities=23%  Similarity=0.399  Sum_probs=35.1

Q ss_pred             ccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502           27 IGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus        27 ~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++..|++||.+..  ..++.+.|+|++|++++++++|+.||...
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             cceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            34556899998865  34778899999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=98.48  E-value=3.1e-07  Score=51.92  Aligned_cols=66  Identities=29%  Similarity=0.414  Sum_probs=44.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~   68 (92)
                      .++++|||+++....... .......++..|++||.......+.+.|+|++|++++++++ |..||..
T Consensus       155 ~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             cEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            357788887754322111 11112234556899998876667788999999999999998 7777643

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=98.47  E-value=4.5e-07  Score=59.28  Aligned_cols=41  Identities=32%  Similarity=0.660  Sum_probs=36.8

Q ss_pred             ccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502           27 IGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus        27 ~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .++..|++||......++.+.|+|++|++++|+++|+.|+.
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            45678999999888788899999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=98.46  E-value=1.4e-08  Score=64.39  Aligned_cols=69  Identities=29%  Similarity=0.491  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG-KKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g-~~~~~~~~   70 (92)
                      .++++|||+++.+...... .......|+..|.+||.+....-....|+.++||+++..++| ..||...-
T Consensus       649 ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~  719 (903)
T KOG1027|consen  649 RAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL  719 (903)
T ss_pred             eEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence            4689999999987543221 123446788899999999877766788999999999887765 78875443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.40  E-value=1.5e-07  Score=61.48  Aligned_cols=76  Identities=25%  Similarity=0.280  Sum_probs=56.1

Q ss_pred             ceEEeeeeceeeeCCCcc-------------cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-------------EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      ++|+.|||+.+.......             .......+|++.|.+|+++.-.+|+...|.|++|+++++++-|..||-+
T Consensus       181 hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  181 HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence            468899998875421100             0011225889999999999988999999999999999999999999766


Q ss_pred             CCCcchhhH
Q 034502           69 YHSDNKLNL   77 (92)
Q Consensus        69 ~~~~~~~~~   77 (92)
                      ...++.+-.
T Consensus       261 dtpeelfg~  269 (1205)
T KOG0606|consen  261 DTPEELFGQ  269 (1205)
T ss_pred             CCHHHHHhh
Confidence            655554433

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.19  E-value=2.3e-06  Score=56.88  Aligned_cols=60  Identities=40%  Similarity=0.681  Sum_probs=43.9

Q ss_pred             ceEEeeeeceeeeC----------------CCcccccccccccCCCccCCccccCC---CCCccchhHHHHHHHHHHHh
Q 034502            2 NPKISDFGLARAFG----------------GDEIEGNTNRVIGTYGYMAPEYASDG---KFSVKSDVFSFGILLLEIIS   61 (92)
Q Consensus         2 ~~kl~dfg~~~~~~----------------~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~ws~g~~~~~~~~   61 (92)
                      .+|++|||++.-..                ........+..+||..|.+||.....   .|+.+.|+||+|++++||+.
T Consensus       735 ~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  735 SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence            57999999987510                00111123446888899999987644   48899999999999999974

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=98.15  E-value=3.9e-06  Score=48.85  Aligned_cols=42  Identities=26%  Similarity=0.443  Sum_probs=34.3

Q ss_pred             CCCccCCccccCC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502           29 TYGYMAPEYASDG--KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus        29 ~~~~~~p~~~~~~--~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      +..|++||.+...  .++.+.|+|++|++++++++|++||....
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             ccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence            3458999988653  36788999999999999999999976554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.11  E-value=1.1e-06  Score=53.60  Aligned_cols=59  Identities=34%  Similarity=0.623  Sum_probs=45.4

Q ss_pred             eEEeeeeceeeeCCCc----ccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh
Q 034502            3 PKISDFGLARAFGGDE----IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS   61 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~   61 (92)
                      +|+.|||+........    .........|+..|++||.+.+..|+.+.|++++|.+++|++.
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            5789999876443211    0112334678899999999999999999999999999999887

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=98.09  E-value=9.9e-07  Score=54.91  Aligned_cols=61  Identities=31%  Similarity=0.464  Sum_probs=47.0

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      +|++|||.+....    .+.-..+.|+..|.+||++.+..|. ...|+|++|+++|......-||.
T Consensus       709 ~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6899999876432    2234457899999999999888876 45799999999998776666654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=98.03  E-value=1.7e-05  Score=49.18  Aligned_cols=65  Identities=22%  Similarity=0.188  Sum_probs=41.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--------------------CC--ccchhHHHHHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--------------------FS--VKSDVFSFGILLLEI   59 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--------------------~~--~~~~~ws~g~~~~~~   59 (92)
                      .+|++|||+++...... .........++.|.+||.+....                    +.  ...|+|++|++++++
T Consensus       347 ~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em  425 (507)
T PLN03224        347 QVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQM  425 (507)
T ss_pred             cEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHH
Confidence            47899999986543211 11111123367799999764321                    11  236999999999999


Q ss_pred             HhCCC-CCC
Q 034502           60 ISGKK-NRG   67 (92)
Q Consensus        60 ~~g~~-~~~   67 (92)
                      +.+.. |+.
T Consensus       426 ~~~~l~p~~  434 (507)
T PLN03224        426 CVPELRPVA  434 (507)
T ss_pred             HhCCCCCcc
Confidence            98764 543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=97.97  E-value=2.3e-06  Score=53.78  Aligned_cols=71  Identities=27%  Similarity=0.397  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGKFSV-KSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||.+..+......  ......+|+..|++||.+....|.+ ..|+|+.|+++..|..|+.|+.--...
T Consensus       458 ~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  458 ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence            4689999998766432111  2233467888999999998888874 479999999999999998887554444

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=97.97  E-value=1.2e-06  Score=50.24  Aligned_cols=61  Identities=30%  Similarity=0.501  Sum_probs=40.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCC--CCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGK--FSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~--~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||..++.+....   .  .-....|-+||.+.   ...  ..+..|+|.+|++++..++|++|++
T Consensus       161 rvKlcDFG~t~k~g~tV~---~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  161 RVKLCDFGLTRKVGTTVK---Y--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             EEEeeecccccccCceeh---h--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            579999999876432111   1  01122345565432   122  3467899999999999999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=97.93  E-value=2.8e-06  Score=52.91  Aligned_cols=59  Identities=34%  Similarity=0.573  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      ++++.|||+++......    .  .+|+..|++||++.  .+....|.|++|++.+++++|..||..
T Consensus       135 hi~~tdfglske~v~~~----~--~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  135 HIKLTDFGLSKEAVKEK----I--ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ccccCCchhhhHhHhhh----h--cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            46788999887543211    1  27788999999986  556778999999999999999999777

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=97.88  E-value=4e-05  Score=46.57  Aligned_cols=72  Identities=29%  Similarity=0.406  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccCCC----CC--ccchhHHHHHHHHHHHhC----------C
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDGK----FS--VKSDVFSFGILLLEIISG----------K   63 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~----~~--~~~~~ws~g~~~~~~~~g----------~   63 (92)
                      .+-++|+|++-.......  .......+|+..|++||++...-    |.  ..+|+|++|.++||+..+          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            356899999865433211  11234468899999999875321    22  347999999999998642          4


Q ss_pred             CCCCCCCCcc
Q 034502           64 KNRGFYHSDN   73 (92)
Q Consensus        64 ~~~~~~~~~~   73 (92)
                      .||....+.+
T Consensus       434 ~Pyyd~Vp~D  443 (513)
T KOG2052|consen  434 LPYYDVVPSD  443 (513)
T ss_pred             CCcccCCCCC
Confidence            6765555443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=97.71  E-value=0.00015  Score=41.18  Aligned_cols=68  Identities=34%  Similarity=0.447  Sum_probs=49.8

Q ss_pred             eEEeeeeceeeeCCCcccc----cccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEG----NTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      +++.|||.++.........    ......++..|.+|+....   .......|+|++|+..++++.+..|+....
T Consensus       141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             EEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            6889999987543321110    1234677888999998876   456778999999999999999998855544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.64  E-value=1.7e-05  Score=50.28  Aligned_cols=63  Identities=27%  Similarity=0.462  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||.+..+.-.  ..+...+.|++.|++||+.-   ...|....|+|+.|+...|+..-++|.
T Consensus       150 DvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  150 DVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             ceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            4789999988655422  22344589999999999753   445778899999998888877666663

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=97.29  E-value=0.00029  Score=40.93  Aligned_cols=48  Identities=21%  Similarity=0.146  Sum_probs=37.6

Q ss_pred             cCCCccCCccccCCCC---CccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502           28 GTYGYMAPEYASDGKF---SVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus        28 ~~~~~~~p~~~~~~~~---~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .++.|++||.+...+-   -..+|+||+++++||+-+...||+...+.+.-
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg  398 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG  398 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh
Confidence            4678999998764442   25689999999999999999998877766543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=97.25  E-value=0.0018  Score=38.07  Aligned_cols=72  Identities=24%  Similarity=0.260  Sum_probs=49.0

Q ss_pred             ceEEeeeecee--eeCCCcc-----ccc-ccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLAR--AFGGDEI-----EGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~--~~~~~~~-----~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+.+.|||+++  .......     ... .....|+..|.++..-.....+...|+|++..++.++..|..|+.......
T Consensus       165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            36789999998  3321110     000 112347777877776666667788999999999999999998986666443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=97.24  E-value=0.00046  Score=42.72  Aligned_cols=82  Identities=23%  Similarity=0.325  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-------CCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-------FSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-------~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|+.|||+.................-...|.+||.+....       .+...|++++|++++|++..+.||........
T Consensus        87 ~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~  166 (484)
T KOG1023|consen   87 VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVED  166 (484)
T ss_pred             EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCC
Confidence            46899999876542110000011112234688999876532       23558999999999999999999876444432


Q ss_pred             -hhHHHHHhh
Q 034502           75 -LNLIGHVSK   83 (92)
Q Consensus        75 -~~~~~~~~~   83 (92)
                       .+.+..+++
T Consensus       167 ~~eii~~~~~  176 (484)
T KOG1023|consen  167 PDEIILRVKK  176 (484)
T ss_pred             hHHHHHHHHh
Confidence             334444444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=97.16  E-value=0.00015  Score=43.64  Aligned_cols=41  Identities=29%  Similarity=0.414  Sum_probs=34.0

Q ss_pred             cccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCC
Q 034502           26 VIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      ..|++++.+||++...+ -+++.|+|+.|+++..+++++.||
T Consensus       237 rAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PF  278 (418)
T KOG1167|consen  237 RAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPF  278 (418)
T ss_pred             cCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccc
Confidence            57889999999875443 567789999999999999988774

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=97.12  E-value=0.0014  Score=35.07  Aligned_cols=56  Identities=38%  Similarity=0.672  Sum_probs=38.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEI   59 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~   59 (92)
                      .++++||+.+........  ......+...|.+|+..... ..+...|+|++|++++++
T Consensus       131 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         131 KVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            367889988775432210  11223455678899887665 566788999999998887

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=96.81  E-value=0.0024  Score=38.20  Aligned_cols=79  Identities=18%  Similarity=0.279  Sum_probs=52.7

Q ss_pred             eEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            3 PKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      +-++|||+++....+...     ...-+..|+-.|++.-.-.+..-+...|+=++|-+++.++.|..|+++.+....-++
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k  247 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK  247 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence            468999999866432111     111123455556655444444445667888999999999999999999988876666


Q ss_pred             HHHH
Q 034502           78 IGHV   81 (92)
Q Consensus        78 ~~~~   81 (92)
                      .++|
T Consensus       248 YeKI  251 (449)
T KOG1165|consen  248 YEKI  251 (449)
T ss_pred             HHHh
Confidence            6554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=96.61  E-value=0.00086  Score=38.42  Aligned_cols=83  Identities=19%  Similarity=0.173  Sum_probs=52.4

Q ss_pred             eEEeeeeceeeeCCCc-----ccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            3 PKISDFGLARAFGGDE-----IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      +-++|||+++......     +........|+-.|.+.-...+..-+...|+=|+|.++..+-.|..|+++.......++
T Consensus       153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            4579999998764321     11112223444444333221112223556788999888888889999999999988888


Q ss_pred             HHHHhhhc
Q 034502           78 IGHVSKMH   85 (92)
Q Consensus        78 ~~~~~~~~   85 (92)
                      .+.|....
T Consensus       233 yEkI~EkK  240 (341)
T KOG1163|consen  233 YEKISEKK  240 (341)
T ss_pred             HHHHHHhh
Confidence            88876543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=96.43  E-value=0.0013  Score=41.99  Aligned_cols=71  Identities=32%  Similarity=0.458  Sum_probs=49.5

Q ss_pred             eEEeeeeceeeeCC-Cccccccccccc-CCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            3 PKISDFGLARAFGG-DEIEGNTNRVIG-TYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         3 ~kl~dfg~~~~~~~-~~~~~~~~~~~~-~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      ++.+|||++..... ..........+| ++.|.+||...... ..+..|+|++|+++..+.+|..|.......+
T Consensus       164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence            57789998876543 111222223466 88899999887643 4577899999999999999988865555443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=96.24  E-value=0.0031  Score=36.78  Aligned_cols=65  Identities=18%  Similarity=0.282  Sum_probs=36.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--------GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      +.++||+.....+..     ......+..+.+||....        ..++.+.|.|.+|++++.+..+..||......
T Consensus       184 v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~  256 (288)
T PF14531_consen  184 VFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE  256 (288)
T ss_dssp             EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG
T ss_pred             EEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc
Confidence            457777665432211     000122345778876533        13567789999999999999999997655433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=95.31  E-value=0.016  Score=39.39  Aligned_cols=50  Identities=26%  Similarity=0.412  Sum_probs=41.4

Q ss_pred             cccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502           26 VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      ..+++.|.+||..........+|.|+.|+.+++.+.|.+||.-..++..+
T Consensus       995 ~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen  995 VVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred             ccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence            56778899999998888888889999999999999999996655554443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=93.89  E-value=0.056  Score=37.41  Aligned_cols=37  Identities=27%  Similarity=0.449  Sum_probs=27.7

Q ss_pred             CccCCccccCC----------C-CCccchhHHHHHHHHHHH-hCCCCCC
Q 034502           31 GYMAPEYASDG----------K-FSVKSDVFSFGILLLEII-SGKKNRG   67 (92)
Q Consensus        31 ~~~~p~~~~~~----------~-~~~~~~~ws~g~~~~~~~-~g~~~~~   67 (92)
                      .|.+||.....          . ..++.|+++.||++.|++ .|+|+|.
T Consensus       192 CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  192 CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            47888865431          1 457789999999999987 5788873

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=91.58  E-value=0.32  Score=33.33  Aligned_cols=62  Identities=16%  Similarity=0.099  Sum_probs=42.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK   63 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~   63 (92)
                      .++|+|||.+-=+..-.+...-.....+-.+.++|..-+..++...|.+.++.+++.|+-|+
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            47899999764222111111222245566778889888888999999999988888877775

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=90.47  E-value=0.85  Score=28.71  Aligned_cols=41  Identities=29%  Similarity=0.256  Sum_probs=29.2

Q ss_pred             cCCCccCCccccCCC--C----CccchhHHHHHHHHHHHhCCCCCCC
Q 034502           28 GTYGYMAPEYASDGK--F----SVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus        28 ~~~~~~~p~~~~~~~--~----~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      |.-..++||+....+  .    -.++|.|..|.+.||.+...-||..
T Consensus       413 GNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  413 GNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            444578888764322  1    1568999999999999987777655

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=88.31  E-value=0.99  Score=28.73  Aligned_cols=46  Identities=15%  Similarity=0.287  Sum_probs=32.8

Q ss_pred             ccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502           25 RVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus        25 ~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      ..+|...|++||.-.-     .......|.+.+++++++++- |+.||++..
T Consensus       175 cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~  226 (637)
T COG4248         175 CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP  226 (637)
T ss_pred             cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence            3567788999986431     223356788999999999875 588987654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=85.09  E-value=0.88  Score=27.82  Aligned_cols=38  Identities=18%  Similarity=0.213  Sum_probs=22.2

Q ss_pred             ceEEeeeeceeeeCCCccccc------ccccccCCCccCCcccc
Q 034502            2 NPKISDFGLARAFGGDEIEGN------TNRVIGTYGYMAPEYAS   39 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~~~~p~~~~   39 (92)
                      .++++|||+++.+........      ..+..+++.+.+||.+.
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            478999999986643211111      12344555677787664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	92
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-06
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-06
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-05
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-05
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-04
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-04
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-04
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-04
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-04
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-04
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-04
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-04
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-04
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-04
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-04
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-04
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-04
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-04
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-04
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-04
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-04
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-04
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-04
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-04
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-04
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-04

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 32/59 (54%), Positives = 42/59 (71%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFGLARA          +R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 173 KISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 32/59 (54%), Positives = 41/59 (69%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFGLARA           R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 167 KISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 32/59 (54%), Positives = 41/59 (69%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFGLARA           R++GT  YMAPE A  G+ + KSD++SFG++LLEII+G
Sbjct: 173 KISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 31/59 (52%), Positives = 41/59 (69%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KISDFGLARA          +R++GT  Y APE A  G+ + KSD++SFG++LLEII+G
Sbjct: 164 KISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 27/61 (44%), Positives = 42/61 (68%), Gaps = 3/61 (4%)
Query: 5   ISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           + DFGLA+    D  + +    + GT G++APEY S GK S K+DVF +G++LLE+I+G+
Sbjct: 183 VGDFGLAKLM--DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 64  K 64
           +
Sbjct: 241 R 241

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/64 (43%), Positives = 43/64 (67%), Gaps = 6/64 (9%)
Query: 3   PKISDFGLARAFGGDEIEGNTNR---VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           PKI+DFG+++   G E+ G T+    V GT GY+ PEY   G+ + KSDV+SFG++L E+
Sbjct: 178 PKITDFGISKK--GTEL-GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 60  ISGK 63
           +  +
Sbjct: 235 LCAR 238

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 41/63 (65%), Gaps = 4/63 (6%)
Query: 3   PKISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           PKI+DFG+++   G E++       V GT GY+ PEY   G+ + KSDV+SFG++L E++
Sbjct: 178 PKITDFGISKK--GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 61  SGK 63
             +
Sbjct: 236 CAR 238

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 26/61 (42%), Positives = 41/61 (67%), Gaps = 3/61 (4%)
Query: 5   ISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           + DFGLA+    D  + +    + G  G++APEY S GK S K+DVF +G++LLE+I+G+
Sbjct: 175 VGDFGLAKLM--DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 64  K 64
           +
Sbjct: 233 R 233

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGLAR +             G Y +MAPE      FS  SDV+S+G+LL E+++G+
Sbjct: 156 KITDFGLAREWH----RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL+EI++
Sbjct: 151 KIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL+EI++
Sbjct: 324 KIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 31/80 (38%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+++  
Sbjct: 145 KIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT-- 201
Query: 64  KNRGFYHSDNKLNLIGHVSK 83
           K R  Y   N   ++  V +
Sbjct: 202 KGRVPYPGMNNREVLEQVER 221

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 156 KVMDFGIARAIADSGNSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 62  GK 63
           G+
Sbjct: 215 GE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 156 KVMDFGIARAIADSGNSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 62  GK 63
           G+
Sbjct: 215 GE 216

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 156 KVVDFGIARAIADSGNSVX-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 62  GK 63
           G+
Sbjct: 215 GE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 156 KVMDFGIARAIADSGNSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 62  GK 63
           G+
Sbjct: 215 GE 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 173 KVMDFGIARAIADSGNSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
Query: 62  GK 63
           G+
Sbjct: 232 GE 233

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 25/62 (40%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFG+ARA    G+ +   T  VIGT  Y++PE A       +SDV+S G +L E+++
Sbjct: 156 KVMDFGIARAIADSGNSVT-QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 62  GK 63
           G+
Sbjct: 215 GE 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 146 LSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 61  S 61
           +
Sbjct: 205 T 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 147 LSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIV 205
Query: 61  S 61
           +
Sbjct: 206 T 206

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 38/60 (63%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E    T R    +   + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 144 KVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 151 KIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 146 LSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 61  S 61
           +
Sbjct: 205 T 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 143 KVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    + GN    +    +MAPE   +G +++KSDV+S+GILL EI 
Sbjct: 212 KICDFGLARDIMSDSNYVVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIF 268
Query: 61  S 61
           S
Sbjct: 269 S 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 142 LSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIV 200
Query: 61  S 61
           +
Sbjct: 201 T 201

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/61 (42%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 141 LSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIV 199
Query: 61  S 61
           +
Sbjct: 200 T 200

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 149 KIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 158 KIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 157 KIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 155 KIADFGLARLIEDNEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 155 KIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 159 KIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 154 KIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 11/58 (18%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR      I+           + APE  + G F++KSDV+SFGILL+EI++
Sbjct: 318 KIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 198 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 254
Query: 61  S 61
           S
Sbjct: 255 S 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 200 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 256
Query: 61  S 61
           S
Sbjct: 257 S 257

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 61  S 61
           S
Sbjct: 261 S 261

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 192 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 248
Query: 61  S 61
           S
Sbjct: 249 S 249

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 206 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 262
Query: 61  S 61
           S
Sbjct: 263 S 263

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 28/61 (45%), Positives = 37/61 (60%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   D  ++V+SDV+S+GILL EI 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 61  S 61
           S
Sbjct: 261 S 261

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 149 KVADFGLSRLMTGDTFTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 150 KIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 151 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YMAPE      +SV+SD++S G+ L+E+  G+
Sbjct: 155 KLCDFGVS----GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 145 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 154 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 147 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 149 KVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 152 KVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 149 KVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 156 KVADFGLSRLMTGDTXTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 164 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 153 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 153 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/58 (44%), Positives = 32/58 (55%), Gaps = 5/58 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +     +  G          + APE   + KFS KSDV+SFGILL EI S
Sbjct: 142 KVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 149 KIADFGLARLIEDAEXTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 151 KVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 397 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/60 (46%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL++A   DE   +  T+       Y APE  +  KFS KSDV+SFG+L+ E  S
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/60 (46%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL++A   DE   +  T+       Y APE  +  KFS KSDV+SFG+L+ E  S
Sbjct: 145 KISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD              + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 152 KVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD              + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 153 KVADFGLSRLMTGDTYTAPAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 28/64 (43%), Positives = 41/64 (64%), Gaps = 4/64 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL++A G D+    T R  G +   + APE  +  KFS +SDV+S+G+ + E +S
Sbjct: 150 KISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 62  -GKK 64
            G+K
Sbjct: 209 YGQK 212

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 28/64 (43%), Positives = 41/64 (64%), Gaps = 4/64 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL++A G D+    T R  G +   + APE  +  KFS +SDV+S+G+ + E +S
Sbjct: 476 KISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 62  -GKK 64
            G+K
Sbjct: 535 YGQK 538

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 207 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 172 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 13/91 (14%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  ++E  T  V+    +MAPE      +  FS +SDV+S+GI+L
Sbjct: 172 KIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRMQDNNPFSFQSDVYSYGIVL 227
Query: 57  LEIISGKKNRGFYHSDNKLNLIGHVSKMHTT 87
            E+++G+    + H +N+  +I  V + + +
Sbjct: 228 YELMTGE--LPYSHINNRDQIIFMVGRGYAS 256

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL R    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 321 KVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KS+V+SFGILL EI++
Sbjct: 149 KIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 23/63 (36%), Positives = 37/63 (58%), Gaps = 4/63 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 148 KLCDFGVS----GQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203
Query: 64  KNR 66
             R
Sbjct: 204 YPR 206

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 31/58 (53%), Gaps = 5/58 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +     +  G          + APE   +  FS KSDV+SFGILL EI S
Sbjct: 148 KVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 32/58 (55%), Gaps = 5/58 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +     +  G          + APE   + KFS KSDV+SFGILL EI S
Sbjct: 329 KVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 26/58 (44%), Positives = 32/58 (55%), Gaps = 5/58 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +     +  G          + APE   + KFS KSDV+SFGILL EI S
Sbjct: 157 KVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 145 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 1/60 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG+A+A     +   TN V+GT  Y +PE A        +D++S GI+L E++ G+
Sbjct: 151 KIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 164 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 179 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 179 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +   FS+KSDV++FG+LL EI +
Sbjct: 170 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 27/64 (42%), Positives = 40/64 (62%), Gaps = 6/64 (9%)
Query: 1   MNPKISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           +N KISD GL R  +  D  ++ GN+   I    +MAPE    GKFS+ SD++S+G++L 
Sbjct: 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLW 238
Query: 58  EIIS 61
           E+ S
Sbjct: 239 EVFS 242

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%), Gaps = 2/58 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           N K+ DFGLAR    DE        +GT  YM+PE  +   ++ KSD++S G LL E+
Sbjct: 154 NVKLGDFGLARILNHDE--DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 151 KISDFGLSKALRADE---NXYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 207 AFSYGQK 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 27/64 (42%), Positives = 40/64 (62%), Gaps = 6/64 (9%)
Query: 1   MNPKISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           +N KISD GL R  +  D  ++ GN+   I    +MAPE    GKFS+ SD++S+G++L 
Sbjct: 165 LNVKISDLGLFREVYAADYYKLLGNSLLPIR---WMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 58  EIIS 61
           E+ S
Sbjct: 222 EVFS 225

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200
Query: 61  SGK 63
           +G+
Sbjct: 201 AGE 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 34/58 (58%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +   NT        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 61  SGK 63
           +G+
Sbjct: 203 AGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEII 60
           N KISDFGLA  F  +  E   N++ GT  Y+APE     +F  +  DV+S GI+L  ++
Sbjct: 142 NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201
Query: 61  SGK 63
           +G+
Sbjct: 202 AGE 204

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 36/58 (62%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR   GDE E N +       +MA E     KF+ +SDV+S+G+ + E+++
Sbjct: 180 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 36/58 (62%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR   GDE E N +       +MA E     KF+ +SDV+S+G+ + E+++
Sbjct: 157 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 27/60 (45%), Positives = 34/60 (56%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR      D +     R+     +MAPE   D  +S KSDV+S+G+LL EI S
Sbjct: 239 KICDFGLARDIYKNPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 157 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 213 AFSYGQK 219

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 167 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 223 AFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 167 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 223 AFSYGQK 229

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 151 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 207 AFSYGQK 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 165 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 221 AFSYGQK 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 167 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 188 KICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 5/61 (8%)
Query: 4   KISDFGLA-RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA     G  I+G     +GT GYMAPE   + +++   D ++ G LL E+I+G
Sbjct: 326 RISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
Query: 63  K 63
           +
Sbjct: 382 Q 382

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 5/61 (8%)
Query: 4   KISDFGLA-RAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +ISD GLA     G  I+G     +GT GYMAPE   + +++   D ++ G LL E+I+G
Sbjct: 326 RISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
Query: 63  K 63
           +
Sbjct: 382 Q 382

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 509 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 565 AFSYGQK 571

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL++A   DE   N  +   T+G     + APE  +  KFS KSDV+SFG+L+ E
Sbjct: 510 KISDFGLSKALRADE---NYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565
Query: 59  IIS-GKK 64
             S G+K
Sbjct: 566 AFSYGQK 572

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%), Gaps = 2/58 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           N K+ DFGLAR    D     T   +GT  YM+PE  +   ++ KSD++S G LL E+
Sbjct: 154 NVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 184 KIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 238 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 240 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 231 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 190 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 179 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 188 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 179 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 25/58 (43%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI S
Sbjct: 184 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 17/62 (27%), Positives = 37/62 (59%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++   S  SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 171 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 173 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 178 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 174 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 61  S 61
           S
Sbjct: 242 S 242

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 174 KVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 144 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 202 PPHSELHPMKVLFLI 216

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 5/61 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG A      +I+ +     G+  +MAPE      +S K DVFS+GI+L E+I+ +
Sbjct: 147 KICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 201
Query: 64  K 64
           K
Sbjct: 202 K 202

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 5/61 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG A      +I+ +     G+  +MAPE      +S K DVFS+GI+L E+I+ +
Sbjct: 146 KICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 64  K 64
           K
Sbjct: 201 K 201

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 27/60 (45%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLAR--AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFG++R  A G     G   +V     + APE  + G++S +SDV+SFGILL E  S
Sbjct: 253 KISDFGMSREEADGVXAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 164 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 222 PPHSELHPMKVLFLI 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 163 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 221
Query: 64  K 64
           K
Sbjct: 222 K 222

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLARAF G  +   T+ V+ T  Y AP+      K+S   D++S G +  E+I+G
Sbjct: 159 KLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
Query: 63  K 63
           K
Sbjct: 217 K 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 3/61 (4%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLARAF G  +   T+ V+ T  Y AP+      K+S   D++S G +  E+I+G
Sbjct: 159 KLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
Query: 63  K 63
           K
Sbjct: 217 K 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 25/75 (33%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 160 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 218 PPNSDMHPMRVLFLI 232

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 64  K 64
           K
Sbjct: 200 K 200

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 64  K 64
           K
Sbjct: 202 K 202

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 144 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 64  K 64
           K
Sbjct: 203 K 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 146 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204
Query: 64  K 64
           K
Sbjct: 205 K 205

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG+ R    D+   +T        + +PE  S  ++S KSDV+SFG+L+ E+ S  
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 64  K 64
           K
Sbjct: 202 K 202

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 163 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 172 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 140 KVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 172 KVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 144 KVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 145 KVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 27/60 (45%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 4   KISDFGLAR--AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFG++R  A G     G   +V     + APE  + G++S +SDV+SFGILL E  S
Sbjct: 253 KISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 189 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 186 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 184 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 2/58 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           N K+ DFGLAR    D         +GT  YM+PE  +   ++ KSD++S G LL E+
Sbjct: 154 NVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 31/58 (53%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R            + +    +MAPE   DG F+  SD++SFG++L EI S
Sbjct: 170 KIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 151 KVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 145 KVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 192 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 170 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 165 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 146 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 61  SG 62
           +G
Sbjct: 206 AG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 61  SG 62
           +G
Sbjct: 205 AG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 144 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 61  SG 62
           +G
Sbjct: 204 AG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 147 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 61  SG 62
           +G
Sbjct: 207 AG 208

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 172 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 173 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 13/76 (17%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNR------------VIGTYGYMAPEYASDGKFSVKSDV 49
           N  ++DFGLAR    ++ +    R            V+G   +MAPE  +   +  K DV
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV 205
Query: 50  FSFGILLLEIISGKKN 65
           FSFGI+L EII G+ N
Sbjct: 206 FSFGIVLCEII-GRVN 220

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 174 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 61  SG 62
           +G
Sbjct: 234 AG 235

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 61  SG 62
           +G
Sbjct: 227 AG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 61  SG 62
           +G
Sbjct: 227 AG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 61  SG 62
           +G
Sbjct: 230 AG 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 191 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTY--GYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR     E     N+        +MA E     KF+ KSDV+SFG+LL E+++
Sbjct: 171 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 61  SG 62
           +G
Sbjct: 227 AG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 61  SG 62
           +G
Sbjct: 230 AG 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 61  SG 62
           +G
Sbjct: 226 AG 227

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+   N  +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 156 KLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 214 PPNSDLHPMRVLFLI 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 151 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 61  SG 62
           +G
Sbjct: 211 AG 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 182 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 179 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 190 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/58 (41%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI +
Sbjct: 183 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 61  SG 62
           +G
Sbjct: 227 AG 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 61  SG 62
           +G
Sbjct: 226 AG 227

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 61  SG 62
           +G
Sbjct: 229 AG 230

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MN KI+DFGLA        +  T  + GT  Y++PE A+     ++SDV+S G +   ++
Sbjct: 149 MNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206
Query: 61  SGK 63
            G+
Sbjct: 207 IGR 209

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 16/62 (25%), Positives = 36/62 (58%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 172 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 61  SG 62
           +G
Sbjct: 232 AG 233

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI D G A+     E+       +GT  Y+APE     K++V  D +SFG L  E I+G
Sbjct: 165 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 3/59 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI D G A+     E+       +GT  Y+APE     K++V  D +SFG L  E I+G
Sbjct: 164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+   N  +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 159 KLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 217 PPHSELHPMKVLFLI 231

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+   N  +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 144 KLADFGVAGQLTDTQIK--RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201
Query: 64  KNRGFYHSDNKLNLI 78
                 H    L LI
Sbjct: 202 PPHSELHPMKVLFLI 216

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D GL R F       ++  ++GT  YM+PE   +  ++ KSD++S G LL E+ + +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233
Query: 64  KNRGFYHSDNKLNLIGHVSKM 84
               FY   +K+NL     K+
Sbjct: 234 SP--FY--GDKMNLYSLCKKI 250

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 203 KICDFGLARDIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 61  S 61
           S
Sbjct: 260 S 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 201 KICDFGLARDIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 61  S 61
           S
Sbjct: 258 S 258

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 208 KICDFGLARHIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 61  S 61
           S
Sbjct: 265 S 265

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 6/61 (9%)
Query: 4   KISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D    ++GN    +    +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 208 KICDFGLARDIKNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 61  S 61
           S
Sbjct: 265 S 265

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 33/58 (56%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           +I+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+L+ EI +
Sbjct: 197 RIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 168 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 23/58 (39%), Positives = 32/58 (55%), Gaps = 1/58 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 160 KVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 172 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 32/58 (55%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI +
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIEGNT----------NRVIGTYGYMAPEYASDGKFSVKSDVFSFG 53
           K+ DFGL  A   DE E                +GT  YM+PE      +S K D+FS G
Sbjct: 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG 217
Query: 54  ILLLEII 60
           ++L E++
Sbjct: 218 LILFELL 224

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    DE    T+ V   +   +  PE     KFS KSD+++FG+L+ EI S
Sbjct: 160 KVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 41.2 bits (95), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFGL+R      +  ++    GT  +MAPE   D   + KSDV+SFG++L E+ +
Sbjct: 179 KVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 4   KISDFGLARA-FGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFG+ +    GD     TN   GT  Y+APE     K++   D +SFG+LL E++ G
Sbjct: 159 KIADFGMCKENMLGD---AKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215
Query: 63  KKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +     +H  ++  L  H  +M   F
Sbjct: 216 QSP---FHGQDEEELF-HSIRMDNPF 237

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIIS 61
           KISDFG ++   G  I   T    GT  YMAPE    G   +   +D++S G  ++E+ +
Sbjct: 149 KISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 206
Query: 62  GK 63
           GK
Sbjct: 207 GK 208

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 11/64 (17%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL+R      IE +   V  T G      + APE     KF+  SDV+S+GI++ 
Sbjct: 185 KVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMW 239
Query: 58  EIIS 61
           E++S
Sbjct: 240 EVMS 243

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGLAR    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/67 (34%), Positives = 32/67 (47%), Gaps = 10/67 (14%)
Query: 4   KISDFGLARAFGGDEIE----------GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG 53
           K+ DFGL  A   DE E                +GT  YM+PE      +S K D+FS G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 54  ILLLEII 60
           ++L E++
Sbjct: 264 LILFELL 270

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 4   KISDFGLARA-FGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFG+ +    GD     TN   GT  Y+APE     K++   D +SFG+LL E++ G
Sbjct: 158 KIADFGMCKENMLGD---AKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
Query: 63  KKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +     +H  ++  L  H  +M   F
Sbjct: 215 QSP---FHGQDEEELF-HSIRMDNPF 236

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 157 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 157 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 154 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 153 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 152 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGD-EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D E    T+       + APE  S  KF+  SDV+SFGI++ E+++
Sbjct: 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 158 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + APE  +  KF+  SDV+S+GI++ E++S
Sbjct: 164 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 160 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 332 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 332 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 157 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 332 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 5/60 (8%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISG 62
           +ISD GLA  F   +   +    +GT+GYMAPE    G  +   +D FS G +L +++ G
Sbjct: 331 RISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 185 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 159 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 154 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 144 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 200 YELMTGQ 206

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 2/58 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFGL+R      +   +    GT  +MAPE   D   + KSDV+SFG++L E+ +
Sbjct: 179 KVCDFGLSRLKASXFLX--SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 144 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 200 YELMTGQ 206

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGL+R    D  +      +G      + APE     KF+  SDV+S+GI++ E++
Sbjct: 149 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 208
Query: 61  S 61
           S
Sbjct: 209 S 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 40.4 bits (93), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 144 KIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 200 YELMTGQ 206

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 161 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 172 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG--YMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFGL +    D+ E    +  G     + APE  ++ KFSV SDV+SFG++L E+ +
Sbjct: 172 KIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 40.4 bits (93), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGL+R    D  +      +G      + APE     KF+  SDV+S+GI++ E++
Sbjct: 175 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234
Query: 61  S 61
           S
Sbjct: 235 S 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 146 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 201
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 202 YELMTGQ 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 164 KIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 219
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 220 YELMTGQ 226

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 160 KIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 216 YELMTGQ 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 148 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 203
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 204 YELMTGQ 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 149 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 204
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 205 YELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 149 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 204
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 205 YELMTGQ 211

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 7/61 (11%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFG+ R    D+   +    +GT     + APE     K+S KSDV++FGIL+ E+ 
Sbjct: 144 KVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 61  S 61
           S
Sbjct: 200 S 200

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 171 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 226
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 227 YELMTGQ 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 172 KIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 227
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 228 YELMTGQ 234

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 172 KIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 227
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 228 YELMTGQ 234

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 40.0 bits (92), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 3/57 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGL  +   D   G   R  GT  YM+PE  S   +  + D+++ G++L E++
Sbjct: 176 KIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLA      E +G   +V+ GT  Y+APE  S    S + DV+S G ++  ++ G
Sbjct: 179 KIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235
Query: 63  K 63
           K
Sbjct: 236 K 236

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLA      E +G   +V+ GT  Y+APE  S    S + DV+S G ++  ++ G
Sbjct: 155 KIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
Query: 63  K 63
           K
Sbjct: 212 K 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 4/61 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLA      E +G   +V+ GT  Y+APE  S    S + DV+S G ++  ++ G
Sbjct: 181 KIGDFGLATKV---EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
Query: 63  K 63
           K
Sbjct: 238 K 238

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 11/67 (16%)
Query: 4   KISDFGLA----RAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI DFGLA    R  G  + E    ++ G+  +MAPE         +S +SDV++FGI+L
Sbjct: 160 KIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 57  LEIISGK 63
            E+++G+
Sbjct: 216 YELMTGQ 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 7/69 (10%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFG A+      +   T  + GT  Y+APE  S   ++   D +SFGIL+ E+++G 
Sbjct: 146 KITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
Query: 64  KNRGFYHSD 72
               FY S+
Sbjct: 201 TP--FYDSN 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+    D+       V+   G     + APE  SD  FS +SDV+SFG++L E
Sbjct: 151 KIADFGLAKLLPLDK----DXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 206
Query: 59  IIS 61
           + +
Sbjct: 207 LFT 209

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 40.0 bits (92), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIIS 61
           KISDFG ++   G  I   T    GT  YMAPE    G   +   +D++S G  ++E+ +
Sbjct: 163 KISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220
Query: 62  GK 63
           GK
Sbjct: 221 GK 222

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 19/60 (31%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG       D  +     ++GT  +MAPE  S   ++ + D++S GI+++E++ G+
Sbjct: 181 KLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 5/77 (6%)
Query: 4   KISDFGLARAFGGDEIEGNT-NRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIIS 61
           K+ DFGLARAFG   I  NT +  + T  Y AP+     + +S   D++S G +L E+I+
Sbjct: 148 KLGDFGLARAFG---IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
Query: 62  GKKNRGFYHSDNKLNLI 78
           GK      + + +L LI
Sbjct: 205 GKPLFPGTNDEEQLKLI 221

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-G 62
           KI DFG++R     +      R +    +M PE     KF+ +SDV+SFG++L EI + G
Sbjct: 175 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 234
Query: 63  KK 64
           K+
Sbjct: 235 KQ 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-G 62
           KI DFG++R     +      R +    +M PE     KF+ +SDV+SFG++L EI + G
Sbjct: 169 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 228
Query: 63  KK 64
           K+
Sbjct: 229 KQ 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-G 62
           KI DFG++R     +      R +    +M PE     KF+ +SDV+SFG++L EI + G
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 63  KK 64
           K+
Sbjct: 258 KQ 259

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 185 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 175 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 158 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 158 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 39.7 bits (91), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL+R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 157 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 156 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 7/62 (11%)
Query: 4   KISDFGLARAFGGDE----IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFGL +    D+    ++      I  Y   APE  ++ KFSV SDV+SFG++L E+
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWY---APESLTESKFSVASDVWSFGVVLYEL 211
Query: 60  IS 61
            +
Sbjct: 212 FT 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 184 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 184 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 210 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 7/62 (11%)
Query: 4   KISDFGLARAFGGDE----IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           KI DFGL +    D+    ++      I  Y   APE  ++ KFSV SDV+SFG++L E+
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---APESLTESKFSVASDVWSFGVVLYEL 210
Query: 60  IS 61
            +
Sbjct: 211 FT 212

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 190 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 200 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 175 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 6/75 (8%)
Query: 4   KISDFGLAR-AFGGD--EIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFG++R  +  D   + G+T   I    +M PE     KF+ +SDV+SFG++L EI 
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTMLPIR---WMPPESIMYRKFTTESDVWSFGVILWEIF 229
Query: 61  SGKKNRGFYHSDNKL 75
           +  K   F  S+ ++
Sbjct: 230 TYGKQPWFQLSNTEV 244

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFGLARAF G  +   T+ V+ T  Y AP+      K+S   D++S G +  E+++G
Sbjct: 140 KIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFGLARAF G  +   T+ V+ T  Y AP+      K+S   D++S G +  E+++G
Sbjct: 140 KIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/62 (35%), Positives = 37/62 (59%), Gaps = 2/62 (3%)
Query: 1   MNPKISDFGLAR-AFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           M  KI+DFGL+R  +  D  + + N  I    +M PE     +++ +SDV+++G++L EI
Sbjct: 211 MVVKIADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEI 269
Query: 60  IS 61
            S
Sbjct: 270 FS 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 39.7 bits (91), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 2/60 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +     N VIGT  +MAPE   +  ++  +D++S GI  +E+  GK
Sbjct: 165 KLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFG++R    D     T R       + APE  +  KF+  SDV+S+GI++ E++S
Sbjct: 150 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFG++R    D     T R       + APE  +  KF+  SDV+S+GI++ E++S
Sbjct: 156 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/59 (37%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFG++R    D     T R       + APE  +  KF+  SDV+S+GI++ E++S
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 4/64 (6%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           M+ KI DFGLA      E +G   + + GT  Y+APE       S + D++S G +L  +
Sbjct: 179 MDVKIGDFGLATKI---EFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 235
Query: 60  ISGK 63
           + GK
Sbjct: 236 LVGK 239

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 20/57 (35%), Positives = 31/57 (54%), Gaps = 3/57 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGL  +   D   G   R  GT  YM+PE  S   +  + D+++ G++L E++
Sbjct: 162 KIGDFGLVTSLKND---GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 39.3 bits (90), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT-YGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL R    D     T R       + +PE  +  KF+  SDV+S+GI+L E++S
Sbjct: 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL+R    ++  ++ +  R+     +MA E   D  ++ +SDV+SFG+LL EI++
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL+R    ++  ++ +  R+     +MA E   D  ++ +SDV+SFG+LL EI++
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 38/60 (63%), Gaps = 4/60 (6%)
Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFGL+R    ++  ++ +  R+     +MA E   D  ++ +SDV+SFG+LL EI++
Sbjct: 190 KISDFGLSRDVYEEDSXVKRSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 6/60 (10%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLA  F  DE   ++    GT  YMAPE +  D  F  K D++S G+++  +++G
Sbjct: 167 KIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+    D+       V+   G     + APE  SD  FS +SDV+SFG++L E
Sbjct: 154 KIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 209
Query: 59  IIS 61
           + +
Sbjct: 210 LFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+    D+       V+   G     + APE  SD  FS +SDV+SFG++L E
Sbjct: 155 KIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 210
Query: 59  IIS 61
           + +
Sbjct: 211 LFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 39.3 bits (90), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 9/63 (14%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+    D+       V+   G     + APE  SD  FS +SDV+SFG++L E
Sbjct: 167 KIADFGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222
Query: 59  IIS 61
           + +
Sbjct: 223 LFT 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D   G  N  IGT  +MAPE  +     D  +  KSD++S GI  +E
Sbjct: 169 KLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
Query: 59  IISG 62
           +  G
Sbjct: 227 MAEG 230

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 23/60 (38%), Positives = 36/60 (60%), Gaps = 3/60 (5%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI+DFGLARAF G  +   T+ ++ T  Y AP+      K+S   D++S G +  E+++G
Sbjct: 140 KIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 4/64 (6%)
Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           M+ KI DFGLA      E +G   + + GT  Y+APE       S + D++S G +L  +
Sbjct: 179 MDVKIGDFGLATKI---EFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTL 235
Query: 60  ISGK 63
           + GK
Sbjct: 236 LVGK 239

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +ISD GLA      + +  T    GT G+MAPE     ++    D F+ G+ L E+I+
Sbjct: 327 NVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 62  GK 63
            +
Sbjct: 385 AR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +ISD GLA      + +  T    GT G+MAPE     ++    D F+ G+ L E+I+
Sbjct: 327 NVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 62  GK 63
            +
Sbjct: 385 AR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +ISD GLA      + +  T    GT G+MAPE     ++    D F+ G+ L E+I+
Sbjct: 327 NVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 62  GK 63
            +
Sbjct: 385 AR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 38.9 bits (89), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 21/62 (33%), Positives = 32/62 (51%), Gaps = 2/62 (3%)
Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +ISD GLA      + +  T    GT G+MAPE     ++    D F+ G+ L E+I+
Sbjct: 327 NVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384
Query: 62  GK 63
            +
Sbjct: 385 AR 386

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 201 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 38.9 bits (89), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 22/58 (37%), Positives = 30/58 (51%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI DFG+AR              +    +M PE   +G F+ K+D +SFG+LL EI S
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 23/63 (36%), Positives = 35/63 (55%), Gaps = 7/63 (11%)
Query: 5   ISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVF------SFGILLLE 58
           I+DFGLA  F   +  G+T+  +GT  YMAPE   +G  + + D F      + G++L E
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 59  IIS 61
           + S
Sbjct: 231 LAS 233

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 21/58 (36%), Positives = 35/58 (60%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    DE E + +       +MA E     +F+ +SDV+S+G+ + E+++
Sbjct: 159 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 38.5 bits (88), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 20/59 (33%), Positives = 34/59 (57%), Gaps = 2/59 (3%)
Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGL++     + E       GT  YMAPE  +    +  +D +SFG+L+ E+++G
Sbjct: 166 KLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	92
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-36
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-32
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-20
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-20
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-19
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-19
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-18
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-18
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-18
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-16
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-16
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-15
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-15
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-15
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-15
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-15
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-15
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-15
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-14
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-14
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-14
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-14
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-14
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-13
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-12
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-11
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-11
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-10
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-10
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-10
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-10
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-10
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-10
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-10
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-10
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-10
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-10
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-10
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-09
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-09
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-08
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-08
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-08
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-08
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-08
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-08
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-08
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-07
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-07
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-07
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-07
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-07
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-07
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-06
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-06
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-06
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-06
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-06
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-06
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-06
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-06
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-06
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-06
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-06
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-06
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-06
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-06
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-05
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-05
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-05
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-05
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-05
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-05
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-05
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-05
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-04
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-04
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-04
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-04
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-04
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-04
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-04
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-04
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  122 bits (308), Expect = 6e-36
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 6/95 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KISDFGLARA         T+R++GT  YMAPE    G+ + KSD++SFG++LLEII
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEII 228

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHT---TFSNIV 92
           +G      +       L+    ++     T  + +
Sbjct: 229 TGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYI 261

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  114 bits (287), Expect = 1e-32
 Identities = 31/86 (36%), Positives = 49/86 (56%), Gaps = 3/86 (3%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
              + DFGLA+     +    T  V GT G++APEY S GK S K+DVF +G++LLE+I+
Sbjct: 172 EAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230

Query: 62  GKKN--RGFYHSDNKLNLIGHVSKMH 85
           G++        +D+ + L+  V  + 
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLL 256

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  103 bits (259), Expect = 1e-28
 Identities = 22/86 (25%), Positives = 38/86 (44%), Gaps = 5/86 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----KFSVKSDVFSFGIL 55
           +   I+DFGLA  F   +  G+T+  +GT  YMAPE             ++ D+++ G++
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 56  LLEIISGKKNRGFYHSDNKLNLIGHV 81
           L E+ S          +  L     +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEI 253

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  101 bits (255), Expect = 6e-28
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 2/94 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
             PKI+DFG+++     +    +  V GT GY+ PEY   G+ + KSDV+SFG++L E++
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHT--TFSNIV 92
             +           +NL     + H       IV
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 80.8 bits (200), Expect = 3e-20
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 3/63 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLA             ++ G+  +MAPE         +S +SDV++FGI+L E++
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219

Query: 61  SGK 63
           +G+
Sbjct: 220 TGQ 222

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.0 bits (200), Expect = 4e-20
 Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 13/90 (14%)

Query: 1   MNPKISDFGLARAFGG------DEIEGNTNRVIGTYGYMAPEYASD-------GKFSVKS 47
               ISDFGL+    G       E +      +GT  YMAPE                + 
Sbjct: 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV 216

Query: 48  DVFSFGILLLEIISGKKNRGFYHSDNKLNL 77
           D+++ G++  EI     +     S  +  +
Sbjct: 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQM 246

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 78.5 bits (194), Expect = 2e-19
 Identities = 25/60 (41%), Positives = 35/60 (58%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGLAR +             G Y +MAPE      FS  SDV+S+G+LL E+++G+
Sbjct: 156 KITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 77.0 bits (190), Expect = 9e-19
 Identities = 25/73 (34%), Positives = 35/73 (47%), Gaps = 12/73 (16%)

Query: 4   KISDFGLARAFGGDEIEGNTNR------------VIGTYGYMAPEYASDGKFSVKSDVFS 51
            ++DFGLAR    ++ +    R            V+G   +MAPE  +   +  K DVFS
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207

Query: 52  FGILLLEIISGKK 64
           FGI+L EII    
Sbjct: 208 FGIVLCEIIGRVN 220

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 77.0 bits (190), Expect = 1e-18
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG A      +I+ +     G+  +MAPE      +S K DVFS+GI+L E+I+ +
Sbjct: 146 KICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200

Query: 64  K 64
           K
Sbjct: 201 K 201

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 76.2 bits (188), Expect = 2e-18
 Identities = 18/66 (27%), Positives = 40/66 (60%), Gaps = 7/66 (10%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILLLE 58
           +  K++DFGL++     +   + + ++G + +MAPE   A +  ++ K+D +SF ++L  
Sbjct: 166 VCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220

Query: 59  IISGKK 64
           I++G+ 
Sbjct: 221 ILTGEG 226

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 75.0 bits (185), Expect = 5e-18
 Identities = 22/63 (34%), Positives = 34/63 (53%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+ DFGL+R      +   +    GT  +MAPE   D   + KSDV+SFG++L E+ 
Sbjct: 176 YTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

Query: 61  SGK 63
           + +
Sbjct: 234 TLQ 236

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 72.8 bits (179), Expect = 4e-17
 Identities = 18/72 (25%), Positives = 29/72 (40%), Gaps = 12/72 (16%)

Query: 4   KISDFGLARAFGGDEIEGNTNR---VIGTYGYMAPE---------YASDGKFSVKSDVFS 51
            I+DFGL    G  +     ++     G   ++APE               FS  SDVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228

Query: 52  FGILLLEIISGK 63
            G +  E+ + +
Sbjct: 229 LGTIWYELHARE 240

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 69.6 bits (171), Expect = 6e-16
 Identities = 22/67 (32%), Positives = 37/67 (55%), Gaps = 11/67 (16%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+  G +E E +        G     +MA E      ++ +SDV+S+G+ + E
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211

Query: 59  IIS-GKK 64
           +++ G K
Sbjct: 212 LMTFGSK 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 69.9 bits (171), Expect = 7e-16
 Identities = 13/60 (21%), Positives = 22/60 (36%), Gaps = 7/60 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D G                + GT G+ APE       +V +D+++ G  L  +    
Sbjct: 221 KLIDLGAVSRINS------FGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 69.3 bits (170), Expect = 7e-16
 Identities = 19/72 (26%), Positives = 34/72 (47%), Gaps = 8/72 (11%)

Query: 4   KISDFGLAR--AFGGDEIEGNTNRVIGTYGYMAPE------YASDGKFSVKSDVFSFGIL 55
            I+D GLA   +   ++++   N  +GT  YMAPE               + D+++FG++
Sbjct: 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212

Query: 56  LLEIISGKKNRG 67
           L E+     + G
Sbjct: 213 LWEVARRMVSNG 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 68.8 bits (169), Expect = 8e-16
 Identities = 26/58 (44%), Positives = 35/58 (60%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI++
Sbjct: 149 KIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 68.9 bits (169), Expect = 1e-15
 Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 11/64 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL+R      +E + +    T G      + APE  +   FS  SDV+SFG+++ 
Sbjct: 191 KVSDFGLSR-----VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245

Query: 58  EIIS 61
           E+++
Sbjct: 246 EVLA 249

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 68.8 bits (169), Expect = 1e-15
 Identities = 25/63 (39%), Positives = 32/63 (50%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFG++R     E         G          APE  + G++S +SDV+SFGILL E
Sbjct: 253 KISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

Query: 59  IIS 61
             S
Sbjct: 308 TFS 310

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 69.1 bits (169), Expect = 1e-15
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 68.0 bits (167), Expect = 2e-15
 Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 11/63 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTN-----RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           K++DFGL+R   GD    +       +      + APE  +  KFS+KSDV++FG+LL E
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWE 204

Query: 59  IIS 61
           I +
Sbjct: 205 IAT 207

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 67.6 bits (166), Expect = 2e-15
 Identities = 13/66 (19%), Positives = 29/66 (43%), Gaps = 10/66 (15%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILLL 57
           M  +IS   +  +F        +   +    ++APE      +      +D++SF +LL 
Sbjct: 150 MTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202

Query: 58  EIISGK 63
           E+++ +
Sbjct: 203 ELVTRE 208

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 68.1 bits (167), Expect = 2e-15
 Identities = 24/70 (34%), Positives = 33/70 (47%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KI+DFGLA+    D+             Y             APE  SD  FS +SDV+S
Sbjct: 167 KIADFGLAKLLPLDKDY-----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215

Query: 52  FGILLLEIIS 61
           FG++L E+ +
Sbjct: 216 FGVVLYELFT 225

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 68.6 bits (168), Expect = 2e-15
 Identities = 24/58 (41%), Positives = 35/58 (60%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI +
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 67.7 bits (166), Expect = 3e-15
 Identities = 25/64 (39%), Positives = 35/64 (54%), Gaps = 10/64 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K++DFGLAR    D  +     V    G      +MA E     KF+ KSDV+SFG+LL 
Sbjct: 168 KVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223

Query: 58  EIIS 61
           E+++
Sbjct: 224 ELMT 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 67.7 bits (166), Expect = 3e-15
 Identities = 16/63 (25%), Positives = 34/63 (53%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           +++DFG+A     D+ +   +            +MA E    GK++ +SDV+S+G+ + E
Sbjct: 155 QVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWE 209

Query: 59  IIS 61
           +++
Sbjct: 210 LMT 212

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 67.2 bits (165), Expect = 3e-15
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFGL+R    DE        +G+     +  PE     KFS KSD+++FG+L+ EI 
Sbjct: 160 KVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215

Query: 61  S 61
           S
Sbjct: 216 S 216

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 67.8 bits (166), Expect = 3e-15
 Identities = 21/72 (29%), Positives = 36/72 (50%), Gaps = 8/72 (11%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPE------YASDGKFSVKSDVFSFGIL 55
            I+D GLA  F    +E++   N  +GT  YM PE        +  +  + +D++SFG++
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241

Query: 56  LLEIISGKKNRG 67
           L E+     + G
Sbjct: 242 LWEVARRCVSGG 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 67.3 bits (165), Expect = 3e-15
 Identities = 22/70 (31%), Positives = 32/70 (45%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KI DFGL +    D+             +             APE  ++ KFSV SDV+S
Sbjct: 154 KIGDFGLTKVLPQDKEF-----------FKVKEPGESPIFWYAPESLTESKFSVASDVWS 202

Query: 52  FGILLLEIIS 61
           FG++L E+ +
Sbjct: 203 FGVVLYELFT 212

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 67.8 bits (166), Expect = 3e-15
 Identities = 26/58 (44%), Positives = 36/58 (62%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL+EI++
Sbjct: 324 KIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 67.9 bits (166), Expect = 4e-15
 Identities = 25/58 (43%), Positives = 35/58 (60%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ +
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 67.4 bits (165), Expect = 4e-15
 Identities = 22/70 (31%), Positives = 29/70 (41%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KI DFGLA+A                  Y             APE   + KF   SDV+S
Sbjct: 174 KIGDFGLAKAVPEGHEY-----------YRVREDGDSPVFWYAPECLKEYKFYYASDVWS 222

Query: 52  FGILLLEIIS 61
           FG+ L E+++
Sbjct: 223 FGVTLYELLT 232

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 67.3 bits (165), Expect = 4e-15
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFG+AR     +I   +    G         M PE   +G F+ K+D +SFG+LL E
Sbjct: 183 KIGDFGMAR-----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237

Query: 59  IIS 61
           I S
Sbjct: 238 IFS 240

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 67.4 bits (165), Expect = 4e-15
 Identities = 20/63 (31%), Positives = 35/63 (55%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLA+  G +E E +        G     +MA E      ++ +SDV+S+G+ + E
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 211

Query: 59  IIS 61
           +++
Sbjct: 212 LMT 214

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 67.5 bits (165), Expect = 4e-15
 Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 8/74 (10%)

Query: 4   KISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPE------YASDGKFSVKSDVFSFGIL 55
            I+D GLA       D I+   N  +GT  YMAPE           +   ++D+++ G++
Sbjct: 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246

Query: 56  LLEIISGKKNRGFY 69
             EI       G +
Sbjct: 247 FWEIARRCSIGGIH 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 67.4 bits (165), Expect = 5e-15
 Identities = 23/64 (35%), Positives = 35/64 (54%), Gaps = 11/64 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL R      +E +      T G      + +PE  +  KF+  SDV+S+GI+L 
Sbjct: 187 KVSDFGLGR-----VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241

Query: 58  EIIS 61
           E++S
Sbjct: 242 EVMS 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 66.9 bits (164), Expect = 5e-15
 Identities = 28/68 (41%), Positives = 36/68 (52%), Gaps = 12/68 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           KISDFGL++A   DE                   + APE  +  KFS KSDV+SFG+L+ 
Sbjct: 157 KISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211

Query: 58  EIIS-GKK 64
           E  S G+K
Sbjct: 212 EAFSYGQK 219

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 67.0 bits (164), Expect = 5e-15
 Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KI DFGL +    D+             Y             APE  ++ KFSV SDV+S
Sbjct: 185 KIGDFGLTKVLPQDKEY-----------YKVKEPGESPIFWYAPESLTESKFSVASDVWS 233

Query: 52  FGILLLEIIS 61
           FG++L E+ +
Sbjct: 234 FGVVLYELFT 243

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 67.0 bits (164), Expect = 5e-15
 Identities = 24/64 (37%), Positives = 36/64 (56%), Gaps = 11/64 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL+R      +E +      T G      + APE  S  KF+  SDV+SFGI++ 
Sbjct: 187 KVSDFGLSR-----VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241

Query: 58  EIIS 61
           E+++
Sbjct: 242 EVMT 245

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 66.9 bits (164), Expect = 5e-15
 Identities = 22/70 (31%), Positives = 30/70 (42%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KI DFGL +A   D+             Y             APE     KF + SDV+S
Sbjct: 166 KIGDFGLTKAIETDKEY-----------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214

Query: 52  FGILLLEIIS 61
           FG+ L E+++
Sbjct: 215 FGVTLHELLT 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.0 bits (164), Expect = 5e-15
 Identities = 24/63 (38%), Positives = 31/63 (49%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFG+AR     +I        G         M PE   +G F+ K+D +SFG+LL E
Sbjct: 224 KIGDFGMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278

Query: 59  IIS 61
           I S
Sbjct: 279 IFS 281

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 66.9 bits (164), Expect = 5e-15
 Identities = 20/65 (30%), Positives = 30/65 (46%), Gaps = 6/65 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KI DFGL RA   ++              + + APE      FS  SD + FG+ L E+ 
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

Query: 61  S-GKK 64
           + G++
Sbjct: 219 TYGQE 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 66.5 bits (163), Expect = 6e-15
 Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISD GL R     E+       +         +MAPE    GKFS+ SD++S+G++L E
Sbjct: 168 KISDLGLFR-----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222

Query: 59  IIS 61
           + S
Sbjct: 223 VFS 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 6e-15
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 10/64 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K++DFGLAR    D ++     V           + A E     +F+ KSDV+SFG+LL 
Sbjct: 164 KVADFGLAR----DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219

Query: 58  EIIS 61
           E+++
Sbjct: 220 ELLT 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 66.5 bits (163), Expect = 6e-15
 Identities = 18/70 (25%), Positives = 30/70 (42%), Gaps = 25/70 (35%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           K+ DFGL+R    ++             Y            M+PE  +  +F+  SDV+ 
Sbjct: 153 KLGDFGLSRYIEDED-------------YYKASVTRLPIKWMSPESINFRRFTTASDVWM 199

Query: 52  FGILLLEIIS 61
           F + + EI+S
Sbjct: 200 FAVCMWEILS 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 67.0 bits (164), Expect = 7e-15
 Identities = 25/58 (43%), Positives = 32/58 (55%), Gaps = 5/58 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+SDFGL +    +         +    + APE   + KFS KSDV+SFGILL EI S
Sbjct: 329 KVSDFGLTK----EASSTQDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 66.1 bits (162), Expect = 7e-15
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFG+ R    D+   +T    GT     + +PE  S  ++S KSDV+SFG+L+ E+ 
Sbjct: 144 KVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199

Query: 61  S 61
           S
Sbjct: 200 S 200

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 66.5 bits (163), Expect = 8e-15
 Identities = 24/63 (38%), Positives = 35/63 (55%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFG++R    D    +  RV G +      +M PE     KF+ +SDV+SFG++L E
Sbjct: 173 KIGDFGMSR----DVYSTDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227

Query: 59  IIS 61
           I +
Sbjct: 228 IFT 230

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 66.1 bits (162), Expect = 8e-15
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           K+SDFG+ R    D+        +GT     + APE     K+S KSDV++FGIL+ E+ 
Sbjct: 144 KVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199

Query: 61  S 61
           S
Sbjct: 200 S 200

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.5 bits (163), Expect = 8e-15
 Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLAR     +I         T G     +MAPE   D  ++ +SDV+SFG+L+ E
Sbjct: 197 KIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251

Query: 59  IIS 61
           I +
Sbjct: 252 IFT 254

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 66.1 bits (162), Expect = 8e-15
 Identities = 25/64 (39%), Positives = 31/64 (48%), Gaps = 17/64 (26%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K+SDFGL +    +                    + APE   + KFS KSDV+SFGILL 
Sbjct: 157 KVSDFGLTK----EASST-------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 205

Query: 58  EIIS 61
           EI S
Sbjct: 206 EIYS 209

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 66.1 bits (162), Expect = 8e-15
 Identities = 24/70 (34%), Positives = 34/70 (48%), Gaps = 23/70 (32%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY------------MAPEYASDGKFSVKSDVFS 51
           KISDFGL++A G D+             Y             APE  +  KFS +SDV+S
Sbjct: 150 KISDFGLSKALGADDSY-----------YTARSAGKWPLKWYAPECINFRKFSSRSDVWS 198

Query: 52  FGILLLEIIS 61
           +G+ + E +S
Sbjct: 199 YGVTMWEALS 208

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.5 bits (163), Expect = 9e-15
 Identities = 25/63 (39%), Positives = 37/63 (58%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KISDFGL+R    D  E ++     + G     +MA E   D  ++ +SDV+SFG+LL E
Sbjct: 190 KISDFGLSR----DVYEEDSYVK-RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244

Query: 59  IIS 61
           I++
Sbjct: 245 IVT 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 66.6 bits (163), Expect = 1e-14
 Identities = 25/63 (39%), Positives = 35/63 (55%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLAR     +I         T G     +MAPE   D  ++ +SDV+SFG+L+ E
Sbjct: 243 KIADFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297

Query: 59  IIS 61
           I +
Sbjct: 298 IFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 66.1 bits (162), Expect = 1e-14
 Identities = 27/63 (42%), Positives = 38/63 (60%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR     +I  ++N ++         +MAPE   D  ++V+SDV+S+GILL E
Sbjct: 204 KIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258

Query: 59  IIS 61
           I S
Sbjct: 259 IFS 261

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.2 bits (162), Expect = 1e-14
 Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFG++R    D    +  RV G        +M PE     KF+ +SDV+SFG++L E
Sbjct: 198 KIGDFGMSR----DIYSTDYYRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252

Query: 59  IIS 61
           I +
Sbjct: 253 IFT 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 65.8 bits (161), Expect = 1e-14
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR     +I  + + V          +MAPE   D  ++++SDV+SFG+LL E
Sbjct: 188 KICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242

Query: 59  IIS 61
           I S
Sbjct: 243 IFS 245

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 66.4 bits (162), Expect = 1e-14
 Identities = 18/58 (31%), Positives = 30/58 (51%), Gaps = 1/58 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           K+ DFGL+R          +   +    +MAPE  +  +F+  SDV+ FG+ + EI+ 
Sbjct: 531 KLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 66.1 bits (161), Expect = 2e-14
 Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGT---YGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           KISDFGL++A G D+                + APE  +  KFS +SDV+S+G+ + E +
Sbjct: 476 KISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533

Query: 61  S 61
           S
Sbjct: 534 S 534

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 65.3 bits (160), Expect = 2e-14
 Identities = 24/63 (38%), Positives = 37/63 (58%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR     +I+ ++N V+         +MAPE   +  ++ +SDV+S+GI L E
Sbjct: 185 KICDFGLAR-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239

Query: 59  IIS 61
           + S
Sbjct: 240 LFS 242

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.8 bits (161), Expect = 2e-14
 Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGL+R      I                  M PE     +++ +SDV+++G++L E
Sbjct: 214 KIADFGLSR-----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 59  IIS 61
           I S
Sbjct: 269 IFS 271

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 65.9 bits (161), Expect = 2e-14
 Identities = 26/63 (41%), Positives = 35/63 (55%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGLAR     +I         T G     +MAPE   D  ++ +SDV+SFG+LL E
Sbjct: 231 KIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285

Query: 59  IIS 61
           I +
Sbjct: 286 IFT 288

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 65.3 bits (160), Expect = 2e-14
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 1/60 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFG+A+A     +   TN V+GT  Y +PE A        +D++S GI+L E++ G+
Sbjct: 151 KIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 65.3 bits (160), Expect = 2e-14
 Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 11/63 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           K+ DFGL+R                + G     +MAPE  +  +F+  SDV+ FG+ + E
Sbjct: 156 KLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209

Query: 59  IIS 61
           I+ 
Sbjct: 210 ILM 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 65.0 bits (159), Expect = 2e-14
 Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFG+ R     +I        G  G      M+PE   DG F+  SDV+SFG++L E
Sbjct: 178 KIGDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232

Query: 59  IIS 61
           I +
Sbjct: 233 IAT 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 65.0 bits (159), Expect = 2e-14
 Identities = 17/60 (28%), Positives = 33/60 (55%), Gaps = 1/60 (1%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
            + DFG+A A   +++       +GT  YMAPE  S+   + ++D+++   +L E ++G 
Sbjct: 174 YLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 65.0 bits (159), Expect = 3e-14
 Identities = 27/63 (42%), Positives = 36/63 (57%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR    D +  +   V          +MAPE   +G +++KSDV+S+GILL E
Sbjct: 212 KICDFGLAR----DIMSDSNYVV-RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266

Query: 59  IIS 61
           I S
Sbjct: 267 IFS 269

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 64.6 bits (158), Expect = 4e-14
 Identities = 18/63 (28%), Positives = 33/63 (52%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
            ++DFGL++        G+  R  G        ++A E  +D  ++ KSDV++FG+ + E
Sbjct: 187 CVADFGLSK----KIYSGDYYRQ-GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241

Query: 59  IIS 61
           I +
Sbjct: 242 IAT 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 64.8 bits (158), Expect = 4e-14
 Identities = 25/64 (39%), Positives = 36/64 (56%), Gaps = 10/64 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG------YMAPEYASDGKFSVKSDVFSFGILLL 57
           K++DFGLAR    D  +   + V    G      +MA E     KF+ KSDV+SFG+LL 
Sbjct: 232 KVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287

Query: 58  EIIS 61
           E+++
Sbjct: 288 ELMT 291

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 64.2 bits (157), Expect = 5e-14
 Identities = 23/63 (36%), Positives = 34/63 (53%), Gaps = 13/63 (20%)

Query: 4   KISDFGLARAFGGDEIEGNTN-----RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI+DFGL+R  G +     T      R      +MA E  +   ++  SDV+S+G+LL E
Sbjct: 182 KIADFGLSR--GQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWE 233

Query: 59  IIS 61
           I+S
Sbjct: 234 IVS 236

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 64.2 bits (157), Expect = 5e-14
 Identities = 24/61 (39%), Positives = 35/61 (57%), Gaps = 1/61 (1%)

Query: 4   KISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K+ DFG+ARA          T  VIGT  Y++PE A       +SDV+S G +L E+++G
Sbjct: 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

Query: 63  K 63
           +
Sbjct: 216 E 216

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 63.9 bits (156), Expect = 7e-14
 Identities = 19/63 (30%), Positives = 34/63 (53%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
            ++DFGL+R        G+  R  G        ++A E  +D  ++V SDV++FG+ + E
Sbjct: 177 CVADFGLSR----KIYSGDYYRQ-GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWE 231

Query: 59  IIS 61
           I++
Sbjct: 232 IMT 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 1e-13
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYG-----YMAPEYASDGKFSVKSDVFSFGILLLE 58
           KI DFGLAR     +I  + + V          +MAPE   D  ++++SDV+SFG+LL E
Sbjct: 233 KICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287

Query: 59  IIS 61
           I S
Sbjct: 288 IFS 290

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 62.7 bits (153), Expect = 2e-13
 Identities = 15/64 (23%), Positives = 25/64 (39%), Gaps = 17/64 (26%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGY-----MAPEYASDGK-FSVKSDVFSFGILLL 57
           K+SD G++      +                   + PE   + K  ++ +D +SFG  L 
Sbjct: 161 KLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLW 209

Query: 58  EIIS 61
           EI S
Sbjct: 210 EICS 213

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 61.8 bits (150), Expect = 4e-13
 Identities = 23/74 (31%), Positives = 32/74 (43%), Gaps = 10/74 (13%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTN----------RVIGTYGYMAPEYASDGKFSVKSDVF 50
              K+ DFGL  A   DE E                +GT  YM+PE      +S K D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 51  SFGILLLEIISGKK 64
           S G++L E++    
Sbjct: 261 SLGLILFELLYSFS 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 59.2 bits (144), Expect = 3e-12
 Identities = 20/64 (31%), Positives = 31/64 (48%), Gaps = 3/64 (4%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGL  +   D   G   R  GT  YM+PE  S   +  + D+++ G++L E++
Sbjct: 159 KQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

Query: 61  SGKK 64
               
Sbjct: 216 HVCD 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 56.5 bits (137), Expect = 3e-11
 Identities = 23/60 (38%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFGLAR    D     T   +GT  YM+PE  +   ++ KSD++S G LL E+ +  
Sbjct: 156 KLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 56.3 bits (136), Expect = 4e-11
 Identities = 18/60 (30%), Positives = 32/60 (53%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           ++ DFG+AR              IGT  Y++PE   +  ++ KSD+++ G +L E+ + K
Sbjct: 165 QLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 55.8 bits (135), Expect = 6e-11
 Identities = 21/61 (34%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFGL    G     G      G   YMAPE    G +   +DVFS G+ +LE+    
Sbjct: 197 KLGDFGLLVELGTA---GAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

Query: 64  K 64
           +
Sbjct: 253 E 253

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 55.6 bits (134), Expect = 7e-11
 Identities = 22/60 (36%), Positives = 36/60 (60%), Gaps = 4/60 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFG++    G  I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+  G+
Sbjct: 172 KLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 55.2 bits (133), Expect = 1e-10
 Identities = 19/63 (30%), Positives = 27/63 (42%), Gaps = 4/63 (6%)

Query: 4   KISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEY---ASDGKFSVKSDVFSFGILLLEI 59
            ISDFGL +            + V GT G++APE          +   D+FS G +   +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

Query: 60  ISG 62
           IS 
Sbjct: 223 ISE 225

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 55.1 bits (133), Expect = 1e-10
 Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 10/70 (14%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRV----------IGTYGYMAPEYASDGKFSVKSDVF 50
              K+ DFGL  A   DE E                +GT  YM+PE      +S K D+F
Sbjct: 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214

Query: 51  SFGILLLEII 60
           S G++L E++
Sbjct: 215 SLGLILFELL 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 55.0 bits (133), Expect = 1e-10
 Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 13/86 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----------YASDGKFSVKSDVFSF 52
           K+ DFG+A     D      +  +GT  YM PE             S  K S KSDV+S 
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225

Query: 53  GILLLEIISGKKNRGFYHSDNKLNLI 78
           G +L  +  GK    F    N+++ +
Sbjct: 226 GCILYYMTYGK--TPFQQIINQISKL 249

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 54.8 bits (132), Expect = 1e-10
 Identities = 25/86 (29%), Positives = 36/86 (41%), Gaps = 13/86 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----------YASDGKFSVKSDVFSF 52
           K+ DFG+A     D      +  +G   YM PE             S  K S KSDV+S 
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253

Query: 53  GILLLEIISGKKNRGFYHSDNKLNLI 78
           G +L  +  GK    F    N+++ +
Sbjct: 254 GCILYYMTYGKTP--FQQIINQISKL 277

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 54.3 bits (131), Expect = 2e-10
 Identities = 24/71 (33%), Positives = 31/71 (43%), Gaps = 11/71 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----------YASDGKFSVKSDVFSF 52
           K+ DFG+A     D      +  +GT  YM PE             S  K S KSDV+S 
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206

Query: 53  GILLLEIISGK 63
           G +L  +  GK
Sbjct: 207 GCILYYMTYGK 217

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 53.4 bits (129), Expect = 3e-10
 Identities = 20/64 (31%), Positives = 35/64 (54%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE----YASDGKFSVKSDVFSFGILLLEI 59
           K+ DFG++     D++  + +   G   YMAPE      +   +SVKSD++S GI ++E+
Sbjct: 150 KMCDFGISGYLV-DDVAKDID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

Query: 60  ISGK 63
              +
Sbjct: 207 AILR 210

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 53.1 bits (128), Expect = 5e-10
 Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI D GLA              VIGT  +MAPE   +  +    DV++FG+ +LE+ + +
Sbjct: 172 KIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 53.1 bits (128), Expect = 5e-10
 Identities = 20/60 (33%), Positives = 34/60 (56%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ D GL R F       ++  ++GT  YM+PE   +  ++ KSD++S G LL E+ + +
Sbjct: 176 KLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 53.1 bits (127), Expect = 5e-10
 Identities = 22/63 (34%), Positives = 30/63 (47%), Gaps = 3/63 (4%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +  KI D G A+     E        +GT  Y+APE     K++V  D +SFG L  E I
Sbjct: 161 LIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI 217

Query: 61  SGK 63
           +G 
Sbjct: 218 TGF 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 52.7 bits (127), Expect = 6e-10
 Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 18/90 (20%)

Query: 2   NPKISDFGLARAF------------GGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSD 48
           N KI DFGLA+                     N    IGT  Y+A E     G ++ K D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213

Query: 49  VFSFGILLLEIISGKKNRGFYHSDNKLNLI 78
           ++S GI+  E+I       F     ++N++
Sbjct: 214 MYSLGIIFFEMIY-----PFSTGMERVNIL 238

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 52.6 bits (126), Expect = 8e-10
 Identities = 23/63 (36%), Positives = 32/63 (50%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK---FSVKSDVFSFGILLLEII 60
           +ISD GLA  F     +   +  +GT+GYMAPE    G     S   D FS G +L +++
Sbjct: 332 RISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLL 385

Query: 61  SGK 63
            G 
Sbjct: 386 RGH 388

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 51.3 bits (123), Expect = 2e-09
 Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 9/68 (13%)

Query: 4   KISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGI 54
            ISDFGL +     +     N N   GT G+ APE         +  + +   D+FS G 
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 55  LLLEIISG 62
           +   I+S 
Sbjct: 228 VFYYILSK 235

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 50.8 bits (121), Expect = 4e-09
 Identities = 8/73 (10%), Positives = 19/73 (26%), Gaps = 16/73 (21%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS----------DGKFSVKSDVF 50
               ++ F           +G +       G+  PE  +              +   D +
Sbjct: 248 GGVFLTGFEHLVR------DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301

Query: 51  SFGILLLEIISGK 63
           + G+ +  I    
Sbjct: 302 TLGLAIYWIWCAD 314

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 49.3 bits (118), Expect = 1e-08
 Identities = 19/65 (29%), Positives = 35/65 (53%), Gaps = 8/65 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----YASDGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D+   + +   G   YMAPE       +   + +++DV+S GI L+E
Sbjct: 165 KLCDFGIS-GRLVDDKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221

Query: 59  IISGK 63
           + +G+
Sbjct: 222 LATGQ 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 48.9 bits (117), Expect = 1e-08
 Identities = 22/73 (30%), Positives = 35/73 (47%), Gaps = 6/73 (8%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
             KI DFGL+  F   +        +GT  Y+APE     K+  K DV+S G++L  +++
Sbjct: 177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232

Query: 62  GKKNRGFYHSDNK 74
           G     F    ++
Sbjct: 233 GY--PPFGGQTDQ 243

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 48.9 bits (116), Expect = 2e-08
 Identities = 8/65 (12%), Positives = 16/65 (24%), Gaps = 7/65 (10%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY--ASDGKFSVKSDVFSFGILLLE 58
               + D       G                Y   E+  AS   F+   + +  G+ +  
Sbjct: 231 GRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285

Query: 59  IISGK 63
           +    
Sbjct: 286 VWCLF 290

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 48.6 bits (116), Expect = 2e-08
 Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           +ISD GLA      +    T    GT G+MAPE     ++    D F+ G+ L E+I+ +
Sbjct: 329 RISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 48.5 bits (116), Expect = 2e-08
 Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N +I DFGL+  F   +        IGT  Y+APE    G +  K DV+S G++L  ++S
Sbjct: 167 NIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222

Query: 62  G 62
           G
Sbjct: 223 G 223

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 48.2 bits (115), Expect = 3e-08
 Identities = 21/60 (35%), Positives = 33/60 (55%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           +ISD GLA      +        +GT GYMAPE   + +++   D ++ G LL E+I+G+
Sbjct: 326 RISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 48.2 bits (115), Expect = 3e-08
 Identities = 16/63 (25%), Positives = 28/63 (44%), Gaps = 3/63 (4%)

Query: 4   KISDFGLARAFGGDEIEGNTNR---VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + DFG A     D +  +      + GT  +MAPE         K D++S   ++L ++
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250

Query: 61  SGK 63
           +G 
Sbjct: 251 NGC 253

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 48.2 bits (115), Expect = 3e-08
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 4/61 (6%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
           N KI DFGL+  F  D         +GT  Y+APE     K++ K DV+S G+++  ++ 
Sbjct: 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242

Query: 62  G 62
           G
Sbjct: 243 G 243

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 48.3 bits (115), Expect = 3e-08
 Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 11/71 (15%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--------YASDGKFSVKSDVFSF 52
              K++DFG AR    DE       + GT  Y+ P+             K+    D++S 
Sbjct: 153 SVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209

Query: 53  GILLLEIISGK 63
           G+      +G 
Sbjct: 210 GVTFYHAATGS 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 48.1 bits (115), Expect = 3e-08
 Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE----YASDGKFSVKSDVFSFGILLLEI 59
           K+ DFG++     D I    +   G   YMAPE     AS   + V+SDV+S GI L E+
Sbjct: 166 KLCDFGIS-GQLVDSIAKTRD--AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

Query: 60  ISGK 63
            +G+
Sbjct: 223 ATGR 226

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 47.8 bits (114), Expect = 4e-08
 Identities = 17/68 (25%), Positives = 27/68 (39%), Gaps = 11/68 (16%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--------YASDGKFSVKSDVFSFGIL 55
           K++DFG AR    DE       + GT  Y+ P+             K+    D++S G+ 
Sbjct: 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212

Query: 56  LLEIISGK 63
                +G 
Sbjct: 213 FYHAATGS 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 47.4 bits (113), Expect = 6e-08
 Identities = 23/59 (38%), Positives = 32/59 (54%), Gaps = 4/59 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGL+  F  +         IGT  Y+APE    G +  K DV+S G++L  ++SG
Sbjct: 164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 47.3 bits (112), Expect = 6e-08
 Identities = 9/60 (15%), Positives = 19/60 (31%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
            + D G +                 T G+   E  S+  ++ + D F     +  ++ G 
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 46.9 bits (112), Expect = 7e-08
 Identities = 10/61 (16%), Positives = 21/61 (34%), Gaps = 7/61 (11%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           KI D G            +     G   ++A E    +     K+D+F+  + ++     
Sbjct: 174 KIGDLGHVTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

Query: 63  K 63
           +
Sbjct: 228 E 228

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 46.9 bits (112), Expect = 7e-08
 Identities = 22/62 (35%), Positives = 32/62 (51%), Gaps = 4/62 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILLLEIIS 61
           KISDFG ++   G  I   T    GT  YMAPE        +   +D++S G  ++E+ +
Sbjct: 163 KISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220

Query: 62  GK 63
           GK
Sbjct: 221 GK 222

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 46.9 bits (111), Expect = 8e-08
 Identities = 8/74 (10%), Positives = 20/74 (27%), Gaps = 17/74 (22%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----------GKFSVKSDV 49
               ++ F           +G       + G+  PE  +               +   D 
Sbjct: 243 GGVFLTGFEHLVR------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 50  FSFGILLLEIISGK 63
           ++ G+++  I    
Sbjct: 297 WALGLVIYWIWCAD 310

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 46.7 bits (111), Expect = 1e-07
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 4/67 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNT--NRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILL 56
              K+ DFGL++ F               GT  ++APE    ++  +  K D +S G+LL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 57  LEIISGK 63
             ++ G 
Sbjct: 267 HLLLMGA 273

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 46.1 bits (110), Expect = 1e-07
 Identities = 15/60 (25%), Positives = 34/60 (56%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ ++++G 
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 46.1 bits (110), Expect = 2e-07
 Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 4/64 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           +  KI DFGLA     D   G   +V+ GT  Y+APE  S    S + DV+S G ++  +
Sbjct: 178 LEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234

Query: 60  ISGK 63
           + GK
Sbjct: 235 LVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 45.6 bits (109), Expect = 2e-07
 Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +  KI DFGLA     D        + GT  Y+APE  S    S + DV+S G ++  ++
Sbjct: 152 LEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209

Query: 61  SGK 63
            GK
Sbjct: 210 VGK 212

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 45.0 bits (107), Expect = 4e-07
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG       ++ + +T  ++GT  +MAPE  +   +  K D++S GI+ +E+I G+
Sbjct: 156 KLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 45.1 bits (107), Expect = 4e-07
 Identities = 19/60 (31%), Positives = 36/60 (60%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+SDFG       D  +  +  ++GT  +MAPE  S   ++ + D++S GI+++E++ G+
Sbjct: 181 KLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 44.6 bits (106), Expect = 5e-07
 Identities = 21/60 (35%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A      +I+ NT   +GT  +MAPE      +  K+D++S GI  +E+  G+
Sbjct: 159 KLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 44.7 bits (106), Expect = 5e-07
 Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+A        + NT  VIGT  +MAPE   +  ++  +D++S GI  +E+  GK
Sbjct: 165 KLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 44.5 bits (106), Expect = 6e-07
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 8/57 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
            I+DFGL++        G  +   GT GY+APE  +   +S   D +S G    ILL
Sbjct: 149 MITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 43.8 bits (104), Expect = 8e-07
 Identities = 15/53 (28%), Positives = 24/53 (45%), Gaps = 2/53 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K+  FG+A   G   +       +GT  +MAPE      +    DV+  G++L
Sbjct: 173 KLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 43.9 bits (104), Expect = 9e-07
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 7/57 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
           KI+DFGL++      +      V GT GY APE      +  + D++S G    ILL
Sbjct: 191 KIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 43.4 bits (103), Expect = 1e-06
 Identities = 23/57 (40%), Positives = 28/57 (49%), Gaps = 8/57 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
           KI DFGL+  F  +         IGT  Y+APE    G +  K DV+S G    ILL
Sbjct: 164 KIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILL 216

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 43.0 bits (102), Expect = 2e-06
 Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 6/64 (9%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVI-GTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
              KI+DFG +          +    + GT  Y+ PE         K D++S G+L  E 
Sbjct: 146 GELKIADFGWSV-----HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

Query: 60  ISGK 63
           + GK
Sbjct: 201 LVGK 204

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 42.7 bits (101), Expect = 2e-06
 Identities = 14/53 (26%), Positives = 27/53 (50%), Gaps = 4/53 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K++DFG A+    + ++        T  Y+APE     K+    D++S G+++
Sbjct: 171 KLTDFGFAKETTQNALQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 42.9 bits (102), Expect = 2e-06
 Identities = 22/63 (34%), Positives = 35/63 (55%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           MN KI+DFGLA        +  T  + GT  Y++PE A+     ++SDV+S G +   ++
Sbjct: 149 MNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206

Query: 61  SGK 63
            G+
Sbjct: 207 IGR 209

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 42.6 bits (101), Expect = 2e-06
 Identities = 15/55 (27%), Positives = 29/55 (52%), Gaps = 4/55 (7%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
             K+ DFGLA  F   ++       +GT  Y++P+   +G +  + D +S G+++
Sbjct: 147 PLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 42.9 bits (101), Expect = 2e-06
 Identities = 15/53 (28%), Positives = 23/53 (43%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K+ DFGL       +   +     GT  + APE A        +D++S G+L 
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 42.7 bits (101), Expect = 2e-06
 Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 12/76 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-----FSVKSDVFSFGILLLE 58
            I+DF +A     +        + GT  YMAPE  S  K     F+V  D +S G+   E
Sbjct: 155 HITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYE 209

Query: 59  IISGKKNRGFYHSDNK 74
           ++ G+  R ++   + 
Sbjct: 210 LLRGR--RPYHIRSST 223

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 42.8 bits (101), Expect = 2e-06
 Identities = 15/59 (25%), Positives = 28/59 (47%), Gaps = 9/59 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE------YASDGKFSVKSDVFSFGILL 56
           ++SDFG +      E       + GT GY+APE        +   +  + D+++ G++L
Sbjct: 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 42.2 bits (100), Expect = 3e-06
 Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 4/55 (7%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
             KI DFGLA  F  DE    +    GT  YMAPE       + K D++S G+++
Sbjct: 165 PIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 42.2 bits (100), Expect = 4e-06
 Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 9/59 (15%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE------YASDGKFSVKSDVFSFGILL 56
           K++DFG +      E       V GT  Y+APE        +   +  + D++S G+++
Sbjct: 164 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 42.0 bits (99), Expect = 4e-06
 Identities = 14/53 (26%), Positives = 26/53 (49%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K+ DFGLA              + GT  ++APE  +     +++D++S G++ 
Sbjct: 159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 42.0 bits (99), Expect = 4e-06
 Identities = 17/53 (32%), Positives = 23/53 (43%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI DFGLA     DEI         T  + APE          +D+++ G+L 
Sbjct: 191 KIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 41.9 bits (99), Expect = 4e-06
 Identities = 16/56 (28%), Positives = 27/56 (48%), Gaps = 6/56 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI+DFG ++  G   +      + GT  Y+APE         ++   D +S G++L
Sbjct: 157 KITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 42.0 bits (99), Expect = 5e-06
 Identities = 14/53 (26%), Positives = 24/53 (45%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K++DFG A+                T  Y+APE     K+    D++S G+++
Sbjct: 204 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 41.9 bits (99), Expect = 5e-06
 Identities = 19/57 (33%), Positives = 28/57 (49%), Gaps = 7/57 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
           K++DFGLA      E     +   GT GY++PE      +S   D+++ G    ILL
Sbjct: 171 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 42.0 bits (99), Expect = 5e-06
 Identities = 23/82 (28%), Positives = 35/82 (42%), Gaps = 14/82 (17%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGIL 55
              K+SDFG +      +I+G      GTY +M PE+ S     +G    K D++S GI 
Sbjct: 189 GRVKLSDFGESEYMVDKKIKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGIC 241

Query: 56  LLEIISGKKNRGFYHSDNKLNL 77
           L  +        F    + + L
Sbjct: 242 LYVMFYNVVP--FSLKISLVEL 261

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 41.8 bits (99), Expect = 5e-06
 Identities = 13/53 (24%), Positives = 26/53 (49%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K+ DFG+A              + GT  ++APE  +     +++D++S G++ 
Sbjct: 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 41.5 bits (98), Expect = 6e-06
 Identities = 14/53 (26%), Positives = 26/53 (49%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           K+ DFGLA              + GT  ++APE  +     +++D++S G++ 
Sbjct: 159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 41.5 bits (98), Expect = 6e-06
 Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI DFGLA              + GT  ++APE  +     +++D++S G++ 
Sbjct: 158 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 41.4 bits (98), Expect = 6e-06
 Identities = 19/57 (33%), Positives = 28/57 (49%), Gaps = 7/57 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
           K++DFGLA      E     +   GT GY++PE      +S   D+++ G    ILL
Sbjct: 148 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 41.6 bits (98), Expect = 6e-06
 Identities = 16/56 (28%), Positives = 27/56 (48%), Gaps = 6/56 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILL 56
           KI+DFG ++  G   +      + GT  Y+APE         ++   D +S G++L
Sbjct: 282 KITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 41.6 bits (98), Expect = 7e-06
 Identities = 18/53 (33%), Positives = 27/53 (50%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI DFGLAR +   E         GT  ++APE  +    S  +D++S G++ 
Sbjct: 229 KIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 41.5 bits (98), Expect = 7e-06
 Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 17/70 (24%)

Query: 4   KISDFGLARAFGGDEIEGN---TNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFG 53
           K++DFGLARAF   +       TNRV+ T  Y  PE       Y          D++  G
Sbjct: 164 KLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAG 216

Query: 54  ILLLEIISGK 63
            ++ E+ +  
Sbjct: 217 CIMAEMWTRS 226

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 41.4 bits (98), Expect = 7e-06
 Identities = 26/67 (38%), Positives = 39/67 (58%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K++DFGLARAF G  +   T+ V+ T  Y AP+       Y++    SV  D++S G + 
Sbjct: 159 KLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKYST----SV--DIWSIGCIF 210

Query: 57  LEIISGK 63
            E+I+GK
Sbjct: 211 AEMITGK 217

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 41.5 bits (98), Expect = 7e-06
 Identities = 18/53 (33%), Positives = 24/53 (45%), Gaps = 2/53 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI DFG AR    D     T     T  Y APE  +   +    D++S G++L
Sbjct: 149 KIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 41.1 bits (97), Expect = 8e-06
 Identities = 15/53 (28%), Positives = 22/53 (41%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI +FG AR     +       +     Y APE       S  +D++S G L+
Sbjct: 144 KIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 41.0 bits (97), Expect = 8e-06
 Identities = 18/67 (26%), Positives = 32/67 (47%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K++DFGLARA      +   N V+ T  Y  P+       Y++     +  D++  G + 
Sbjct: 140 KLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGSTDYST----QI--DMWGVGCIF 191

Query: 57  LEIISGK 63
            E+ +G+
Sbjct: 192 YEMATGR 198

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 41.1 bits (97), Expect = 8e-06
 Identities = 18/57 (31%), Positives = 28/57 (49%), Gaps = 6/57 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFG----ILL 56
           K++DFGLA    G++         GT GY++PE      +    D+++ G    ILL
Sbjct: 153 KLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 41.1 bits (97), Expect = 8e-06
 Identities = 16/53 (30%), Positives = 28/53 (52%), Gaps = 3/53 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           KI DFG++R  G          ++GT  Y+APE  +    +  +D+++ GI+ 
Sbjct: 174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 41.1 bits (97), Expect = 8e-06
 Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           KI DFGLARAF G  I   T+ +I T  Y  PE       Y++    SV  D++S   + 
Sbjct: 177 KIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEILLGSRHYST----SV--DIWSIACIW 228

Query: 57  LEIISGK 63
            E++   
Sbjct: 229 AEMLMKT 235

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 41.1 bits (97), Expect = 9e-06
 Identities = 15/53 (28%), Positives = 24/53 (45%), Gaps = 2/53 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILL 56
           +I DFG A+    +     T     T  ++APE      +    D++S G+LL
Sbjct: 160 RICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 41.0 bits (97), Expect = 9e-06
 Identities = 21/67 (31%), Positives = 34/67 (50%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K++DFGLA++F G      T++V+ T  Y APE       Y       V  D+++ G +L
Sbjct: 152 KLADFGLAKSF-GSPNRAYTHQVV-TRWYRAPELLFGARMY------GVGVDMWAVGCIL 203

Query: 57  LEIISGK 63
            E++   
Sbjct: 204 AELLLRV 210

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 41.0 bits (97), Expect = 9e-06
 Identities = 25/67 (37%), Positives = 39/67 (58%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFGLARAF G  +   ++ V+ T  Y AP+       Y++    S+  D++S G +L
Sbjct: 148 KLGDFGLARAF-GIPVNTFSSEVV-TLWYRAPDVLMGSRTYST----SI--DIWSCGCIL 199

Query: 57  LEIISGK 63
            E+I+GK
Sbjct: 200 AEMITGK 206

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 40.7 bits (96), Expect = 1e-05
 Identities = 17/66 (25%), Positives = 27/66 (40%), Gaps = 10/66 (15%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNR---VIGTYGYMAPEYASDGKFSVKSDVFSFGILLL 57
              KI+DFG +       +   + R   + GT  Y+ PE         K D++  G+L  
Sbjct: 151 GELKIADFGWS-------VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCY 203

Query: 58  EIISGK 63
           E + G 
Sbjct: 204 EFLVGM 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 40.6 bits (96), Expect = 1e-05
 Identities = 19/68 (27%), Positives = 35/68 (51%), Gaps = 15/68 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+++FGLARAF G  +   +  V+ T  Y  P+       Y++    S+  D++S G + 
Sbjct: 141 KLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYST----SI--DMWSAGCIF 192

Query: 57  LEIISGKK 64
            E+ +  +
Sbjct: 193 AELANAGR 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 40.2 bits (95), Expect = 2e-05
 Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           KI+DFGLARAF G  +   T+ ++ T  Y AP+       Y++    ++  D++S G + 
Sbjct: 140 KIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKKYST----TI--DIWSVGCIF 191

Query: 57  LEIISGK 63
            E+++G 
Sbjct: 192 AEMVNGT 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 40.3 bits (94), Expect = 2e-05
 Identities = 11/67 (16%), Positives = 23/67 (34%), Gaps = 7/67 (10%)

Query: 4   KISDFGLARAFGGDEIEGNT-----NRVIGTYGYMAPE--YASDGKFSVKSDVFSFGILL 56
            +S      +                  +    +++PE    +   +  KSD++S GI  
Sbjct: 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227

Query: 57  LEIISGK 63
            E+ +G 
Sbjct: 228 CELANGH 234

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 40.1 bits (94), Expect = 2e-05
 Identities = 23/65 (35%), Positives = 32/65 (49%), Gaps = 7/65 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----YASDGKFSVKSDVFSFGILLLE 58
           K+ DFG++     D   G  N  IGT  +MAPE        D  +  KSD++S GI  +E
Sbjct: 169 KLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 59  IISGK 63
           +  G 
Sbjct: 227 MAEGA 231

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 39.6 bits (93), Expect = 3e-05
 Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 4/64 (6%)

Query: 4   KISDFGL-ARAFGGDEIEGNTNR--VIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEI 59
           +I+DFG+ A    G +I  N  R   +GT  +MAPE     + +  K+D++SFGI  +E+
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

Query: 60  ISGK 63
            +G 
Sbjct: 221 ATGA 224

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 39.7 bits (93), Expect = 3e-05
 Identities = 21/60 (35%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFGLAR          T  V+ T  Y APE      +    D++S G ++ E+I G 
Sbjct: 167 KILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 39.8 bits (93), Expect = 3e-05
 Identities = 20/60 (33%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFGLAR          T  V+ T  Y APE      +    D++S G ++ E++  K
Sbjct: 204 KILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 39.7 bits (93), Expect = 3e-05
 Identities = 15/64 (23%), Positives = 31/64 (48%), Gaps = 6/64 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----YASDGKFSVKSDVFSFGILLLE 58
           +++DFG       D     ++  +GT  Y++PE         G++  + D +S G+ + E
Sbjct: 215 RLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

Query: 59  IISG 62
           ++ G
Sbjct: 274 MLYG 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 39.6 bits (93), Expect = 3e-05
 Identities = 19/66 (28%), Positives = 34/66 (51%), Gaps = 5/66 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSV---KSDVFSFGILLL 57
            + KI+DFG++  F G   +   +  +GT  +MAPE  S+ +        DV++ G+ L 
Sbjct: 174 GHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 58  EIISGK 63
             + G+
Sbjct: 232 CFVFGQ 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 39.2 bits (92), Expect = 4e-05
 Identities = 18/63 (28%), Positives = 26/63 (41%), Gaps = 10/63 (15%)

Query: 4   KISDFGLARAF--GGDEIEGNTNR---VIGTYGYMAPE-----YASDGKFSVKSDVFSFG 53
           KI DF L       GD    +T       G+  YMAPE           +  + D++S G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213

Query: 54  ILL 56
           ++L
Sbjct: 214 VIL 216

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 39.1 bits (92), Expect = 4e-05
 Identities = 19/67 (28%), Positives = 28/67 (41%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFG AR       +   + V  T  Y +PE       Y       V  DV++ G + 
Sbjct: 142 KLCDFGFARLL-TGPSDYYDDEVA-TRWYRSPELLVGDTQYGP----PV--DVWAIGCVF 193

Query: 57  LEIISGK 63
            E++SG 
Sbjct: 194 AELLSGV 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 39.1 bits (92), Expect = 4e-05
 Identities = 26/63 (41%), Positives = 36/63 (57%), Gaps = 1/63 (1%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEI 59
            N KISDFGLA  F  +  E   N++ GT  Y+APE     +F     DV+S GI+L  +
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

Query: 60  ISG 62
           ++G
Sbjct: 202 LAG 204

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 39.3 bits (92), Expect = 4e-05
 Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 8/66 (12%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           +++DFG       D     +   +GT  Y++PE           G +  + D ++ G+  
Sbjct: 202 RLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260

Query: 57  LEIISG 62
            E+  G
Sbjct: 261 YEMFYG 266

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 38.7 bits (91), Expect = 5e-05
 Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLAR +     +   T+ V+ T  Y APE      ++   D++S G +  E+   
Sbjct: 160 KLADFGLARIYS---FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

Query: 63  K 63
           K
Sbjct: 216 K 216

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 38.8 bits (91), Expect = 5e-05
 Identities = 17/65 (26%), Positives = 26/65 (40%), Gaps = 2/65 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF--SVKSDVFSFGILLLE 58
              KIS  G+A A      +       G+  +  PE A+        K D++S G+ L  
Sbjct: 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205

Query: 59  IISGK 63
           I +G 
Sbjct: 206 ITTGL 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 38.8 bits (91), Expect = 6e-05
 Identities = 16/59 (27%), Positives = 32/59 (54%), Gaps = 5/59 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           +++DFG A+      ++G T  + GT   +APE      ++   D ++ G+L+ E+ +G
Sbjct: 181 QVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 38.7 bits (91), Expect = 6e-05
 Identities = 21/67 (31%), Positives = 29/67 (43%), Gaps = 15/67 (22%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFG AR       E   + V  T  Y APE       Y      +V  DV++ G L+
Sbjct: 164 KLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPELLVGDVKYGK----AV--DVWAIGCLV 215

Query: 57  LEIISGK 63
            E+  G+
Sbjct: 216 TEMFMGE 222

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 38.8 bits (91), Expect = 6e-05
 Identities = 25/66 (37%), Positives = 35/66 (53%), Gaps = 7/66 (10%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS----DGKFSVKSDVFSFGILL 56
            N KISDFGLA  F  +  E   N++ GT  Y+APE         +     DV+S GI+L
Sbjct: 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE---PVDVWSCGIVL 198

Query: 57  LEIISG 62
             +++G
Sbjct: 199 TAMLAG 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 38.7 bits (91), Expect = 7e-05
 Identities = 19/61 (31%), Positives = 30/61 (49%), Gaps = 5/61 (8%)

Query: 4   KISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG 62
           K++DFGLAR +     +   T  V+ T  Y APE      ++   D++S G +  E+   
Sbjct: 160 KLADFGLARIYS---YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

Query: 63  K 63
           K
Sbjct: 216 K 216

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 38.5 bits (90), Expect = 8e-05
 Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 7/65 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-----YASDGKFSVKSDVFSFGILLLE 58
           +++DFG++        + ++   IGT  +MAPE        D  +  K+D++S GI L+E
Sbjct: 157 RLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214

Query: 59  IISGK 63
           +   +
Sbjct: 215 MAQIE 219

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 38.2 bits (89), Expect = 9e-05
 Identities = 17/77 (22%), Positives = 26/77 (33%), Gaps = 15/77 (19%)

Query: 1   MNPKISDFGLAR-----------AFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVK 46
              K+ DFG A            A     +E    R   T  Y  PE     S+     K
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN-TTPMYRTPEIIDLYSNFPIGEK 233

Query: 47  SDVFSFGILLLEIISGK 63
            D+++ G +L  +   +
Sbjct: 234 QDIWALGCILYLLCFRQ 250

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 37.8 bits (88), Expect = 1e-04
 Identities = 18/95 (18%), Positives = 32/95 (33%), Gaps = 23/95 (24%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS----DGKFSVKSDVFSFGILL 56
              K+ DFG A      ++        GT  Y APE        G    + +++S G+ L
Sbjct: 167 FTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGP---ELEMWSLGVTL 220

Query: 57  LEIISG--------KKNRGFYH-----SDNKLNLI 78
             ++          +      H     S   ++L+
Sbjct: 221 YTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 38.1 bits (88), Expect = 1e-04
 Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFG+ +    D     T    GT  Y+APE  +   +    D ++FG+LL E+++G+
Sbjct: 482 KIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 37.6 bits (88), Expect = 1e-04
 Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 4/63 (6%)

Query: 4   KISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR            +  ++ T  Y +P    S   ++   D+++ G +  E++
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

Query: 61  SGK 63
           +GK
Sbjct: 220 TGK 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 37.8 bits (88), Expect = 1e-04
 Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 9/63 (14%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDVFSFGILLLEII 60
           K+ DFG A          N+   +GT  +MAPE      +G++  K DV+S GI  +E+ 
Sbjct: 194 KLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

Query: 61  SGK 63
             K
Sbjct: 248 ERK 250

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 37.6 bits (87), Expect = 2e-04
 Identities = 13/63 (20%), Positives = 25/63 (39%), Gaps = 5/63 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +  KI+D G A  +            I T  Y + E      ++  +D++S   +  E+ 
Sbjct: 233 LKVKIADLGNAC-WVHKHF----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287

Query: 61  SGK 63
           +G 
Sbjct: 288 TGD 290

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 37.6 bits (88), Expect = 2e-04
 Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 4/63 (6%)

Query: 4   KISDFGLARAFGGDEIEGN--TNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEII 60
           KI DFGLAR    D       T  V  T  Y APE   +   ++   D++S G +L E++
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

Query: 61  SGK 63
           S +
Sbjct: 227 SNR 229

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 37.3 bits (87), Expect = 2e-04
 Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 12/74 (16%)

Query: 1   MNPKISDFGLAR--------AFGGDEIEGNTNRVIGTYGYMAPE---YASDGKFSVKSDV 49
             P + D G           +     ++    +   T  Y APE     S      ++DV
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSVQSHCVIDERTDV 229

Query: 50  FSFGILLLEIISGK 63
           +S G +L  ++ G+
Sbjct: 230 WSLGCVLYAMMFGE 243

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 37.4 bits (87), Expect = 2e-04
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGL +    D          GT  Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 289 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 37.4 bits (87), Expect = 2e-04
 Identities = 17/63 (26%), Positives = 31/63 (49%), Gaps = 5/63 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE----YASDGKFSVKSDVFSFGILLLEI 59
           K++DFG       + +    +  +GT  Y++PE       DG +  + D +S G+ L E+
Sbjct: 208 KLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266

Query: 60  ISG 62
           + G
Sbjct: 267 LVG 269

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 37.4 bits (87), Expect = 2e-04
 Identities = 17/61 (27%), Positives = 29/61 (47%), Gaps = 4/61 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEIISG 62
           K+ DFG A+       E +   +   + Y APE      +++   D++S G +  E+I G
Sbjct: 182 KLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 63  K 63
           K
Sbjct: 239 K 239

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 37.3 bits (87), Expect = 2e-04
 Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 5/64 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEI 59
              K+ DFG                  GT  Y  PE+    ++    + V+S GILL ++
Sbjct: 187 GELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242

Query: 60  ISGK 63
           + G 
Sbjct: 243 VCGD 246

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 36.9 bits (86), Expect = 2e-04
 Identities = 21/64 (32%), Positives = 31/64 (48%), Gaps = 4/64 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEI 59
           MN KI+DFG +  F         +   G   Y APE     K+   + DV+S G++L  +
Sbjct: 151 MNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207

Query: 60  ISGK 63
           +SG 
Sbjct: 208 VSGS 211

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 37.1 bits (87), Expect = 2e-04
 Identities = 24/62 (38%), Positives = 35/62 (56%), Gaps = 11/62 (17%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEII 60
           KI+DFG A+      +   T  + GT  Y+APE  S     K S+  D +SFGIL+ E++
Sbjct: 146 KITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEML 197

Query: 61  SG 62
           +G
Sbjct: 198 AG 199

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 37.1 bits (86), Expect = 3e-04
 Identities = 17/69 (24%), Positives = 31/69 (44%), Gaps = 16/69 (23%)

Query: 4   KISDFGLARAFG--GDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGI 54
           KI+D G AR F      +      V+ T+ Y APE       Y      ++  D+++ G 
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTK----AI--DIWAIGC 224

Query: 55  LLLEIISGK 63
           +  E+++ +
Sbjct: 225 IFAELLTSE 233

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 36.9 bits (86), Expect = 3e-04
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 7/64 (10%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK----FSVKSDVFSFGILLLEI 59
            ++DFGL++ F  DE E       GT  YMAP+    G      +V  D +S G+L+ E+
Sbjct: 199 VLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYEL 255

Query: 60  ISGK 63
           ++G 
Sbjct: 256 LTGA 259

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 36.5 bits (85), Expect = 3e-04
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 16/67 (23%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFG A+       E N + +   Y Y APE       Y      +   D++S G ++
Sbjct: 182 KLIDFGSAKIL--IAGEPNVSYICSRY-YRAPELIFGATNY------TTNIDIWSTGCVM 232

Query: 57  LEIISGK 63
            E++ G+
Sbjct: 233 AELMQGQ 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 36.4 bits (85), Expect = 3e-04
 Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI+DFGL +    D          GT  Y+APE   D  +    D +  G+++ E++ G+
Sbjct: 145 KITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 36.5 bits (85), Expect = 4e-04
 Identities = 19/61 (31%), Positives = 28/61 (45%), Gaps = 4/61 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEY-ASDGKFSVKSDVFSFGILLLEIISG 62
            I DF LAR    D  +  T+ V     Y APE       F+   D++S G ++ E+ + 
Sbjct: 174 TICDFNLAREDTADANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

Query: 63  K 63
           K
Sbjct: 231 K 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 36.5 bits (85), Expect = 4e-04
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 16/67 (23%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFG A+     E   N   +   Y Y APE       Y      +   D++S G + 
Sbjct: 172 KLCDFGSAKKLSPSEP--NVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIF 222

Query: 57  LEIISGK 63
            E++ G+
Sbjct: 223 AEMMLGE 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 36.1 bits (84), Expect = 4e-04
 Identities = 22/61 (36%), Positives = 34/61 (55%), Gaps = 6/61 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLAR    +     T  V+ T  Y APE   +  +++   D++S G ++ E+I+G
Sbjct: 168 KILDFGLARQADSEM----TGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

Query: 63  K 63
           K
Sbjct: 223 K 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 36.2 bits (84), Expect = 5e-04
 Identities = 20/61 (32%), Positives = 32/61 (52%), Gaps = 6/61 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLAR    +     T  V  T  Y APE   +   ++   D++S G ++ E+++G
Sbjct: 172 KILDFGLARHTADEM----TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

Query: 63  K 63
           +
Sbjct: 227 R 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 36.0 bits (84), Expect = 5e-04
 Identities = 20/60 (33%), Positives = 33/60 (55%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFGL++     E         GT  YMAPE  +    +  +D +SFG+L+ E+++G 
Sbjct: 166 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 36.1 bits (84), Expect = 5e-04
 Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 5/60 (8%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISG 62
           K+ DFG   A   D          GT  Y  PE+ S  ++  + + V+S GILL +++ G
Sbjct: 180 KLIDFGSG-ALLHD---EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 36.2 bits (84), Expect = 5e-04
 Identities = 20/60 (33%), Positives = 29/60 (48%), Gaps = 10/60 (16%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS----DGKFSVKSDVFSFGILL 56
              KI DFG +++        +T   +GT  Y+APE       DGK    +DV+S G+ L
Sbjct: 155 PRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRQEYDGK---IADVWSCGVTL 208

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 36.0 bits (84), Expect = 6e-04
 Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFGL +    D     T+   GT  YMAPE       +   D +S G L+ ++++G 
Sbjct: 161 KLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 35.7 bits (83), Expect = 6e-04
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 6/61 (9%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEIISG 62
           KI DFGLAR    +     T  V+ T  Y APE   S   ++   D++S G ++ E+++G
Sbjct: 166 KILDFGLARHADAEM----TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

Query: 63  K 63
           K
Sbjct: 221 K 221

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 35.7 bits (83), Expect = 6e-04
 Identities = 17/60 (28%), Positives = 30/60 (50%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG+ +    +     T    GT  Y+APE   +  +    D ++ G+LL E++ G 
Sbjct: 164 KLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 35.7 bits (83), Expect = 7e-04
 Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 13/71 (18%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYM----------APEY-ASDGKFSVKSDVFSF 52
           K+ DFGLAR    DE   + +   G    M          APE   +  K+S   DV+S 
Sbjct: 152 KVCDFGLARII--DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209

Query: 53  GILLLEIISGK 63
           G +L E+   +
Sbjct: 210 GCILAELFLRR 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 35.8 bits (83), Expect = 7e-04
 Identities = 15/60 (25%), Positives = 31/60 (51%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++D+G+ +          T+   GT  Y+APE      +    D ++ G+L+ E+++G+
Sbjct: 193 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 35.7 bits (83), Expect = 8e-04
 Identities = 15/60 (25%), Positives = 31/60 (51%), Gaps = 2/60 (3%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++D+G+ +          T+   GT  Y+APE      +    D ++ G+L+ E+++G+
Sbjct: 150 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 35.7 bits (83), Expect = 8e-04
 Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 4/62 (6%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLEIISG 62
           ++ D+GLA        +    RV   Y +  PE   D +    S D++S G +L  +I  
Sbjct: 171 RLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227

Query: 63  KK 64
           K+
Sbjct: 228 KE 229

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 35.5 bits (82), Expect = 8e-04
 Identities = 20/67 (29%), Positives = 30/67 (44%), Gaps = 16/67 (23%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-------YASDGKFSVKSDVFSFGILL 56
           K+ DFG A+       E N + +   Y Y APE       Y      +   DV+S G +L
Sbjct: 197 KLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVL 247

Query: 57  LEIISGK 63
            E++ G+
Sbjct: 248 AELLLGQ 254

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	92
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.75
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.73
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.72
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.71
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.71
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.7
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.7
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.69
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.69
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.69
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.68
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.67
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.64
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.63
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.62
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.59
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.57
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.53
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.47
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.46
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.45
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.45
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.45
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.45
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.43
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.43
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.43
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.42
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.42
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.42
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.42
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.42
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.41
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.41
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.41
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.41
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.4
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.4
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.4
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.39
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.39
3niz_A	311	Rhodanese family protein; structural genomics, str	99.39
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.39
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.39
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.38
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.38
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.37
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.37
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.37
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.37
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.37
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.37
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.37
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.36
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.36
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.36
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.36
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.35
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.35
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.35
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.34
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.34
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.33
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.33
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.33
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.33
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.32
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.32
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.31
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.3
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.3
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.3
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.3
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.29
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.29
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.29
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.28
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.25
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.24
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.24
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.22
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.22
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.21
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.2
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.2
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.2
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.2
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.2
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.18
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.18
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.18
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.18
3bhy_A	283	Death-associated protein kinase 3; death associate	99.18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.16
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.15
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.15
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.14
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.13
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.12
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.12
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.11
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.11
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.11
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.1
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.1
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.1
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.1
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.1
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.1
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.1
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.1
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.1
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.09
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.09
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.08
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.08
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.06
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.06
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.06
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.06
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.06
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.05
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.04
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.04
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.04
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.03
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.03
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.02
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.02
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	98.99
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	98.98
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	98.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	98.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	98.96
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	98.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	98.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	98.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	98.87
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	98.86
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	98.85
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	98.83
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	98.81
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	98.65
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	98.55
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	98.41
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	97.6
3uqc_A	286	Probable conserved transmembrane protein; structur	97.57
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	97.27

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.75  E-value=5.2e-19  Score=100.73  Aligned_cols=69  Identities=22%  Similarity=0.455  Sum_probs=56.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.+..........+.+||+.|++||++....|+.++|+||+|++++++++|++||...+
T Consensus       170 ~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  238 (311)
T 4aw0_A          170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  238 (311)
T ss_dssp             CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            579999999987653322233445789999999999988889999999999999999999999976543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.73  E-value=3.5e-18  Score=98.50  Aligned_cols=67  Identities=27%  Similarity=0.452  Sum_probs=55.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+||+|||+++.+....  ......+|++.|++||++....|+.++|+||+||+++++++|++||....
T Consensus       208 ~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          208 RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             CEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            57999999998764322  12334689999999999988889999999999999999999999976543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.72  E-value=5.5e-18  Score=96.32  Aligned_cols=68  Identities=29%  Similarity=0.464  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++......  ......+||+.|++||++....|+.++|+||+|++++++++|++||...+.
T Consensus       164 ~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~  231 (304)
T 3ubd_A          164 HIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR  231 (304)
T ss_dssp             CEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence            57999999998643221  123346899999999999888899999999999999999999999765443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.71  E-value=1.1e-17  Score=96.16  Aligned_cols=74  Identities=23%  Similarity=0.297  Sum_probs=55.9

Q ss_pred             ceEEeeeeceeeeCCCccc---ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIE---GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      ++||+|||+++.+......   ......+||+.|++||++....|+.++|+||+||+++++++|++||.........
T Consensus       189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~  265 (336)
T 4g3f_A          189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC  265 (336)
T ss_dssp             CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH
T ss_pred             EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence            4899999999875432111   1123357999999999998888999999999999999999999998766554443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.71  E-value=9.9e-18  Score=98.74  Aligned_cols=67  Identities=27%  Similarity=0.452  Sum_probs=55.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+||+|||+++.+....  ......+|++.|++||++....|+.+.|+||+||+++++++|++||....
T Consensus       285 ~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          285 RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             CEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            57999999998764322  12344689999999999988889999999999999999999999976543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.70  E-value=1.1e-17  Score=95.28  Aligned_cols=70  Identities=33%  Similarity=0.485  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+||+|||+++..............+|++.|++||++..   ..|+.++|+||+|++++|+++|++||.....
T Consensus       170 ~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN  242 (307)
T ss_dssp             EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence            579999999986532222222334679999999999853   3478899999999999999999999876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.70  E-value=3.1e-18  Score=97.55  Aligned_cols=71  Identities=35%  Similarity=0.500  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+||+|||+++...............|++.|++||.+....|+.++|+||+|+++||+++ |++||......
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            579999999985532221222334578889999999988889999999999999999998 89998765543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.69  E-value=1.1e-17  Score=96.01  Aligned_cols=70  Identities=33%  Similarity=0.474  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+||+|||+++...............|++.|++||++....++.++|+||+|+++||+++ |+.||.....
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~  266 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN  266 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence            579999999986543222222334568889999999998889999999999999999998 8999766543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.69  E-value=1.1e-17  Score=96.79  Aligned_cols=71  Identities=38%  Similarity=0.448  Sum_probs=56.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+||+|||+++...............|++.|++||++....|+.++|+||+|+++||+++ |++||......
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~  294 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  294 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence            589999999986543322222334577889999999988889999999999999999998 89998766543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.69  E-value=7e-18  Score=97.41  Aligned_cols=67  Identities=27%  Similarity=0.443  Sum_probs=54.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+||+|||+++.....  .......+|++.|++||++....|+.++|+||+||+++++++|++||....
T Consensus       163 ~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~  229 (350)
T 4b9d_A          163 TVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS  229 (350)
T ss_dssp             CEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence            5799999999865321  112234679999999999988889999999999999999999999976544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.68  E-value=5e-18  Score=96.36  Aligned_cols=70  Identities=30%  Similarity=0.426  Sum_probs=54.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............|++.|++||.+....|+.++|+||+|+++||+++ |++||.....
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~  236 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN  236 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            579999999985533221112223467889999999988889999999999999999998 8999766543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.67  E-value=9.5e-17  Score=90.79  Aligned_cols=64  Identities=33%  Similarity=0.511  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+||+|||+++.....    .....+||+.|++||++.. .|+.++|+||+|++++++++|++||....
T Consensus       170 ~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~  233 (290)
T 3fpq_A          170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  233 (290)
T ss_dssp             CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             CEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            5799999999753221    2334689999999998864 68999999999999999999999986543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.64  E-value=3.8e-16  Score=87.79  Aligned_cols=65  Identities=28%  Similarity=0.397  Sum_probs=44.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ++|++|||+++.....   ......+||+.|++||++....+ +.++|+||+|++++++++|+.||...
T Consensus       150 ~vkl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          150 NVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             CEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CEEEeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            5799999999765322   12334689999999999987775 47899999999999999999997543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.63  E-value=4.6e-16  Score=95.87  Aligned_cols=73  Identities=30%  Similarity=0.518  Sum_probs=57.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      ++||+|||+++.+...    ...+.+|++.|++||++.. ..|+.++|+||+||++++|++|++||......+.....
T Consensus       330 ~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~  403 (689)
T 3v5w_A          330 HVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  403 (689)
T ss_dssp             CEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred             CEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            5899999999876432    2334689999999999864 56889999999999999999999998765554443333

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.62  E-value=4.6e-16  Score=91.25  Aligned_cols=79  Identities=24%  Similarity=0.278  Sum_probs=57.8

Q ss_pred             ceEEeeeeceeeeCCCc--ccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDE--IEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||+++.+....  ........+||+.|++||++.... ++.+.|+||+||+++++++|++||.+.+..+.+..+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            57999999998653221  111233468999999999987654 678899999999999999999998776655555444


Q ss_pred             HH
Q 034502           79 GH   80 (92)
Q Consensus        79 ~~   80 (92)
                      ..
T Consensus       276 ~~  277 (398)
T 4b99_A          276 MM  277 (398)
T ss_dssp             HH
T ss_pred             HH
Confidence            33

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.59  E-value=9.2e-16  Score=93.35  Aligned_cols=67  Identities=27%  Similarity=0.393  Sum_probs=55.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.+....   .....+|++.|++||++....|+.+.|+||+||++++|++|++||.....
T Consensus       295 ~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~  361 (573)
T 3uto_A          295 ELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND  361 (573)
T ss_dssp             CEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             CEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence            47999999998764322   23346799999999999988899999999999999999999999765543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.57  E-value=4.8e-15  Score=86.01  Aligned_cols=42  Identities=29%  Similarity=0.445  Sum_probs=37.1

Q ss_pred             cccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+||+.|++||++.... ++.+.|+||+||+++++++|+.||.
T Consensus       206 ~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          206 RAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             cccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            47899999999987654 7888999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.53  E-value=3.1e-15  Score=85.03  Aligned_cols=66  Identities=29%  Similarity=0.406  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCC------CCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDG------KFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~------~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      ++||+|||+++........  ......+|++.|++||++...      .++.++|+||+|++++|+++|++|+.
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            5899999999866432211  112235789999999998643      24567999999999999999987653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.47  E-value=3.5e-14  Score=80.64  Aligned_cols=60  Identities=38%  Similarity=0.643  Sum_probs=41.3

Q ss_pred             ceEEeeeeceeeeCCCccc----------ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh
Q 034502            2 NPKISDFGLARAFGGDEIE----------GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS   61 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~   61 (92)
                      .+|++|||+++........          ......+||+.|++||++....|+.++|+||+|++++++++
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence            5799999999865432111          11223579999999999988889999999999999999985

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.46  E-value=2.7e-13  Score=77.47  Aligned_cols=78  Identities=19%  Similarity=0.239  Sum_probs=59.3

Q ss_pred             eEEeeeeceeeeCCCcccc-----cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            3 PKISDFGLARAFGGDEIEG-----NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      +|++|||+++.........     ......|+..|++||.+....++.+.|+|++|++++++++|+.||......+....
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~  228 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER  228 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence            8999999998654321110     12345788999999999888888999999999999999999999988766555444


Q ss_pred             HHH
Q 034502           78 IGH   80 (92)
Q Consensus        78 ~~~   80 (92)
                      ...
T Consensus       229 ~~~  231 (330)
T 2izr_A          229 YQK  231 (330)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.45  E-value=7.5e-14  Score=80.71  Aligned_cols=66  Identities=14%  Similarity=0.092  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++.+.............|+..|++||++....++.+.|+|++|++++++++|+.||.
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            579999999975432111122334578999999999988888999999999999999999998864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.45  E-value=1.1e-13  Score=82.53  Aligned_cols=72  Identities=28%  Similarity=0.252  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+|++|||+++.....   .......+++.|++||++....++.+.|+|++|++++++++|++||.+.+..+...
T Consensus       202 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~  273 (464)
T 3ttj_A          202 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN  273 (464)
T ss_dssp             CEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            5799999999865322   11233578899999999988889999999999999999999999987765444433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.45  E-value=9.1e-14  Score=80.96  Aligned_cols=77  Identities=31%  Similarity=0.371  Sum_probs=54.8

Q ss_pred             ceEEeeeeceeeeCCCc-------------------ccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHh
Q 034502            2 NPKISDFGLARAFGGDE-------------------IEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIIS   61 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~-------------------~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~   61 (92)
                      .+|++|||+++......                   ........++++.|++||++.. ..++.+.|+||+|++++++++
T Consensus       147 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  226 (388)
T 3oz6_A          147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC  226 (388)
T ss_dssp             CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence            57999999998653210                   0011223578889999999875 557889999999999999999


Q ss_pred             CCCCCCCCCCcchhhHH
Q 034502           62 GKKNRGFYHSDNKLNLI   78 (92)
Q Consensus        62 g~~~~~~~~~~~~~~~~   78 (92)
                      |++||......+....+
T Consensus       227 g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          227 GKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             SSCSCCCSSHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHH
Confidence            99998776654444333

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.45  E-value=1.2e-13  Score=85.50  Aligned_cols=68  Identities=29%  Similarity=0.432  Sum_probs=55.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++||+|||+++......  ......+|++.|++||++....++.+.|+|++|++++++++|++||...+.
T Consensus       480 ~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~  547 (674)
T 3pfq_A          480 HIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  547 (674)
T ss_dssp             CEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence            57999999998543221  123346789999999999888899999999999999999999999866543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.43  E-value=2.3e-13  Score=78.33  Aligned_cols=67  Identities=27%  Similarity=0.440  Sum_probs=53.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||+++.....  .......+|++.|++||++....++.+.|+|++|++++++++|++||...+
T Consensus       143 ~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          143 HIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             CEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence            5799999998753221  112334578899999999988888999999999999999999999976544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.43  E-value=1.5e-13  Score=79.52  Aligned_cols=68  Identities=29%  Similarity=0.432  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++.....  .......+|++.|++||++....++.+.|+|++|++++++++|++||.....
T Consensus       159 ~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~  226 (353)
T 2i0e_A          159 HIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  226 (353)
T ss_dssp             CEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence            5799999998753221  1123346788999999999888889999999999999999999999765443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.43  E-value=5.3e-13  Score=75.03  Aligned_cols=76  Identities=14%  Similarity=0.212  Sum_probs=57.4

Q ss_pred             eEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            3 PKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      +|++|||+++........     .......++..|++||......++.+.|+|++|++++++++|+.||...........
T Consensus       150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  229 (298)
T 1csn_A          150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  229 (298)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence            899999999865432111     112335678899999999888888999999999999999999999887665444433


Q ss_pred             H
Q 034502           78 I   78 (92)
Q Consensus        78 ~   78 (92)
                      .
T Consensus       230 ~  230 (298)
T 1csn_A          230 Y  230 (298)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.42  E-value=1.9e-13  Score=78.88  Aligned_cols=68  Identities=32%  Similarity=0.476  Sum_probs=53.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++......  ......+|++.|++||++....++.+.|+|++|++++++++|++||...+.
T Consensus       156 ~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  223 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE  223 (345)
T ss_dssp             CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence            57999999987532211  123346788999999999888889999999999999999999999765543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.42  E-value=1.2e-12  Score=76.52  Aligned_cols=73  Identities=26%  Similarity=0.454  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      ++|++|||+++......   ......|++.|++||++..   ..++.+.|+|++|++++++++|+.||...........
T Consensus       153 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~  228 (384)
T 4fr4_A          153 HVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI  228 (384)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred             CEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence            57999999998654321   2334678899999999863   3477889999999999999999999876555444333

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.42  E-value=2e-13  Score=79.39  Aligned_cols=69  Identities=23%  Similarity=0.336  Sum_probs=55.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++.....     .....+++.|++||.+....++.+.|+|++|++++++++|++||......+..
T Consensus       199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~  267 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM  267 (382)
T ss_dssp             CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4799999999865322     22356788899999998888899999999999999999999998765544433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.42  E-value=1e-13  Score=82.22  Aligned_cols=70  Identities=21%  Similarity=0.385  Sum_probs=53.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      ++|++|||+++....... ......+|++.|++||++.     ...++.+.|+|++|++++++++|++||......
T Consensus       213 ~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~  287 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV  287 (437)
T ss_dssp             CEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             CEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence            579999999976543211 1122357899999999986     445788999999999999999999998655433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.42  E-value=1.4e-13  Score=81.33  Aligned_cols=71  Identities=23%  Similarity=0.287  Sum_probs=56.0

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      +|++|||+++.....     .....+++.|++||++....++.+.|+|++|++++++++|++||......+.+..+
T Consensus       241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i  311 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM  311 (429)
T ss_dssp             EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            799999998754321     22356788899999998888899999999999999999999998776654444333

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.42  E-value=4.3e-14  Score=81.74  Aligned_cols=68  Identities=25%  Similarity=0.386  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++.....  .......+|++.|++||++....++.+.|+|++|++++++++|++||.....
T Consensus       162 ~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~  229 (353)
T 3txo_A          162 HCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE  229 (353)
T ss_dssp             CEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence            5799999998753221  1123346789999999998777788999999999999999999999766544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.42  E-value=2.6e-13  Score=79.06  Aligned_cols=67  Identities=24%  Similarity=0.350  Sum_probs=53.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||+++.....  .......+|++.|++||++....++.+.|+|++|++++++++|++||...+
T Consensus       177 ~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          177 HIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             CEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             CEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            5799999998753221  112334678999999999988888999999999999999999999976544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.41  E-value=1.1e-13  Score=81.42  Aligned_cols=69  Identities=22%  Similarity=0.394  Sum_probs=53.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC----CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK----FSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++....... ......+|++.|++||++....    ++.+.|+|++|++++++++|++||.....
T Consensus       206 ~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  278 (410)
T 3v8s_A          206 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  278 (410)
T ss_dssp             CEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence            579999999986543221 1223467899999999987554    67889999999999999999999765443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.41  E-value=3.5e-13  Score=77.70  Aligned_cols=69  Identities=30%  Similarity=0.361  Sum_probs=54.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++.....     .....+++.|++||.+....++.+.|+|++|++++++++|+.||......+..
T Consensus       200 ~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          200 GIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             CEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             CEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence            4789999999754321     22356788999999998888999999999999999999999998765544433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.41  E-value=3.8e-13  Score=76.82  Aligned_cols=64  Identities=34%  Similarity=0.488  Sum_probs=52.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||+++.....     ....+|++.|++||.+....++.+.|+|++|++++++++|++||....
T Consensus       144 ~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  207 (318)
T 1fot_A          144 HIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  207 (318)
T ss_dssp             CEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            5799999999864321     223578899999999988888899999999999999999999976544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.41  E-value=3.8e-13  Score=79.24  Aligned_cols=69  Identities=26%  Similarity=0.297  Sum_probs=53.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      +|++|||+++.......   .....+++.|++||++... .++.+.|+|++|++++++++|++||......+.
T Consensus       196 ~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~  265 (420)
T 1j1b_A          196 LKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ  265 (420)
T ss_dssp             EEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            69999999986543211   2235678899999998654 588899999999999999999999876554333

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.40  E-value=3.8e-13  Score=78.12  Aligned_cols=72  Identities=33%  Similarity=0.421  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.......
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            579999999986543221112222345667999999988888999999999999999998 999987655433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.40  E-value=8.3e-13  Score=74.13  Aligned_cols=74  Identities=22%  Similarity=0.217  Sum_probs=56.2

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++........     .......++..|++||......++.+.|+|++|++++++++|+.||.........
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  224 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  224 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh
Confidence            4789999999865432111     1122346788899999998888889999999999999999999999776554433

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.40  E-value=4.1e-13  Score=78.80  Aligned_cols=66  Identities=23%  Similarity=0.477  Sum_probs=53.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      ++|++|||+++.....  .......+|++.|++||++....++.+.|+|++|++++++++|++||...
T Consensus       191 ~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          191 HIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             CEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            5799999999753221  12234467899999999998888999999999999999999999998543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.39  E-value=1.1e-12  Score=73.70  Aligned_cols=72  Identities=21%  Similarity=0.219  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++........     .......++..|++||......++.+.|+|++|++++++++|+.||......+
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  222 (296)
T 3uzp_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT  222 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence            4789999999865432111     01223567888999999988888899999999999999999999987755443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.39  E-value=4.2e-13  Score=79.70  Aligned_cols=67  Identities=25%  Similarity=0.400  Sum_probs=53.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.......  ......|++.|++||++....++.+.|+|++|++++++++|.+||....
T Consensus       151 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~  217 (444)
T 3soa_A          151 AVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED  217 (444)
T ss_dssp             CEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence            479999999976543211  1223578899999999988888999999999999999999999975543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.39  E-value=1.5e-12  Score=74.01  Aligned_cols=76  Identities=34%  Similarity=0.443  Sum_probs=56.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~   79 (92)
                      .+|++|||+++......  .......++..|++||.+.. ..++.+.|+|++|++++++++|++||......+....+.
T Consensus       157 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  233 (311)
T 3niz_A          157 ALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF  233 (311)
T ss_dssp             CEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred             CEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            47999999998654221  11223467888999998865 457889999999999999999999988777666554443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.39  E-value=1e-12  Score=79.76  Aligned_cols=67  Identities=31%  Similarity=0.492  Sum_probs=54.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||+++.......  .....+|++.|++||++....++.+.|+|++|++++++++|++||....
T Consensus       327 ~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          327 NVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             CEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence            579999999987543211  1233578999999999988889999999999999999999999987654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.39  E-value=1.3e-12  Score=78.40  Aligned_cols=78  Identities=21%  Similarity=0.247  Sum_probs=58.9

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+||+|||+++........     .......|+..|++||.+....++.+.|+|++|++++++++|+.||..........
T Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  223 (483)
T 3sv0_A          144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (483)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred             eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence            4799999999865432111     01123568889999999988888899999999999999999999998776654443


Q ss_pred             HHH
Q 034502           77 LIG   79 (92)
Q Consensus        77 ~~~   79 (92)
                      .+.
T Consensus       224 ~~~  226 (483)
T 3sv0_A          224 KYE  226 (483)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            333

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.39  E-value=4.7e-13  Score=75.62  Aligned_cols=67  Identities=27%  Similarity=0.491  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++........  ......|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       154 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          154 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             CEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            478999999876543221  2233568889999999988888999999999999999999999986554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.38  E-value=1.5e-12  Score=75.61  Aligned_cols=66  Identities=24%  Similarity=0.393  Sum_probs=53.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......|++.|++||++....++.+.|+|++|++++++++|.+||....
T Consensus       157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~  222 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (361)
T ss_dssp             CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            57999999998654321   1233568899999999988788899999999999999999999976543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.38  E-value=2.4e-13  Score=78.30  Aligned_cols=76  Identities=22%  Similarity=0.406  Sum_probs=56.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLIG   79 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~~   79 (92)
                      .+|++|||+++......  .......+++.|++||.+....++.+.|+|++|++++++++|++||.............
T Consensus       158 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~  233 (342)
T 2qr7_A          158 SIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA  233 (342)
T ss_dssp             GEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH
T ss_pred             eEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH
Confidence            37999999998654321  12233567889999999876667888999999999999999999987654444333333

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.38  E-value=2.7e-13  Score=79.86  Aligned_cols=71  Identities=20%  Similarity=0.382  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-------DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-------~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      ++|++|||+++....... ......+|++.|++||++.       ...++.+.|+|++|++++++++|++||......+
T Consensus       200 ~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             CEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            579999999986543211 1122357899999999886       3457888999999999999999999986655433

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.38  E-value=7.6e-13  Score=75.31  Aligned_cols=73  Identities=33%  Similarity=0.560  Sum_probs=54.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++|+.||......+.
T Consensus       177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~  249 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM  249 (321)
T ss_dssp             CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred             CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence            5799999998764322111112234578889999998777788999999999999999999999866554433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.37  E-value=1.2e-12  Score=76.72  Aligned_cols=67  Identities=24%  Similarity=0.356  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....   ......++++.|++||++....++.+.|+|++|++++++++|+.||.....
T Consensus       202 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  268 (400)
T 1nxk_A          202 ILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  268 (400)
T ss_dssp             CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred             cEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence            4799999999865322   112335678899999999888889999999999999999999999865543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.37  E-value=4.6e-13  Score=75.80  Aligned_cols=70  Identities=26%  Similarity=0.355  Sum_probs=54.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++......   ......+++.|++||.+....++.+.|+|++|++++++++|++||......+.
T Consensus       158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ  227 (308)
T ss_dssp             CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred             CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            47999999987543221   12335678899999999888889999999999999999999999766554433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.37  E-value=6.2e-13  Score=76.84  Aligned_cols=64  Identities=25%  Similarity=0.371  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....     .....|++.|++||.+....++.+.|+|++|++++++++|++||....
T Consensus       179 ~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          179 YIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             CEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence            4799999999865322     223578889999999988888999999999999999999999976544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.37  E-value=7.4e-13  Score=77.46  Aligned_cols=72  Identities=24%  Similarity=0.280  Sum_probs=54.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+|++|||+++.......   .....+++.|++||.+... .++.+.|+|++|++++++++|++||......+.+.
T Consensus       180 ~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~  252 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV  252 (394)
T ss_dssp             EEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            479999999986533221   2235678889999988654 47889999999999999999999987665444433

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.37  E-value=3.5e-13  Score=79.80  Aligned_cols=68  Identities=26%  Similarity=0.425  Sum_probs=52.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+||+|||+++.....  ........|++.|++||++....++.+.|+|++|++++++++|+.||.....
T Consensus       287 ~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  354 (446)
T 4ejn_A          287 HIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  354 (446)
T ss_dssp             CEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence            5799999998743221  1122335788999999999888889999999999999999999999765543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.37  E-value=8.7e-13  Score=76.45  Aligned_cols=66  Identities=27%  Similarity=0.426  Sum_probs=52.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......|++.|++||++....++.+.|+|++|++++++++|++||...+
T Consensus       169 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~  234 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  234 (362)
T ss_dssp             CEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            47999999987654221   1223568889999999988788899999999999999999999975543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.37  E-value=1.4e-12  Score=75.78  Aligned_cols=67  Identities=19%  Similarity=0.192  Sum_probs=54.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+|++|++++++++|+.||......+
T Consensus       234 ~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  300 (397)
T 1wak_A          234 KVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE  300 (397)
T ss_dssp             CEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred             ceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence            5899999999764321     223467889999999988888999999999999999999999987665543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.37  E-value=4.6e-13  Score=76.39  Aligned_cols=73  Identities=23%  Similarity=0.356  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||........
T Consensus       153 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  226 (325)
T 3kex_A          153 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV  226 (325)
T ss_dssp             CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH
T ss_pred             eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH
Confidence            479999999986543222222233456678999999887778899999999999999999 9999876554433

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.36  E-value=8.2e-13  Score=75.52  Aligned_cols=68  Identities=28%  Similarity=0.386  Sum_probs=37.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......++..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       147 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          147 EIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR  214 (325)
T ss_dssp             EEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred             cEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence            57999999997653321  112234678889999999888888999999999999999999999876543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.36  E-value=3.3e-13  Score=76.95  Aligned_cols=70  Identities=30%  Similarity=0.454  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++...............+++.|++||.+...     .++.+.|+|++|++++++++|+.||.....
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            5799999999876543222223335678899999988653     244567999999999999999999866543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.36  E-value=1.1e-12  Score=75.20  Aligned_cols=71  Identities=23%  Similarity=0.305  Sum_probs=55.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+|++|++++++++|++||......+....
T Consensus       180 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (355)
T 2eu9_A          180 SIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM  250 (355)
T ss_dssp             CEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            4789999998754221     2234678899999999888888999999999999999999999876654443333

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.36  E-value=1.2e-12  Score=75.90  Aligned_cols=69  Identities=30%  Similarity=0.407  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++.....     .....+++.|++||.+.. ..++.+.|+|++|++++++++|++||...+..+..
T Consensus       166 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l  235 (367)
T 1cm8_A          166 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL  235 (367)
T ss_dssp             CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4799999999864321     223467888999998876 56888999999999999999999998766544433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.36  E-value=1.1e-12  Score=75.86  Aligned_cols=69  Identities=14%  Similarity=0.174  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.+......     .......|+..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            5789999999765322110     01122458889999999988888999999999999999999999987543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.35  E-value=9.6e-13  Score=76.43  Aligned_cols=71  Identities=28%  Similarity=0.416  Sum_probs=46.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++.....     .....++..|++||.+.. ..++.+.|+|++|++++++++|++||...+..+....
T Consensus       170 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          170 ELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            5799999998764321     223567889999998876 5678889999999999999999999877665444333

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.35  E-value=1.3e-12  Score=74.48  Aligned_cols=71  Identities=28%  Similarity=0.322  Sum_probs=55.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+|++|++++++++|+.||...+..+....
T Consensus       175 ~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  245 (339)
T 1z57_A          175 DIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM  245 (339)
T ss_dssp             CEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred             CceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            3789999998764221     2234678889999999887888999999999999999999999876655444333

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.35  E-value=1.7e-12  Score=74.19  Aligned_cols=66  Identities=26%  Similarity=0.384  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  221 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  221 (326)
T ss_dssp             CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            57999999998654221   1223568889999999987788899999999999999999999976544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.35  E-value=2e-12  Score=73.57  Aligned_cols=71  Identities=32%  Similarity=0.440  Sum_probs=53.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++.......  ......++..|++||.+... .++.+.|+|++|++++++++|++||......+.
T Consensus       146 ~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  217 (317)
T 2pmi_A          146 QLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ  217 (317)
T ss_dssp             CEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            479999999986532211  12234678899999998653 578899999999999999999999876654433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.34  E-value=1.2e-12  Score=74.81  Aligned_cols=67  Identities=28%  Similarity=0.394  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       159 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence            47999999987532211  11223568889999999988788899999999999999999999976544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.34  E-value=5.1e-13  Score=78.09  Aligned_cols=68  Identities=34%  Similarity=0.462  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----------GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++...............|++.|++||++..           ..++.+.|+|++|++++++++|++||...
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            479999999976533221111233568899999998754           24778899999999999999999998654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.34  E-value=6.5e-13  Score=76.13  Aligned_cols=66  Identities=32%  Similarity=0.522  Sum_probs=51.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....   .......|++.|++||.+....+. .+.|+|++|++++++++|+.||....
T Consensus       152 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          152 NIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             CEEECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            5799999998754322   123345788999999998777654 68999999999999999999976554

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.34  E-value=3.3e-13  Score=77.10  Aligned_cols=72  Identities=29%  Similarity=0.432  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.......
T Consensus       155 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  227 (327)
T 3poz_A          155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  227 (327)
T ss_dssp             EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence            478999999876543222212222345667999999888888899999999999999999 999987655443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.34  E-value=1.6e-12  Score=75.66  Aligned_cols=66  Identities=30%  Similarity=0.378  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.......   .....+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       227 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          227 QIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             EEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            479999999987543221   223468889999999887778889999999999999999999976554

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.33  E-value=2.1e-12  Score=75.19  Aligned_cols=71  Identities=28%  Similarity=0.315  Sum_probs=54.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++......   ......+++.|++||.+.... ++.+.|+|++|++++++++|++||......+..
T Consensus       180 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  251 (383)
T 3eb0_A          180 TLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL  251 (383)
T ss_dssp             EEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHH
Confidence            47999999998654322   122346788899999887644 788999999999999999999998765544433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.33  E-value=1.4e-12  Score=76.28  Aligned_cols=66  Identities=27%  Similarity=0.355  Sum_probs=53.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......+++.|++||++....++.+.|+|++|++++++++|+.||....
T Consensus       189 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  254 (387)
T 1kob_A          189 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  254 (387)
T ss_dssp             CEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             ceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence            47999999998654321   1223467889999999988788899999999999999999999976544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.33  E-value=1.3e-12  Score=75.35  Aligned_cols=65  Identities=23%  Similarity=0.490  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      ++|++|||+++......  ......+|++.|++||.+....++.+.|+|++|++++++++|++||..
T Consensus       148 ~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          148 HIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            57999999987532211  123345788999999999888888999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.33  E-value=2.1e-12  Score=78.86  Aligned_cols=67  Identities=31%  Similarity=0.540  Sum_probs=54.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++|++|||+++......   ......|++.|++||++....++.+.|+|++|++++++++|++||.....
T Consensus       324 ~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~  390 (576)
T 2acx_A          324 HIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK  390 (576)
T ss_dssp             CEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred             CeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence            57999999998654321   12235788999999999887888999999999999999999999876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.33  E-value=1.5e-12  Score=74.05  Aligned_cols=68  Identities=34%  Similarity=0.490  Sum_probs=45.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       177 ~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             cEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            57999999987543221  112235678899999999888888999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.33  E-value=2.1e-12  Score=73.67  Aligned_cols=67  Identities=28%  Similarity=0.492  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.......  ......|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       179 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            479999999876543211  1233568889999999988788899999999999999999999975543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.32  E-value=6.4e-13  Score=76.35  Aligned_cols=68  Identities=35%  Similarity=0.471  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----------GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++...............|++.|++||.+..           ..++.+.|+|++|++++++++|+.||...
T Consensus       145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            478999999876543221112234578899999998753           45778899999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.32  E-value=3.2e-12  Score=73.49  Aligned_cols=78  Identities=24%  Similarity=0.309  Sum_probs=55.7

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||+++.......  ........+++.|++||.+.. ..++.+.|+|++|++++++++|++||...........+
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  241 (351)
T 3mi9_A          162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  241 (351)
T ss_dssp             CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            479999999986542111  111223467888999998865 44788999999999999999999998766544444433


Q ss_pred             H
Q 034502           79 G   79 (92)
Q Consensus        79 ~   79 (92)
                      .
T Consensus       242 ~  242 (351)
T 3mi9_A          242 S  242 (351)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.32  E-value=2e-12  Score=73.76  Aligned_cols=74  Identities=23%  Similarity=0.349  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++......  .......++..|++||.+.. ..++.+.|+|++|++++++++|++||......+....
T Consensus       138 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  212 (324)
T 3mtl_A          138 ELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF  212 (324)
T ss_dssp             CEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            47899999987543221  11223466888999998865 4578889999999999999999999876654444333

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.31  E-value=1.5e-12  Score=75.60  Aligned_cols=67  Identities=30%  Similarity=0.297  Sum_probs=45.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||...+.
T Consensus       165 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  231 (371)
T 2xrw_A          165 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  231 (371)
T ss_dssp             CEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            47999999987543221   12235678899999999888888999999999999999999999766543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.31  E-value=1.4e-12  Score=74.54  Aligned_cols=66  Identities=27%  Similarity=0.355  Sum_probs=52.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......+++.|++||.+....++.+.|+|++|++++++++|.+||....
T Consensus       142 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  207 (321)
T 1tki_A          142 TIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             CEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence            47999999998654321   1233567889999999987778889999999999999999999976544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.31  E-value=8.2e-13  Score=75.55  Aligned_cols=72  Identities=29%  Similarity=0.432  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.......
T Consensus       155 ~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~  227 (327)
T 3lzb_A          155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  227 (327)
T ss_dssp             EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence            478999999976533221111222344567999999887788899999999999999999 999987655443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.31  E-value=2.5e-12  Score=74.28  Aligned_cols=65  Identities=25%  Similarity=0.306  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            4789999998764321     2224678889999999888888999999999999999999999876553

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.30  E-value=2.6e-12  Score=73.94  Aligned_cols=69  Identities=25%  Similarity=0.348  Sum_probs=52.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++......   ......++..|++||.+.... ++.+.|+|++|++++++++|++||.......
T Consensus       170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  239 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG  239 (360)
T ss_dssp             EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence            47899999997654322   122346788899999886544 7889999999999999999999977655433

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.30  E-value=1.7e-12  Score=74.17  Aligned_cols=70  Identities=37%  Similarity=0.524  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++...............|++.|++||.+....+ +.+.|+|++|++++++++|+.||.....
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence            479999999875432211112233567889999999876664 5679999999999999999999866544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.30  E-value=1.7e-12  Score=75.56  Aligned_cols=69  Identities=36%  Similarity=0.411  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            479999999876543221122222345667999999888888899999999999999998 999976554

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.30  E-value=4e-12  Score=73.37  Aligned_cols=66  Identities=26%  Similarity=0.389  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++.......  ......|++.|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            379999999986543211  122356888999999998888889999999999999999999997653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.29  E-value=1.7e-12  Score=73.79  Aligned_cols=72  Identities=24%  Similarity=0.369  Sum_probs=46.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||......+
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~  247 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE  247 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence            579999999876533221111222344567999999887778899999999999999999 899987655433

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.29  E-value=2.5e-12  Score=73.98  Aligned_cols=65  Identities=29%  Similarity=0.425  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||++.......   .....+|++.|++||.+....+ +.+.|+|++|++++++++|+.||...
T Consensus       146 ~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          146 NVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             CEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             CEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            57999999987543221   1233578899999999877665 57899999999999999999998654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.29  E-value=2.2e-12  Score=73.14  Aligned_cols=69  Identities=35%  Similarity=0.519  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....... ........|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       154 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            478999999875532211 111223467889999999988888899999999999999999999986554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.29  E-value=1.7e-12  Score=74.67  Aligned_cols=70  Identities=37%  Similarity=0.432  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       231 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  301 (359)
T 3vhe_A          231 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  301 (359)
T ss_dssp             CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence            479999999875432221112223456778999999887778899999999999999998 9999876554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.28  E-value=3.7e-12  Score=73.24  Aligned_cols=67  Identities=21%  Similarity=0.255  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcc-----cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-----EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++.......     ........++..|++||.+....++.+.|+|++|++++++++|+.||..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            579999999976532110     0011234678899999998887888999999999999999999999854

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.28  E-value=1.9e-12  Score=73.04  Aligned_cols=68  Identities=34%  Similarity=0.501  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++...... ........|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       149 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          149 TLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             CEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             CEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            47899999987543221 111223567889999999988888888999999999999999999986554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.28  E-value=3.1e-13  Score=78.37  Aligned_cols=70  Identities=33%  Similarity=0.436  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............+++.|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~  292 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN  292 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            379999999874321111112223456778999999877788899999999999999998 9999765543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.28  E-value=2.7e-12  Score=75.21  Aligned_cols=70  Identities=23%  Similarity=0.394  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+||+|||+++....... ........+++.|++||++... .++.+.|+|++|++++++++|++||.....
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            579999999976532211 1122335778899999998764 478889999999999999999999865543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.28  E-value=5e-12  Score=71.04  Aligned_cols=70  Identities=31%  Similarity=0.484  Sum_probs=43.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++...............++..|++||.+.   ...++.+.|+|++|++++++++|+.||.....
T Consensus       158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  230 (289)
T 3og7_A          158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  230 (289)
T ss_dssp             EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence            47899999987543211111122346788899999886   45567789999999999999999999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.28  E-value=4e-12  Score=72.62  Aligned_cols=67  Identities=24%  Similarity=0.418  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......+++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  238 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN  238 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            47999999998654221   12235678899999999888888999999999999999999999765543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.28  E-value=6e-12  Score=72.80  Aligned_cols=77  Identities=32%  Similarity=0.406  Sum_probs=55.2

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||+++........ .......+++.|++||.+.. ..++.+.|+|++|++++++++|++||......+....+
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            4799999999865322111 11223467888999998654 44788899999999999999999998776655544333

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.27  E-value=3.5e-12  Score=73.96  Aligned_cols=63  Identities=11%  Similarity=0.150  Sum_probs=50.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++.....     .....+++.|++||.+..  ..++.+.|+|++|++++++++|+.||...
T Consensus       232 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          232 RLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            4799999999864321     112345588999999876  56888999999999999999999998766

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.27  E-value=8.9e-13  Score=76.68  Aligned_cols=70  Identities=34%  Similarity=0.432  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       251 ~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~  321 (377)
T 3cbl_A          251 VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN  321 (377)
T ss_dssp             CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred             cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            479999999876432211111111223556999999877778889999999999999998 9999766543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.26  E-value=8.1e-12  Score=75.03  Aligned_cols=66  Identities=35%  Similarity=0.524  Sum_probs=52.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......|++.|++||.+. ..++.+.|+|++|++++++++|++||.....
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            47999999998654321   123356889999999876 4578899999999999999999999876544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.26  E-value=1.5e-12  Score=75.67  Aligned_cols=64  Identities=13%  Similarity=0.174  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-----------KFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-----------~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....     ......| ..|++||.+...           .++.+.|+|++|++++++++|+.||....
T Consensus       244 ~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~  317 (377)
T 3byv_A          244 GVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA  317 (377)
T ss_dssp             CEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccc
Confidence            479999999985321     1223456 889999998766           68889999999999999999999986554


Q ss_pred             C
Q 034502           71 S   71 (92)
Q Consensus        71 ~   71 (92)
                      .
T Consensus       318 ~  318 (377)
T 3byv_A          318 A  318 (377)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.26  E-value=3.1e-12  Score=71.88  Aligned_cols=70  Identities=33%  Similarity=0.442  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++......  .......++..|++||.+... .++.+.|+|++|++++++++|++||......+
T Consensus       138 ~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (288)
T 1ob3_A          138 ELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (288)
T ss_dssp             CEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            47899999987543211  112234678889999988654 47889999999999999999999987655433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.26  E-value=5.7e-12  Score=72.19  Aligned_cols=70  Identities=26%  Similarity=0.302  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.......  ........+++.|++||.+..  ..++.+.|+|++|++++++++|+.||.....
T Consensus       208 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  281 (345)
T 3hko_A          208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND  281 (345)
T ss_dssp             CEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence            579999999876432111  111223567888999998864  4577899999999999999999999765443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.26  E-value=3.3e-12  Score=72.28  Aligned_cols=72  Identities=32%  Similarity=0.395  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............++..|++||......++.+.|+|++|++++++++ |+.||.......
T Consensus       188 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            478999999986543222111222345667999999877778889999999999999998 999987655433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.26  E-value=2e-11  Score=68.64  Aligned_cols=63  Identities=29%  Similarity=0.419  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++......  .......++..|++||.+.... ++.+.|+|++|++++++++|..|+
T Consensus       139 ~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          139 ELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            57999999998654221  1223346788899999987655 788999999999999999877663

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.26  E-value=5.9e-12  Score=71.60  Aligned_cols=66  Identities=26%  Similarity=0.467  Sum_probs=51.2

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCcccc--------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS--------DGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--------~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      +|++|||+++......   ......++..|++||.+.        ...++.+.|+|++|++++++++|+.||.....
T Consensus       155 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  228 (319)
T 4euu_A          155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (319)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             EEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            6899999998654322   122346788899999875        45677889999999999999999999865543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.26  E-value=8e-12  Score=74.88  Aligned_cols=66  Identities=33%  Similarity=0.530  Sum_probs=51.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......|++.|++||++. ..++.+.|+|++|++++++++|++||.....
T Consensus       177 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  242 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD  242 (494)
T ss_dssp             CEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            37999999988654321   123356889999999875 4588899999999999999999999766543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.26  E-value=1.4e-11  Score=69.03  Aligned_cols=66  Identities=27%  Similarity=0.579  Sum_probs=50.6

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCcccc--CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS--DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      +|++|||+++....     ......++..|++||.+.  ...++.+.|+|++|++++++++|+.||.......
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  235 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK  235 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence            79999999874322     122356788999999883  3446788999999999999999999987655433

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.26  E-value=1e-11  Score=74.35  Aligned_cols=66  Identities=30%  Similarity=0.478  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   .....+|++.|++||.+....+ +.+.|+|++|++++++++|+.||....
T Consensus       154 ~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  220 (476)
T 2y94_A          154 NAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH  220 (476)
T ss_dssp             CEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence            57999999998654321   1233578899999999877665 578999999999999999999976544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.25  E-value=8e-12  Score=71.16  Aligned_cols=66  Identities=24%  Similarity=0.393  Sum_probs=52.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  222 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (321)
T ss_dssp             CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence            57999999998654321   1223467888999999987788899999999999999999999976543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.25  E-value=1.3e-11  Score=71.30  Aligned_cols=69  Identities=28%  Similarity=0.486  Sum_probs=50.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++...... ........|++.|++||.+..  ..++.+.|+|++|++++++++|+.||.....
T Consensus       197 ~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  267 (355)
T 1vzo_A          197 HVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE  267 (355)
T ss_dssp             CEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred             cEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence            57999999998653221 112233568899999999874  3367889999999999999999999865443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.25  E-value=4.9e-12  Score=72.98  Aligned_cols=66  Identities=29%  Similarity=0.387  Sum_probs=44.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......|++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       189 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  254 (349)
T 2w4o_A          189 PLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER  254 (349)
T ss_dssp             CEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred             CEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence            47999999987543221   1223567889999999988788899999999999999999999975544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.25  E-value=1.2e-11  Score=70.32  Aligned_cols=68  Identities=26%  Similarity=0.326  Sum_probs=53.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++.....   .......++..|++||.+....++.+.|+|++|++++++++|++||......
T Consensus       158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (326)
T 1blx_A          158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  225 (326)
T ss_dssp             CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            4789999998754321   1122346788899999998878889999999999999999999997665543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.25  E-value=9.1e-12  Score=73.98  Aligned_cols=68  Identities=38%  Similarity=0.485  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+|++|++++++++ |+.||......+.
T Consensus       327 ~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  395 (450)
T 1k9a_A          327 VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  395 (450)
T ss_dssp             CEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred             CEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            4799999998854221     112345678999999988888999999999999999998 9999876655443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.24  E-value=6.8e-12  Score=75.04  Aligned_cols=66  Identities=33%  Similarity=0.482  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......|++.|++||++.. .++.+.|+|++|++++++++|++||.....
T Consensus       162 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  227 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE  227 (486)
T ss_dssp             CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            47999999987543221   1223468889999999865 478899999999999999999999765543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.24  E-value=1.1e-11  Score=69.24  Aligned_cols=65  Identities=28%  Similarity=0.434  Sum_probs=52.0

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      +|++|||.+.......   ......+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       147 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          147 VKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             EEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence            7999999987654321   1223467888999999988888899999999999999999999975543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.24  E-value=6.9e-12  Score=70.97  Aligned_cols=73  Identities=25%  Similarity=0.341  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+|++|||+++.......  ......++..|++||.+.. ..++.+.|+|++|++++++++|++||......+...
T Consensus       140 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  213 (311)
T 4agu_A          140 VIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY  213 (311)
T ss_dssp             CEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            478999999976542211  1223467788999998865 457889999999999999999999987766544433

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.24  E-value=1.7e-11  Score=69.08  Aligned_cols=66  Identities=29%  Similarity=0.431  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC---CCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK---FSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~---~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++.......  ......+++.|++||.+....   ++.+.|+|++|++++++++|+.||...
T Consensus       175 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          175 HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             CEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            479999999986543211  122356788999999986544   256789999999999999999997543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.24  E-value=3.3e-12  Score=73.21  Aligned_cols=70  Identities=39%  Similarity=0.455  Sum_probs=52.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||++................++..|++||.+....++.+.|+|++|++++++++ |..||.....
T Consensus       210 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            478999999875432211111222345667999999877778899999999999999998 9999876654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.24  E-value=9.9e-12  Score=72.13  Aligned_cols=65  Identities=29%  Similarity=0.372  Sum_probs=48.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....     .....+++.|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       182 ~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  247 (371)
T 4exu_A          182 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY  247 (371)
T ss_dssp             CEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            4799999998754321     223467888999998876 5678899999999999999999999766543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.24  E-value=1.3e-11  Score=71.00  Aligned_cols=68  Identities=26%  Similarity=0.351  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......+++.|++||.+... .++.+.|+|++|++++++++|.+||.....
T Consensus       150 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~  218 (346)
T 1ua2_A          150 VLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD  218 (346)
T ss_dssp             CEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            47999999987543221  112234678889999998654 477889999999999999999999765543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.23  E-value=5.2e-12  Score=72.23  Aligned_cols=69  Identities=29%  Similarity=0.311  Sum_probs=48.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      +|++|||+++......  .......++..|++||.+.... ++.+.|+|++|++++++++|++||......+
T Consensus       176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  245 (329)
T 3gbz_A          176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID  245 (329)
T ss_dssp             EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence            7999999987543221  1122346688899999987644 7889999999999999999999976655433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.23  E-value=5.4e-12  Score=74.26  Aligned_cols=64  Identities=16%  Similarity=0.193  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccc----------cCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA----------SDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----------~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+||+|||+++.....     .....| +.|++||.+          ....++.+.|+|++|++++++++|+.||.....
T Consensus       249 ~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~  322 (413)
T 3dzo_A          249 GVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA  322 (413)
T ss_dssp             CEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG
T ss_pred             eEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence            4799999998764221     223456 889999988          444577789999999999999999999866543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.23  E-value=7.6e-12  Score=70.89  Aligned_cols=71  Identities=23%  Similarity=0.322  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++...............++..|.+||......++.+.|+|++|++++++++ |..||......
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  256 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH  256 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence            578999999875532211111222345667999999888788899999999999999999 88887665543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.23  E-value=1.2e-11  Score=70.65  Aligned_cols=70  Identities=26%  Similarity=0.334  Sum_probs=48.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++......  .......++..|++||.+... .++.+.|+|++|++++++++|++||......+
T Consensus       162 ~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  232 (331)
T 4aaa_A          162 VVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID  232 (331)
T ss_dssp             CEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            47899999987543221  112234678889999988765 57788999999999999999999976655433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.23  E-value=7e-12  Score=70.99  Aligned_cols=70  Identities=37%  Similarity=0.432  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            478999999875432221112223455678999999877778899999999999999998 9999866553

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.23  E-value=9.1e-12  Score=72.16  Aligned_cols=67  Identities=27%  Similarity=0.379  Sum_probs=42.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVK-SDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....   .......|++.|++||.+....+... .|+|++|++++++++|+.||.....
T Consensus       156 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  223 (361)
T 3uc3_A          156 RLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE  223 (361)
T ss_dssp             CEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred             eEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence            3799999998743221   11233568889999999877776655 7999999999999999999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.22  E-value=1.1e-11  Score=70.02  Aligned_cols=65  Identities=28%  Similarity=0.404  Sum_probs=51.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||+++....    .......+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       147 ~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  211 (304)
T 2jam_A          147 KIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET  211 (304)
T ss_dssp             CEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEccCCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            478999998864322    11223467889999999988888899999999999999999999976543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.22  E-value=1.4e-11  Score=72.59  Aligned_cols=67  Identities=27%  Similarity=0.422  Sum_probs=46.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....   .......|++.|++||.+..   ..++.+.|+|++|++++++++|++||.....
T Consensus       280 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          280 LIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             eEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence            4899999998764321   11233568889999998753   4567789999999999999999999876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.22  E-value=3.4e-12  Score=76.23  Aligned_cols=66  Identities=33%  Similarity=0.497  Sum_probs=51.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......|++.|++||.+.. .++.+.|+|++|++++++++|++||.....
T Consensus       167 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~  232 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE  232 (484)
T ss_dssp             CEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence            47999999987653321   1233568889999998865 578899999999999999999999866543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.22  E-value=6.6e-12  Score=70.99  Aligned_cols=70  Identities=33%  Similarity=0.404  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            468999999876543221111222345667999998877778899999999999999998 9999876554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.22  E-value=1.1e-11  Score=71.35  Aligned_cols=69  Identities=16%  Similarity=0.202  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++........     .......+++.|++||......++.+.|+|++|++++++++|+.||....
T Consensus       199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            5789999999755321110     01122467889999999988788899999999999999999999987654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.22  E-value=1.2e-11  Score=73.46  Aligned_cols=68  Identities=26%  Similarity=0.296  Sum_probs=46.0

Q ss_pred             ceEEeeeeceeeeCCCccc-------------------------ccccccccCCCccCCcccc-CCCCCccchhHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIE-------------------------GNTNRVIGTYGYMAPEYAS-DGKFSVKSDVFSFGIL   55 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~ws~g~~   55 (92)
                      .+||+|||+++........                         ......+|++.|++||++. ...++.+.|+|++||+
T Consensus       194 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~i  273 (458)
T 3rp9_A          194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI  273 (458)
T ss_dssp             CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred             CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHH
Confidence            5799999999764321100                         0122346788999999764 5568899999999999


Q ss_pred             HHHHHh-----------CCCCCCCC
Q 034502           56 LLEIIS-----------GKKNRGFY   69 (92)
Q Consensus        56 ~~~~~~-----------g~~~~~~~   69 (92)
                      ++++++           |+++|.+.
T Consensus       274 l~elltg~~~~~~~~~~~~p~f~g~  298 (458)
T 3rp9_A          274 FAELLNMIKENVAYHADRGPLFPGS  298 (458)
T ss_dssp             HHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred             HHHHHHhccccccccccccccCCCC
Confidence            999998           66666554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.22  E-value=1.6e-11  Score=69.31  Aligned_cols=70  Identities=44%  Similarity=0.606  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++...............++..|++||.... .++.+.|+|++|++++++++|++||......
T Consensus       171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            578999999876543211111223467888999998754 4678899999999999999999998765543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.21  E-value=2.7e-11  Score=67.57  Aligned_cols=65  Identities=23%  Similarity=0.367  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......+++.|++||.... .++.+.|+|++|++++++++|+.||....
T Consensus       147 ~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (277)
T 3f3z_A          147 PLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT  211 (277)
T ss_dssp             CEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence            47899999987654322   1223467888999998754 47888999999999999999999976644

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.21  E-value=6.1e-12  Score=71.97  Aligned_cols=69  Identities=35%  Similarity=0.427  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            479999999986543221111222345567999998877778889999999999999998 999976544

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.21  E-value=2.5e-12  Score=73.58  Aligned_cols=69  Identities=28%  Similarity=0.384  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            478999999875432111111222455677999999877778899999999999999998 998976544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.21  E-value=1.9e-11  Score=68.06  Aligned_cols=70  Identities=37%  Similarity=0.524  Sum_probs=51.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+................++..|++||......+ +.+.|+|++|++++++++|+.||.....
T Consensus       143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            478999999875432111111223467788999999876664 5679999999999999999999866543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.21  E-value=2.2e-11  Score=68.74  Aligned_cols=67  Identities=30%  Similarity=0.524  Sum_probs=52.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       157 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          157 EVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             CEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence            47899999987654321  11223467788999999988788889999999999999999999976544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.21  E-value=1.1e-11  Score=71.47  Aligned_cols=63  Identities=33%  Similarity=0.455  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....      .....+++.|++||.+.   ...++.+.|+|++|++++++++|++||....
T Consensus       192 ~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  257 (348)
T 1u5q_A          192 LVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  257 (348)
T ss_dssp             EEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            478999999875422      12346788999999874   4557888999999999999999999976543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.21  E-value=1.6e-11  Score=70.53  Aligned_cols=65  Identities=22%  Similarity=0.296  Sum_probs=51.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++......   ......|++.|++||.+....+ +.+.|+|++|++++++++|+.||...
T Consensus       168 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  233 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL  233 (335)
T ss_dssp             CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred             cEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence            57999999998654321   1223567889999999877765 67889999999999999999998553

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.21  E-value=4e-11  Score=68.01  Aligned_cols=64  Identities=36%  Similarity=0.508  Sum_probs=46.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      +|++|||++......     .....++..|++||......++.+.|+|++|++++++++|+.||.....
T Consensus       145 ~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  208 (307)
T 2eva_A          145 LKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG  208 (307)
T ss_dssp             EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred             EEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence            689999998754321     1224578899999999887888999999999999999999999875443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.20  E-value=5e-12  Score=72.18  Aligned_cols=71  Identities=38%  Similarity=0.427  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |..||......
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            468999999875432211111222345667999998877778899999999999999998 88898765543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.20  E-value=2e-11  Score=68.24  Aligned_cols=66  Identities=27%  Similarity=0.410  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||++......    ......++..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       147 ~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  212 (279)
T 3fdn_A          147 ELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY  212 (279)
T ss_dssp             CEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             CEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence            4789999987543221    12234678889999998877788899999999999999999999765543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.20  E-value=2.6e-11  Score=69.47  Aligned_cols=67  Identities=33%  Similarity=0.446  Sum_probs=52.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       179 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  245 (335)
T 2owb_A          179 EVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  245 (335)
T ss_dssp             CEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence            47899999988653221  11223467888999999887778889999999999999999999976544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.20  E-value=5.6e-12  Score=77.40  Aligned_cols=72  Identities=35%  Similarity=0.499  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++ |+.||......+
T Consensus       474 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~  547 (613)
T 2ozo_A          474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE  547 (613)
T ss_dssp             EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred             cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence            4799999998754321111 11111234567999999887788999999999999999998 999987765443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.20  E-value=6.4e-12  Score=71.54  Aligned_cols=65  Identities=43%  Similarity=0.715  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++....... .......|++.|++||.+....++.+.|+|++|++++++++|+.||.
T Consensus       172 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            579999999986542211 11223457889999999877778889999999999999999999974

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.19  E-value=2.9e-11  Score=68.49  Aligned_cols=70  Identities=37%  Similarity=0.553  Sum_probs=51.8

Q ss_pred             ceEEeeeeceeeeCCCcccc------------cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG------------NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~------------~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++.........            ......|++.|++||.+....++.+.|+|++|++++++++|..|+...
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            47999999997653221110            011346788899999998888899999999999999999999887654


Q ss_pred             CC
Q 034502           70 HS   71 (92)
Q Consensus        70 ~~   71 (92)
                      ..
T Consensus       226 ~~  227 (310)
T 3s95_A          226 LP  227 (310)
T ss_dssp             SC
T ss_pred             hh
Confidence            43

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.19  E-value=9.1e-12  Score=69.68  Aligned_cols=71  Identities=28%  Similarity=0.399  Sum_probs=43.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++....... .......+++.|++||......++.+.|+|++|++++++++ |.+||......+
T Consensus       154 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          154 CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             CEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            478999999876533211 11122344567999999877778889999999999999996 999987655443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.19  E-value=2.4e-11  Score=71.97  Aligned_cols=68  Identities=32%  Similarity=0.459  Sum_probs=46.6

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||+++....... ........|++.|++||.+..   ..++.+.|+|++|++++++++ |..||...
T Consensus       161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            467999999986532211 111233568899999999863   445678999999999999999 88887543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.19  E-value=2.6e-11  Score=67.88  Aligned_cols=65  Identities=25%  Similarity=0.346  Sum_probs=51.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++......    ......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       152 ~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  216 (284)
T 2vgo_A          152 ELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS  216 (284)
T ss_dssp             CEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence            4789999988754321    1223467888999999888778889999999999999999999976544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.19  E-value=2.3e-11  Score=71.95  Aligned_cols=61  Identities=26%  Similarity=0.429  Sum_probs=42.9

Q ss_pred             ceEEeeeeceeeeCCCccc--------------------ccccccccCCCccCCccc-cCCCCCccchhHHHHHHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIE--------------------GNTNRVIGTYGYMAPEYA-SDGKFSVKSDVFSFGILLLEII   60 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~ws~g~~~~~~~   60 (92)
                      .+|++|||+++........                    ......++++.|++||.+ ....++.+.|+|++||++++++
T Consensus       167 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            5799999999865422110                    012345788999999986 4455888999999999999999


Q ss_pred             hC
Q 034502           61 SG   62 (92)
Q Consensus        61 ~g   62 (92)
                      +|
T Consensus       247 ~g  248 (432)
T 3n9x_A          247 NM  248 (432)
T ss_dssp             TT
T ss_pred             hc
Confidence            74

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.18  E-value=4.3e-12  Score=75.42  Aligned_cols=69  Identities=39%  Similarity=0.557  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++........ ......++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       322 ~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~  391 (454)
T 1qcf_A          322 VCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  391 (454)
T ss_dssp             CEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             cEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence            5799999999764321111 1111234567999999887788899999999999999998 9999866543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.18  E-value=3.9e-11  Score=67.48  Aligned_cols=67  Identities=33%  Similarity=0.446  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+.......  .......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       153 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  219 (294)
T 2rku_A          153 EVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC  219 (294)
T ss_dssp             CEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            47899999987653221  11223467888999999887778889999999999999999999976544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.18  E-value=8.7e-12  Score=69.31  Aligned_cols=65  Identities=38%  Similarity=0.595  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||.++......    .....++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  218 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID  218 (271)
T ss_dssp             CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            37999999987543221    123467888999999887778889999999999999999999986654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.18  E-value=1.3e-11  Score=70.00  Aligned_cols=69  Identities=35%  Similarity=0.454  Sum_probs=46.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-----------GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-----------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+..           ..++.+.|+|++|++++++++|+.||....
T Consensus       164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            478999999875532211111223467888999998764           356778999999999999999999986543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.18  E-value=1.2e-11  Score=74.30  Aligned_cols=71  Identities=35%  Similarity=0.484  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++........ ......++..|++||.+....++.+.|+|++|++++++++ |+.||.......
T Consensus       356 ~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~  427 (495)
T 1opk_A          356 LVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  427 (495)
T ss_dssp             CEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             cEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            4799999999865432111 1112234567999999887778899999999999999998 999987655433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.18  E-value=3.4e-11  Score=71.27  Aligned_cols=68  Identities=34%  Similarity=0.516  Sum_probs=47.2

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccC-------CCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASD-------GKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~-------~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+|++|||+++........  .......|++.|++||++..       ..++.+.|+|++|++++++++ |+.||...
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            4799999999865432111  01223468889999998865       457788999999999999998 89998644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.18  E-value=2.4e-11  Score=67.91  Aligned_cols=66  Identities=23%  Similarity=0.397  Sum_probs=50.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......+++.|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       150 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  215 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET  215 (283)
T ss_dssp             CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence            57999999987653221   1223457788999999887788889999999999999999999976544

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.18  E-value=3e-11  Score=70.04  Aligned_cols=66  Identities=24%  Similarity=0.474  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD------GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......   ......|++.|++||.+..      ..++.+.|+|++|++++++++|+.||....
T Consensus       238 ~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  309 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR  309 (365)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence            47899999987654321   1233567889999998752      246788999999999999999999975543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.17  E-value=4.3e-11  Score=67.80  Aligned_cols=67  Identities=33%  Similarity=0.520  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       163 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          163 HAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             CEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            47899999987654321  11223467788999999887778889999999999999999999976543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.17  E-value=5.5e-12  Score=71.65  Aligned_cols=69  Identities=30%  Similarity=0.469  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            578999999875432111111222345667999999877778889999999999999998 888876544

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.17  E-value=2.8e-11  Score=67.54  Aligned_cols=67  Identities=30%  Similarity=0.480  Sum_probs=33.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .++++|||++.......  .......+++.|++||......++.+.|+|++|++++++++|+.||....
T Consensus       150 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          150 NIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             CEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            47899999987653221  11223467788999999877778889999999999999999999986544

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.17  E-value=2.4e-11  Score=69.82  Aligned_cols=71  Identities=28%  Similarity=0.347  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCcccc--------cccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEG--------NTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++.........        ......|+..|++||.+.. ..++.+.|+|++|++++++++|++||......
T Consensus       150 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  229 (353)
T 2b9h_A          150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR  229 (353)
T ss_dssp             CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            47999999988653221100        0112356788999998654 55788899999999999999999998766543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.17  E-value=9.7e-12  Score=71.73  Aligned_cols=66  Identities=30%  Similarity=0.508  Sum_probs=50.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++....    .......++..|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       170 ~~kl~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  235 (360)
T 3eqc_A          170 EIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  235 (360)
T ss_dssp             CEEECCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred             CEEEEECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            478999998864321    112234678899999999888888999999999999999999999866543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.16  E-value=9.2e-11  Score=66.85  Aligned_cols=64  Identities=22%  Similarity=0.338  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++......   ......++..|++||.+.. ..++.+.|+|++|++++++++|+.||..
T Consensus       169 ~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          169 KLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             EEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             EEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            47899999998654322   1223467788999998866 5578899999999999999999999743

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.16  E-value=2e-11  Score=68.26  Aligned_cols=71  Identities=27%  Similarity=0.431  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++....... .......++..|++||......++.+.|+|++|++++++++ |+.||......+
T Consensus       151 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~  222 (281)
T 3cc6_A          151 CVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD  222 (281)
T ss_dssp             EEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred             cEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence            468999999875432211 11122344567999999877778889999999999999998 999986554433

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.16  E-value=9.6e-12  Score=71.08  Aligned_cols=70  Identities=31%  Similarity=0.432  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++......... ......++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  260 (325)
T 3kul_A          189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN  260 (325)
T ss_dssp             CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence            57999999998654321111 1111234556999999877778889999999999999998 9999765543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.16  E-value=5.3e-12  Score=72.01  Aligned_cols=69  Identities=33%  Similarity=0.443  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++...............++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  250 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  250 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence            378999998864322211112223456778999999877778899999999999999998 888976544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.16  E-value=2.2e-11  Score=70.94  Aligned_cols=72  Identities=35%  Similarity=0.482  Sum_probs=44.4

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++........  .......++..|++||.+....++.+.|+|++|++++++++ |.+||......+
T Consensus       230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~  304 (373)
T 3c1x_A          230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD  304 (373)
T ss_dssp             CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred             CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence            5799999998754321110  01112345567999999887788899999999999999998 777876655443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.16  E-value=2.7e-11  Score=69.90  Aligned_cols=67  Identities=27%  Similarity=0.292  Sum_probs=44.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       172 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          172 DITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             CEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             CEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            47899999987543221   1223467788999998866 5578889999999999999999999766543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.16  E-value=5.4e-11  Score=67.11  Aligned_cols=69  Identities=25%  Similarity=0.275  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+................++..|++||......  ++.+.|+|++|++++++++|+.||....
T Consensus       147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (305)
T 2wtk_C          147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN  217 (305)
T ss_dssp             CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence            47899999987654221112222345788899999886543  3567899999999999999999976543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.16  E-value=1.7e-11  Score=68.95  Aligned_cols=69  Identities=28%  Similarity=0.334  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccc--cccccccCCCccCCccccCC------CCCccchhHHHHHHHHHHHhC----------C
Q 034502            2 NPKISDFGLARAFGGDEIEG--NTNRVIGTYGYMAPEYASDG------KFSVKSDVFSFGILLLEIISG----------K   63 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~------~~~~~~~~ws~g~~~~~~~~g----------~   63 (92)
                      .+|++|||+++.........  ......+++.|++||.+...      .++.+.|+|++|++++++++|          +
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            57999999987654321111  11224678899999998665      334678999999999999999          7


Q ss_pred             CCCCCCC
Q 034502           64 KNRGFYH   70 (92)
Q Consensus        64 ~~~~~~~   70 (92)
                      .||....
T Consensus       231 ~pf~~~~  237 (301)
T 3q4u_A          231 PPFYDVV  237 (301)
T ss_dssp             CTTTTTS
T ss_pred             ccccccC
Confidence            7875543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.15  E-value=2.7e-11  Score=69.73  Aligned_cols=65  Identities=29%  Similarity=0.372  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.....     .....++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       164 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  229 (353)
T 3coi_A          164 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY  229 (353)
T ss_dssp             CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred             cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4789999988753221     223467888999998866 4577889999999999999999999766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.15  E-value=1.1e-11  Score=73.73  Aligned_cols=68  Identities=38%  Similarity=0.520  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++........ ......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       318 ~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          318 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             CEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence            4799999998765322111 1112334567999999887788899999999999999998 899976554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.15  E-value=6.4e-11  Score=67.26  Aligned_cols=61  Identities=31%  Similarity=0.506  Sum_probs=45.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++......   ......|++.|++||.+.. .++.+.|+|++|++++++++|..++
T Consensus       195 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          195 RCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             CEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             CEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            47999999987653221   1223457889999998865 6788999999999999999997653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.15  E-value=1.8e-11  Score=68.71  Aligned_cols=70  Identities=36%  Similarity=0.512  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            4789999999865432111 11112344667999999877778889999999999999998 9999866554

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.15  E-value=5.3e-11  Score=69.35  Aligned_cols=72  Identities=15%  Similarity=0.220  Sum_probs=51.6

Q ss_pred             ceEEeeeeceeeeCCCc-----ccccccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDE-----IEGNTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||.+.......     .........++..|++||.+..  ..++.+.|+|++|++++++++|++||.......
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  244 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  244 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            47899999876432110     0111122366778999999876  468889999999999999999999987655444

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.15  E-value=9.6e-12  Score=69.39  Aligned_cols=67  Identities=34%  Similarity=0.506  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.++......  .......++..|++||......++.+.|+|++|++++++++|+.||....
T Consensus       154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            47899999987543211  11223467888999999887778889999999999999999999976654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.14  E-value=4e-11  Score=68.03  Aligned_cols=68  Identities=25%  Similarity=0.389  Sum_probs=42.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++....... ........++..|++||.+....++.+.|+|++|++++++++|+.||....
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          172 FAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             CEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             CEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence            47899999887543221 111223467788999999887778889999999999999999999976543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.14  E-value=5.7e-12  Score=77.65  Aligned_cols=71  Identities=39%  Similarity=0.483  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+||+|||+++....... ........++..|++||.+....++.+.|+|++|++++++++ |+.||......
T Consensus       507 ~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~  579 (635)
T 4fl3_A          507 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  579 (635)
T ss_dssp             EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            479999999875532211 111122344567999999987788999999999999999998 99998765543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.14  E-value=3.3e-11  Score=67.62  Aligned_cols=65  Identities=34%  Similarity=0.466  Sum_probs=46.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......++..|++||.+. ..++.+.|+|++|++++++++|+.||....
T Consensus       165 ~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          165 PIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             CEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            47999999987543221   122346788899999875 457788999999999999999999986554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.13  E-value=4.5e-11  Score=67.66  Aligned_cols=70  Identities=26%  Similarity=0.367  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++....... ........++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  230 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE  230 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence            478999999875432111 111222456778999998754 5578889999999999999999999776553

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.13  E-value=1.2e-10  Score=65.36  Aligned_cols=64  Identities=33%  Similarity=0.493  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++......    ......+++.|++||.+. ..++.+.|+|++|++++++++|+.||....
T Consensus       170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  233 (290)
T 1t4h_A          170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ  233 (290)
T ss_dssp             CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence            4789999998643222    122346788999999875 457889999999999999999999986644

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.12  E-value=5.6e-11  Score=66.79  Aligned_cols=69  Identities=30%  Similarity=0.404  Sum_probs=48.8

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG-KKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g-~~~~~~~~   70 (92)
                      .+|++|||+++.......  ........++..|.+||......++.+.|+|++|++++++++| .+|+....
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~  233 (298)
T 3pls_A          162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID  233 (298)
T ss_dssp             CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence            579999999875432110  1112223456679999999888888999999999999999994 55554443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.12  E-value=4.2e-11  Score=68.15  Aligned_cols=67  Identities=34%  Similarity=0.549  Sum_probs=44.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++.......  .......++..|++||.+.     ...++.+.|+|++|++++++++|+.||....
T Consensus       167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            47899999887543211  1122346788899999886     3457788999999999999999999976544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.12  E-value=2.4e-11  Score=67.48  Aligned_cols=69  Identities=36%  Similarity=0.487  Sum_probs=50.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++........ ......++..|++||......++.+.|+|++|++++++++ |+.||.....
T Consensus       142 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  211 (268)
T 3sxs_A          142 CVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN  211 (268)
T ss_dssp             CEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence            4789999998765432211 1112234456999999877778889999999999999998 9999765543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.11  E-value=4.1e-11  Score=67.10  Aligned_cols=71  Identities=35%  Similarity=0.479  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .++++|||++........ .......++..|++||.+....++.+.|+|++|++++++++ |..||...+...
T Consensus       149 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~  220 (288)
T 3kfa_A          149 LVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  220 (288)
T ss_dssp             CEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             CEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            478999999875432211 11222344567999999877778889999999999999998 999977655443

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.11  E-value=1.2e-11  Score=72.31  Aligned_cols=66  Identities=26%  Similarity=0.461  Sum_probs=49.9

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD--------GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      +|++|||+++......   ......++..|++||.+..        ..++.+.|+|++|++++++++|+.||.....
T Consensus       155 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~  228 (396)
T 4eut_A          155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (396)
T ss_dssp             EEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             EEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            7899999998654321   1223567889999998753        3456788999999999999999999865443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.11  E-value=5.1e-11  Score=67.92  Aligned_cols=65  Identities=35%  Similarity=0.537  Sum_probs=34.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA----SDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++......   ......++..|++||.+    ....++.+.|+|++|++++++++|+.||...
T Consensus       164 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          164 NIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             EEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            47899999987543221   12223577889999987    3445778899999999999999999998653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.11  E-value=5.5e-11  Score=67.72  Aligned_cols=68  Identities=21%  Similarity=0.143  Sum_probs=36.2

Q ss_pred             ceEEeeeeceeeeCCCccc----------ccccccccCCCccCCccc---cCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE----------GNTNRVIGTYGYMAPEYA---SDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++........          .......+++.|++||.+   ....++.+.|+|++|++++++++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            4789999998765322110          001123577889999987   445577889999999999999999999754


Q ss_pred             C
Q 034502           69 Y   69 (92)
Q Consensus        69 ~   69 (92)
                      .
T Consensus       256 ~  256 (337)
T 3ll6_A          256 G  256 (337)
T ss_dssp             -
T ss_pred             h
Confidence            3

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.10  E-value=3.1e-11  Score=70.23  Aligned_cols=69  Identities=33%  Similarity=0.451  Sum_probs=40.8

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++......... ......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~  255 (373)
T 2qol_A          185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS  255 (373)
T ss_dssp             CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred             CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            57999999987653221110 1111233557999999887788899999999999999997 999975544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.10  E-value=2.6e-11  Score=69.61  Aligned_cols=66  Identities=23%  Similarity=0.324  Sum_probs=35.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......    .....+++.|++||.+....++.+.|+|++|++++++++|+.||.....
T Consensus       169 ~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  234 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG  234 (336)
T ss_dssp             CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence            37999999987653221    2234668889999998777788889999999999999999999855443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.10  E-value=6.8e-11  Score=66.53  Aligned_cols=71  Identities=35%  Similarity=0.449  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcc--cccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEI--EGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++.......  ........++..|++||......++.+.|+|++|++++++++ +.+|+......
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~  239 (298)
T 3f66_A          166 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF  239 (298)
T ss_dssp             CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred             CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence            579999999875532211  011122345567999999877778889999999999999999 66676555443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.10  E-value=1.5e-10  Score=66.06  Aligned_cols=61  Identities=34%  Similarity=0.502  Sum_probs=43.2

Q ss_pred             ceEEeeeeceeeeCCCcccc--cccccccCCCccCCccccCCCCCcc------chhHHHHHHHHHHHhC
Q 034502            2 NPKISDFGLARAFGGDEIEG--NTNRVIGTYGYMAPEYASDGKFSVK------SDVFSFGILLLEIISG   62 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~------~~~ws~g~~~~~~~~g   62 (92)
                      .+|++|||+++.........  ......|+..|++||.+........      .|+|++|++++++++|
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            47999999987653321110  1123467889999999876655544      8999999999999999

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.10  E-value=6.9e-11  Score=65.98  Aligned_cols=66  Identities=39%  Similarity=0.497  Sum_probs=46.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .++++|||+++.....     .....++..|.+||.+....++.+.|+|++|++++++++ |+.||......
T Consensus       155 ~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  221 (278)
T 1byg_A          155 VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  221 (278)
T ss_dssp             CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             cEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            4789999988754321     112345677999999877778889999999999999998 99998765443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.10  E-value=3.3e-11  Score=74.57  Aligned_cols=69  Identities=29%  Similarity=0.389  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++....... .......++..|++||.+....++.+.|+|++|++++++++ |.+||.....
T Consensus       529 ~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  598 (656)
T 2j0j_A          529 CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  598 (656)
T ss_dssp             EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             CEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence            478999999876533211 11122345567999999877778899999999999999996 9999766543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.10  E-value=4.7e-11  Score=68.39  Aligned_cols=69  Identities=35%  Similarity=0.447  Sum_probs=45.0

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  255 (333)
T 1mqb_A          185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS  255 (333)
T ss_dssp             CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence            5789999998765322111 01111234557999999887788889999999999999998 999975543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.10  E-value=2.3e-11  Score=68.35  Aligned_cols=70  Identities=40%  Similarity=0.474  Sum_probs=49.9

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++......... ......++..|++||.+....++.+.|+|++|++++++++ |+.||.....
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  226 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  226 (291)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            46899999987654321111 1112234567999999877777888999999999999998 9999766543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.10  E-value=7.4e-11  Score=66.08  Aligned_cols=65  Identities=31%  Similarity=0.465  Sum_probs=41.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccc----cCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA----SDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++......   ......+++.|++||.+    ....++.+.|+|++|++++++++|+.||...
T Consensus       148 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          148 QVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             CEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            47899999987653321   12224678889999986    3445778899999999999999999998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.09  E-value=1.3e-10  Score=66.12  Aligned_cols=67  Identities=27%  Similarity=0.418  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc---CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS---DGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......++..|++||.+.   ...++.+.|+|++|++++++++|+.||.....
T Consensus       155 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          155 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             CEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             eEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            37999999988653221   122346788999999863   44577889999999999999999999866543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.09  E-value=1.9e-11  Score=67.97  Aligned_cols=68  Identities=34%  Similarity=0.438  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...... ........++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       144 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~  212 (269)
T 4hcu_A          144 VIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  212 (269)
T ss_dssp             CEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence            47899999987543211 111112334557999999877778899999999999999998 899976544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.08  E-value=2.2e-11  Score=69.56  Aligned_cols=65  Identities=28%  Similarity=0.472  Sum_probs=45.7

Q ss_pred             ceEEeeeeceeeeCCCcc------cccccccccCCCccCCccccC-------CCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI------EGNTNRVIGTYGYMAPEYASD-------GKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~~p~~~~~-------~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++.......      ........|+..|++||.+..       ..++.+.|+|++|++++++++|..|+
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            579999999986542211      111123467889999999865       23446789999999999999996654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.08  E-value=5.3e-11  Score=66.45  Aligned_cols=68  Identities=40%  Similarity=0.557  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||++......... ......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       147 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  215 (279)
T 1qpc_A          147 SCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (279)
T ss_dssp             CEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             CEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence            5789999998865432111 1112344567999999876777888999999999999998 898976544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.08  E-value=2.1e-11  Score=68.21  Aligned_cols=69  Identities=36%  Similarity=0.466  Sum_probs=50.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .++++|||+++...... ........++..|++||......++.+.|+|++|++++++++ |+.||.....
T Consensus       158 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~  227 (283)
T 3gen_A          158 VVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN  227 (283)
T ss_dssp             CEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             CEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence            47899999987543211 111112234556999999887778899999999999999998 9999766543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.08  E-value=1.7e-10  Score=66.14  Aligned_cols=66  Identities=29%  Similarity=0.440  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSV-KSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~-~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||.+......    ......++..|++||..... .+.. +.|+|++|++++++++|+.||.....
T Consensus       190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             cEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            4789999998765332    12234677889999998766 4555 89999999999999999999876544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.07  E-value=1.2e-10  Score=65.94  Aligned_cols=66  Identities=30%  Similarity=0.453  Sum_probs=41.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .+|++|||+++......  .......++..|++||.+....++.+.|+|++|++++++++|+.||...
T Consensus       174 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          174 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             CEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            47899999987543221  1122345778899999988878889999999999999999999997543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.06  E-value=7.1e-11  Score=66.95  Aligned_cols=69  Identities=25%  Similarity=0.321  Sum_probs=46.4

Q ss_pred             eEEeeeeceeeeCCCcc-----cccccccccCCCccCCccccC-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEI-----EGNTNRVIGTYGYMAPEYASD-----GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      +|++|||+++.......     ........++..|++||.+..     ..++.+.|+|++|++++++++|+.||.....
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  231 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG  231 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence            79999998865421100     001122457888999998753     3467789999999999999999999876543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.06  E-value=1.3e-10  Score=66.13  Aligned_cols=64  Identities=36%  Similarity=0.596  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCccc----------ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE----------GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .+|++|||+++........          .......+++.|++||.+....++.+.|+|++|++++++++|..+
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~  275 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST  275 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCC
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCC
Confidence            4799999999866432110          111224678899999999888889999999999999999998765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.06  E-value=1.9e-11  Score=74.07  Aligned_cols=68  Identities=38%  Similarity=0.515  Sum_probs=50.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+||+|||+++....... .......++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       401 ~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          401 VCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             CEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             cEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            479999999875432110 01111234567999999887788899999999999999998 899976554

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.06  E-value=6.5e-11  Score=67.48  Aligned_cols=63  Identities=25%  Similarity=0.411  Sum_probs=48.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++......    .....++..|++||.+....+ +.+.|+|++|++++++++|+.||..
T Consensus       188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            47899999988654321    223467888999998865554 5678999999999999999999754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.06  E-value=3.8e-11  Score=67.30  Aligned_cols=69  Identities=29%  Similarity=0.393  Sum_probs=48.7

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++........ .......++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  229 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  229 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence            4689999998765432111 11122345567999999877777888999999999999998 999976544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.06  E-value=1.1e-10  Score=65.54  Aligned_cols=67  Identities=33%  Similarity=0.505  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.......  ......++..|++||.+....  ++.+.|+|++|++++++++|+.||....
T Consensus       161 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          161 VLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             CEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             CEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            478999999876532211  122346778899999875432  6788999999999999999999976543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.05  E-value=4.8e-11  Score=68.07  Aligned_cols=66  Identities=32%  Similarity=0.350  Sum_probs=48.0

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .+|++|||+++....   ........++..|++||.+....++.+.|+|++|++++++++ |+.||....
T Consensus       180 ~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          180 VAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             CEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            478999999864221   111222345667999999877778889999999999999998 999976544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.05  E-value=4e-10  Score=70.00  Aligned_cols=63  Identities=35%  Similarity=0.532  Sum_probs=51.0

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      +|++|||.++......   ......++..|++||.+....++.+.|+|++|++++++++|+.||..
T Consensus       163 vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             EEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            6899999987653321   12235678899999999888888999999999999999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.04  E-value=2.9e-10  Score=63.96  Aligned_cols=66  Identities=26%  Similarity=0.475  Sum_probs=49.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS------DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||.+.......   ......++..|++||.+.      ...++.+.|+|++|++++++++|+.||....
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  233 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  233 (298)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence            47899999987654321   122346778899999874      3456788999999999999999999975543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.04  E-value=2.2e-10  Score=63.76  Aligned_cols=65  Identities=29%  Similarity=0.465  Sum_probs=42.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||++.......   ......+++.|++||.+....+ +.+.|+|++|++++++++|+.||...
T Consensus       149 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          149 NAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             CEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            47899999987543221   1223457788999999876654 47899999999999999999997654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.04  E-value=8e-11  Score=66.23  Aligned_cols=66  Identities=33%  Similarity=0.468  Sum_probs=45.5

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++|..|+.
T Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            4789999998765322111 11122344556999999887788899999999999999999988754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.04  E-value=1.8e-10  Score=65.22  Aligned_cols=66  Identities=30%  Similarity=0.554  Sum_probs=42.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++.......   ......++..|++||.+.     ...++.+.|+|++|++++++++|+.||....
T Consensus       163 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (318)
T 2dyl_A          163 QIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK  233 (318)
T ss_dssp             CEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence            47899999987543221   122346788899999984     3446778999999999999999999986543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.03  E-value=1.4e-10  Score=65.07  Aligned_cols=65  Identities=34%  Similarity=0.488  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++.......   ......++..|++||.+.. .++.+.|+|++|++++++++|+.||....
T Consensus       162 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (287)
T 2wei_A          162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (287)
T ss_dssp             CEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence            47999999887543221   1122356778999998764 47888999999999999999999976544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.03  E-value=5.1e-11  Score=66.05  Aligned_cols=68  Identities=34%  Similarity=0.438  Sum_probs=49.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~   70 (92)
                      .++++|||+++...... ........++..|++||......++.+.|+|++|++++++++ |+.||....
T Consensus       142 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (267)
T 3t9t_A          142 VIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  210 (267)
T ss_dssp             CEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence            47899999887543211 111112344567999999877778889999999999999999 898976543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.02  E-value=9.3e-11  Score=65.97  Aligned_cols=70  Identities=27%  Similarity=0.474  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcc---cccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEI---EGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||++........   ........++..|++||.+.. ..++.+.|+|++|++++++++|+.||.....
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  232 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP  232 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence            478999998865432110   011123467888999998754 3467889999999999999999999876543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.02  E-value=2.3e-10  Score=63.82  Aligned_cols=62  Identities=31%  Similarity=0.575  Sum_probs=49.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++......   ......++..|++||......++.+.|+|++|++++++++|..|+
T Consensus       160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            47899999987654321   122346788999999988777889999999999999999998774

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.00  E-value=2.8e-10  Score=64.53  Aligned_cols=69  Identities=28%  Similarity=0.254  Sum_probs=46.6

Q ss_pred             ceEEeeeeceeeeCCCc---ccccccccccCCCccCCccccC---------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDE---IEGNTNRVIGTYGYMAPEYASD---------GKFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~~~~p~~~~~---------~~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++++|||+++......   .........++..|++||.+..         ..++.+.|+|++|++++++++|+.||...
T Consensus       167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46899999876432110   0111222356778999998764         23677899999999999999999997654


Q ss_pred             C
Q 034502           70 H   70 (92)
Q Consensus        70 ~   70 (92)
                      .
T Consensus       247 ~  247 (319)
T 2y4i_B          247 P  247 (319)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=98.99  E-value=9.5e-11  Score=66.71  Aligned_cols=67  Identities=31%  Similarity=0.352  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++|+.|+..
T Consensus       172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            4789999999865432111 112223456679999998777788889999999999999999988643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=98.98  E-value=1e-10  Score=66.75  Aligned_cols=66  Identities=35%  Similarity=0.411  Sum_probs=49.2

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++|+.|+.
T Consensus       165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            4789999999865432111 11222345667999999877778889999999999999999998853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=98.97  E-value=3.1e-10  Score=64.89  Aligned_cols=61  Identities=30%  Similarity=0.421  Sum_probs=43.8

Q ss_pred             ceEEeeeeceeeeCCCcccc--cccccccCCCccCCccccCCC------CCccchhHHHHHHHHHHHhC
Q 034502            2 NPKISDFGLARAFGGDEIEG--NTNRVIGTYGYMAPEYASDGK------FSVKSDVFSFGILLLEIISG   62 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~p~~~~~~~------~~~~~~~ws~g~~~~~~~~g   62 (92)
                      .+|++|||+++.........  ......++..|++||.+....      ++.+.|+|++|++++++++|
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            47999999987654322110  122346788899999886542      22568999999999999999

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=98.96  E-value=4.8e-10  Score=63.51  Aligned_cols=63  Identities=27%  Similarity=0.449  Sum_probs=48.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCC-ccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFS-VKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~-~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++......    .....++..|++||.+....+. .+.|+|++|++++++++|+.||..
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            47899999987654321    2234578889999987655543 478999999999999999999754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=98.96  E-value=1.3e-10  Score=65.49  Aligned_cols=67  Identities=27%  Similarity=0.421  Sum_probs=46.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccc-----cCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-----SDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-----~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||++......  ........++..|++||.+     ....++.+.|+|++|++++++++|+.||....
T Consensus       155 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          155 DIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             CEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            4689999986432110  0111224577889999987     34557788999999999999999999976654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=98.96  E-value=2.3e-10  Score=64.09  Aligned_cols=61  Identities=26%  Similarity=0.370  Sum_probs=45.4

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhC-CCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISG-KKNRGFY   69 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g-~~~~~~~   69 (92)
                      +|++|||++.....      .....++..|++||.+.. ..++.+.|+|++|++++++++| .+|+...
T Consensus       160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~  222 (289)
T 4fvq_A          160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL  222 (289)
T ss_dssp             EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence            78999998754321      122456778999999876 5578889999999999999995 4554443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=98.94  E-value=1.7e-10  Score=65.00  Aligned_cols=65  Identities=32%  Similarity=0.445  Sum_probs=48.3

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .++++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++|..|+
T Consensus       164 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            4789999999865432111 1122234566799999987777888899999999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=98.91  E-value=9.7e-10  Score=61.30  Aligned_cols=59  Identities=17%  Similarity=0.240  Sum_probs=45.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||.+......      ....++..|++||.+... .++.+.|+|++|++++++++|.+++
T Consensus       172 ~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             CEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             EEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence            4799999998765322      123577889999998655 4557899999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=98.87  E-value=4.5e-10  Score=64.09  Aligned_cols=66  Identities=33%  Similarity=0.474  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++........ .......++..|++||.+....++.+.|+|++|++++++++|..|+.
T Consensus       183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            4789999998865432111 11112344556999999877777888999999999999999988754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=98.86  E-value=1.3e-09  Score=67.64  Aligned_cols=60  Identities=25%  Similarity=0.376  Sum_probs=47.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++.....      ....|++.|++||.+... .+.+.|+|++|++++++++|.+|+..
T Consensus       219 ~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          219 QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            4789999999864321      235688899999987654 37789999999999999999888654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=98.85  E-value=2e-09  Score=59.64  Aligned_cols=46  Identities=20%  Similarity=0.286  Sum_probs=37.1

Q ss_pred             cccCCCccCCccccCCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           26 VIGTYGYMAPEYASDGKFSV---KSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        26 ~~~~~~~~~p~~~~~~~~~~---~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ..+++.|++||.+....+..   +.|+|++|++++++++|+.||.....
T Consensus       168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  216 (271)
T 3kmu_A          168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN  216 (271)
T ss_dssp             CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred             ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence            35678899999987655443   68999999999999999999865543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=98.81  E-value=2.1e-09  Score=60.91  Aligned_cols=67  Identities=22%  Similarity=0.270  Sum_probs=47.0

Q ss_pred             ceEEeeeeceeeeCCCcccc-------cccccccCCCccCCccccCCC---CCccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-------NTNRVIGTYGYMAPEYASDGK---FSVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~~p~~~~~~~---~~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .++++|||.+..........       ......++..|++||.+....   ++.+.|+|++|++++++++|+.||..
T Consensus       172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            47899999876542110000       011234577899999876543   56789999999999999999999743

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=98.65  E-value=3.1e-08  Score=55.57  Aligned_cols=60  Identities=37%  Similarity=0.550  Sum_probs=39.1

Q ss_pred             ceEEeeeeceeeeCCCcc------------cccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHh
Q 034502            2 NPKISDFGLARAFGGDEI------------EGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIIS   61 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~   61 (92)
                      .+|++|||+++.......            ........++..|++||.+... .++.+.|+|++|++++++++
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            478999998875432100            0112234577889999998654 57888999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=98.55  E-value=1.9e-08  Score=57.60  Aligned_cols=58  Identities=12%  Similarity=0.004  Sum_probs=43.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHH-HHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGIL-LLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~-~~~~~~g~~~~~   67 (92)
                      .+|++|||+++.....       ...|++.|++||++.... +.+.|+|+++.. ..++++|..||.
T Consensus       220 ~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          220 QVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             EEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             eEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            5799999999865321       246888999999987655 778999997665 556677887753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=98.41  E-value=2.9e-07  Score=51.92  Aligned_cols=28  Identities=18%  Similarity=0.374  Sum_probs=23.6

Q ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 034502           42 KFSVKSDVFSFGILLLEIISGKKNRGFY   69 (92)
Q Consensus        42 ~~~~~~~~ws~g~~~~~~~~g~~~~~~~   69 (92)
                      .++.+.|+|++|++++++++|+.||...
T Consensus       174 ~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          174 KYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             GGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             cCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            3567789999999999999999998544

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=97.60  E-value=8.9e-07  Score=54.37  Aligned_cols=54  Identities=13%  Similarity=0.074  Sum_probs=25.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE   58 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~   58 (92)
                      .+||+|||+++......  ......+|++.|++||++... +....|+|+.|+..++
T Consensus       377 ~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~  430 (569)
T 4azs_A          377 HARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFN  430 (569)
T ss_dssp             CEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CC
T ss_pred             CEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhh
Confidence            57999999998653321  223446789999999988543 4456788888875443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=97.57  E-value=4.1e-05  Score=43.14  Aligned_cols=30  Identities=10%  Similarity=0.047  Sum_probs=25.7

Q ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502           42 KFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus        42 ~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++.+.|+|++|++++++++|+.||.....
T Consensus       178 ~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          178 DANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence            356789999999999999999999876544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=97.27  E-value=8.6e-06  Score=49.81  Aligned_cols=66  Identities=18%  Similarity=0.126  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccc-----cccccccCCCccCCccccC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEG-----NTNRVIGTYGYMAPEYASD--GKFSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~p~~~~~--~~~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++.........     ......|++.|++||++..  ..|+...|.|+...-..+...++..|.
T Consensus       467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            47999999998764321111     1134678899999998865  446667789998887777777776653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	92
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-21
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-19
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-18
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-17
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-17
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-17
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-17
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-17
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-17
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-17
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-16
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-16
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-16
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-16
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-15
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-15
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-15
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-14
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-14
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-14
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-14
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-14
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-13
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-13
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-13
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-13
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-13
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-13
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-13
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-13
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-12
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-12
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-12
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-12
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-12
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-12
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-12
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-12
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-12
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-12
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-11
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-11
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-11
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-11
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-10
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-10
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-10
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-10
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-10
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-09
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-09
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-09
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-09
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-08
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-07
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-07
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-07
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-06
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-06
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-06
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.3 bits (203), Expect = 3e-21
 Identities = 25/88 (28%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA---SDGKFSVKSDVFSFGILLL 57
           +  KI DFGLA             ++ G+  +MAPE         +S +SDV++FGI+L 
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200

Query: 58  EIISGKKNRGFYHSDNKLNLIGHVSKMH 85
           E+++G+    + + +N+  +I  V + +
Sbjct: 201 ELMTGQLP--YSNINNRDQIIFMVGRGY 226

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.4 bits (190), Expect = 3e-19
 Identities = 21/63 (33%), Positives = 35/63 (55%), Gaps = 4/63 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+ DFG++       I+   N  +GT  YM+PE      +SV+SD++S G+ L+E+ 
Sbjct: 142 GEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197

Query: 61  SGK 63
            G+
Sbjct: 198 VGR 200

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.6 bits (183), Expect = 2e-18
 Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + KI D GLA              VIGT  +MAPE   + K+    DV++FG+ +LE+ 
Sbjct: 152 GSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMA 206

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           + +    +    N   +   V+ 
Sbjct: 207 TSE--YPYSECQNAAQIYRRVTS 227

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.1 bits (176), Expect = 2e-17
 Identities = 21/83 (25%), Positives = 39/83 (46%), Gaps = 2/83 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + KI+DFGLA+  G +E E +         +MA E      ++ +SDV+S+G+ + E++
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           +       Y       +   + K
Sbjct: 208 TFGSK--PYDGIPASEISSILEK 228

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.1 bits (176), Expect = 3e-17
 Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 4/85 (4%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNR--VIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
              K++DFGLAR     E +   N+        +MA E     KF+ KSDV+SFG+LL E
Sbjct: 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 226

Query: 59  IISGKKNRGFYHSDNKLNLIGHVSK 83
           +++       Y   N  ++  ++ +
Sbjct: 227 LMTRGAP--PYPDVNTFDITVYLLQ 249

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.2 bits (174), Expect = 4e-17
 Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 5/83 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            N K+ DFGLAR    D         +GT  YM+PE  +   ++ KSD++S G LL E+ 
Sbjct: 151 QNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           +       + + ++  L G + +
Sbjct: 209 ALMP---PFTAFSQKELAGKIRE 228

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.8 bits (173), Expect = 4e-17
 Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 7/92 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI+DFG +              + GT  Y+ PE         K D++S G+L  E +
Sbjct: 143 GELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV 92
            GK     + ++        +S++  TF + V
Sbjct: 199 VGKP---PFEANTYQETYKRISRVEFTFPDFV 227

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.9 bits (173), Expect = 5e-17
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 3/85 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           +  K++DFGLAR    +E             + APE A  G+F++KSDV+SFGILL E+ 
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMH 85
           +  +    Y       ++  V + +
Sbjct: 209 TKGRV--PYPGMVNREVLDQVERGY 231

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.4 bits (172), Expect = 6e-17
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 3/90 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEI 59
            N KISDFGLA  F  +  E   N++ GT  Y+APE     +F +   DV+S GI+L  +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           ++G+    +    +         +  T  +
Sbjct: 200 LAGELP--WDQPSDSCQEYSDWKEKKTYLN 227

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 70.6 bits (172), Expect = 9e-17
 Identities = 22/83 (26%), Positives = 38/83 (45%), Gaps = 2/83 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M  KI+DFGL+R     +             +M PE     +++ +SDV+++G++L EI 
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           S       Y+      +I +V  
Sbjct: 237 SYGLQ--PYYGMAHEEVIYYVRD 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 4e-16
 Identities = 24/76 (31%), Positives = 42/76 (55%), Gaps = 1/76 (1%)

Query: 1   MNPKISDFGLARAFGGDEIEGNT-NRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
           +  K+SDFGL+R    D     T +       + APE  S  KF+  SDV+SFGI++ E+
Sbjct: 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206

Query: 60  ISGKKNRGFYHSDNKL 75
           ++  +   +  S++++
Sbjct: 207 MTYGERPYWELSNHEV 222

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.8 bits (165), Expect = 6e-16
 Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 3/83 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           ++ KI+DFGLAR    +E             + APE  + G F++KSDV+SFGILL EI+
Sbjct: 146 LSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           +  +    Y       +I ++ +
Sbjct: 205 THGRI--PYPGMTNPEVIQNLER 225

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (164), Expect = 9e-16
 Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 1/75 (1%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+SDFG+ R    D+   ++        + +PE  S  ++S KSDV+SFG+L+ E+ 
Sbjct: 138 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196

Query: 61  SGKKNRGFYHSDNKL 75
           S  K      S++++
Sbjct: 197 SEGKIPYENRSNSEV 211

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (164), Expect = 9e-16
 Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 3/84 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTN-RVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
              KISDFGL++A   DE              + APE  +  KFS KSDV+SFG+L+ E 
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSK 83
            S  +    Y       +   + K
Sbjct: 204 FSYGQK--PYRGMKGSEVTAMLEK 225

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.8 bits (160), Expect = 5e-15
 Identities = 19/88 (21%), Positives = 45/88 (51%), Gaps = 3/88 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
           M+ +I+DFG A+    +  +   N  +GT  Y++PE  ++      SD+++ G ++ +++
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +G      + + N+  +   + K+   F
Sbjct: 205 AGLP---PFRAGNEYLIFQKIIKLEYDF 229

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.1 bits (158), Expect = 7e-15
 Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 3/83 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+SDFGL+R    DE   +         +  PE     KFS KSD+++FG+L+ EI 
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           S  K    Y          H+++
Sbjct: 196 SLGKM--PYERFTNSETAEHIAQ 216

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (158), Expect = 9e-15
 Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 8/80 (10%)

Query: 1   MNPKISDFGLARAF--GGDEIEGNTNRVIGTYGYMAPEYASD------GKFSVKSDVFSF 52
               I+D GLA       D I+   N  +GT  YMAPE   D       +   ++D+++ 
Sbjct: 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204

Query: 53  GILLLEIISGKKNRGFYHSD 72
           G++  EI       G +   
Sbjct: 205 GLVFWEIARRCSIGGIHEDY 224

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 64.6 bits (157), Expect = 1e-14
 Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 12/86 (13%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA---SDGKFSVKSDVFSFGILLL 57
              K+ DFG A            N  +GT  +MAPE      +G++  K DV+S GI  +
Sbjct: 152 GLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 58  EIISGKKNRGFYHSDNKLNLIGHVSK 83
           E+      +    + N ++ + H+++
Sbjct: 206 ELAER---KPPLFNMNAMSALYHIAQ 228

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.2 bits (156), Expect = 2e-14
 Identities = 18/63 (28%), Positives = 35/63 (55%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + K++DFG       ++     + ++GT  +MAPE  +   +  K D++S GI+ +E+I
Sbjct: 153 GSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Query: 61  SGK 63
            G+
Sbjct: 211 EGE 213

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.0 bits (155), Expect = 2e-14
 Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 5/86 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIG---TYGYMAPEYASDGKFSVKSDVFSFGILLL 57
           +  K+SDFGL+R    D  +      +G      + APE     KF+  SDV+S+GI++ 
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224

Query: 58  EIISGKKNRGFYHSDNKLNLIGHVSK 83
           E++S  +    Y      ++I  + +
Sbjct: 225 EVMSYGER--PYWDMTNQDVINAIEQ 248

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.7 bits (152), Expect = 5e-14
 Identities = 29/85 (34%), Positives = 40/85 (47%), Gaps = 7/85 (8%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+SDFGL +     E     +       + APE   + KFS KSDV+SFGILL EI 
Sbjct: 140 NVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMH 85
           S  +    Y      +++  V K +
Sbjct: 195 SFGRV--PYPRIPLKDVVPRVEKGY 217

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.7 bits (152), Expect = 7e-14
 Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYA-----SDGKFSVKSDVFSFGIL 55
            + K++DFG++            +  IGT  +MAPE        D  +  K+DV+S GI 
Sbjct: 147 GDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 204

Query: 56  LLEIISGKKNRGFYHSDNKLNLIGHVSK 83
           L+E+   +     +H  N + ++  ++K
Sbjct: 205 LIEMAEIEP---PHHELNPMRVLLKIAK 229

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.0 bits (150), Expect = 1e-13
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K++DFGL+R   GD    +         + APE  +  KFS+KSDV++FG+LL EI 
Sbjct: 152 HLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           +   +   Y   +   +   + K
Sbjct: 211 TYGMS--PYPGIDLSQVYELLEK 231

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.1 bits (150), Expect = 1e-13
 Identities = 27/83 (32%), Positives = 36/83 (43%), Gaps = 1/83 (1%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGLAR    D              +MAPE   +G +++KSDV+S+GILL EI 
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           S      +       N    +  
Sbjct: 261 SLGV-NPYPGIPVDANFYKLIQN 282

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (149), Expect = 1e-13
 Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 3/84 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGN-TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
              KISDFGL++A G D+      +       + APE  +  KFS +SDV+S+G+ + E 
Sbjct: 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSK 83
           +S  +    Y       ++  + +
Sbjct: 206 LSYGQK--PYKKMKGPEVMAFIEQ 227

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (149), Expect = 1e-13
 Identities = 23/83 (27%), Positives = 36/83 (43%), Gaps = 5/83 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI+DFGL+R     E+            +MA E  +   ++  SDV+S+G+LL EI+
Sbjct: 164 YVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           S       Y       L   + +
Sbjct: 221 SLGGT--PYCGMTCAELYEKLPQ 241

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 61.0 bits (147), Expect = 2e-13
 Identities = 11/86 (12%), Positives = 29/86 (33%), Gaps = 5/86 (5%)

Query: 4   KISDFGLARAFGGDEIEGN-----TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLE 58
            + DFG+ + +     + +        + GT  YM+       + S + D+ + G + + 
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 205

Query: 59  IISGKKNRGFYHSDNKLNLIGHVSKM 84
            + G        +         + + 
Sbjct: 206 FLRGSLPWQGLKAATNKQKYERIGEK 231

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.3 bits (145), Expect = 5e-13
 Identities = 25/64 (39%), Positives = 32/64 (50%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGLAR    D              +MAPE   D  ++++SDV+SFG+LL EI 
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230

Query: 61  SGKK 64
           S   
Sbjct: 231 SLGA 234

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.2 bits (145), Expect = 6e-13
 Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 6/87 (6%)

Query: 2   NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS 61
             KI DFGLA              + GT  ++APE  +     +++D++S G++   ++S
Sbjct: 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

Query: 62  GKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           G      +  D K   + +VS ++  F
Sbjct: 212 GAS---PFLGDTKQETLANVSAVNYEF 235

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.4 bits (143), Expect = 9e-13
 Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 3/84 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
              KI DFGL RA   ++            + + APE      FS  SD + FG+ L E+
Sbjct: 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSK 83
            +  +    +   N   ++  + K
Sbjct: 208 FTYGQE--PWIGLNGSQILHKIDK 229

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.4 bits (143), Expect = 1e-12
 Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 5/92 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + KI+DFG+ +     + + NT    GT  Y+APE     K++   D +SFG+LL E++
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV 92
            G+     +H  ++  L   +   +  +   +
Sbjct: 198 IGQS---PFHGQDEEELFHSIRMDNPFYPRWL 226

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.5 bits (143), Expect = 1e-12
 Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 2/83 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFG+ R     +      + +    +M+PE   DG F+  SDV+SFG++L EI 
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229

Query: 61  SGKKNRGFYHSDNKLNLIGHVSK 83
           +  +    Y   +   ++  V +
Sbjct: 230 TLAEQ--PYQGLSNEQVLRFVME 250

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (142), Expect = 1e-12
 Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 1/75 (1%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+ DFGL+R +  D      ++      +MAPE  +  +F+  SDV+ FG+ + EI+
Sbjct: 145 DCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

Query: 61  SGKKNRGFYHSDNKL 75
                      +N +
Sbjct: 204 MHGVKPFQGVKNNDV 218

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 59.3 bits (143), Expect = 1e-12
 Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 6/85 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           KI DFGLA     DEI         T  + APE          +D+++ G+L   ++SG 
Sbjct: 169 KIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225

Query: 64  KNRGFYHSDNKLNLIGHVSKMHTTF 88
                +  ++ L  + +V +    F
Sbjct: 226 S---PFAGEDDLETLQNVKRCDWEF 247

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 58.9 bits (142), Expect = 2e-12
 Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 6/85 (7%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K+ DFGL       +   +     GT  + APE A        +D++S G+L   ++SG 
Sbjct: 166 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222

Query: 64  KNRGFYHSDNKLNLIGHVSKMHTTF 88
                +  +N    + +V       
Sbjct: 223 S---PFGGENDDETLRNVKSCDWNM 244

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.7 bits (141), Expect = 2e-12
 Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 2/85 (2%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI+DFGLAR     +    T        +MAPE   D  ++ +SDV+SFG+LL EI 
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMH 85
           +   +   Y       L   + + H
Sbjct: 232 TLGGS--PYPGVPVEELFKLLKEGH 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 58.5 bits (141), Expect = 2e-12
 Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 6/88 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
               ISDFGL++      +    +   GT GY+APE  +   +S   D +S G++   ++
Sbjct: 147 SKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
            G      ++ +N   L   + K    F
Sbjct: 204 CGYP---PFYDENDAKLFEQILKAEYEF 228

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.5 bits (138), Expect = 4e-12
 Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 5/93 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGN-----TNRVIGTYGYMAPEYASDGKFSVKSDVFSFGIL 55
               I DFGLA+ +       +        + GT  Y +       + S + D+ S G +
Sbjct: 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202

Query: 56  LLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           L+    G        +  K      +S+   + 
Sbjct: 203 LMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (137), Expect = 7e-12
 Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 6/88 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI +FG AR     +   N   +     Y APE       S  +D++S G L+  ++
Sbjct: 141 STIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           SG      + ++    +I ++     TF
Sbjct: 198 SGIN---PFLAETNQQIIENIMNAEYTF 222

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 56.7 bits (136), Expect = 8e-12
 Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 1/64 (1%)

Query: 1   MNPKISDFGLARAFG-GDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEI 59
              K+ DFG+ARA          T  VIGT  Y++PE A       +SDV+S G +L E+
Sbjct: 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207

Query: 60  ISGK 63
           ++G+
Sbjct: 208 LTGE 211

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.2 bits (132), Expect = 4e-11
 Identities = 22/75 (29%), Positives = 32/75 (42%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGLAR    D              +MAPE   +  ++ +SDV+S+GI L E+ 
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

Query: 61  SGKKNRGFYHSDNKL 75
           S   +       +  
Sbjct: 242 SLGSSPYPGMPVDSK 256

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.9 bits (131), Expect = 4e-11
 Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 6/92 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNR--VIGTYGYMAPEYASDGK-FSVKSDVFSFGILLL 57
              K++DFGLARAF   +          + T  Y  PE     + +    D++  G ++ 
Sbjct: 154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMA 213

Query: 58  EIISGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           E+ +          + + + +  +S++  + +
Sbjct: 214 EMWTRSP---IMQGNTEQHQLALISQLCGSIT 242

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.5 bits (130), Expect = 6e-11
 Identities = 22/90 (24%), Positives = 41/90 (45%), Gaps = 6/90 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEI 59
              K++DFGLA++FG           + T  Y APE     + + V  D+++ G +L E+
Sbjct: 137 GVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           +       F   D+ L+ +  + +   T +
Sbjct: 195 LLR---VPFLPGDSDLDQLTRIFETLGTPT 221

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.3 bits (130), Expect = 7e-11
 Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 8/88 (9%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + KI+DFG A+      +   T  + GT  Y+APE  S   ++   D +SFGIL+ E++
Sbjct: 141 GHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +G      ++  N +     +      F
Sbjct: 196 AGYT---PFYDSNTMKTYEKILNAELRF 220

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (128), Expect = 1e-10
 Identities = 18/77 (23%), Positives = 29/77 (37%), Gaps = 7/77 (9%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEI 59
              K+ DFG                  GT  Y  PE+    ++    + V+S GILL ++
Sbjct: 148 GELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

Query: 60  ISGKKNRGFYHSDNKLN 76
           + G     F H +  + 
Sbjct: 204 VCGD--IPFEHDEEIIR 218

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (125), Expect = 3e-10
 Identities = 20/92 (21%), Positives = 43/92 (46%), Gaps = 4/92 (4%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K++DFGLARAFG   +   T+ V+  +            +S   D++S G +  E++
Sbjct: 139 GAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFSNIV 92
           + +     +  D++++ +  + +   T   +V
Sbjct: 198 TRRA---LFPGDSEIDQLFRIFRTLGTPDEVV 226

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (124), Expect = 4e-10
 Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 6/89 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K++DFGLAR +           V+ T  Y APE      ++   D++S G +  E+ 
Sbjct: 153 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 209

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
             K     +   + ++ +G +  +     
Sbjct: 210 RRKP---LFRGSSDVDQLGKILDVIGLPG 235

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 51.2 bits (122), Expect = 7e-10
 Identities = 19/94 (20%), Positives = 40/94 (42%), Gaps = 12/94 (12%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS------DGKFSVKSDVFSFGI 54
           MN K++DFG +      E       V GT  Y+APE            +  + D++S G+
Sbjct: 147 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203

Query: 55  LLLEIISGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           ++  +++G      +    ++ ++  +   +  F
Sbjct: 204 IMYTLLAGSP---PFWHRKQMLMLRMIMSGNYQF 234

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (121), Expect = 9e-10
 Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 3/90 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+++FGLARAFG   +   +  V+  +            +S   D++S G +  E+ 
Sbjct: 138 GELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFSN 90
           +    R  +  ++  + +  + ++  T + 
Sbjct: 197 NAG--RPLFPGNDVDDQLKRIFRLLGTPTE 224

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (119), Expect = 2e-09
 Identities = 18/63 (28%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
            + KI+DFGL +    D          GT  Y+APE   D  +    D +  G+++ E++
Sbjct: 142 GHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199

Query: 61  SGK 63
            G+
Sbjct: 200 CGR 202

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 49.1 bits (116), Expect = 4e-09
 Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 6/90 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEI 59
              KI+DFGLARAFG    +      I T  Y AP+      K+S   D++S G +  E+
Sbjct: 137 GELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEM 194

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           ++G      +   ++ + +  + ++  T +
Sbjct: 195 VNGTP---LFPGVSEADQLMRIFRILGTPN 221

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.3 bits (117), Expect = 4e-09
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 5/64 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEI 59
            + +ISD GLA  F     +   +  +GT+GYMAPE    G  +   +D FS G +L ++
Sbjct: 144 GHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 199

Query: 60  ISGK 63
           + G 
Sbjct: 200 LRGH 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.1 bits (116), Expect = 6e-09
 Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 5/91 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNT-NRVIGTYGYMAPEYASDGKFSVKS-DVFSFGILLLE 58
            + KI DFGLAR    D          + T  Y APE   + K   KS D++S G +L E
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205

Query: 59  IISGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           ++S +     +   + L+ + H+  +  + S
Sbjct: 206 MLSNRP---IFPGKHYLDQLNHILGILGSPS 233

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (112), Expect = 2e-08
 Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 4   KISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK 63
           K++DFG A+         +      T  Y+APE     K+    D++S G+++  ++ G 
Sbjct: 154 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 1e-07
 Identities = 18/89 (20%), Positives = 37/89 (41%), Gaps = 5/89 (5%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              K+ DFG A+     E   N + +   Y            ++   DV+S G +L E++
Sbjct: 160 AVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
            G+     +  D+ ++ +  + K+  T +
Sbjct: 218 LGQP---IFPGDSGVDQLVEIIKVLGTPT 243

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 44.1 bits (103), Expect = 3e-07
 Identities = 18/88 (20%), Positives = 40/88 (45%), Gaps = 6/88 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEI 59
              ++ D+GLA  +   +     N  + +  +  PE   D + +    D++S G +L  +
Sbjct: 167 RKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSKMHTT 87
           I  K+   F+H  +  + +  ++K+  T
Sbjct: 224 IFRKEP--FFHGHDNYDQLVRIAKVLGT 249

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 44.3 bits (103), Expect = 3e-07
 Identities = 13/91 (14%), Positives = 31/91 (34%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
               +    +A        + +    I T  Y +PE      +   +D++S   L+ E+I
Sbjct: 164 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFSNI 91
           +G          +      H++++      +
Sbjct: 224 TGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 8e-07
 Identities = 21/89 (23%), Positives = 34/89 (38%), Gaps = 6/89 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGLAR  G           + T  Y APE      +    D++S G ++ E++
Sbjct: 156 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
             K     +   + ++    V +   T  
Sbjct: 213 RHKI---LFPGRDYIDQWNKVIEQLGTPC 238

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 3e-06
 Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 9/89 (10%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPE-YASDGKFSVKSDVFSFGILLLEI 59
              KI DFGLAR     + +      + T  Y APE   +  +++   D++S G ++ E+
Sbjct: 158 CELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212

Query: 60  ISGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           I+GK     +   + L+ +  + K+  T 
Sbjct: 213 ITGKT---LFKGSDHLDQLKEIMKVTGTP 238

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.2 bits (93), Expect = 7e-06
 Identities = 18/88 (20%), Positives = 39/88 (44%), Gaps = 8/88 (9%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              +++DFG A+      ++G T  + GT   +APE      ++   D ++ G+L+ E+ 
Sbjct: 178 GYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +G      + +D  + +   +      F
Sbjct: 233 AGYP---PFFADQPIQIYEKIVSGKVRF 257

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 7e-06
 Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 6/90 (6%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLE 58
            +  ++DFGL++ F  DE E       GT  YMAP+    G        D +S G+L+ E
Sbjct: 166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224

Query: 59  IISGKKNRGFYHSDNKLNLIGHVSKMHTTF 88
           +++G      +  D + N    +S+     
Sbjct: 225 LLTGAS---PFTVDGEKNSQAEISRRILKS 251

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 6e-05
 Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 7/89 (7%)

Query: 1   MNPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEII 60
              KI DFGLAR    +     T  V   +        +   ++   D++S G ++ E++
Sbjct: 158 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

Query: 61  SGKKNRGFYHSDNKLNLIGHVSKMHTTFS 89
           +G+     +   + ++ +  + ++  T  
Sbjct: 214 TGRT---LFPGTDHIDQLKLILRLVGTPG 239

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	92
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.68
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.64
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.64
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.64
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.64
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.64
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.63
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.62
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.62
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.61
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.61
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.61
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.59
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.59
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.59
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.58
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.57
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.57
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.57
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.56
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.56
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.55
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.55
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.54
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.54
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.54
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.53
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.53
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.52
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.51
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.51
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.5
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.49
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.49
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.48
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.47
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.43
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.42
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.42
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.42
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.41
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.41
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.4
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.4
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.38
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.38
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.38
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.37
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.37
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.37
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.36
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.34
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.33
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.31
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.31
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.31
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.3
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.21
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.21
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.16
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.15
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.04

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=9.5e-18  Score=93.44  Aligned_cols=69  Identities=22%  Similarity=0.455  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.+.............|++.|++||++....++.++|+||+|++++++++|+.||...+
T Consensus       146 ~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  214 (288)
T d1uu3a_         146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  214 (288)
T ss_dssp             CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence            579999999987643322222334578999999999988889999999999999999999999976544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.5e-16  Score=90.24  Aligned_cols=68  Identities=26%  Similarity=0.432  Sum_probs=55.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  ......+|++.|++||++....|+.++|+||+|++++++++|++||...+.
T Consensus       143 ~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~  210 (337)
T d1o6la_         143 HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             CEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence            57999999998653321  223346789999999999988899999999999999999999999766543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=6.7e-17  Score=88.99  Aligned_cols=65  Identities=28%  Similarity=0.427  Sum_probs=53.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....    ......|++.|++||++....++.++|+||+|++++++++|++||....
T Consensus       144 ~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  208 (263)
T d2j4za1         144 ELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT  208 (263)
T ss_dssp             CEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence            5799999999754322    2234578999999999988888999999999999999999999976544

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.1e-16  Score=88.54  Aligned_cols=70  Identities=37%  Similarity=0.524  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++..............+|++.|++||++....+ +.++|+||+|++++++++|++||.....
T Consensus       141 ~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence            579999999986532222222334678999999999887775 4678999999999999999999865543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.4e-16  Score=88.89  Aligned_cols=67  Identities=27%  Similarity=0.502  Sum_probs=54.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ++|++|||+++.+....  ......+|++.|++||++....++.++|+||+|++++++++|++||....
T Consensus       154 ~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         154 SVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence            57999999998764322  12334578999999999988888999999999999999999999976544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=9.9e-17  Score=88.82  Aligned_cols=71  Identities=31%  Similarity=0.460  Sum_probs=49.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~   72 (92)
                      .+|++|||+++...............|++.|++||++..   ..++.++|+||+|++++|+++|+.||......
T Consensus       142 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~  215 (276)
T d1uwha_         142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR  215 (276)
T ss_dssp             SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence            579999999876543222222334578889999999853   34778899999999999999999998765543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=3.9e-17  Score=90.17  Aligned_cols=68  Identities=34%  Similarity=0.497  Sum_probs=50.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......  .......|++.|++||++....++.++|+||+|++++++++|++||.....
T Consensus       152 ~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~  219 (269)
T d2java1         152 NVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ  219 (269)
T ss_dssp             CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence            57999999998654321  112346789999999999888899999999999999999999999865543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.62  E-value=3.1e-16  Score=88.23  Aligned_cols=64  Identities=34%  Similarity=0.488  Sum_probs=53.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....     ....+|++.|++||++....++.++|+||+|++++++++|+.||....
T Consensus       142 ~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         142 HIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             CEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence            5799999999875432     233678999999999988889999999999999999999999976544

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.62  E-value=1.5e-16  Score=89.26  Aligned_cols=66  Identities=27%  Similarity=0.370  Sum_probs=43.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....   ......+|++.|++||++....++.++|+||+|++++++++|++||....
T Consensus       148 ~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  213 (307)
T d1a06a_         148 KIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN  213 (307)
T ss_dssp             CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence            4799999999765322   11234578999999999988889999999999999999999999976543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.61  E-value=2.5e-16  Score=89.70  Aligned_cols=64  Identities=25%  Similarity=0.371  Sum_probs=53.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+||+|||+++.....     .....|++.|++||++....++.++|+||+|++++++++|++||....
T Consensus       179 ~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  242 (350)
T d1rdqe_         179 YIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             CEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC
Confidence            5799999999876432     223578899999999988889999999999999999999999976543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.3e-16  Score=89.95  Aligned_cols=66  Identities=30%  Similarity=0.508  Sum_probs=53.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++....    ......+|++.|++||++....|+.+.|+||+||+++++++|+.||...+.
T Consensus       143 ~vkl~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         143 EIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             CEEECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             CEEEeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            579999999875421    123346899999999999988899999999999999999999999866543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=9.8e-17  Score=90.53  Aligned_cols=72  Identities=39%  Similarity=0.463  Sum_probs=55.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++...............+++.|++||.+....++.++|+||+|++++|+++ |++||.......
T Consensus       202 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            579999999986543222222233567888999999988889999999999999999997 899987665443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.59  E-value=1.3e-15  Score=87.04  Aligned_cols=70  Identities=31%  Similarity=0.540  Sum_probs=55.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++.....    ......|++.|++||++.. ..++.++|+||+||+++++++|++||......+..
T Consensus       145 ~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~  215 (364)
T d1omwa3         145 HVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  215 (364)
T ss_dssp             CEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred             cEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            5799999999865432    1233578999999999864 45888999999999999999999998766554443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=2.2e-15  Score=83.19  Aligned_cols=64  Identities=33%  Similarity=0.511  Sum_probs=51.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.....    ......|++.|++||++.. .++.++|+||+|++++++++|+.||....
T Consensus       153 ~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~  216 (270)
T d1t4ha_         153 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ  216 (270)
T ss_dssp             CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred             CEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence            5799999999753221    1234678999999998864 58899999999999999999999986544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.59  E-value=6.6e-16  Score=87.94  Aligned_cols=66  Identities=27%  Similarity=0.396  Sum_probs=54.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++.+....   ......|++.|++||++....++.+.|+||+|++++++++|+.||....
T Consensus       164 ~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  229 (350)
T d1koaa2         164 ELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  229 (350)
T ss_dssp             CEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence            47999999998764322   2334678999999999988888999999999999999999999976544

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.58  E-value=9.8e-16  Score=87.28  Aligned_cols=67  Identities=27%  Similarity=0.352  Sum_probs=54.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......+++.|++||++....++.++|+||+|++++++++|++||.....
T Consensus       167 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~  233 (352)
T d1koba_         167 SVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD  233 (352)
T ss_dssp             CEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred             eEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence            47999999998764322   23335788899999999888899999999999999999999999765543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.57  E-value=4.2e-15  Score=82.74  Aligned_cols=77  Identities=14%  Similarity=0.200  Sum_probs=59.1

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .+|++|||+++........     .......||+.|++||.+....++.+.|+||+|++++++++|+.||..........
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~  223 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  223 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence            4799999999875432111     11233578999999999988889999999999999999999999998766655443


Q ss_pred             HH
Q 034502           77 LI   78 (92)
Q Consensus        77 ~~   78 (92)
                      ..
T Consensus       224 ~~  225 (293)
T d1csna_         224 KY  225 (293)
T ss_dssp             HH
T ss_pred             HH
Confidence            33

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=5.9e-16  Score=87.04  Aligned_cols=72  Identities=29%  Similarity=0.432  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      ++|++|||+++...............|+..|++||.+....++.++|+||+|++++|+++ |++||.......
T Consensus       149 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~  221 (317)
T d1xkka_         149 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE  221 (317)
T ss_dssp             EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred             CeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence            579999999986543222222223457889999999888889999999999999999998 788977655443

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.1e-15  Score=85.17  Aligned_cols=70  Identities=36%  Similarity=0.380  Sum_probs=48.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhC-CCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISG-KKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g-~~~~~~~~~   71 (92)
                      .+||+|||+++...............|++.|++||.+....++.++|+||+|+++++++++ ++||.....
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            5799999999865433222223345788899999999888899999999999999999986 567765543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1.1e-15  Score=85.06  Aligned_cols=70  Identities=29%  Similarity=0.404  Sum_probs=52.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc-----CCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS-----DGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||+++.....  ........|++.|++||++.     ...++.++|+||+|++++++++|++||......+
T Consensus       148 ~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~  222 (288)
T d2jfla1         148 DIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR  222 (288)
T ss_dssp             CEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred             CEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence            5799999998764321  11123467899999999874     3446788999999999999999999986655433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1.8e-15  Score=85.26  Aligned_cols=67  Identities=33%  Similarity=0.482  Sum_probs=54.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......  .......|++.|++||++....++.++|+||+||+++++++|+.||....
T Consensus       141 ~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         141 HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence            57999999998654322  22333578899999999998889999999999999999999999976543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.6e-15  Score=85.86  Aligned_cols=66  Identities=24%  Similarity=0.362  Sum_probs=54.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......|++.|++||++....|+.++|+||+|++++++++|++||....
T Consensus       152 ~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         152 ILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             CEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             cccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            47999999998654322   2234578999999999988789999999999999999999999986544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=3.3e-15  Score=83.37  Aligned_cols=70  Identities=26%  Similarity=0.338  Sum_probs=55.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++....   ........|++.|++||++....++.+.|+||+|++++++++|++||......+.
T Consensus       154 ~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  223 (305)
T d1blxa_         154 QIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  223 (305)
T ss_dssp             CEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             Ceeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence            468999999875422   1223346789999999999888899999999999999999999999866554333

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.1e-15  Score=84.89  Aligned_cols=71  Identities=35%  Similarity=0.501  Sum_probs=54.3

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++........ .......+++.|++||.+....++.++|+||+|++++|+++ |++||......
T Consensus       147 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~  219 (285)
T d1u59a_         147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP  219 (285)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred             ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            5799999999876432211 11223456778999999887788999999999999999997 89998765543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.3e-15  Score=83.16  Aligned_cols=66  Identities=26%  Similarity=0.384  Sum_probs=53.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++......   ......+++.|++||++....++.+.|+||+|++++++++|+.||....
T Consensus       155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  220 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  220 (293)
T ss_dssp             CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence            47999999998754321   1233567889999999988888999999999999999999999976544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.6e-15  Score=83.12  Aligned_cols=75  Identities=27%  Similarity=0.345  Sum_probs=55.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||+++......  ......++++.|++||.+... .++.+.|+||+|++++++++|++||......+.+..+
T Consensus       138 ~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i  213 (299)
T d1ua2a_         138 VLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI  213 (299)
T ss_dssp             CEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH
Confidence            57999999997543321  112235788999999988654 4788999999999999999999997665544443333

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=1.1e-14  Score=81.19  Aligned_cols=75  Identities=21%  Similarity=0.217  Sum_probs=55.1

Q ss_pred             ceEEeeeeceeeeCCCccc-----ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 034502            2 NPKISDFGLARAFGGDEIE-----GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLN   76 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~   76 (92)
                      .++++|||+++........     .......|++.|++||......++.+.|+||+|++++++++|+.||..........
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~  223 (299)
T d1ckia_         144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  223 (299)
T ss_dssp             CEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred             eeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence            4789999999876432111     11233578999999999988888999999999999999999999987766554433

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.53  E-value=1.8e-15  Score=84.49  Aligned_cols=71  Identities=31%  Similarity=0.417  Sum_probs=44.5

Q ss_pred             ceEEeeeeceeeeCCCcccc---cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEG---NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      ++||+|||+++.........   ......+++.|++||.+....++.+.|+||+|++++|+++ |++||......
T Consensus       166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~  240 (299)
T d1jpaa_         166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ  240 (299)
T ss_dssp             CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence            58999999998654321111   1111345778999999988888999999999999999997 89997665543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=3.9e-15  Score=81.81  Aligned_cols=67  Identities=34%  Similarity=0.456  Sum_probs=42.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~   69 (92)
                      .+||+|||+++....... .......|+..|++||.+....++.+.|+||+|++++|+++ |++|+...
T Consensus       139 ~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~  206 (263)
T d1sm2a_         139 VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  206 (263)
T ss_dssp             CEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred             CeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence            579999999986543211 11223467788999999988889999999999999999998 56665443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=5.9e-15  Score=82.77  Aligned_cols=63  Identities=33%  Similarity=0.440  Sum_probs=50.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC---CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD---GKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      .+|++|||+++....      .....|++.|++||++..   ..|+.++|+||+|++++++++|+.||....
T Consensus       153 ~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         153 LVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             EEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            479999999975422      223578999999998853   347888999999999999999999976544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=3.5e-15  Score=82.35  Aligned_cols=72  Identities=28%  Similarity=0.376  Sum_probs=45.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++...... ........+++.|++||.+....++.++|+||+|++++|+++ |.+||......+.
T Consensus       146 ~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~  218 (273)
T d1mp8a_         146 CVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV  218 (273)
T ss_dssp             EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             cEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence            47999999998654322 112233466788999999988888999999999999999987 8999776655443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=2.2e-15  Score=83.42  Aligned_cols=70  Identities=40%  Similarity=0.488  Sum_probs=52.3

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++........ .......|++.|++||.+....++.++|+||+|++++|+++ |++||.....
T Consensus       145 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~  216 (277)
T d1xbba_         145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG  216 (277)
T ss_dssp             EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred             cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence            4689999999865432211 11223467788999999988888899999999999999997 8999876543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.49  E-value=4.3e-15  Score=82.98  Aligned_cols=69  Identities=26%  Similarity=0.338  Sum_probs=50.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK-KNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~-~~~~~~~   70 (92)
                      .+||+|||+++...............++..|++||.+....++.+.|+||+|++++|++++. +||....
T Consensus       178 ~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            57999999987553322222233356777899999998888999999999999999999885 5655544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=1.6e-14  Score=79.71  Aligned_cols=65  Identities=40%  Similarity=0.547  Sum_probs=49.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK-KNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~-~~~~   67 (92)
                      .+||+|||+++....... .......++..|++||.+....++.++|+||+|++++|+++|. +|+.
T Consensus       147 ~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~  212 (272)
T d1qpca_         147 SCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP  212 (272)
T ss_dssp             CEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            579999999987643221 1122345778899999988778889999999999999999855 4543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.1e-14  Score=79.94  Aligned_cols=71  Identities=35%  Similarity=0.474  Sum_probs=54.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||+++........ ......++..|++||.+....++.+.|+||+|++++|+++ |+.||......+
T Consensus       138 ~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         138 VVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             CEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             cEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            5799999999765432211 2223457778999999988888999999999999999997 788977665433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=2.8e-14  Score=79.06  Aligned_cols=64  Identities=36%  Similarity=0.465  Sum_probs=42.5

Q ss_pred             ceEEeeeeceeeeCCCccc-ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE-GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .+||+|||+++........ .......|+..|++||.+....++.++|+||+|++++|++++..|
T Consensus       148 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         148 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence            5799999999865322111 111223567789999999888899999999999999999986544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=2.5e-14  Score=78.92  Aligned_cols=63  Identities=25%  Similarity=0.410  Sum_probs=49.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKF-SVKSDVFSFGILLLEIISGKKNRGF   68 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~ws~g~~~~~~~~g~~~~~~   68 (92)
                      .+|++|||+++.....    ......|++.|++||++....+ +.+.|+||+|++++++++|+.||..
T Consensus       149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence            4789999999764322    1233578999999999876554 4668999999999999999999754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.42  E-value=6.6e-14  Score=77.27  Aligned_cols=69  Identities=35%  Similarity=0.524  Sum_probs=46.5

Q ss_pred             ceEEeeeeceeeeCCCc-ccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDE-IEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~   70 (92)
                      ..+++|||.++...... .........|++.|++||++....++.++|+||+|++++++++|++||....
T Consensus       149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  218 (277)
T d1o6ya_         149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS  218 (277)
T ss_dssp             CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence            35788999876543221 1112334578999999999988888999999999999999999999986544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.7e-14  Score=79.68  Aligned_cols=71  Identities=28%  Similarity=0.383  Sum_probs=51.1

Q ss_pred             ceEEeeeeceeeeCCCcccc-cccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEG-NTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++......... ......++..|++||.+....++.+.|+||+|++++|+++ |++||......
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~  221 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS  221 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence            47999999998764332211 1222456678999999988788888999999999999997 89997655433

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=6.2e-14  Score=78.93  Aligned_cols=67  Identities=27%  Similarity=0.355  Sum_probs=53.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......+++.|++||......++.++|+||+|++++++++|++||.....
T Consensus       142 ~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~  208 (321)
T d1tkia_         142 TIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN  208 (321)
T ss_dssp             CEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             EEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence            57899999998654321   12335678889999998888889999999999999999999999766543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.41  E-value=6.3e-14  Score=77.82  Aligned_cols=63  Identities=38%  Similarity=0.539  Sum_probs=48.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      .+||+|||+++....... .......++..|++||.+....++.+.|+||+|+++++++++..|
T Consensus       153 ~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p  215 (287)
T d1opja_         153 LVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS  215 (287)
T ss_dssp             CEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCC
Confidence            579999999986543221 112223467789999998888899999999999999999986655

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=2.2e-14  Score=80.37  Aligned_cols=69  Identities=30%  Similarity=0.437  Sum_probs=52.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK-KNRGFYH   70 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~-~~~~~~~   70 (92)
                      ++||+|||+++...............+++.|++||.+....++.+.|+||+|++++|+++|. +|+....
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            57999999997553322222233346788899999988888888999999999999999884 6765544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=2e-13  Score=76.47  Aligned_cols=76  Identities=24%  Similarity=0.302  Sum_probs=54.2

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNL   77 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~   77 (92)
                      .+|++|||+++........  ......+|++.|++||.+... .++.+.|+||+|++++++++|++||...+.......
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  233 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL  233 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence            4799999999765422111  112224688899999998654 578899999999999999999999866554333333

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=2.6e-13  Score=77.06  Aligned_cols=71  Identities=27%  Similarity=0.290  Sum_probs=54.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcchh
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNKL   75 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~   75 (92)
                      .+|++|||+++.......   .....|+..|.+||.+.. ..++.+.|+||+|++++++++|++||......+.+
T Consensus       161 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l  232 (350)
T d1q5ka_         161 VLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL  232 (350)
T ss_dssp             CEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             ceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence            478999999986543221   223567889999998764 45789999999999999999999998766544433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=1.4e-13  Score=76.44  Aligned_cols=63  Identities=40%  Similarity=0.569  Sum_probs=43.7

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKN   65 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~   65 (92)
                      ++||+|||+++....... .......+++.|++||.+....++.+.|+||+|++++++++|..|
T Consensus       151 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p  213 (285)
T d1fmka3         151 VCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV  213 (285)
T ss_dssp             CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence            579999999976532211 112234577889999999888889999999999999999986544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=5e-13  Score=75.21  Aligned_cols=76  Identities=29%  Similarity=0.490  Sum_probs=54.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK--FSVKSDVFSFGILLLEIISGKKNRGFYHSDNKLNLI   78 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~~~~~   78 (92)
                      .+|++|||+++.+..... .......+++.|++||.+....  ++.+.|+||+||+++++++|+.||......+....+
T Consensus       167 ~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i  244 (322)
T d1vzoa_         167 HVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  244 (322)
T ss_dssp             CEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             CEEEeeccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            478999999986543221 1233356788899999886543  567899999999999999999998666555443333

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=6.6e-14  Score=78.07  Aligned_cols=70  Identities=36%  Similarity=0.401  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~   71 (92)
                      .+|++|||+++...............+++.|++||.+....++.+.|+||+|++++++++ |.+||.....
T Consensus       173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~  243 (299)
T d1fgka_         173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  243 (299)
T ss_dssp             CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence            468999999876543222222333567778999999988889999999999999999997 6888665443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=2.7e-13  Score=75.46  Aligned_cols=68  Identities=31%  Similarity=0.406  Sum_probs=52.1

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||.++......  .......+++.|++||...... ++.++|+||+|++++++++|+.||...+.
T Consensus       140 ~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~  208 (298)
T d1gz8a_         140 AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE  208 (298)
T ss_dssp             CEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence            46899999997654322  1233357888999999876655 46789999999999999999999865543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=1.5e-13  Score=77.01  Aligned_cols=72  Identities=33%  Similarity=0.418  Sum_probs=54.3

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~~   73 (92)
                      .+|++|||.++...............+++.|++||.+....++.++|+||+|++++++++ |++++......+
T Consensus       183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            468999999986543222223334577888999999988888999999999999999998 677766655443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.37  E-value=3.1e-13  Score=74.71  Aligned_cols=67  Identities=25%  Similarity=0.469  Sum_probs=51.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCcccc------CCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYAS------DGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~------~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++.+....   ......|+..|.+||.+.      ...++.+.|+|++|++++++++|+.||.....
T Consensus       148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            47999999998764321   123356888899999774      23467789999999999999999999876553

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=6.8e-13  Score=75.18  Aligned_cols=73  Identities=30%  Similarity=0.381  Sum_probs=53.4

Q ss_pred             ceEEeeeeceeeeCCCcc-cccccccccCCCccCCccccC-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEI-EGNTNRVIGTYGYMAPEYASD-GKFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++....... .......+|++.|++||.+.. ..++.+.|+||+|++++++++|++||......+.
T Consensus       147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~  221 (345)
T d1pmea_         147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  221 (345)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH
Confidence            579999999976532211 112233568889999998754 4467889999999999999999999866554333

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=2.3e-13  Score=75.99  Aligned_cols=66  Identities=29%  Similarity=0.390  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCC------CCccchhHHHHHHHHHHHhCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGK------FSVKSDVFSFGILLLEIISGKKNRG   67 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~------~~~~~~~ws~g~~~~~~~~g~~~~~   67 (92)
                      .+|++|||+++........  .......|++.|++||.+....      ++.+.|+||+|++++|+++|.+|+.
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            5799999999866432211  1223457889999999876432      4467899999999999999987653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=4e-13  Score=73.76  Aligned_cols=66  Identities=39%  Similarity=0.497  Sum_probs=45.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIIS-GKKNRGFYHSD   72 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~-g~~~~~~~~~~   72 (92)
                      .+|++|||+++.....     .....++..|++||.+....++.+.|+||+|++++|+++ |++|+......
T Consensus       141 ~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         141 VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             CEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence            4789999998764322     122456778999999887788999999999999999997 68786554433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=1.5e-12  Score=73.69  Aligned_cols=68  Identities=29%  Similarity=0.391  Sum_probs=52.9

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDG-KFSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||+++.....     .....+++.|++||.+... .++.+.|+||+|++++++++|++||...+..+.
T Consensus       159 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~  227 (346)
T d1cm8a_         159 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  227 (346)
T ss_dssp             CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence            5789999999865332     2235678899999988654 467889999999999999999999876654443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=8e-13  Score=74.06  Aligned_cols=65  Identities=37%  Similarity=0.531  Sum_probs=48.9

Q ss_pred             ceEEeeeeceeeeCCCccc--ccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIE--GNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||+++........  .......++..|++||.+....++.+.|+||+|++++|+++|..|+
T Consensus       168 ~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~  234 (311)
T d1r0pa_         168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  234 (311)
T ss_dssp             CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence            5799999999865422111  1122245677899999988888899999999999999999976654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.31  E-value=7e-13  Score=73.34  Aligned_cols=70  Identities=33%  Similarity=0.436  Sum_probs=49.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcc
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDN   73 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~   73 (92)
                      .+|++|||.+........  ......+++.|.+||.+.... ++.+.|+||+|++++++++|+.||......+
T Consensus       138 ~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~  208 (286)
T d1ob3a_         138 ELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD  208 (286)
T ss_dssp             CEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             CEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence            478999999876543221  122346778899999886544 6788999999999999999999976554333

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.30  E-value=7.8e-13  Score=73.98  Aligned_cols=65  Identities=31%  Similarity=0.300  Sum_probs=47.6

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCC-CCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGK-KNRGFY   69 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~-~~~~~~   69 (92)
                      .+|++|||+++.....   .......++..|++||.+....++.++|+||+|++++++++|. +||...
T Consensus       165 ~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence            4789999998754221   1122345778899999998888899999999999999999865 565443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.21  E-value=7.6e-12  Score=70.94  Aligned_cols=64  Identities=25%  Similarity=0.311  Sum_probs=49.5

Q ss_pred             eEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            3 PKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         3 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      ++++|||.+.....     ......+++.|++||......++.++|+||+|++++++++|+.||.....
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            68899999875432     12335688899999998888889999999999999999999999865544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=7.2e-12  Score=71.15  Aligned_cols=67  Identities=28%  Similarity=0.256  Sum_probs=46.2

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGKFSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .++++|||+++.....   .......+++.|++||++....++.+.|+||+||+++++++|++||...+.
T Consensus       157 ~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~  223 (355)
T d2b1pa1         157 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_dssp             CEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceeeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence            4688999987754322   123345778899999999888889999999999999999999999765543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.16  E-value=4.7e-11  Score=67.03  Aligned_cols=67  Identities=22%  Similarity=0.335  Sum_probs=51.5

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHS   71 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~   71 (92)
                      .+|++|||+++......   ......+++.|.+||...... ++.+.|+|++|++++++++|+.||.....
T Consensus       168 ~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         168 KLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             EEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             eeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence            36899999998654321   123356788899999876544 68889999999999999999999755443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=6.6e-11  Score=65.31  Aligned_cols=63  Identities=29%  Similarity=0.411  Sum_probs=46.8

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCC
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNR   66 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~   66 (92)
                      .+|++|||.++.......  ......++..+.+||.+.... ++.+.|+||+|++++++++|+.||
T Consensus       139 ~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  202 (292)
T d1unla_         139 ELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence            468999999986543221  122234566788888876554 578899999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.04  E-value=6.3e-11  Score=66.90  Aligned_cols=68  Identities=26%  Similarity=0.368  Sum_probs=47.4

Q ss_pred             ceEEeeeeceeeeCCCcccccccccccCCCccCCccccCCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCcch
Q 034502            2 NPKISDFGLARAFGGDEIEGNTNRVIGTYGYMAPEYASDGK-FSVKSDVFSFGILLLEIISGKKNRGFYHSDNK   74 (92)
Q Consensus         2 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~ws~g~~~~~~~~g~~~~~~~~~~~~   74 (92)
                      .+|++|||.+.....     ......|+..|++||...... ++.+.|+||+|++++++++|++||.+.+....
T Consensus       159 ~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~  227 (348)
T d2gfsa1         159 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  227 (348)
T ss_dssp             CEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            468999998865321     122356777899999876554 56889999999999999999999876554333